<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">24880830</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>01</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>09</Month>
<Day>17</Day>
</DateCompleted>
<DateRevised>
<Year>2014</Year>
<Month>10</Month>
<Day>24</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1474-547X</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>384</Volume>
<Issue>9945</Issue>
<PubDate>
<Year>2014</Year>
<Month>Aug</Month>
<Day>30</Day>
</PubDate>
</JournalIssue>
<Title>Lancet</Title>
<ISOAbbreviation>Lancet</ISOAbbreviation>
</Journal>
<ArticleTitle>Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: a systematic analysis for the Global Burden of Disease Study 2013.</ArticleTitle>
<Pagination>
<MedlinePgn>766-81</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/S0140-6736(14)60460-8</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0140-6736(14)60460-8</ELocationID>
<Abstract>
<AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">In 2010, overweight and obesity were estimated to cause 3·4 million deaths, 3·9% of years of life lost, and 3·8% of disability-adjusted life-years (DALYs) worldwide. The rise in obesity has led to widespread calls for regular monitoring of changes in overweight and obesity prevalence in all populations. Comparable, up-to-date information about levels and trends is essential to quantify population health effects and to prompt decision makers to prioritise action. We estimate the global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">We systematically identified surveys, reports, and published studies (n=1769) that included data for height and weight, both through physical measurements and self-reports. We used mixed effects linear regression to correct for bias in self-reports. We obtained data for prevalence of obesity and overweight by age, sex, country, and year (n=19,244) with a spatiotemporal Gaussian process regression model to estimate prevalence with 95% uncertainty intervals (UIs).</AbstractText>
<AbstractText Label="FINDINGS" NlmCategory="RESULTS">Worldwide, the proportion of adults with a body-mass index (BMI) of 25 kg/m(2) or greater increased between 1980 and 2013 from 28·8% (95% UI 28·4-29·3) to 36·9% (36·3-37·4) in men, and from 29·8% (29·3-30·2) to 38·0% (37·5-38·5) in women. Prevalence has increased substantially in children and adolescents in developed countries; 23·8% (22·9-24·7) of boys and 22·6% (21·7-23·6) of girls were overweight or obese in 2013. The prevalence of overweight and obesity has also increased in children and adolescents in developing countries, from 8·1% (7·7-8·6) to 12·9% (12·3-13·5) in 2013 for boys and from 8·4% (8·1-8·8) to 13·4% (13·0-13·9) in girls. In adults, estimated prevalence of obesity exceeded 50% in men in Tonga and in women in Kuwait, Kiribati, Federated States of Micronesia, Libya, Qatar, Tonga, and Samoa. Since 2006, the increase in adult obesity in developed countries has slowed down.</AbstractText>
<AbstractText Label="INTERPRETATION" NlmCategory="CONCLUSIONS">Because of the established health risks and substantial increases in prevalence, obesity has become a major global health challenge. Not only is obesity increasing, but no national success stories have been reported in the past 33 years. Urgent global action and leadership is needed to help countries to more effectively intervene.</AbstractText>
<AbstractText Label="FUNDING" NlmCategory="BACKGROUND">Bill &amp; Melinda Gates Foundation.</AbstractText>
<CopyrightInformation>Copyright © 2014 Elsevier Ltd. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Ng</LastName>
<ForeName>Marie</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Institute for Health Metrics and Evaluation, Seattle, WA, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Fleming</LastName>
<ForeName>Tom</ForeName>
<Initials>T</Initials>
<AffiliationInfo>
<Affiliation>Institute for Health Metrics and Evaluation, Seattle, WA, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Robinson</LastName>
<ForeName>Margaret</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Institute for Health Metrics and Evaluation, Seattle, WA, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Thomson</LastName>
<ForeName>Blake</ForeName>
<Initials>B</Initials>
<AffiliationInfo>
<Affiliation>Institute for Health Metrics and Evaluation, Seattle, WA, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Graetz</LastName>
<ForeName>Nicholas</ForeName>
<Initials>N</Initials>
<AffiliationInfo>
<Affiliation>Institute for Health Metrics and Evaluation, Seattle, WA, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Margono</LastName>
<ForeName>Christopher</ForeName>
<Initials>C</Initials>
<AffiliationInfo>
<Affiliation>Institute for Health Metrics and Evaluation, Seattle, WA, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Mullany</LastName>
<ForeName>Erin C</ForeName>
<Initials>EC</Initials>
<AffiliationInfo>
<Affiliation>Institute for Health Metrics and Evaluation, Seattle, WA, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Biryukov</LastName>
<ForeName>Stan</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Institute for Health Metrics and Evaluation, Seattle, WA, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Abbafati</LastName>
<ForeName>Cristiana</ForeName>
<Initials>C</Initials>
<AffiliationInfo>
<Affiliation>"La Sapienza" University of Rome, Rome, Italy.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Abera</LastName>
<ForeName>Semaw Ferede</ForeName>
<Initials>SF</Initials>
<AffiliationInfo>
<Affiliation>School of Public Health, College of Health Sciences, Mekelle University, Mekelle, Ethiopia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Abraham</LastName>
<ForeName>Jerry P</ForeName>
<Initials>JP</Initials>
<AffiliationInfo>
<Affiliation>University of Texas School of Medicine, San Antonio, TX, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Abu-Rmeileh</LastName>
<ForeName>Niveen M E</ForeName>
<Initials>NM</Initials>
<AffiliationInfo>
<Affiliation>Institute of Community and Public Health, Birzeti University, Ramallah, West Bank, Occupied Palestinian Territory.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Achoki</LastName>
<ForeName>Tom</ForeName>
<Initials>T</Initials>
<AffiliationInfo>
<Affiliation>Institute for Health Metrics and Evaluation, Seattle, WA, USA; Ministry of Health, Gaborone, Botswana.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>AlBuhairan</LastName>
<ForeName>Fadia S</ForeName>
<Initials>FS</Initials>
<AffiliationInfo>
<Affiliation>King Abdulaziz Medical City, King Saud bin Abdulaziz University for Health Sciences and King Abdullah International Medical Research Center, Riyadh, Saudi Arabia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Alemu</LastName>
<ForeName>Zewdie A</ForeName>
<Initials>ZA</Initials>
<AffiliationInfo>
<Affiliation>Debre Markos University, Debre Markos, Ethiopia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Alfonso</LastName>
<ForeName>Rafael</ForeName>
<Initials>R</Initials>
<AffiliationInfo>
<Affiliation>University of Washington, Seattle, WA, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Ali</LastName>
<ForeName>Mohammed K</ForeName>
<Initials>MK</Initials>
<AffiliationInfo>
<Affiliation>Emory University, Atlanta, GA, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Ali</LastName>
<ForeName>Raghib</ForeName>
<Initials>R</Initials>
<AffiliationInfo>
<Affiliation>University of Oxford, Oxford, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Guzman</LastName>
<ForeName>Nelson Alvis</ForeName>
<Initials>NA</Initials>
<AffiliationInfo>
<Affiliation>Universidad de Cartagena, Cartagena de Indias, Colombia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Ammar</LastName>
<ForeName>Walid</ForeName>
<Initials>W</Initials>
<AffiliationInfo>
<Affiliation>Ministry of Public Health, Beirut, Lebanon.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Anwari</LastName>
<ForeName>Palwasha</ForeName>
<Initials>P</Initials>
<AffiliationInfo>
<Affiliation>UNFPA, Kabul, Afghanistan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Banerjee</LastName>
<ForeName>Amitava</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>University of Birmingham, Birmingham, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Barquera</LastName>
<ForeName>Simon</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>National Institute of Public Health, Cuernavaca, Morelos, Mexico.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Basu</LastName>
<ForeName>Sanjay</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Stanford University, Stanford, CA, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Bennett</LastName>
<ForeName>Derrick A</ForeName>
<Initials>DA</Initials>
<AffiliationInfo>
<Affiliation>University of Oxford, Oxford, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Bhutta</LastName>
<ForeName>Zulfiqar</ForeName>
<Initials>Z</Initials>
<AffiliationInfo>
<Affiliation>Aga Khan University Medical Center, Karachi, Pakistan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Blore</LastName>
<ForeName>Jed</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>University of Melbourne, Melbourne, VIC, Australia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Cabral</LastName>
<ForeName>Norberto</ForeName>
<Initials>N</Initials>
<AffiliationInfo>
<Affiliation>Universidad de Joinville-Univille, Joinville, Brazil.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Nonato</LastName>
<ForeName>Ismael Campos</ForeName>
<Initials>IC</Initials>
<AffiliationInfo>
<Affiliation>National Institute of Public Health, Cuernavaca, Morelos, Mexico.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Chang</LastName>
<ForeName>Jung-Chen</ForeName>
<Initials>JC</Initials>
<AffiliationInfo>
<Affiliation>National Taiwan University, Taipei, Taiwan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Chowdhury</LastName>
<ForeName>Rajiv</ForeName>
<Initials>R</Initials>
<AffiliationInfo>
<Affiliation>University of Cambridge, Cambridge, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Courville</LastName>
<ForeName>Karen J</ForeName>
<Initials>KJ</Initials>
<AffiliationInfo>
<Affiliation>Hospital Dr. Gustavo N. Collado, Chitre, Herrera, Panama.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Criqui</LastName>
<ForeName>Michael H</ForeName>
<Initials>MH</Initials>
<AffiliationInfo>
<Affiliation>University of California San Diego, San Diego, CA, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Cundiff</LastName>
<ForeName>David K</ForeName>
<Initials>DK</Initials>
<AffiliationInfo>
<Affiliation>Independent Researcher, Long Beach, CA, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Dabhadkar</LastName>
<ForeName>Kaustubh C</ForeName>
<Initials>KC</Initials>
<AffiliationInfo>
<Affiliation>Emory University, Atlanta, GA, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Dandona</LastName>
<ForeName>Lalit</ForeName>
<Initials>L</Initials>
<AffiliationInfo>
<Affiliation>Institute for Health Metrics and Evaluation, Seattle, WA, USA; Public Health Foundation of India, New Delhi, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Davis</LastName>
<ForeName>Adrian</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Public Health England, London, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Dayama</LastName>
<ForeName>Anand</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Emory University, Atlanta, GA, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Dharmaratne</LastName>
<ForeName>Samath D</ForeName>
<Initials>SD</Initials>
<AffiliationInfo>
<Affiliation>University of Peradeniya, Peradeniya, Sri Lanka.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Ding</LastName>
<ForeName>Eric L</ForeName>
<Initials>EL</Initials>
<AffiliationInfo>
<Affiliation>Harvard School of Public Health, Boston, MA USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Durrani</LastName>
<ForeName>Adnan M</ForeName>
<Initials>AM</Initials>
<AffiliationInfo>
<Affiliation>National Institutes of Health, Bethesda and Montgomery, MD, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Esteghamati</LastName>
<ForeName>Alireza</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Endocrinology and Metabolism Research Center, Tehran University of Medical Sciences, Tehran, Iran.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Farzadfar</LastName>
<ForeName>Farshad</ForeName>
<Initials>F</Initials>
<AffiliationInfo>
<Affiliation>Endocrinology and Metabolism Research Center, Tehran University of Medical Sciences, Tehran, Iran.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Fay</LastName>
<ForeName>Derek F J</ForeName>
<Initials>DF</Initials>
<AffiliationInfo>
<Affiliation>Public Health England, London, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Feigin</LastName>
<ForeName>Valery L</ForeName>
<Initials>VL</Initials>
<AffiliationInfo>
<Affiliation>National Institute for Stroke and Applied Neurosciences, AUT University, Auckland, New Zealand.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Flaxman</LastName>
<ForeName>Abraham</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Institute for Health Metrics and Evaluation, Seattle, WA, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Forouzanfar</LastName>
<ForeName>Mohammad H</ForeName>
<Initials>MH</Initials>
<AffiliationInfo>
<Affiliation>Institute for Health Metrics and Evaluation, Seattle, WA, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Goto</LastName>
<ForeName>Atsushi</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Department of Diabetes Research, National Center for Global Health and Medicine, Tokyo, Japan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Green</LastName>
<ForeName>Mark A</ForeName>
<Initials>MA</Initials>
<AffiliationInfo>
<Affiliation>University of Sheffield, Sheffield, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Gupta</LastName>
<ForeName>Rajeev</ForeName>
<Initials>R</Initials>
<AffiliationInfo>
<Affiliation>Fortis Escorts Hospital, Jaipur, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Hafezi-Nejad</LastName>
<ForeName>Nima</ForeName>
<Initials>N</Initials>
<AffiliationInfo>
<Affiliation>Endocrinology and Metabolism Research Center, Tehran University of Medical Sciences, Tehran, Iran.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Hankey</LastName>
<ForeName>Graeme J</ForeName>
<Initials>GJ</Initials>
<AffiliationInfo>
<Affiliation>School of Medicine and Pharmacology, University of Western Australia, Perth, WA, Australia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Harewood</LastName>
<ForeName>Heather C</ForeName>
<Initials>HC</Initials>
<AffiliationInfo>
<Affiliation>Eunice Gibson Polyclinic, Bridgetown, Barbados.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Havmoeller</LastName>
<ForeName>Rasmus</ForeName>
<Initials>R</Initials>
<AffiliationInfo>
<Affiliation>Karolinska Institute, Stockholm, Sweden.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Hay</LastName>
<ForeName>Simon</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>University of Oxford, Oxford, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Hernandez</LastName>
<ForeName>Lucia</ForeName>
<Initials>L</Initials>
<AffiliationInfo>
<Affiliation>National Institute of Public Health, Cuernavaca, Morelos, Mexico.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Husseini</LastName>
<ForeName>Abdullatif</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Birzeit University, Birzeit, Ramallah, Palestine.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Idrisov</LastName>
<ForeName>Bulat T</ForeName>
<Initials>BT</Initials>
<AffiliationInfo>
<Affiliation>Brandeis University, Waltham, MA, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Ikeda</LastName>
<ForeName>Nayu</ForeName>
<Initials>N</Initials>
<AffiliationInfo>
<Affiliation>National Institute of Health and Nutrition, Tokyo, Japan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Islami</LastName>
<ForeName>Farhad</ForeName>
<Initials>F</Initials>
<AffiliationInfo>
<Affiliation>American Cancer Society, Atlanta, GA, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Jahangir</LastName>
<ForeName>Eiman</ForeName>
<Initials>E</Initials>
<AffiliationInfo>
<Affiliation>Ochsner Medical Center, New Orleans, LA, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Jassal</LastName>
<ForeName>Simerjot K</ForeName>
<Initials>SK</Initials>
<AffiliationInfo>
<Affiliation>VA San Diego, University of California San Diego, San Diego, CA, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Jee</LastName>
<ForeName>Sun Ha</ForeName>
<Initials>SH</Initials>
<AffiliationInfo>
<Affiliation>Graduate School of Public Health, Yonsei University, Seoul, Korea.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Jeffreys</LastName>
<ForeName>Mona</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>University of Bristol, Bristol, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Jonas</LastName>
<ForeName>Jost B</ForeName>
<Initials>JB</Initials>
<AffiliationInfo>
<Affiliation>Department of Ophthalmology, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Kabagambe</LastName>
<ForeName>Edmond K</ForeName>
<Initials>EK</Initials>
<AffiliationInfo>
<Affiliation>Vanderbilt University, Nashville, TN, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Khalifa</LastName>
<ForeName>Shams Eldin Ali Hassan</ForeName>
<Initials>SE</Initials>
<AffiliationInfo>
<Affiliation>Supreme Council of Health, Doha, Qatar.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Kengne</LastName>
<ForeName>Andre Pascal</ForeName>
<Initials>AP</Initials>
<AffiliationInfo>
<Affiliation>South African Medical Research Council, Cape Town, South Africa.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Khader</LastName>
<ForeName>Yousef Saleh</ForeName>
<Initials>YS</Initials>
<AffiliationInfo>
<Affiliation>Jordan University of Science and Technology, AlRamtha, Jordan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Khang</LastName>
<ForeName>Young-Ho</ForeName>
<Initials>YH</Initials>
<AffiliationInfo>
<Affiliation>Institute of Health Policy and Management, Seoul National University College of Medicine, Seoul, Korea.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Kim</LastName>
<ForeName>Daniel</ForeName>
<Initials>D</Initials>
<AffiliationInfo>
<Affiliation>Northeastern University, Boston, MA, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Kimokoti</LastName>
<ForeName>Ruth W</ForeName>
<Initials>RW</Initials>
<AffiliationInfo>
<Affiliation>Simmons College, Boston, MA, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Kinge</LastName>
<ForeName>Jonas M</ForeName>
<Initials>JM</Initials>
<AffiliationInfo>
<Affiliation>The Norwegian Institute of Public Health, Oslo, Norway.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Kokubo</LastName>
<ForeName>Yoshihiro</ForeName>
<Initials>Y</Initials>
<AffiliationInfo>
<Affiliation>Department of Preventive Cardiology, Department of Preventive Medicine and Epidemiologic Informatics, National Cerebral and Cardiovascular Center, Osaka, Japan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Kosen</LastName>
<ForeName>Soewarta</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Center for Community Empowerment, Health Policy &amp; Informatics, NIHRD, Jakarta, Indonesia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Kwan</LastName>
<ForeName>Gene</ForeName>
<Initials>G</Initials>
<AffiliationInfo>
<Affiliation>Boston Medical Center, Boston, MA, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Lai</LastName>
<ForeName>Taavi</ForeName>
<Initials>T</Initials>
<AffiliationInfo>
<Affiliation>Fourth View Consulting, Tallinn, Estonia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Leinsalu</LastName>
<ForeName>Mall</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>The National Institute for Health Development, Tallinn, Estonia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Li</LastName>
<ForeName>Yichong</ForeName>
<Initials>Y</Initials>
<AffiliationInfo>
<Affiliation>National Center for Chronic and Non-communicable Disease Control and Prevention, Beijing, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Liang</LastName>
<ForeName>Xiaofeng</ForeName>
<Initials>X</Initials>
<AffiliationInfo>
<Affiliation>Chinese Center for Disease Control and Prevention, Beijing, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Liu</LastName>
<ForeName>Shiwei</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Chinese Center for Disease Control and Prevention, Beijing, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Logroscino</LastName>
<ForeName>Giancarlo</ForeName>
<Initials>G</Initials>
<AffiliationInfo>
<Affiliation>University of Bari, Bari, Italy.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Lotufo</LastName>
<ForeName>Paulo A</ForeName>
<Initials>PA</Initials>
<AffiliationInfo>
<Affiliation>University of São Paulo, São Paulo, Brazil.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Lu</LastName>
<ForeName>Yuan</ForeName>
<Initials>Y</Initials>
<AffiliationInfo>
<Affiliation>Harvard School of Public Health, Boston, MA USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Ma</LastName>
<ForeName>Jixiang</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>Chinese Center for Disease Control and Prevention, Beijing, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Mainoo</LastName>
<ForeName>Nana Kwaku</ForeName>
<Initials>NK</Initials>
<AffiliationInfo>
<Affiliation>Xpharmconsult, Kumasi, Ghana.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Mensah</LastName>
<ForeName>George A</ForeName>
<Initials>GA</Initials>
<AffiliationInfo>
<Affiliation>Center for Translation Research and Implementation Science (CTRIS), National Heart, Lung, and Blood Institute, Bethesda and Montgomery, MD, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Merriman</LastName>
<ForeName>Tony R</ForeName>
<Initials>TR</Initials>
<AffiliationInfo>
<Affiliation>University of Otago, Dunedin, New Zealand.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Mokdad</LastName>
<ForeName>Ali H</ForeName>
<Initials>AH</Initials>
<AffiliationInfo>
<Affiliation>Institute for Health Metrics and Evaluation, Seattle, WA, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Moschandreas</LastName>
<ForeName>Joanna</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>University of Crete, Crete, Greece.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Naghavi</LastName>
<ForeName>Mohsen</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Institute for Health Metrics and Evaluation, Seattle, WA, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Naheed</LastName>
<ForeName>Aliya</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>International Centre for Diarrhoeal Diseases Research, Dhaka, Bangladesh.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Nand</LastName>
<ForeName>Devina</ForeName>
<Initials>D</Initials>
<AffiliationInfo>
<Affiliation>Ministry of Health, Suva, Republic of Fiji.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Narayan</LastName>
<ForeName>K M Venkat</ForeName>
<Initials>KM</Initials>
<AffiliationInfo>
<Affiliation>Emory University, Atlanta, GA, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Nelson</LastName>
<ForeName>Erica Leigh</ForeName>
<Initials>EL</Initials>
<AffiliationInfo>
<Affiliation>Institute for Health Metrics and Evaluation, Seattle, WA, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Neuhouser</LastName>
<ForeName>Marian L</ForeName>
<Initials>ML</Initials>
<AffiliationInfo>
<Affiliation>Fred Hutchinson Cancer Research Center, Seattle, WA, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Nisar</LastName>
<ForeName>Muhammad Imran</ForeName>
<Initials>MI</Initials>
<AffiliationInfo>
<Affiliation>Aga Khan University Medical Center, Karachi, Pakistan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Ohkubo</LastName>
<ForeName>Takayoshi</ForeName>
<Initials>T</Initials>
<AffiliationInfo>
<Affiliation>Teikyo University School of Medicine, Tokyo, Japan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Oti</LastName>
<ForeName>Samuel O</ForeName>
<Initials>SO</Initials>
<AffiliationInfo>
<Affiliation>African Population and Health Research Center, Nairobi, Kenya.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Pedroza</LastName>
<ForeName>Andrea</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>National Institute of Public Health, Cuernavaca, Morelos, Mexico.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Prabhakaran</LastName>
<ForeName>Dorairaj</ForeName>
<Initials>D</Initials>
<AffiliationInfo>
<Affiliation>Centre for Chronic Disease Control, New Delhi, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Roy</LastName>
<ForeName>Nobhojit</ForeName>
<Initials>N</Initials>
<AffiliationInfo>
<Affiliation>BARC Hospital, Mumbai, Maharashtra, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Sampson</LastName>
<ForeName>Uchechukwu</ForeName>
<Initials>U</Initials>
<AffiliationInfo>
<Affiliation>Vanderbilt University, Nashville, TN, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Seo</LastName>
<ForeName>Hyeyoung</ForeName>
<Initials>H</Initials>
<AffiliationInfo>
<Affiliation>Department of Public Health, Graduate School, Seoul, Korea.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Sepanlou</LastName>
<ForeName>Sadaf G</ForeName>
<Initials>SG</Initials>
<AffiliationInfo>
<Affiliation>Digestive Diseases Research Institute, Tehran University of Medical Sciences, Tehran, Iran.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Shibuya</LastName>
<ForeName>Kenji</ForeName>
<Initials>K</Initials>
<AffiliationInfo>
<Affiliation>University of Tokyo, Tokyo, Japan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Shiri</LastName>
<ForeName>Rahman</ForeName>
<Initials>R</Initials>
<AffiliationInfo>
<Affiliation>Finnish institute of Occupational Health, Helsinki, Finland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Shiue</LastName>
<ForeName>Ivy</ForeName>
<Initials>I</Initials>
<AffiliationInfo>
<Affiliation>Heriot-Watt University, Edinburgh, Scotland, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Singh</LastName>
<ForeName>Gitanjali M</ForeName>
<Initials>GM</Initials>
<AffiliationInfo>
<Affiliation>Harvard School of Public Health, Boston, MA USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Singh</LastName>
<ForeName>Jasvinder A</ForeName>
<Initials>JA</Initials>
<AffiliationInfo>
<Affiliation>University of Alabama at Birmingham, Birmingham, AL, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Skirbekk</LastName>
<ForeName>Vegard</ForeName>
<Initials>V</Initials>
<AffiliationInfo>
<Affiliation>The Norwegian Institute of Public Health, Oslo, Norway.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Stapelberg</LastName>
<ForeName>Nicolas J C</ForeName>
<Initials>NJ</Initials>
<AffiliationInfo>
<Affiliation>Griffith University, Southport, QLD, Australia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Sturua</LastName>
<ForeName>Lela</ForeName>
<Initials>L</Initials>
<AffiliationInfo>
<Affiliation>National Center for Disease Control and Public Health, Tbilisi, Georgia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Sykes</LastName>
<ForeName>Bryan L</ForeName>
<Initials>BL</Initials>
<AffiliationInfo>
<Affiliation>University of California-Irvine, Irvine, CA USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Tobias</LastName>
<ForeName>Martin</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Institute for Health Metrics and Evaluation, Seattle, WA, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Tran</LastName>
<ForeName>Bach X</ForeName>
<Initials>BX</Initials>
<AffiliationInfo>
<Affiliation>Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Trasande</LastName>
<ForeName>Leonardo</ForeName>
<Initials>L</Initials>
<AffiliationInfo>
<Affiliation>NYU School of Medicine, New York, NY, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Toyoshima</LastName>
<ForeName>Hideaki</ForeName>
<Initials>H</Initials>
<AffiliationInfo>
<Affiliation>Health Care Center of Anjo Kosei Hospital, Anjo City, Japan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>van de Vijver</LastName>
<ForeName>Steven</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>African Population and Health Research Center, Nairobi, Kenya.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Vasankari</LastName>
<ForeName>Tommi J</ForeName>
<Initials>TJ</Initials>
<AffiliationInfo>
<Affiliation>UKK Institute for Health Promotion Research, Tampere, Finland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Veerman</LastName>
<ForeName>J Lennert</ForeName>
<Initials>JL</Initials>
<AffiliationInfo>
<Affiliation>University of Queensland, Brisbane, QLD, Australia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Velasquez-Melendez</LastName>
<ForeName>Gustavo</ForeName>
<Initials>G</Initials>
<AffiliationInfo>
<Affiliation>Universidade Federal de Minas Gerais, Escola de Enfermagem, Belo Horizonte, Minas Gerais, Brazil.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Vlassov</LastName>
<ForeName>Vasiliy Victorovich</ForeName>
<Initials>VV</Initials>
<AffiliationInfo>
<Affiliation>National Research University Higher School of Economics, Moscow, Russia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Vollset</LastName>
<ForeName>Stein Emil</ForeName>
<Initials>SE</Initials>
<AffiliationInfo>
<Affiliation>The Norwegian Institute of Public Health, Oslo, Norway; University of Bergen, Bergen, Norway.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Vos</LastName>
<ForeName>Theo</ForeName>
<Initials>T</Initials>
<AffiliationInfo>
<Affiliation>Institute for Health Metrics and Evaluation, Seattle, WA, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Wang</LastName>
<ForeName>Claire</ForeName>
<Initials>C</Initials>
<AffiliationInfo>
<Affiliation>Columbia University, New York, NY, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Wang</LastName>
<ForeName>XiaoRong</ForeName>
<Initials>X</Initials>
<AffiliationInfo>
<Affiliation>Shandong University affiliated Jinan Central Hospital, Jinan, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Weiderpass</LastName>
<ForeName>Elisabete</ForeName>
<Initials>E</Initials>
<AffiliationInfo>
<Affiliation>Department of Medical Epidemiology and Biostatistics, Stockholm, Sweden.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Werdecker</LastName>
<ForeName>Andrea</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Institute of Medical Sociology and Social Medicine, Marburg, Hessen, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Wright</LastName>
<ForeName>Jonathan L</ForeName>
<Initials>JL</Initials>
<AffiliationInfo>
<Affiliation>School of Medicine, Seattle, WA, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Yang</LastName>
<ForeName>Y Claire</ForeName>
<Initials>YC</Initials>
<AffiliationInfo>
<Affiliation>University of North Carolina, Chapel Hill, NC, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Yatsuya</LastName>
<ForeName>Hiroshi</ForeName>
<Initials>H</Initials>
<AffiliationInfo>
<Affiliation>Fujita Health University, Toyoake, Japan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Yoon</LastName>
<ForeName>Jihyun</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>Department of Preventive Medicine, Seoul, Korea.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Yoon</LastName>
<ForeName>Seok-Jun</ForeName>
<Initials>SJ</Initials>
<AffiliationInfo>
<Affiliation>Korea University, Seoul, Korea.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Zhao</LastName>
<ForeName>Yong</ForeName>
<Initials>Y</Initials>
<AffiliationInfo>
<Affiliation>Chongqing Medical University, Chongqing, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Zhou</LastName>
<ForeName>Maigeng</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>National Center for Chronic and Non-communicable Disease Control and Prevention, Beijing, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Zhu</LastName>
<ForeName>Shankuan</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Zhejiang University School of Public Health, Hangzhou, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Lopez</LastName>
<ForeName>Alan D</ForeName>
<Initials>AD</Initials>
<AffiliationInfo>
<Affiliation>University of Melbourne, Melbourne, VIC, Australia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Murray</LastName>
<ForeName>Christopher J L</ForeName>
<Initials>CJ</Initials>
<AffiliationInfo>
<Affiliation>Institute for Health Metrics and Evaluation, Seattle, WA, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Gakidou</LastName>
<ForeName>Emmanuela</ForeName>
<Initials>E</Initials>
<AffiliationInfo>
<Affiliation>Institute for Health Metrics and Evaluation, Seattle, WA, USA. Electronic address: gakidou@uw.edu.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>095066</GrantID>
<Agency>Wellcome Trust</Agency>
<Country>United Kingdom</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>05</Month>
<Day>29</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>England</Country>
<MedlineTA>Lancet</MedlineTA>
<NlmUniqueID>2985213R</NlmUniqueID>
<ISSNLinking>0140-6736</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList>
<CommentsCorrections RefType="CommentIn">
<RefSource>Nat Rev Endocrinol. 2014 Sep;10(9):513-4</RefSource>
<PMID Version="1">25048038</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="CommentIn">
<RefSource>Lancet. 2014 Aug 30;384(9945):728-30</RefSource>
<PMID Version="1">24880831</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="CommentIn">
<RefSource>Gesundheitswesen. 2014 Sep;76(8-9):464-5</RefSource>
<PMID Version="1">25208131</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="ErratumIn">
<RefSource>Lancet. 2014 Aug 30;384(9945):746</RefSource>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000293">Adolescent</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000328">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002648">Child</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D017281">Cost of Illness</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008962">Models, Theoretical</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009765">Obesity</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000453">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D050177">Overweight</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000453">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015995">Prevalence</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012044">Regression Analysis</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">24880831</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>01</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>09</Month>
<Day>17</Day>
</DateCompleted>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1474-547X</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>384</Volume>
<Issue>9945</Issue>
<PubDate>
<Year>2014</Year>
<Month>Aug</Month>
<Day>30</Day>
</PubDate>
</JournalIssue>
<Title>Lancet</Title>
<ISOAbbreviation>Lancet</ISOAbbreviation>
</Journal>
<ArticleTitle>Reducing the global prevalence of overweight and obesity.</ArticleTitle>
<Pagination>
<MedlinePgn>728-30</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/S0140-6736(14)60767-4</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0140-6736(14)60767-4</ELocationID>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>McPherson</LastName>
<ForeName>Klim</ForeName>
<Initials>K</Initials>
<AffiliationInfo>
<Affiliation>New College, University of Oxford, Oxford OX1 3BN, UK. Electronic address: klim.mcpherson@obs-gyn.ox.ac.uk.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016420">Comment</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>05</Month>
<Day>29</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>England</Country>
<MedlineTA>Lancet</MedlineTA>
<NlmUniqueID>2985213R</NlmUniqueID>
<ISSNLinking>0140-6736</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList>
<CommentsCorrections RefType="CommentOn">
<RefSource>Lancet. 2014 Aug 30;384(9945):766-81</RefSource>
<PMID Version="1">24880830</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D017281">Cost of Illness</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009765">Obesity</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000453">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D050177">Overweight</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000453">epidemiology</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25176531</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>01</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>09</Month>
<Day>17</Day>
</DateCompleted>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">1474-547X</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>384</Volume>
<Issue>9945</Issue>
<PubDate>
<Year>2014</Year>
<Month>Aug</Month>
<Day>30</Day>
</PubDate>
</JournalIssue>
<Title>Lancet</Title>
<ISOAbbreviation>Lancet</ISOAbbreviation>
</Journal>
<ArticleTitle>Obesity: a growing threat to health in China.</ArticleTitle>
<Pagination>
<MedlinePgn>716</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/S0140-6736(14)61421-5</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0140-6736(14)61421-5</ELocationID>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016421">Editorial</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>England</Country>
<MedlineTA>Lancet</MedlineTA>
<NlmUniqueID>2985213R</NlmUniqueID>
<ISSNLinking>0140-6736</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000328">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" Type="Geographic" UI="D002681">China</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000453">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009765">Obesity</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000453">epidemiology</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25176549</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>01</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>09</Month>
<Day>17</Day>
</DateCompleted>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">1474-547X</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>384</Volume>
<Issue>9945</Issue>
<PubDate>
<Year>2014</Year>
<Month>Aug</Month>
<Day>30</Day>
</PubDate>
</JournalIssue>
<Title>Lancet</Title>
<ISOAbbreviation>Lancet</ISOAbbreviation>
</Journal>
<ArticleTitle>Can China diminish its burden of non-communicable diseases and injuries by promoting health in its policies, practices, and incentives?</ArticleTitle>
<Pagination>
<MedlinePgn>783-92</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/S0140-6736(14)61214-9</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0140-6736(14)61214-9</ELocationID>
<Abstract>
<AbstractText>China has rapidly progressed through epidemiological and demographic transitions and is now confronting an increasing burden from non-communicable diseases and injuries. China could take advantage of what has been learnt about prevention and control of non-communicable diseases and injuries, which is well summarised in the WHO best buys (a set of affordable, feasible, and cost-effective intervention strategies in any resource setting), to improve individual and population health. Implementation of these strategies could allow China to exceed the incremental gains in decreasing non-communicable diseases and injury burdens of high-income countries, and greatly shorten the interval needed to achieve decreased morbidity and mortality in its population. With the lessons learnt from other countries and its own programmes and policies, China could provide a health model for the world. </AbstractText>
<CopyrightInformation>Copyright © 2014 Elsevier Ltd. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Huang</LastName>
<ForeName>Cheng</ForeName>
<Initials>C</Initials>
<AffiliationInfo>
<Affiliation>Department of Global Health, Milken Institute School of Public Health, George Washington University, Washington, DC, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Yu</LastName>
<ForeName>Hai</ForeName>
<Initials>H</Initials>
<AffiliationInfo>
<Affiliation>Center for Health Policy Studies, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Koplan</LastName>
<ForeName>Jeffrey P</ForeName>
<Initials>JP</Initials>
<AffiliationInfo>
<Affiliation>Emory Global Health Institute, Emory University, Atlanta, GA, USA. Electronic address: jkoplan@emory.edu.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>England</Country>
<MedlineTA>Lancet</MedlineTA>
<NlmUniqueID>2985213R</NlmUniqueID>
<ISSNLinking>0140-6736</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000293">Adolescent</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000328">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" Type="Geographic" UI="D002681">China</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D017281">Cost of Illness</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D004787">Environmental Pollution</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000191">economics</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D006293">Health Promotion</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008603">Mental Health</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000191">economics</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008875">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009765">Obesity</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000191">economics</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000453">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012907">Smoking</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000191">economics</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000517">prevention &amp; control</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D014947">Wounds and Injuries</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000191">economics</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D055815">Young Adult</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25184159</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>02</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>09</Month>
<Day>30</Day>
</DateCompleted>
<DateRevised>
<Year>2014</Year>
<Month>11</Month>
<Day>20</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">1365-2796</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>276</Volume>
<Issue>2</Issue>
<PubDate>
<Year>2014</Year>
<Month>Aug</Month>
</PubDate>
</JournalIssue>
<Title>Journal of internal medicine</Title>
<ISOAbbreviation>J. Intern. Med.</ISOAbbreviation>
</Journal>
<ArticleTitle>Comment on letter to the editor from F. Lapostolle:  ‘Worldwide relation between the number of McDonald’s  restaurants and the prevalence of obesity’.</ArticleTitle>
<Pagination>
<MedlinePgn>199-200</MedlinePgn>
</Pagination>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Smagghe</LastName>
<ForeName>D</ForeName>
<Initials>D</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016420">Comment</PublicationType>
<PublicationType UI="D016422">Letter</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>England</Country>
<MedlineTA>J Intern Med</MedlineTA>
<NlmUniqueID>8904841</NlmUniqueID>
<ISSNLinking>0954-6820</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList>
<CommentsCorrections RefType="CommentOn">
<RefSource>J Intern Med. 2013 Dec;274(6):610-1</RefSource>
<PMID Version="1">23961962</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D014943">Global Health</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000706">statistics &amp; numerical data</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009765">Obesity</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000453">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012147">Restaurants</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000706">statistics &amp; numerical data</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25028397</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>02</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>18</Day>
</DateCompleted>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1522-1555</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>307</Volume>
<Issue>5</Issue>
<PubDate>
<Year>2014</Year>
<Month>Sep</Month>
<Day>1</Day>
</PubDate>
</JournalIssue>
<Title>American journal of physiology. Endocrinology and metabolism</Title>
<ISOAbbreviation>Am. J. Physiol. Endocrinol. Metab.</ISOAbbreviation>
</Journal>
<ArticleTitle>Impaired mitochondrial function in human placenta with increased maternal adiposity.</ArticleTitle>
<Pagination>
<MedlinePgn>E419-25</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1152/ajpendo.00025.2014</ELocationID>
<Abstract>
<AbstractText>The placenta plays a key role in regulation of fetal growth and development and in mediating in utero developmental programming. Obesity, which is associated with chronic inflammation and mitochondrial dysfunction in many tissues, exerts a programming effect in pregnancy. We determined the effect of increasing maternal adiposity and of fetal sex on placental ATP generation, mitochondrial biogenesis, expression of electron transport chain subunits, and mitochondrial function in isolated trophoblasts. Placental tissue was collected from women with prepregnancy BMI ranging from 18.5 to 45 following C-section at term with no labor. Increasing maternal adiposity was associated with excessive production of reactive oxygen species and a significant reduction in placental ATP levels in placentae with male and female fetuses. To explore the potential mechanism of placental mitochondrial dysfunction, levels of transcription factors regulating the expression of genes involved in electron transport and mitochondrial biogenesis were measured. Our in vitro studies showed significant reduction in mitochondrial respiration in cultured primary trophoblasts with increasing maternal obesity along with an abnormal metabolic flexibility of these cells. This reduction in placental mitochondrial respiration in pregnancies complicated by maternal obesity could compromise placental function and potentially underlie the increased susceptibility of these pregnancies to fetal demise in late gestation and to developmental programming. </AbstractText>
<CopyrightInformation>Copyright © 2014 the American Physiological Society.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Mele</LastName>
<ForeName>James</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>Center for Pregnancy and Newborn Research, Department of Ob/Gyn, University of Texas Health Science Center San Antonio, San Antonio, Texas.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Muralimanoharan</LastName>
<ForeName>Sribalasubashini</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Center for Pregnancy and Newborn Research, Department of Ob/Gyn, University of Texas Health Science Center San Antonio, San Antonio, Texas.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Maloyan</LastName>
<ForeName>Alina</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Center for Pregnancy and Newborn Research, Department of Ob/Gyn, University of Texas Health Science Center San Antonio, San Antonio, Texas.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Myatt</LastName>
<ForeName>Leslie</ForeName>
<Initials>L</Initials>
<AffiliationInfo>
<Affiliation>Center for Pregnancy and Newborn Research, Department of Ob/Gyn, University of Texas Health Science Center San Antonio, San Antonio, Texas myattl@uthscsa.edu.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>HL-075297</GrantID>
<Acronym>HL</Acronym>
<Agency>NHLBI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>UL1RR025767</GrantID>
<Acronym>RR</Acronym>
<Agency>NCRR NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>07</Month>
<Day>15</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Am J Physiol Endocrinol Metab</MedlineTA>
<NlmUniqueID>100901226</NlmUniqueID>
<ISSNLinking>0193-1849</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D017382">Reactive Oxygen Species</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>8L70Q75FXE</RegistryNumber>
<NameOfSubstance UI="D000255">Adenosine Triphosphate</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000255">Adenosine Triphosphate</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D050154">Adiposity</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000502">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000328">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015992">Body Mass Index</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002478">Cells, Cultured</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002824">Chorionic Villi</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D004734">Energy Metabolism</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000502">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008928">Mitochondria</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000502">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009765">Obesity</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000378">metabolism</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000503">physiopathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D010920">Placenta</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000648">ultrastructure</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011247">Pregnancy</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011248">Pregnancy Complications</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000503">physiopathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D017382">Reactive Oxygen Species</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
</MeshHeadingList>
<OtherID Source="NLM">PMC4154072 [Available on 09/01/15]</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">mitochondria</Keyword>
<Keyword MajorTopicYN="N">obesity</Keyword>
<Keyword MajorTopicYN="N">placenta</Keyword>
</KeywordList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25053402</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>02</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>18</Day>
</DateCompleted>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1522-1555</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>307</Volume>
<Issue>5</Issue>
<PubDate>
<Year>2014</Year>
<Month>Sep</Month>
<Day>1</Day>
</PubDate>
</JournalIssue>
<Title>American journal of physiology. Endocrinology and metabolism</Title>
<ISOAbbreviation>Am. J. Physiol. Endocrinol. Metab.</ISOAbbreviation>
</Journal>
<ArticleTitle>Selective inhibition of sphingosine kinase-1 protects adipose tissue against LPS-induced inflammatory response in Zucker diabetic fatty rats.</ArticleTitle>
<Pagination>
<MedlinePgn>E437-46</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1152/ajpendo.00059.2014</ELocationID>
<Abstract>
<AbstractText>Obesity is associated with a state of chronic inflammation. The chemokine (C-C motif) ligand 5 (CCL5) has been proposed to modulate the inflammatory response in adipose tissue (AT). However, the mechanisms underlying CCL5 upregulation in AT remain undefined. The objective of the present study was to evaluate whether the enzyme sphingosine kinase-1 (SK1) would modulate the expression of CCL5 and other inflammatory biomarkers in primary adipocytes and its potential role in lipopolysaccharide (LPS)-induced AT inflammation in a rat model of diabetes. To address this, LPS-stimulated primary adipocytes and 3T3-L1 cells were treated with a SK inhibitor, and the expression of Ccl5 and other CC chemokines were studied. Moreover, the effect of SK1 knockdown on cytokine production was analyzed in 3T3-L1 cells by transfection of SK1-specific small-interfering RNA (siRNA). The anti-inflammatory effects of SK inhibitor in AT were also investigated in vivo using the Zucker lean normoglycemic control (ZLC) rats. LPS treatment stimulated Ccl5, IL-6, pentraxin 3 (Ptx3), and Tnfα mRNA expression in primary adipocytes and 3T3-L1 cells, whereas pharmacologically and siRNA-mediated SK1 inhibition strongly reduced mRNA levels of proinflammatory cytokines in these cells. Similarly, administration of SK inhibitor to ZLC rats prevented the LPS-induced inflammatory response in AT. Our data demonstrate a role for SK1 in endotoxin-induced cytokine expression in adipocytes and suggest that inhibition of SK1 may be a potential therapeutic tool in the prevention and treatment of chronic and common metabolic disorders, including obesity, insulin-resistance, and type 2 diabetes. </AbstractText>
<CopyrightInformation>Copyright © 2014 the American Physiological Society.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Tous</LastName>
<ForeName>Monica</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Cardiovascular Research Center, Centro Superior de Investigaciones Científicas-Instituto Catalan de Ciencias Cardiovasculares (CSIC-ICCC), IIB Sant Pau, Hospital de la Santa Creu i Sant Pau (Universitat Autonoma de Barcelona), Barcelona, Spain mtousm@yahoo.es.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Ferrer-Lorente</LastName>
<ForeName>Raquel</ForeName>
<Initials>R</Initials>
<AffiliationInfo>
<Affiliation>Cardiovascular Research Center, Centro Superior de Investigaciones Científicas-Instituto Catalan de Ciencias Cardiovasculares (CSIC-ICCC), IIB Sant Pau, Hospital de la Santa Creu i Sant Pau (Universitat Autonoma de Barcelona), Barcelona, Spain.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Badimon</LastName>
<ForeName>Lina</ForeName>
<Initials>L</Initials>
<AffiliationInfo>
<Affiliation>Cardiovascular Research Center, Centro Superior de Investigaciones Científicas-Instituto Catalan de Ciencias Cardiovasculares (CSIC-ICCC), IIB Sant Pau, Hospital de la Santa Creu i Sant Pau (Universitat Autonoma de Barcelona), Barcelona, Spain.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>07</Month>
<Day>22</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Am J Physiol Endocrinol Metab</MedlineTA>
<NlmUniqueID>100901226</NlmUniqueID>
<ISSNLinking>0193-1849</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D004791">Enzyme Inhibitors</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D008070">Lipopolysaccharides</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D034741">RNA, Small Interfering</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 2.7.1.-</RegistryNumber>
<NameOfSubstance UI="D017853">Phosphotransferases (Alcohol Group Acceptor)</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 2.7.1.-</RegistryNumber>
<NameOfSubstance UI="C022648">sphingosine kinase</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D041721">3T3-L1 Cells</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000273">Adipose Tissue</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000187">drug effects</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000818">Animals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002478">Cells, Cultured</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D019610">Cytoprotection</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000187">drug effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D003921">Diabetes Mellitus, Experimental</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000150">complications</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000378">metabolism</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D004791">Enzyme Inhibitors</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000494">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007249">Inflammation</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000517">prevention &amp; control</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008070">Lipopolysaccharides</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000494">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D051379">Mice</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009765">Obesity</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000150">complications</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000378">metabolism</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D017853">Phosphotransferases (Alcohol Group Acceptor)</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000037">antagonists &amp; inhibitors</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000235">genetics</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D034741">RNA, Small Interfering</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000494">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D051381">Rats</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011924">Rats, Zucker</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D013379">Substrate Specificity</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Zucker diabetic fatty rats</Keyword>
<Keyword MajorTopicYN="N">adipose tissue</Keyword>
<Keyword MajorTopicYN="N">chemokine (C-C motif) ligand 5</Keyword>
<Keyword MajorTopicYN="N">inflammation</Keyword>
<Keyword MajorTopicYN="N">lipopolysaccharide</Keyword>
<Keyword MajorTopicYN="N">sphingosine kinase-1</Keyword>
</KeywordList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25178568</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>02</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>10</Month>
<Day>24</Day>
</DateCompleted>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">1539-3704</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>161</Volume>
<Issue>5</Issue>
<PubDate>
<Year>2014</Year>
<Month>Sep</Month>
<Day>2</Day>
</PubDate>
</JournalIssue>
<Title>Annals of internal medicine</Title>
<ISOAbbreviation>Ann. Intern. Med.</ISOAbbreviation>
</Journal>
<ArticleTitle>Effects of low-carbohydrate and low-fat diets: a randomized trial.</ArticleTitle>
<Pagination>
<MedlinePgn>309-18</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.7326/M14-0180</ELocationID>
<Abstract>
<AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Low-carbohydrate diets are popular for weight loss, but their cardiovascular effects have not been well-studied, particularly in diverse populations.</AbstractText>
<AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To examine the effects of a low-carbohydrate diet compared with a low-fat diet on body weight and cardiovascular risk factors.</AbstractText>
<AbstractText Label="DESIGN" NlmCategory="METHODS">A randomized, parallel-group trial. (ClinicalTrials.gov: NCT00609271).</AbstractText>
<AbstractText Label="SETTING" NlmCategory="METHODS">A large academic medical center.</AbstractText>
<AbstractText Label="PARTICIPANTS" NlmCategory="METHODS">148 men and women without clinical cardiovascular disease and diabetes.</AbstractText>
<AbstractText Label="INTERVENTION" NlmCategory="METHODS">A low-carbohydrate (&lt;40 g/d) or low-fat (&lt;30% of daily energy intake from total fat [&lt;7% saturated fat]) diet. Both groups received dietary counseling at regular intervals throughout the trial.</AbstractText>
<AbstractText Label="MEASUREMENTS" NlmCategory="METHODS">Data on weight, cardiovascular risk factors, and dietary composition were collected at 0, 3, 6, and 12 months.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">Sixty participants (82%) in the low-fat group and 59 (79%) in the low-carbohydrate group completed the intervention. At 12 months, participants on the low-carbohydrate diet had greater decreases in weight (mean difference in change, -3.5 kg [95% CI, -5.6 to -1.4 kg]; P = 0.002), fat mass (mean difference in change, -1.5% [CI, -2.6% to -0.4%]; P = 0.011), ratio of total-high-density lipoprotein (HDL) cholesterol (mean difference in change, -0.44 [CI, -0.71 to -0.16]; P = 0.002), and triglyceride level (mean difference in change, -0.16 mmol/L [-14.1 mg/dL] [CI, -0.31 to -0.01 mmol/L {-27.4 to -0.8 mg/dL}]; P = 0.038) and greater increases in HDL cholesterol level (mean difference in change, 0.18 mmol/L [7.0 mg/dL] [CI, 0.08 to 0.28 mmol/L {3.0 to 11.0 mg/dL}]; P &lt; 0.001) than those on the low-fat diet.</AbstractText>
<AbstractText Label="LIMITATION" NlmCategory="CONCLUSIONS">Lack of clinical cardiovascular disease end points.</AbstractText>
<AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">The low-carbohydrate diet was more effective for weight loss and cardiovascular risk factor reduction than the low-fat diet. Restricting carbohydrate may be an option for persons seeking to lose weight and reduce cardiovascular risk factors.</AbstractText>
<AbstractText Label="PRIMARY FUNDING SOURCE" NlmCategory="BACKGROUND">National Institutes of Health.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Bazzano</LastName>
<ForeName>Lydia A</ForeName>
<Initials>LA</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Hu</LastName>
<ForeName>Tian</ForeName>
<Initials>T</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Reynolds</LastName>
<ForeName>Kristi</ForeName>
<Initials>K</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Yao</LastName>
<ForeName>Lu</ForeName>
<Initials>L</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Bunol</LastName>
<ForeName>Calynn</ForeName>
<Initials>C</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Liu</LastName>
<ForeName>Yanxi</ForeName>
<Initials>Y</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Chen</LastName>
<ForeName>Chung-Shiuan</ForeName>
<Initials>CS</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Klag</LastName>
<ForeName>Michael J</ForeName>
<Initials>MJ</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Whelton</LastName>
<ForeName>Paul K</ForeName>
<Initials>PK</Initials>
</Author>
<Author ValidYN="Y">
<LastName>He</LastName>
<ForeName>Jiang</ForeName>
<Initials>J</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<DataBankList CompleteYN="Y">
<DataBank>
<DataBankName>ClinicalTrials.gov</DataBankName>
<AccessionNumberList>
<AccessionNumber>NCT00609271</AccessionNumber>
</AccessionNumberList>
</DataBank>
</DataBankList>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>P20-RR017659</GrantID>
<Acronym>RR</Acronym>
<Agency>NCRR NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D003160">Comparative Study</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016449">Randomized Controlled Trial</PublicationType>
<PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Ann Intern Med</MedlineTA>
<NlmUniqueID>0372351</NlmUniqueID>
<ISSNLinking>0003-4819</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D001786">Blood Glucose</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D008076">Cholesterol, HDL</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D008078">Cholesterol, LDL</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D007328">Insulin</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D014280">Triglycerides</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>9007-41-4</RegistryNumber>
<NameOfSubstance UI="D002097">C-Reactive Protein</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>AYI8EX34EU</RegistryNumber>
<NameOfSubstance UI="D003404">Creatinine</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList>
<CommentsCorrections RefType="SummaryForPatientsIn">
<RefSource>Ann Intern Med. 2014 Sep 2;161(5). doi: 10.7326/P14-9029</RefSource>
<PMID Version="1">25178581</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000328">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000368">Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001786">Blood Glucose</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001794">Blood Pressure</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002097">C-Reactive Protein</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002318">Cardiovascular Diseases</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000517">prevention &amp; control</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008076">Cholesterol, HDL</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000097">blood</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008078">Cholesterol, LDL</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000097">blood</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D003404">Creatinine</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000097">blood</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D050528">Diet, Carbohydrate-Restricted</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D018752">Diet, Fat-Restricted</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007328">Insulin</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000097">blood</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008875">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009765">Obesity</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000178">diet therapy</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012307">Risk Factors</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D014280">Triglycerides</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000097">blood</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D055105">Waist Circumference</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D015431">Weight Loss</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D055815">Young Adult</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25178581</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>02</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>10</Month>
<Day>24</Day>
</DateCompleted>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">1539-3704</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>161</Volume>
<Issue>5</Issue>
<PubDate>
<Year>2014</Year>
<Month>Sep</Month>
<Day>2</Day>
</PubDate>
</JournalIssue>
<Title>Annals of internal medicine</Title>
<ISOAbbreviation>Ann. Intern. Med.</ISOAbbreviation>
</Journal>
<ArticleTitle>Summaries for patients. Comparing low-fat and low-carbohydrate diets.</ArticleTitle>
<ELocationID EIdType="doi" ValidYN="Y">10.7326/P14-9029</ELocationID>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D003160">Comparative Study</PublicationType>
<PublicationType UI="D029282">Patient Education Handout</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Ann Intern Med</MedlineTA>
<NlmUniqueID>0372351</NlmUniqueID>
<ISSNLinking>0003-4819</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D008055">Lipids</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList>
<CommentsCorrections RefType="OriginalReportIn">
<RefSource>Ann Intern Med. 2014 Sep 2;161(5):309-18</RefSource>
<PMID Version="1">25178568</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000328">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000368">Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002318">Cardiovascular Diseases</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000517">prevention &amp; control</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D050528">Diet, Carbohydrate-Restricted</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D018752">Diet, Fat-Restricted</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008055">Lipids</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000097">blood</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008875">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009765">Obesity</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000178">diet therapy</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012307">Risk Factors</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D055105">Waist Circumference</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D015431">Weight Loss</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D055815">Young Adult</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25178080</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>02</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>10</Month>
<Day>16</Day>
</DateCompleted>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0022-9040</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>54</Volume>
<Issue>6</Issue>
<PubDate>
<Year>2014</Year>
</PubDate>
</JournalIssue>
<Title>Kardiologiia</Title>
<ISOAbbreviation>Kardiologiia</ISOAbbreviation>
</Journal>
<ArticleTitle>[Populational characteristics of metabolic syndrome in open male population].</ArticleTitle>
<Pagination>
<MedlinePgn>58-61</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">to assess prevalence of various clusters of metabolic syndrome (MS) in open male population aged 25- 64 years.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">This cross sectional epidemiological study was conducted on a representative population sample formed from lists of male voters in one of administrative districts in Tumen. NCEP ATP III (2004) MS criteria were used in analysis.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">Prevalences of MS were different in various 20 year age intervals. Most frequent 3-component MS variant (5.6%) was combination of arterial hypertension, abdominal obesity, and hyperglycemia; combination of these factors with hypertriglyceridemia was most frequent 4-componet variant (1.5%).</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Akimova</LastName>
<ForeName>E V</ForeName>
<Initials>EV</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Kaiumov</LastName>
<ForeName>R Kh</ForeName>
<Initials>RKh</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Gakova</LastName>
<ForeName>E I</ForeName>
<Initials>EI</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Smaznov</LastName>
<ForeName>V Iu</ForeName>
<Initials>VIu</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Gafarov</LastName>
<ForeName>V V</ForeName>
<Initials>VV</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Kuznetsov</LastName>
<ForeName>V A</ForeName>
<Initials>VA</Initials>
</Author>
</AuthorList>
<Language>rus</Language>
<PublicationTypeList>
<PublicationType UI="D004740">English Abstract</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>Russia (Federation)</Country>
<MedlineTA>Kardiologiia</MedlineTA>
<NlmUniqueID>0376351</NlmUniqueID>
<ISSNLinking>0022-9040</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000328">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000367">Age Factors</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001795">Blood Pressure Determination</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D003430">Cross-Sectional Studies</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D050171">Dyslipidemias</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000097">blood</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000453">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006943">Hyperglycemia</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000097">blood</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000453">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D024821">Metabolic Syndrome X</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000097">blood</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000175">diagnosis</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000453">epidemiology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000503">physiopathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008875">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009765">Obesity</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000453">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015995">Prevalence</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012107">Research Design</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" Type="Geographic" UI="D012426">Russia</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000453">epidemiology</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25177812</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>02</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>10</Month>
<Day>16</Day>
</DateCompleted>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0022-9040</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>54</Volume>
<Issue>7</Issue>
<PubDate>
<Year>2014</Year>
</PubDate>
</JournalIssue>
<Title>Kardiologiia</Title>
<ISOAbbreviation>Kardiologiia</ISOAbbreviation>
</Journal>
<ArticleTitle>[Uric acid and factors of cardiometabolic risk in adolescents with arterial hypertension].</ArticleTitle>
<Pagination>
<MedlinePgn>36-42</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText Label="AIM" NlmCategory="OBJECTIVE">To elucidate links of blood serum uric acid level (SUAL) with cardiometabolic risk factors (CMR) in adolescent boys with arterial hypertension (AH).</AbstractText>
<AbstractText Label="MATERIAL AND METHODS" NlmCategory="METHODS">We examined 261 adolescent boys (mean age 15.8+/-1.3 years) with primary AH. Examination included 24-hour blood pressure (BP) monitoring, and measurement of office BP, BMI Z-score, levels of serum glucose, uric acid, total cholesterol (TC), high density lipoprotein cholesterol (HDL) and triglycerides (TG). Low density lipoprotein cholesterol (LDL) was calculated using Friedwald equation.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">SUAL was significantly and independently of patient age related to BMI Z-score (=0.0000001) and TG level (=0.01). There were no correlation between SUAL and glucose level. According to logistic regression analysis highest tertile of SUAL was regardless of age significantly associated with excess body mass and obesity (odds ratio [OR] 3.5 [95% confidence interval [CI] 1.9-6.7; =0.0001]), and dyslipidemia (OR 3.05, 95%CI 1.3-6.9; =0,007]). Significant relationship was also found between elevated SUAL and clasterization of 2-3 CMR (OR 3.2, CI 1.3-7.7; =0.01]).</AbstractText>
<AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Hyperuricemia in adolescent boys with AH is a marker of high cardiometabolic risk. This justifies screening for high SUA levels among boys with elevated BP with subsequent estimation of individual risk and timely initiation of preventive measures.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Pogodina</LastName>
<ForeName>A V</ForeName>
<Initials>AV</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Dolgikh</LastName>
<ForeName>V V</ForeName>
<Initials>VV</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Rychkova</LastName>
<ForeName>L V</ForeName>
<Initials>LV</Initials>
</Author>
</AuthorList>
<Language>rus</Language>
<PublicationTypeList>
<PublicationType UI="D004740">English Abstract</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>Russia (Federation)</Country>
<MedlineTA>Kardiologiia</MedlineTA>
<NlmUniqueID>0376351</NlmUniqueID>
<ISSNLinking>0022-9040</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D008055">Lipids</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>268B43MJ25</RegistryNumber>
<NameOfSubstance UI="D014527">Uric Acid</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>IY9XDZ35W2</RegistryNumber>
<NameOfSubstance UI="D005947">Glucose</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000293">Adolescent</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D018660">Blood Pressure Monitoring, Ambulatory</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015992">Body Mass Index</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005947">Glucose</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000032">analysis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D006331">Heart Diseases</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000453">epidemiology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000209">etiology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000517">prevention &amp; control</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D006973">Hypertension</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000097">blood</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000150">complications</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000175">diagnosis</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000453">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008055">Lipids</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000097">blood</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009765">Obesity</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000150">complications</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000453">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D016017">Odds Ratio</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011314">Preventive Health Services</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000458">organization &amp; administration</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D018570">Risk Assessment</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012307">Risk Factors</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D013223">Statistics as Topic</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D014527">Uric Acid</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000097">blood</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25023454</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>02</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>10</Month>
<Day>27</Day>
</DateCompleted>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1759-4804</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>10</Volume>
<Issue>9</Issue>
<PubDate>
<Year>2014</Year>
<Month>Sep</Month>
</PubDate>
</JournalIssue>
<Title>Nature reviews. Rheumatology</Title>
<ISOAbbreviation>Nat Rev Rheumatol</ISOAbbreviation>
</Journal>
<ArticleTitle>Osteoarthritis: Is OA a mechanical or systemic disease?</ArticleTitle>
<Pagination>
<MedlinePgn>515-6</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1038/nrrheum.2014.114</ELocationID>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Cicuttini</LastName>
<ForeName>Flavia M</ForeName>
<Initials>FM</Initials>
<AffiliationInfo>
<Affiliation>Department of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine, Monash University, Alfred Hospital, Melbourne, VIC 3004, Australia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Wluka</LastName>
<ForeName>Anita E</ForeName>
<Initials>AE</Initials>
<AffiliationInfo>
<Affiliation>Department of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine, Monash University, Alfred Hospital, Melbourne, VIC 3004, Australia.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>07</Month>
<Day>15</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Nat Rev Rheumatol</MedlineTA>
<NlmUniqueID>101500080</NlmUniqueID>
<ISSNLinking>1759-4790</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D016207">Cytokines</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001696">Biomechanical Phenomena</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D016207">Cytokines</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006225">Hand</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007249">Inflammation</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009765">Obesity</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000503">physiopathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D010003">Osteoarthritis</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000503">physiopathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D020370">Osteoarthritis, Knee</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25181784</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>03</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>09</Month>
<Day>30</Day>
</DateCompleted>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">1046-7041</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>25</Volume>
<Issue>3</Issue>
<PubDate>
<Year>2014</Year>
<Season>Summer</Season>
</PubDate>
</JournalIssue>
<Title>The ABNF journal : official journal of the Association of Black Nursing Faculty in Higher Education, Inc</Title>
<ISOAbbreviation>ABNF J</ISOAbbreviation>
</Journal>
<ArticleTitle>Pilot study of an action plan intervention for self-management in overweight/obese adults in a medically underserved minority population: phase I.</ArticleTitle>
<Pagination>
<MedlinePgn>64-71</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>This study was conducted to evaluate an action plan intervention for self-management in overweight/obese adults in a minority population. Study variables were patient activation, health self-efficacy, and health-related practice. A mixed QUAN (qual) quasi-experimental single group pre-test post-test study was conducted. Action plan intervention was implemented and evaluated in a random sample of 19 African American adults. Results showed that post intervention scores increased in health-related practice and health self-efficacy that were positively correlated. Action plan achievement was predicted by the pre-intervention activation score. Findings suggest that the roles of patient activation and self-efficacy are essential for success in self-management.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Onubogu</LastName>
<ForeName>Uloma</ForeName>
<Initials>U</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Graham</LastName>
<ForeName>Mary Ella</ForeName>
<Initials>ME</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Robinson</LastName>
<ForeName>Temple O</ForeName>
<Initials>TO</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>G12MD007582</GrantID>
<Acronym>MD</Acronym>
<Agency>NIMHD NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D017426">Clinical Trial, Phase I</PublicationType>
<PublicationType UI="D003160">Comparative Study</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016449">Randomized Controlled Trial</PublicationType>
<PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>ABNF J</MedlineTA>
<NlmUniqueID>9112807</NlmUniqueID>
<ISSNLinking>1046-7041</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>N</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000328">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001741">African Americans</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000523">psychology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001294">Attitude to Health</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000208">ethnology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" Type="Geographic" UI="D005431">Florida</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007722">Health Knowledge, Attitudes, Practice</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008507">Medically Underserved Area</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008875">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008913">Minority Groups</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009765">Obesity</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000178">diet therapy</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000208">ethnology</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000523">psychology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D010353">Patient Education as Topic</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D010865">Pilot Projects</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015397">Program Evaluation</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012648">Self Care</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000523">psychology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D020377">Self Efficacy</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" Type="Geographic" UI="D014481">United States</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25181906</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>03</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>09</Month>
<Day>26</Day>
</DateCompleted>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">1068-8838</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>88</Volume>
<Issue>7</Issue>
<PubDate>
<Year>2014</Year>
<Month>Jul</Month>
</PubDate>
</JournalIssue>
<Title>Hospitals &amp; health networks / AHA</Title>
<ISOAbbreviation>Hosp Health Netw</ISOAbbreviation>
</Journal>
<ArticleTitle>Hospitals ratchet up their obesity battle.</ArticleTitle>
<Pagination>
<MedlinePgn>55-6, 58, 60, 1</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>Critics say the efforts so far have been anemic and uncoordinated. That's changing as hospitals embrace new strategies and new partners--from schools to professional football teams.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Aston</LastName>
<ForeName>Geri</ForeName>
<Initials>G</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Hosp Health Netw</MedlineTA>
<NlmUniqueID>9312077</NlmUniqueID>
<ISSNLinking>1068-8838</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000328">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000368">Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000369">Aged, 80 and over</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002648">Child</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D003299">Cooperative Behavior</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005538">Football</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006266">Health Education</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000458">organization &amp; administration</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006293">Health Promotion</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000458">organization &amp; administration</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008875">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009765">Obesity</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000453">epidemiology</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000517">prevention &amp; control</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012574">Schools</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012952">Societies</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" Type="Geographic" UI="D014481">United States</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D055815">Young Adult</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25002559</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>03</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>10</Month>
<Day>27</Day>
</DateCompleted>
<DateRevised>
<Year>2014</Year>
<Month>11</Month>
<Day>09</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1488-2329</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>186</Volume>
<Issue>12</Issue>
<PubDate>
<Year>2014</Year>
<Month>Sep</Month>
<Day>2</Day>
</PubDate>
</JournalIssue>
<Title>CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne</Title>
<ISOAbbreviation>CMAJ</ISOAbbreviation>
</Journal>
<ArticleTitle>Body size and physical activity in relation to incidence of chronic obstructive pulmonary disease.</ArticleTitle>
<Pagination>
<MedlinePgn>E457-69</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1503/cmaj.140025</ELocationID>
<Abstract>
<AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Limited evidence suggests that adiposity and lack of physical activity may increase the risk of chronic obstructive pulmonary disease (COPD). We investigated the relation of body size and physical activity with incidence of COPD.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">We obtained data on anthropometric measurements and physical activity from 113,279 participants in the National Institutes of Health-AARP Diet and Health Study who reported no diagnosis of COPD at baseline (1995-1996). We estimated associations between these measurements and subsequent diagnosis of COPD between 1996 and 2006, with extensive adjustment for smoking and other potentially confounding variables.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">Participants reported 3648 new COPD diagnoses during follow-up. The incidence of COPD was higher in both severely obese (body mass index [BMI] ≥ 35) and underweight (BMI &lt; 18.5) participants, but after adjustment for waist circumference, only underweight remained positively associated with COPD (relative risk [RR] 1.56, 95% confidence interval [CI] 1.15-2.11). Larger waist circumference (highest v. normal categories, adjusted RR 1.72, 95% CI 1.37-2.16) and higher waist-hip ratio (highest v. normal categories, adjusted RR 1.46, 95% CI 1.23-1.73) were also positively associated with COPD. In contrast, hip circumference (highest v. normal categories, adjusted RR 0.78, 95% CI 0.62-0.98) and physical activity (≥ 5 v. 0 times/wk, adjusted RR 0.71, 95% CI 0.63-0.79) were inversely associated with COPD.</AbstractText>
<AbstractText Label="INTERPRETATION" NlmCategory="CONCLUSIONS">Obesity, in particular abdominal adiposity, was associated with an increased risk of COPD, and increased hip circumference and physical activity were associated with a decreased risk of COPD. These findings suggest that following guidelines for a healthy body weight, body shape and physical activity decrease the risk of COPD.</AbstractText>
<CopyrightInformation>© 2014 Canadian Medical Association or its licensors.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Behrens</LastName>
<ForeName>Gundula</ForeName>
<Initials>G</Initials>
<AffiliationInfo>
<Affiliation>Department of Epidemiology and Preventive Medicine (Behrens, Leitzmann), University of Regensburg, Regensburg, Germany; Division of Cancer Epidemiology and Genetics (Matthews, Moore), National Cancer Institute, National Institutes of Health, US Department of Health and Human Services, Bethesda, Md.; AARP (Hollenbeck), Washington, DC gundula.behrens@klinik.uni-regensburg.de.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Matthews</LastName>
<ForeName>Charles E</ForeName>
<Initials>CE</Initials>
<AffiliationInfo>
<Affiliation>Department of Epidemiology and Preventive Medicine (Behrens, Leitzmann), University of Regensburg, Regensburg, Germany; Division of Cancer Epidemiology and Genetics (Matthews, Moore), National Cancer Institute, National Institutes of Health, US Department of Health and Human Services, Bethesda, Md.; AARP (Hollenbeck), Washington, DC.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Moore</LastName>
<ForeName>Steven C</ForeName>
<Initials>SC</Initials>
<AffiliationInfo>
<Affiliation>Department of Epidemiology and Preventive Medicine (Behrens, Leitzmann), University of Regensburg, Regensburg, Germany; Division of Cancer Epidemiology and Genetics (Matthews, Moore), National Cancer Institute, National Institutes of Health, US Department of Health and Human Services, Bethesda, Md.; AARP (Hollenbeck), Washington, DC.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Hollenbeck</LastName>
<ForeName>Albert R</ForeName>
<Initials>AR</Initials>
<AffiliationInfo>
<Affiliation>Department of Epidemiology and Preventive Medicine (Behrens, Leitzmann), University of Regensburg, Regensburg, Germany; Division of Cancer Epidemiology and Genetics (Matthews, Moore), National Cancer Institute, National Institutes of Health, US Department of Health and Human Services, Bethesda, Md.; AARP (Hollenbeck), Washington, DC.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Leitzmann</LastName>
<ForeName>Michael F</ForeName>
<Initials>MF</Initials>
<AffiliationInfo>
<Affiliation>Department of Epidemiology and Preventive Medicine (Behrens, Leitzmann), University of Regensburg, Regensburg, Germany; Division of Cancer Epidemiology and Genetics (Matthews, Moore), National Cancer Institute, National Institutes of Health, US Department of Health and Human Services, Bethesda, Md.; AARP (Hollenbeck), Washington, DC.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D052060">Research Support, N.I.H., Intramural</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>07</Month>
<Day>07</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Canada</Country>
<MedlineTA>CMAJ</MedlineTA>
<NlmUniqueID>9711805</NlmUniqueID>
<ISSNLinking>0820-3946</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList>
<CommentsCorrections RefType="Cites">
<RefSource>Med Sci Sports Exerc. 1999 Nov;31(11 Suppl):S547-52</RefSource>
<PMID Version="1">10593526</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Thorax. 2014 Aug;69(8):731-9</RefSource>
<PMID Version="1">24558112</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Eur J Appl Physiol. 2001 Jan-Feb;84(1-2):1-6</RefSource>
<PMID Version="1">11394236</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Am J Epidemiol. 2001 Dec 15;154(12):1119-25</RefSource>
<PMID Version="1">11744517</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Chest. 2002 Feb;121(2):370-6</RefSource>
<PMID Version="1">11834645</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Am J Epidemiol. 2002 May 15;155(10):965-71</RefSource>
<PMID Version="1">11994237</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Soc Secur Bull. 2001-2002;64(1):45-51</RefSource>
<PMID Version="1">12428517</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Epidemiology. 1990 Nov;1(6):466-73</RefSource>
<PMID Version="1">2090285</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Am J Epidemiol. 1994 Dec 1;140(11):1016-9</RefSource>
<PMID Version="1">7985649</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>BMJ. 1995 Jul 15;311(6998):158-61</RefSource>
<PMID Version="1">7613427</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Br J Sports Med. 2005 May;39(5):294-7; discussion 294-7</RefSource>
<PMID Version="1">15849294</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Am Coll Cardiol. 2005 May 17;45(10):1563-9</RefSource>
<PMID Version="1">15893167</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Environ Health. 2005;4(1):7</RefSource>
<PMID Version="1">15890079</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Am J Clin Nutr. 2005 Nov;82(5):996-1003</RefSource>
<PMID Version="1">16280430</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Am J Respir Crit Care Med. 2006 May 1;173(9):985-90</RefSource>
<PMID Version="1">16439715</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Thorax. 2006 Nov;61(11):935-9</RefSource>
<PMID Version="1">17071833</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Obesity (Silver Spring). 2007 Jan;15(1):188-96</RefSource>
<PMID Version="1">17228047</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Am J Respir Crit Care Med. 2007 Mar 1;175(5):458-63</RefSource>
<PMID Version="1">17158282</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Int J Obes (Lond). 2008 Sep;32(9):1423-30</RefSource>
<PMID Version="1">18645577</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Thorax. 2008 Dec;63(12):1110-7</RefSource>
<PMID Version="1">19020276</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Thorax. 2009 Jan;64(1):6-12</RefSource>
<PMID Version="1">18678700</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Am J Clin Nutr. 2009 Feb;89(2):500-8</RefSource>
<PMID Version="1">19116329</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Eur Respir J. 2009 Feb;33(2):262-72</RefSource>
<PMID Version="1">19010994</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Int J Health Geogr. 2009;8:2</RefSource>
<PMID Version="1">19154599</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Scand J Prim Health Care. 2009;27(3):141-7</RefSource>
<PMID Version="1">19306158</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mol Cell Endocrinol. 2010 Apr 29;318(1-2):69-78</RefSource>
<PMID Version="1">19948207</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Clin Respir J. 2010 Jan;4(1):13-21</RefSource>
<PMID Version="1">20298413</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>CMAJ. 2010 Apr 20;182(7):673-8</RefSource>
<PMID Version="1">20371646</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Phys Act Health. 2010 Sep;7(5):622-6</RefSource>
<PMID Version="1">20864757</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Gerontol A Biol Sci Med Sci. 2011 Jul;66(7):801-8</RefSource>
<PMID Version="1">21498841</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>BMC Public Health. 2011;11:612</RefSource>
<PMID Version="1">21806798</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Endocrinology. 2011 Oct;152(10):3769-78</RefSource>
<PMID Version="1">21862623</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Appl Physiol (1985). 2012 Jan;112(1):118-26</RefSource>
<PMID Version="1">21940844</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Eur Respir J. 2012 Feb;39(2):254-64</RefSource>
<PMID Version="1">21700603</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Lancet. 2012 Apr 7;379(9823):1341-51</RefSource>
<PMID Version="1">22314182</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Am J Respir Crit Care Med. 2013 Jan 1;187(1):8-13</RefSource>
<PMID Version="1">23281350</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>BMC Public Health. 2013;13:16</RefSource>
<PMID Version="1">23302258</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>COPD. 2013 Oct;10(5):567-72</RefSource>
<PMID Version="1">23844907</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>World Health Organ Tech Rep Ser. 2000;894:i-xii, 1-253</RefSource>
<PMID Version="1">11234459</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000368">Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000369">Aged, 80 and over</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D015992">Body Mass Index</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005500">Follow-Up Studies</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006306">Health Surveys</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015994">Incidence</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008875">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D009043">Motor Activity</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015999">Multivariate Analysis</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009765">Obesity</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000150">complications</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D056128">Obesity, Abdominal</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000150">complications</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011446">Prospective Studies</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D029424">Pulmonary Disease, Chronic Obstructive</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000453">epidemiology</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000209">etiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012307">Risk Factors</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D013851">Thinness</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000150">complications</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" Type="Geographic" UI="D014481">United States</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000453">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D055105">Waist Circumference</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<OtherID Source="NLM">PMC4150732</OtherID>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25182399</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>03</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>10</Month>
<Day>09</Day>
</DateCompleted>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">1428-345X</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>18</Volume>
<Issue>3</Issue>
<PubDate>
<MedlineDate>2014 Jul-Sep</MedlineDate>
</PubDate>
</JournalIssue>
<Title>Developmental period medicine</Title>
<ISOAbbreviation>Dev Period Med</ISOAbbreviation>
</Journal>
<ArticleTitle>[Association between dental caries and nutritional status of 7-and 12-years-old children].</ArticleTitle>
<Pagination>
<MedlinePgn>349-55</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText Label="UNLABELLED">One of the etiological factors of dental caries are improper eating habits, which also influence the nutritional state of the organism. This similarity tends to establish the relationship between the intensity of tooth decay, and body weight disorders.</AbstractText>
<AbstractText Label="AIM" NlmCategory="OBJECTIVE">The aim of this study was to assess the prevalence of dental caries in 7 and 12-year-old children, depending on the nutritional status.</AbstractText>
<AbstractText Label="MATERIAL AND METHODS" NlmCategory="METHODS">The study included 225 children of both sex, age 7 (132) and 12 years (93) attending to randomly selected schools in Poznań. Dental examination was performed by dentists in schools in artificial light using mirrors and dental probe (criteria according to WHO 1997 ). Based on collected data, caries frequency and caries intensity were calculated (DMF-t -7 and 12-year-olds and dmf-t 7-year olds). Anthropometric measurements such as height and weight were made by school nurses in accordance with guidelines for the performance of screening tests for people of school age. A deficiency or excess body weight in surveyed children rated BMI (Body Mass Index), including percentile ranges for the population of children in Poznań. Assessment of dental caries in groups of pupils were formed due to nutritional status of the respondents i. e. normal-weight and underweight and overweight.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">Caries frequency in children of normal weight in the population of 7-year-olds was 82.2% and 53.2% of children aged 12 years. In the group of 7-year-old pupils with overweight and underweight was respectively, 95.0% and 90.9%, 84.2% and 50.0% in the older group. A statistically significant difference between the attendance of dental caries in a group of 12-year-old children with overweight and normal weight and its deficiency was show. The average value of dmf-t in 7-year-old children was 4.02, and the DMF-permanent dentition - 0.19 and the children with over- and underweight respectively dmf- 4.25 and 3,82 and DMF- 0.35 and 0,27. In population of 12-year olds caries DMF was - 1.62, and for children with overweight and underweight, respectively, 2.68 and 1.25. Approximately 66.7% of 12- year old children were classified as normal weight, 20.4% as overweight and 12,9% as underweight, in the 7- year olds respectively 76.5%, 15.2% and 8.3%. Statistically relevant difference between DMF-t values at examined children of both gender with normal weight and overweight were observed only in the group of 12 years old. The surveys revealed that with increase of body the weight prevalence of dental caries grows in the group of older children.</AbstractText>
<AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">The children with observed abnormal body weight status should be classified in the higher dental caries risk group.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Chłapowska</LastName>
<ForeName>Joanna</ForeName>
<Initials>J</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Rataj-Kulmacz</LastName>
<ForeName>Agata</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Katedra i Klinika Stomatologii Dziecięcej, Uniwersytet Medyczny im. Karola Marcinkowskiego, w Poznaniu ul. bukowska 70, 60-812 Poznań, tel. (61) 854-70-53, fax. (61) 854-70-59, e-mail: klstomdz@ump.edu.pl.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Krzyżaniak</LastName>
<ForeName>Alicja</ForeName>
<Initials>A</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Borysewicz-Lewicka</LastName>
<ForeName>Maria</ForeName>
<Initials>M</Initials>
</Author>
</AuthorList>
<Language>pol</Language>
<PublicationTypeList>
<PublicationType UI="D004740">English Abstract</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<VernacularTitle>Zalezność wystepowania próchnicy od stanu odzywienia u dzieci 7-i 12-letnich.</VernacularTitle>
</Article>
<MedlineJournalInfo>
<Country>Poland</Country>
<MedlineTA>Dev Period Med</MedlineTA>
<NlmUniqueID>101636421</NlmUniqueID>
<ISSNLinking>1428-345X</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015984">Causality</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002648">Child</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015897">Comorbidity</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D004245">DMF Index</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D003731">Dental Caries</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000453">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D003793">Dental Restoration, Permanent</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000706">statistics &amp; numerical data</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D009752">Nutritional Status</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009765">Obesity</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000453">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D050177">Overweight</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" Type="Geographic" UI="D011044">Poland</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015995">Prevalence</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012737">Sex Factors</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D013851">Thinness</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000453">epidemiology</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25182097</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>03</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>09</Month>
<Day>22</Day>
</DateCompleted>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">1538-3598</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>312</Volume>
<Issue>9</Issue>
<PubDate>
<Year>2014</Year>
<Month>Sep</Month>
<Day>3</Day>
</PubDate>
</JournalIssue>
<Title>JAMA</Title>
<ISOAbbreviation>JAMA</ISOAbbreviation>
</Journal>
<ArticleTitle>The current state of the evidence for bariatric surgery.</ArticleTitle>
<Pagination>
<MedlinePgn>898-9</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1001/jama.2014.10940</ELocationID>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Arterburn</LastName>
<ForeName>David E</ForeName>
<Initials>DE</Initials>
<AffiliationInfo>
<Affiliation>Group Health Research Institute, Seattle, Washington.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Fisher</LastName>
<ForeName>David P</ForeName>
<Initials>DP</Initials>
<AffiliationInfo>
<Affiliation>The Permanente Medical Group, Kaiser Permanente Northern California, Bariatric Surgery Center, Richmond.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016420">Comment</PublicationType>
<PublicationType UI="D016421">Editorial</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>JAMA</MedlineTA>
<NlmUniqueID>7501160</NlmUniqueID>
<ISSNLinking>0098-7484</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList>
<CommentsCorrections RefType="CommentOn">
<RefSource>JAMA. 2014 Sep 3;312(9):934-42</RefSource>
<PMID Version="1">25182102</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="CommentOn">
<RefSource>JAMA. 2014 Sep 3;312(9):915-22</RefSource>
<PMID Version="1">25182100</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D050110">Bariatric Surgery</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D023381">Endpoint Determination</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009407">Nerve Block</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009765">Obesity</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000601">surgery</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009767">Obesity, Morbid</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000628">therapy</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D014630">Vagus Nerve</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25182098</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>03</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>09</Month>
<Day>22</Day>
</DateCompleted>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">1538-3598</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>312</Volume>
<Issue>9</Issue>
<PubDate>
<Year>2014</Year>
<Month>Sep</Month>
<Day>3</Day>
</PubDate>
</JournalIssue>
<Title>JAMA</Title>
<ISOAbbreviation>JAMA</ISOAbbreviation>
</Journal>
<ArticleTitle>A diet by any other name is still about energy.</ArticleTitle>
<Pagination>
<MedlinePgn>900-1</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1001/jama.2014.10837</ELocationID>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Van Horn</LastName>
<ForeName>Linda</ForeName>
<Initials>L</Initials>
<AffiliationInfo>
<Affiliation>Department of Preventive Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016420">Comment</PublicationType>
<PublicationType UI="D016421">Editorial</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>JAMA</MedlineTA>
<NlmUniqueID>7501160</NlmUniqueID>
<ISSNLinking>0098-7484</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList>
<CommentsCorrections RefType="CommentOn">
<RefSource>JAMA. 2014 Sep 3;312(9):923-33</RefSource>
<PMID Version="1">25182101</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D050528">Diet, Carbohydrate-Restricted</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D018752">Diet, Fat-Restricted</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009765">Obesity</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000178">diet therapy</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25182101</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>03</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>09</Month>
<Day>22</Day>
</DateCompleted>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">1538-3598</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>312</Volume>
<Issue>9</Issue>
<PubDate>
<Year>2014</Year>
<Month>Sep</Month>
<Day>3</Day>
</PubDate>
</JournalIssue>
<Title>JAMA</Title>
<ISOAbbreviation>JAMA</ISOAbbreviation>
</Journal>
<ArticleTitle>Comparison of weight loss among named diet programs in overweight and obese adults: a meta-analysis.</ArticleTitle>
<Pagination>
<MedlinePgn>923-33</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1001/jama.2014.10397</ELocationID>
<Abstract>
<AbstractText Label="IMPORTANCE" NlmCategory="OBJECTIVE">Many claims have been made regarding the superiority of one diet or another for inducing weight loss. Which diet is best remains unclear.</AbstractText>
<AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To determine weight loss outcomes for popular diets based on diet class (macronutrient composition) and named diet.</AbstractText>
<AbstractText Label="DATA SOURCES" NlmCategory="METHODS">Search of 6 electronic databases: AMED, CDSR, CENTRAL, CINAHL, EMBASE, and MEDLINE from inception of each database to April 2014.</AbstractText>
<AbstractText Label="STUDY SELECTION" NlmCategory="METHODS">Overweight or obese adults (body mass index ≥25) randomized to a popular self-administered named diet and reporting weight or body mass index data at 3-month follow-up or longer.</AbstractText>
<AbstractText Label="DATA EXTRACTION AND SYNTHESIS" NlmCategory="METHODS">Two reviewers independently extracted data on populations, interventions, outcomes, risk of bias, and quality of evidence. A Bayesian framework was used to perform a series of random-effects network meta-analyses with meta-regression to estimate the relative effectiveness of diet classes and programs for change in weight and body mass index from baseline. Our analyses adjusted for behavioral support and exercise.</AbstractText>
<AbstractText Label="MAIN OUTCOMES AND MEASURES" NlmCategory="METHODS">Weight loss and body mass index at 6- and 12-month follow-up (±3 months for both periods).</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">Among 59 eligible articles reporting 48 unique randomized trials (including 7286 individuals) and compared with no diet, the largest weight loss was associated with low-carbohydrate diets (8.73 kg [95% credible interval {CI}, 7.27 to 10.20 kg] at 6-month follow-up and 7.25 kg [95% CI, 5.33 to 9.25 kg] at 12-month follow-up) and low-fat diets (7.99 kg [95% CI, 6.01 to 9.92 kg] at 6-month follow-up and 7.27 kg [95% CI, 5.26 to 9.34 kg] at 12-month follow-up). Weight loss differences between individual diets were minimal. For example, the Atkins diet resulted in a 1.71 kg greater weight loss than the Zone diet at 6-month follow-up. Between 6- and 12-month follow-up, the influence of behavioral support (3.23 kg [95% CI, 2.23 to 4.23 kg] at 6-month follow-up vs 1.08 kg [95% CI, -1.82 to 3.96 kg] at 12-month follow-up) and exercise (0.64 kg [95% CI, -0.35 to 1.66 kg] vs 2.13 kg [95% CI, 0.43 to 3.85 kg], respectively) on weight loss differed.</AbstractText>
<AbstractText Label="CONCLUSIONS AND RELEVANCE" NlmCategory="CONCLUSIONS">Significant weight loss was observed with any low-carbohydrate or low-fat diet. Weight loss differences between individual named diets were small. This supports the practice of recommending any diet that a patient will adhere to in order to lose weight.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Johnston</LastName>
<ForeName>Bradley C</ForeName>
<Initials>BC</Initials>
<AffiliationInfo>
<Affiliation>Hospital for Sick Children Research Institute, Toronto, Ontario, Canada2Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada3Department of Clinical Epidemiology and Biostatistics, McMaster University, Hami.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Kanters</LastName>
<ForeName>Steve</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>School of Population and Public Health, University of British Columbia, Vancouver, Canada6Faculty of Health Sciences, University of Ottawa, Ottawa, Ontario, Canada7Redwood Outcomes, Vancouver, British Columbia, Canada.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Bandayrel</LastName>
<ForeName>Kristofer</ForeName>
<Initials>K</Initials>
<AffiliationInfo>
<Affiliation>Hospital for Sick Children Research Institute, Toronto, Ontario, Canada4Department of Anesthesia and Pain Medicine, Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Wu</LastName>
<ForeName>Ping</ForeName>
<Initials>P</Initials>
<AffiliationInfo>
<Affiliation>Faculty of Health Sciences, University of Ottawa, Ottawa, Ontario, Canada.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Naji</LastName>
<ForeName>Faysal</ForeName>
<Initials>F</Initials>
<AffiliationInfo>
<Affiliation>Michael G. DeGroote School of Medicine, McMaster University, Hamilton, Ontario, Canada.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Siemieniuk</LastName>
<ForeName>Reed A</ForeName>
<Initials>RA</Initials>
<AffiliationInfo>
<Affiliation>Department of Medicine, University of Toronto, Toronto, Ontario, Canada.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Ball</LastName>
<ForeName>Geoff D C</ForeName>
<Initials>GD</Initials>
<AffiliationInfo>
<Affiliation>Department of Pediatrics, University of Alberta, Edmonton, Canada11Department of Agricultural, Food and Nutritional Science, University of Alberta, Edmonton, Canada.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Busse</LastName>
<ForeName>Jason W</ForeName>
<Initials>JW</Initials>
<AffiliationInfo>
<Affiliation>Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Ontario, Canada12Michael G. DeGroote Institute for Pain Research and Care, McMaster University, Hamilton, Ontario, Canada13Department of Anesthesia, McMaster University.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Thorlund</LastName>
<ForeName>Kristian</ForeName>
<Initials>K</Initials>
<AffiliationInfo>
<Affiliation>Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Ontario, Canada7Redwood Outcomes, Vancouver, British Columbia, Canada14Stanford Prevention Research Center, Stanford University School of Medicine, Stanford University.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Guyatt</LastName>
<ForeName>Gordon</ForeName>
<Initials>G</Initials>
<AffiliationInfo>
<Affiliation>Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Ontario, Canada.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Jansen</LastName>
<ForeName>Jeroen P</ForeName>
<Initials>JP</Initials>
<AffiliationInfo>
<Affiliation>Redwood Outcomes, Vancouver, British Columbia, Canada15Department of Public Health and Community Medicine, Tufts University, Boston, Massachusetts.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Mills</LastName>
<ForeName>Edward J</ForeName>
<Initials>EJ</Initials>
<AffiliationInfo>
<Affiliation>Redwood Outcomes, Vancouver, British Columbia, Canada14Stanford Prevention Research Center, Stanford University School of Medicine, Stanford University, Stanford, California.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>201104</GrantID>
<Agency>Canadian Institutes of Health Research</Agency>
<Country>Canada</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D003160">Comparative Study</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D017418">Meta-Analysis</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>JAMA</MedlineTA>
<NlmUniqueID>7501160</NlmUniqueID>
<ISSNLinking>0098-7484</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList>
<CommentsCorrections RefType="CommentIn">
<RefSource>JAMA. 2014 Sep 3;312(9):900-1</RefSource>
<PMID Version="1">25182098</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000328">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D050528">Diet, Carbohydrate-Restricted</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D018752">Diet, Fat-Restricted</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009275">Names</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009765">Obesity</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000178">diet therapy</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D016032">Randomized Controlled Trials as Topic</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015431">Weight Loss</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25182102</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>03</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>09</Month>
<Day>22</Day>
</DateCompleted>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">1538-3598</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>312</Volume>
<Issue>9</Issue>
<PubDate>
<Year>2014</Year>
<Month>Sep</Month>
<Day>3</Day>
</PubDate>
</JournalIssue>
<Title>JAMA</Title>
<ISOAbbreviation>JAMA</ISOAbbreviation>
</Journal>
<ArticleTitle>Long-term follow-up after bariatric surgery: a systematic review.</ArticleTitle>
<Pagination>
<MedlinePgn>934-42</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1001/jama.2014.10706</ELocationID>
<Abstract>
<AbstractText Label="IMPORTANCE" NlmCategory="OBJECTIVE">Bariatric surgery is an accepted treatment for obesity. Despite extensive literature, few studies report long-term follow-up in cohorts with adequate retention rates.</AbstractText>
<AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To assess the quality of evidence and treatment effectiveness 2 years after bariatric procedures for weight loss, type 2 diabetes, hypertension, and hyperlipidemia in severely obese adults.</AbstractText>
<AbstractText Label="EVIDENCE REVIEW" NlmCategory="METHODS">MEDLINE and Cochrane databases were searched from 1946 through May 15, 2014. Search terms included bariatric surgery, individual bariatric procedures, and obesity. Studies were included if they described outcomes for gastric bypass, gastric band, or sleeve gastrectomy performed on patients with a body mass index of 35 or greater, had more than 2 years of outcome information, and had follow-up measures for at least 80% of the initial cohort. Two investigators reviewed each study and a third resolved study inclusion disagreements.</AbstractText>
<AbstractText Label="FINDINGS" NlmCategory="RESULTS">Of 7371 clinical studies reviewed, 29 studies (0.4%, 7971 patients) met inclusion criteria. All gastric bypass studies (6 prospective cohorts, 5 retrospective cohorts) and sleeve gastrectomy studies (2 retrospective cohorts) had 95% confidence intervals for the reported mean, median, or both exceeding 50% excess weight loss. This amount of excess weight loss occurred in 31% of gastric band studies (9 prospective cohorts, 5 retrospective cohorts). The mean sample-size-weighted percentage of excess weight loss for gastric bypass was 65.7% (n = 3544) vs 45.0% (n = 4109) for gastric band. Nine studies measured comorbidity improvement. For type 2 diabetes (glycated hemoglobin &lt;6.5% without medication), sample-size-weighted remission rates were 66.7% for gastric bypass (n = 428) and 28.6% for gastric band (n = 96). For hypertension (blood pressure &lt;140/90 mm Hg without medication), remission rates were 38.2% for gastric bypass ( n = 808) and 17.4% for gastric band (n = 247). For hyperlipidemia (cholesterol &lt;200 mg/dL, high-density lipoprotein &gt;40 mg/dL, low-density lipoprotein &lt;160 mg/dL, and triglycerides &lt;200 mg/dL), remission rates were 60.4% for gastric bypass (n = 477) and 22.7% for gastric band (n = 97).</AbstractText>
<AbstractText Label="CONCLUSIONS AND RELEVANCE" NlmCategory="CONCLUSIONS">Very few bariatric surgery studies report long-term results with sufficient patient follow-up to minimize biased results. Gastric bypass has better outcomes than gastric band procedures for long-term weight loss, type 2 diabetes control and remission, hypertension, and hyperlipidemia. Insufficient evidence exists regarding long-term outcomes for gastric sleeve resections.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Puzziferri</LastName>
<ForeName>Nancy</ForeName>
<Initials>N</Initials>
<AffiliationInfo>
<Affiliation>Department of Surgery, University of Texas Southwestern Medical Center, Dallas2Department of Surgery, North Texas Veterans Administration Healthcare System, Dallas.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Roshek</LastName>
<ForeName>Thomas B</ForeName>
<Initials>TB</Initials>
<Suffix>3rd</Suffix>
<AffiliationInfo>
<Affiliation>Department of Surgery, University of Texas Southwestern Medical Center, Dallas.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Mayo</LastName>
<ForeName>Helen G</ForeName>
<Initials>HG</Initials>
<AffiliationInfo>
<Affiliation>University of Texas Southwestern Medical Center Library, Dallas.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Gallagher</LastName>
<ForeName>Ryan</ForeName>
<Initials>R</Initials>
<AffiliationInfo>
<Affiliation>Department of Surgery, University of Texas Southwestern Medical Center, Dallas.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Belle</LastName>
<ForeName>Steven H</ForeName>
<Initials>SH</Initials>
<AffiliationInfo>
<Affiliation>Departments of Epidemiology and Biostatistics, University of Pittsburgh, Pittsburgh, Pennsylvania.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Livingston</LastName>
<ForeName>Edward H</ForeName>
<Initials>EH</Initials>
<AffiliationInfo>
<Affiliation>Department of Surgery, University of Texas Southwestern Medical Center, Dallas2Department of Surgery, North Texas Veterans Administration Healthcare System, Dallas5Department of Biomedical Engineering, University of Texas-Arlington, Arlington6Deputy Edito.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>KL2TR001103</GrantID>
<Acronym>TR</Acronym>
<Agency>NCATS NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
<PublicationType UI="D016454">Review</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>JAMA</MedlineTA>
<NlmUniqueID>7501160</NlmUniqueID>
<ISSNLinking>0098-7484</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList>
<CommentsCorrections RefType="CommentIn">
<RefSource>JAMA. 2014 Sep 3;312(9):898-9</RefSource>
<PMID Version="1">25182097</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D050110">Bariatric Surgery</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D003920">Diabetes Mellitus</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D023381">Endpoint Determination</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005500">Follow-Up Studies</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006949">Hyperlipidemias</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000150">complications</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006973">Hypertension</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000150">complications</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009765">Obesity</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000150">complications</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000601">surgery</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D013997">Time Factors</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D016896">Treatment Outcome</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015431">Weight Loss</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25182103</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>03</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>09</Month>
<Day>22</Day>
</DateCompleted>
<DateRevised>
<Year>2014</Year>
<Month>10</Month>
<Day>21</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">1538-3598</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>312</Volume>
<Issue>9</Issue>
<PubDate>
<Year>2014</Year>
<Month>Sep</Month>
<Day>3</Day>
</PubDate>
</JournalIssue>
<Title>JAMA</Title>
<ISOAbbreviation>JAMA</ISOAbbreviation>
</Journal>
<ArticleTitle>Assessment and lifestyle management of patients with obesity: clinical recommendations from systematic reviews.</ArticleTitle>
<Pagination>
<MedlinePgn>943-52</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1001/jama.2014.10432</ELocationID>
<Abstract>
<AbstractText Label="IMPORTANCE" NlmCategory="OBJECTIVE">Even though one-third of US adults are obese, identification and treatment rates for obesity remain low. Clinician engagement is vital to provide guidance and assistance to patients who are overweight or obese to address the underlying cause of many chronic diseases.</AbstractText>
<AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">To describe current best practices for assessment and lifestyle management of obesity and to demonstrate how the updated Guidelines (2013) for Managing Overweight and Obesity in Adults based on a systematic evidence review sponsored by the National Heart, Lung, and Blood Institute (NHLBI) can be applied to an individual patient.</AbstractText>
<AbstractText Label="EVIDENCE REVIEW" NlmCategory="METHODS">Systematic evidence review conducted for the Guidelines (2013) for Managing Overweight and Obesity in Adults supports treatment recommendations in 5 areas (risk assessment, weight loss benefits, diets for weight loss, comprehensive lifestyle intervention approaches, and bariatric surgery); for areas outside this scope, recommendations are supported by other guidelines (for obesity, 1998 NHLBI-sponsored obesity guidelines and those from the National Center for Health and Clinical Excellence and Canadian and US professional societies such as the American Association of Clinical Endocrinologists and American Society of Bariatric Physicians; for physical activity recommendations, the 2008 Physical Activity Guidelines for Americans); a PubMed search identified recent systematic reviews covering depression and obesity, motivational interviewing for weight management, metabolic adaptation to weight loss, and obesity pharmacotherapy.</AbstractText>
<AbstractText Label="FINDINGS" NlmCategory="RESULTS">The first step in obesity management is to screen all adults for overweight and obesity. A medical history should be obtained assessing for the multiple determinants of obesity, including dietary and physical activity patterns, psychosocial factors, weight-gaining medications, and familial traits. Emphasis on the complications of obesity to identify patients who will benefit the most from treatment is more useful than using body mass index (BMI; calculated as weight in kilograms divided by height in meters squared) alone for treatment decisions. The Guidelines (2013) recommend that clinicians offer patients who would benefit from weight loss (either BMI of ≥30 with or without comorbidities or ≥25 along with 1 comorbidity or risk factor) intensive, multicomponent behavioral intervention. Some clinicians do this within their primary care practices; others refer patients for these services. Weight loss is achieved by creating a negative energy balance through modification of food and physical activity behaviors. The Guidelines (2013) endorse comprehensive lifestyle treatment by intensive intervention. Treatment can be implemented either in a clinician's office or by referral to a registered dietitian or commercial weight loss program. Weight loss of 5% to 10% is the usual goal. It is not necessary for patients to attain a BMI of less than 25 to achieve a health benefit.</AbstractText>
<AbstractText Label="CONCLUSIONS AND RELEVANCE" NlmCategory="CONCLUSIONS">Screening and assessment of patients for obesity followed by initiation or referral of treatment should be incorporated into primary care practice settings. If clinicians can identify appropriate patients for weight loss efforts and provide informed advice and assistance on how to achieve and sustain modest weight loss, they will be addressing the underlying driver of many comorbidities and can have a major influence on patients' health status.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Kushner</LastName>
<ForeName>Robert F</ForeName>
<Initials>RF</Initials>
<AffiliationInfo>
<Affiliation>Division of Endocrinology, Metabolism and Molecular Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Ryan</LastName>
<ForeName>Donna H</ForeName>
<Initials>DH</Initials>
<AffiliationInfo>
<Affiliation>Pennington Biomedical Research Center, Baton Rouge, Louisiana.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D002363">Case Reports</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016454">Review</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>JAMA</MedlineTA>
<NlmUniqueID>7501160</NlmUniqueID>
<ISSNLinking>0098-7484</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList>
<CommentsCorrections RefType="ErratumIn">
<RefSource>JAMA. 2014 Oct 15;312(15):1593</RefSource>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000328">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D008019">Life Style</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008487">Medical History Taking</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009765">Obesity</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000175">diagnosis</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000628">therapy</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D017410">Practice Guidelines as Topic</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011320">Primary Health Care</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015431">Weight Loss</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25182106</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>03</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>09</Month>
<Day>22</Day>
</DateCompleted>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">1538-3598</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>312</Volume>
<Issue>9</Issue>
<PubDate>
<Year>2014</Year>
<Month>Sep</Month>
<Day>3</Day>
</PubDate>
</JournalIssue>
<Title>JAMA</Title>
<ISOAbbreviation>JAMA</ISOAbbreviation>
</Journal>
<ArticleTitle>Changes in bariatric surgery procedure use in Michigan, 2006-2013.</ArticleTitle>
<Pagination>
<MedlinePgn>959-61</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1001/jama.2014.7651</ELocationID>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Reames</LastName>
<ForeName>Bradley N</ForeName>
<Initials>BN</Initials>
<AffiliationInfo>
<Affiliation>Department of Surgery, University of Michigan, Ann Arbor.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Finks</LastName>
<ForeName>Jonathan F</ForeName>
<Initials>JF</Initials>
<AffiliationInfo>
<Affiliation>Department of Surgery, University of Michigan, Ann Arbor.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Bacal</LastName>
<ForeName>Daniel</ForeName>
<Initials>D</Initials>
<AffiliationInfo>
<Affiliation>Oakwood Hospital and Medical Center, Dearborn, Michigan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Carlin</LastName>
<ForeName>Arthur M</ForeName>
<Initials>AM</Initials>
<AffiliationInfo>
<Affiliation>Henry Ford Health System, Detroit, Michigan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Dimick</LastName>
<ForeName>Justin B</ForeName>
<Initials>JB</Initials>
<AffiliationInfo>
<Affiliation>Department of Surgery, University of Michigan, Ann Arbor.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>5T32CA009672-23</GrantID>
<Acronym>CA</Acronym>
<Agency>NCI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>JAMA</MedlineTA>
<NlmUniqueID>7501160</NlmUniqueID>
<ISSNLinking>0098-7484</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D050110">Bariatric Surgery</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000379">methods</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000639">trends</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000656">utilization</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007297">Inpatients</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" Type="Geographic" UI="D008824">Michigan</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009765">Obesity</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000601">surgery</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D010045">Outpatients</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012189">Retrospective Studies</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25157000</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>03</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>10</Month>
<Day>30</Day>
</DateCompleted>
<DateRevised>
<Year>2014</Year>
<Month>11</Month>
<Day>20</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">1098-4275</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>134</Volume>
<Issue>3</Issue>
<PubDate>
<Year>2014</Year>
<Month>Sep</Month>
</PubDate>
</JournalIssue>
<Title>Pediatrics</Title>
<ISOAbbreviation>Pediatrics</ISOAbbreviation>
</Journal>
<ArticleTitle>Smart-phone obesity prevention trial for adolescent boys in low-income communities: the ATLAS RCT.</ArticleTitle>
<Pagination>
<MedlinePgn>e723-31</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1542/peds.2014-1012</ELocationID>
<Abstract>
<AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">The goal of this study was to evaluate the impact of the Active Teen Leaders Avoiding Screen-time (ATLAS) intervention for adolescent boys, an obesity prevention intervention using smartphone technology.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">ATLAS was a cluster randomized controlled trial conducted in 14 secondary schools in low-income communities in New South Wales, Australia. Participants were 361 adolescent boys (aged 12-14 years) considered at risk of obesity. The 20-week intervention was guided by self-determination theory and social cognitive theory and involved: teacher professional development, provision of fitness equipment to schools, face-to-face physical activity sessions, lunchtime student mentoring sessions, researcher-led seminars, a smartphone application and Web site, and parental strategies for reducing screen-time. Outcome measures included BMI and waist circumference, percent body fat, physical activity (accelerometers), screen-time, sugar-sweetened beverage intake, muscular fitness, and resistance training skill competency.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">Overall, there were no significant intervention effects for BMI, waist circumference, percent body fat, or physical activity. Significant intervention effects were found for screen-time (mean ± SE: -30 ± 10.08 min/d; P = .03), sugar-sweetened beverage consumption (mean: -0.6 ± 0.26 glass/d; P = .01), muscular fitness (mean: 0.9 ± 0.49 repetition; P = .04), and resistance training skills (mean: 5.7 ± 0.67 units; P &lt; .001).</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">This school-based intervention targeting low-income adolescent boys did not result in significant effects on body composition, perhaps due to an insufficient activity dose. However, the intervention was successful in improving muscular fitness, movement skills, and key weight-related behaviors.</AbstractText>
<CopyrightInformation>Copyright © 2014 by the American Academy of Pediatrics.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Smith</LastName>
<ForeName>Jordan J</ForeName>
<Initials>JJ</Initials>
<AffiliationInfo>
<Affiliation>Priority Research Centre in Physical Activity and Nutrition, School of Education, University of Newcastle, Callaghan, New South Wales, Australia;</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Morgan</LastName>
<ForeName>Philip J</ForeName>
<Initials>PJ</Initials>
<AffiliationInfo>
<Affiliation>Priority Research Centre in Physical Activity and Nutrition, School of Education, University of Newcastle, Callaghan, New South Wales, Australia;</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Plotnikoff</LastName>
<ForeName>Ronald C</ForeName>
<Initials>RC</Initials>
<AffiliationInfo>
<Affiliation>Priority Research Centre in Physical Activity and Nutrition, School of Education, University of Newcastle, Callaghan, New South Wales, Australia;</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Dally</LastName>
<ForeName>Kerry A</ForeName>
<Initials>KA</Initials>
<AffiliationInfo>
<Affiliation>Priority Research Centre in Physical Activity and Nutrition, School of Education, University of Newcastle, Callaghan, New South Wales, Australia;</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Salmon</LastName>
<ForeName>Jo</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>Centre for Physical Activity and Nutrition Research, Deakin University, Burwood, Victoria, Australia; and.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Okely</LastName>
<ForeName>Anthony D</ForeName>
<Initials>AD</Initials>
<AffiliationInfo>
<Affiliation>Interdisciplinary Educational Research Institute, University of Wollongong, Wollongong, New South Wales, Australia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Finn</LastName>
<ForeName>Tara L</ForeName>
<Initials>TL</Initials>
<AffiliationInfo>
<Affiliation>Priority Research Centre in Physical Activity and Nutrition, School of Education, University of Newcastle, Callaghan, New South Wales, Australia;</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Lubans</LastName>
<ForeName>David R</ForeName>
<Initials>DR</Initials>
<AffiliationInfo>
<Affiliation>Priority Research Centre in Physical Activity and Nutrition, School of Education, University of Newcastle, Callaghan, New South Wales, Australia; david.lubans@newcastle.edu.au.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<DataBankList CompleteYN="Y">
<DataBank>
<DataBankName>ANZCTR</DataBankName>
<AccessionNumberList>
<AccessionNumber>ACTRN12612000978864;</AccessionNumber>
</AccessionNumberList>
</DataBank>
</DataBankList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016449">Randomized Controlled Trial</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Pediatrics</MedlineTA>
<NlmUniqueID>0376422</NlmUniqueID>
<ISSNLinking>0031-4005</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList>
<CommentsCorrections RefType="CommentIn">
<RefSource>Pediatrics. 2014 Sep;134(3):e846-7</RefSource>
<PMID Version="1">25157019</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000293">Adolescent</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001835">Body Weight</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D040421">Cell Phones</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000191">economics</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000656">utilization</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002648">Child</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D016000">Cluster Analysis</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005500">Follow-Up Studies</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006293">Health Promotion</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000191">economics</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009043">Motor Activity</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000502">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" Type="Geographic" UI="D009517">New South Wales</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000453">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009765">Obesity</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000191">economics</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000453">epidemiology</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000517">prevention &amp; control</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D010865">Pilot Projects</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011203">Poverty</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000191">economics</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D012111">Residence Characteristics</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">adolescent</Keyword>
<Keyword MajorTopicYN="N">intervention studies</Keyword>
<Keyword MajorTopicYN="N">obesity</Keyword>
<Keyword MajorTopicYN="N">physical activity</Keyword>
<Keyword MajorTopicYN="N">physical fitness</Keyword>
<Keyword MajorTopicYN="N">randomized controlled trial</Keyword>
<Keyword MajorTopicYN="N">schools</Keyword>
<Keyword MajorTopicYN="N">sedentary lifestyle</Keyword>
</KeywordList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25157012</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>03</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>10</Month>
<Day>30</Day>
</DateCompleted>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">1098-4275</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>134</Volume>
<Issue>3</Issue>
<PubDate>
<Year>2014</Year>
<Month>Sep</Month>
</PubDate>
</JournalIssue>
<Title>Pediatrics</Title>
<ISOAbbreviation>Pediatrics</ISOAbbreviation>
</Journal>
<ArticleTitle>Insufficient sleep in adolescents and young adults: an update on causes and consequences.</ArticleTitle>
<Pagination>
<MedlinePgn>e921-32</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1542/peds.2014-1696</ELocationID>
<Abstract>
<AbstractText>Chronic sleep loss and associated sleepiness and daytime impairments in adolescence are a serious threat to the academic success, health, and safety of our nation's youth and an important public health issue. Understanding the extent and potential short- and long-term repercussions of sleep restriction, as well as the unhealthy sleep practices and environmental factors that contribute to sleep loss in adolescents, is key in setting public policies to mitigate these effects and in counseling patients and families in the clinical setting. This report reviews the current literature on sleep patterns in adolescents, factors contributing to chronic sleep loss (ie, electronic media use, caffeine consumption), and health-related consequences, such as depression, increased obesity risk, and higher rates of drowsy driving accidents. The report also discusses the potential role of later school start times as a means of reducing adolescent sleepiness. </AbstractText>
<CopyrightInformation>Copyright © 2014 by the American Academy of Pediatrics.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Owens</LastName>
<ForeName>Judith</ForeName>
<Initials>J</Initials>
</Author>
<Author ValidYN="Y">
<CollectiveName>Adolescent Sleep Working Group</CollectiveName>
</Author>
<Author ValidYN="Y">
<CollectiveName>Committee on Adolescence</CollectiveName>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016454">Review</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Pediatrics</MedlineTA>
<NlmUniqueID>0376422</NlmUniqueID>
<ISSNLinking>0031-4005</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>3G6A5W338E</RegistryNumber>
<NameOfSubstance UI="D002110">Caffeine</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000063">Accidents, Traffic</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000517">prevention &amp; control</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000523">psychology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000293">Adolescent</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002110">Caffeine</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000009">adverse effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D003146">Communications Media</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000639">trends</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D003863">Depression</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000175">diagnosis</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000453">epidemiology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000523">psychology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009765">Obesity</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000175">diagnosis</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000453">epidemiology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000523">psychology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012890">Sleep</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000502">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012892">Sleep Deprivation</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000175">diagnosis</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000453">epidemiology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000523">psychology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012893">Sleep Disorders</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000175">diagnosis</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000453">epidemiology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000523">psychology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D055815">Young Adult</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">adolescents</Keyword>
<Keyword MajorTopicYN="N">caffeine</Keyword>
<Keyword MajorTopicYN="N">car crashes</Keyword>
<Keyword MajorTopicYN="N">media use</Keyword>
<Keyword MajorTopicYN="N">obesity</Keyword>
<Keyword MajorTopicYN="N">sleep loss</Keyword>
<Keyword MajorTopicYN="N">sleepiness</Keyword>
</KeywordList>
<InvestigatorList>
<Investigator ValidYN="Y">
<LastName>Au</LastName>
<ForeName>Rhoda</ForeName>
<Initials>R</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Carskadon</LastName>
<ForeName>Mary</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Millman</LastName>
<ForeName>Richard</ForeName>
<Initials>R</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Wolfson</LastName>
<ForeName>Amy</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Braverman</LastName>
<ForeName>Paula K</ForeName>
<Initials>PK</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Adelman</LastName>
<ForeName>William P</ForeName>
<Initials>WP</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Breuner</LastName>
<ForeName>Cora C</ForeName>
<Initials>CC</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Levine</LastName>
<ForeName>David A</ForeName>
<Initials>DA</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Marcell</LastName>
<ForeName>Arik V</ForeName>
<Initials>AV</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Murray</LastName>
<ForeName>Pamela J</ForeName>
<Initials>PJ</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>O'Brien</LastName>
<ForeName>Rebecca F</ForeName>
<Initials>RF</Initials>
</Investigator>
</InvestigatorList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25157019</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>03</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>10</Month>
<Day>30</Day>
</DateCompleted>
<DateRevised>
<Year>2014</Year>
<Month>11</Month>
<Day>20</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">1098-4275</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>134</Volume>
<Issue>3</Issue>
<PubDate>
<Year>2014</Year>
<Month>Sep</Month>
</PubDate>
</JournalIssue>
<Title>Pediatrics</Title>
<ISOAbbreviation>Pediatrics</ISOAbbreviation>
</Journal>
<ArticleTitle>Let's call it as it is: on results, reach, and resolution in population-based obesity trials.</ArticleTitle>
<Pagination>
<MedlinePgn>e846-7</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1542/peds.2014-1940</ELocationID>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Wake</LastName>
<ForeName>Melissa</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Department of Pediatrics, The University of Melbourne, Melbourne, Australia; Murdoch Children's Research Institute, Melbourne, Australia; and Centre for Community Child Health, The Royal Children's Hospital, Melbourne, Australia melissa.wake@rch.org.au.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Lycett</LastName>
<ForeName>Kate</ForeName>
<Initials>K</Initials>
<AffiliationInfo>
<Affiliation>Department of Pediatrics, The University of Melbourne, Melbourne, Australia; Murdoch Children's Research Institute, Melbourne, Australia; and Centre for Community Child Health, The Royal Children's Hospital, Melbourne, Australia.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016420">Comment</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Pediatrics</MedlineTA>
<NlmUniqueID>0376422</NlmUniqueID>
<ISSNLinking>0031-4005</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList>
<CommentsCorrections RefType="CommentOn">
<RefSource>Pediatrics. 2014 Sep;134(3):e723-31</RefSource>
<PMID Version="1">25157000</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D040421">Cell Phones</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000191">economics</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000656">utilization</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009765">Obesity</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000191">economics</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000517">prevention &amp; control</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011203">Poverty</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000191">economics</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D012111">Residence Characteristics</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">(bias) epidemiology</Keyword>
<Keyword MajorTopicYN="N">BMI</Keyword>
<Keyword MajorTopicYN="N">clinical trials (epidemiology)</Keyword>
<Keyword MajorTopicYN="N">data interpretation (statistical)</Keyword>
<Keyword MajorTopicYN="N">obesity</Keyword>
<Keyword MajorTopicYN="N">screen time</Keyword>
</KeywordList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25183752</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>03</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>06</Day>
</DateCompleted>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">1098-4275</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>134 Suppl 1</Volume>
<PubDate>
<Year>2014</Year>
<Month>Sep</Month>
</PubDate>
</JournalIssue>
<Title>Pediatrics</Title>
<ISOAbbreviation>Pediatrics</ISOAbbreviation>
</Journal>
<ArticleTitle>A longitudinal analysis of sugar-sweetened beverage intake in infancy and obesity at 6 years.</ArticleTitle>
<Pagination>
<MedlinePgn>S29-35</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1542/peds.2014-0646F</ELocationID>
<Abstract>
<AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To examine whether sugar-sweetened beverage (SSB) intake during infancy predicts obesity at age 6 years.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">We included 1189 children who participated in the Infant Feeding Practices Study II in 2005-2007 and were followed up at 6 years in 2012. Children's weight and height were measured by mothers. Obesity was defined as gender-specific BMI-for-age ≥95th percentile. We used logistic regression to estimate the associations of any SSB intake and age at SSB introduction before 12 months and mean SSB intake during ages 10 to 12 months with obesity at 6 years controlling for baseline characteristics.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">The obesity prevalence at 6 years among children who consumed SSBs during infancy was twice as high as that among non-SSB consumers (17.0% vs 8.6%). The adjusted odds of obesity at 6 years was 71% higher for any SSB intake and 92% higher for SSB introduction before 6 months compared with no SSB intake during infancy. Children who consumed SSBs ≥3 times per week during ages 10 to 12 months had twice the odds of obesity compared with those who consumed no SSBs in this period. However, among children who consumed SSBs, the odds of obesity at 6 years did not differ by age at SSB introduction during infancy or by mean weekly SSB intake during ages 10 to 12 months.</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Children who consumed SSBs during infancy had higher odds of obesity at 6 years than non-SSB consumers. SSB consumption during infancy may be a risk factor for obesity in early childhood. Whether unmeasured behaviors contributed to the association is unclear.</AbstractText>
<CopyrightInformation>Copyright © 2014 by the American Academy of Pediatrics.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Pan</LastName>
<ForeName>Liping</ForeName>
<Initials>L</Initials>
<AffiliationInfo>
<Affiliation>Division of Nutrition, Physical Activity, and Obesity, Centers for Disease Control and Prevention, Atlanta, Georgia lpan@cdc.gov.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Li</LastName>
<ForeName>Ruowei</ForeName>
<Initials>R</Initials>
<AffiliationInfo>
<Affiliation>Division of Nutrition, Physical Activity, and Obesity, Centers for Disease Control and Prevention, Atlanta, Georgia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Park</LastName>
<ForeName>Sohyun</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Division of Nutrition, Physical Activity, and Obesity, Centers for Disease Control and Prevention, Atlanta, Georgia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Galuska</LastName>
<ForeName>Deborah A</ForeName>
<Initials>DA</Initials>
<AffiliationInfo>
<Affiliation>Division of Nutrition, Physical Activity, and Obesity, Centers for Disease Control and Prevention, Atlanta, Georgia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Sherry</LastName>
<ForeName>Bettylou</ForeName>
<Initials>B</Initials>
<AffiliationInfo>
<Affiliation>Division of Nutrition, Physical Activity, and Obesity, Centers for Disease Control and Prevention, Atlanta, Georgia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Freedman</LastName>
<ForeName>David S</ForeName>
<Initials>DS</Initials>
<AffiliationInfo>
<Affiliation>Division of Nutrition, Physical Activity, and Obesity, Centers for Disease Control and Prevention, Atlanta, Georgia.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
<PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Pediatrics</MedlineTA>
<NlmUniqueID>0376422</NlmUniqueID>
<ISSNLinking>0031-4005</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D019422">Dietary Sucrose</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000293">Adolescent</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000328">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D001628">Beverages</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000009">adverse effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002648">Child</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D019422">Dietary Sucrose</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000008">administration &amp; dosage</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000009">adverse effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005500">Follow-Up Studies</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007223">Infant</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008137">Longitudinal Studies</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009765">Obesity</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000175">diagnosis</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000453">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D011795">Questionnaires</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D055815">Young Adult</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">childhood obesity</Keyword>
<Keyword MajorTopicYN="N">infancy</Keyword>
<Keyword MajorTopicYN="N">population-based studies</Keyword>
<Keyword MajorTopicYN="N">public health</Keyword>
<Keyword MajorTopicYN="N">sugar-sweetened beverages</Keyword>
</KeywordList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25183755</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>03</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>06</Day>
</DateCompleted>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">1098-4275</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>134 Suppl 1</Volume>
<PubDate>
<Year>2014</Year>
<Month>Sep</Month>
</PubDate>
</JournalIssue>
<Title>Pediatrics</Title>
<ISOAbbreviation>Pediatrics</ISOAbbreviation>
</Journal>
<ArticleTitle>Adherence to breastfeeding guidelines and maternal weight 6 years after delivery.</ArticleTitle>
<Pagination>
<MedlinePgn>S42-9</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1542/peds.2014-0646H</ELocationID>
<Abstract>
<AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">There is a dearth of information on the long-term maternal effects of breastfeeding. The objective of this study was to examine adherence to breastfeeding recommendations of exclusive breastfeeding for ≥4 months and continuation of breastfeeding for ≥1 year and maternal weight retention 6 years after delivery.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">Using data from the Infant Feeding Practices Study II (IFPS II), we categorized women by the degree to which they met breastfeeding recommendations. Mothers' self-reported weight 6 years after delivery (IFPS Year 6 Follow-Up) was compared with self-reported prepregnancy weight from IFPS II. Using linear regression models, adjusting for covariates, we examined associations between breastfeeding recommendation adherence and weight retention.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">Of the 726 women in our study, 17.9% never breastfed. Among those who initiated breastfeeding, 29.0% breastfed exclusively for ≥4 months, and 20.3% breastfed exclusively for ≥4 months and continued breastfeeding for ≥12 months. Prepregnancy BMI modified the association between breastfeeding recommendation adherence and weight retention. Adjusting for covariates, we found no association between breastfeeding recommendations adherence and weight retention among normal and overweight mothers. Among obese mothers, there was a significant linear trend (P = .03), suggesting that those who fully adhered to breastfeeding recommendations retained less weight (-8.0 kg) than obese women who never breastfed.</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">This study suggests that improving adherence to breastfeeding recommendations may help reduce long-term maternal weight retention among obese mothers. Larger studies, with diverse populations and similar longitudinal designs, are needed to explore this relationship.</AbstractText>
<CopyrightInformation>Copyright © 2014 by the American Academy of Pediatrics.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Sharma</LastName>
<ForeName>Andrea J</ForeName>
<Initials>AJ</Initials>
<AffiliationInfo>
<Affiliation>US Public Health Service Commissioned Corps, Atlanta, Georgia; Division of Reproductive Health, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia; and AJSharma@cdc.gov.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Dee</LastName>
<ForeName>Deborah L</ForeName>
<Initials>DL</Initials>
<AffiliationInfo>
<Affiliation>US Public Health Service Commissioned Corps, Atlanta, Georgia; Division of Reproductive Health, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia; and.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Harden</LastName>
<ForeName>Samantha M</ForeName>
<Initials>SM</Initials>
<AffiliationInfo>
<Affiliation>Department of Human Nutrition, Foods, and Exercise, Virginia Tech, Blacksburg, Virginia.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Pediatrics</MedlineTA>
<NlmUniqueID>0376422</NlmUniqueID>
<ISSNLinking>0031-4005</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000328">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001835">Body Weight</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000502">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001942">Breast Feeding</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000523">psychology</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000639">trends</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D036861">Delivery, Obstetric</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000639">trends</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D042241">Early Diagnosis</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005247">Feeding Behavior</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000502">physiology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000523">psychology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005500">Follow-Up Studies</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008137">Longitudinal Studies</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D039382">Maternal Nutritional Physiological Phenomena</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000502">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009765">Obesity</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000175">diagnosis</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000453">epidemiology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000523">psychology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D010349">Patient Compliance</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000523">psychology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D057566">Self Report</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">benefits</Keyword>
<Keyword MajorTopicYN="N">breastfeeding</Keyword>
<Keyword MajorTopicYN="N">duration</Keyword>
<Keyword MajorTopicYN="N">exclusivity</Keyword>
<Keyword MajorTopicYN="N">human milk</Keyword>
<Keyword MajorTopicYN="N">maternal weight</Keyword>
</KeywordList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25185323</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>04</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>09</Month>
<Day>25</Day>
</DateCompleted>
<DateRevised>
<Year>2014</Year>
<Month>11</Month>
<Day>09</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0022-0892</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>77</Volume>
<Issue>1</Issue>
<PubDate>
<MedlineDate>2014 Jul-Aug</MedlineDate>
</PubDate>
</JournalIssue>
<Title>Journal of environmental health</Title>
<ISOAbbreviation>J Environ Health</ISOAbbreviation>
</Journal>
<ArticleTitle>Incorporating occupational risk in heat stress vulnerability mapping.</ArticleTitle>
<Pagination>
<MedlinePgn>16-22</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>Both obesity and strenuous outdoor work are known risk factors for heat-related illness (HRI). These risk factors may be compounded by more and longer periods of extreme heat in the southeastern U.S. To quantify occupational risk and investigate the possible predictive value of a GIS-based tool, a weighted occupation-based metabolic equivalent (MET) index was created. The correlation between current MET-weighted employment rates or obesity rates and 2012 HRI report rates in Alabama were then determined. With the current dataset, results indicate occupational and obesity rates may explain some of the geographical variation seen in HRI report rates, although results are not statistically significant with this limited dataset. Mapping occupational and physiological risk factors with HRI rates may be useful for environmental and occupational health professionals to identify "hotspots" that may require special attention.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Crider</LastName>
<ForeName>Kyle G</ForeName>
<Initials>KG</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Maples</LastName>
<ForeName>Elizabeth H</ForeName>
<Initials>EH</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Gohlke</LastName>
<ForeName>Julia M</ForeName>
<Initials>JM</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>R21 ES020205</GrantID>
<Acronym>ES</Acronym>
<Agency>NIEHS NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>J Environ Health</MedlineTA>
<NlmUniqueID>0405525</NlmUniqueID>
<ISSNLinking>0022-0892</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList>
<CommentsCorrections RefType="Cites">
<RefSource>Med Sci Sports Exerc. 1996 Aug;28(8):939-44</RefSource>
<PMID Version="1">8871901</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Epidemiol Community Health. 2012 Sep;66(9):759-60</RefSource>
<PMID Version="1">22766781</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>South Med J. 2000 Aug;93(8):787-92</RefSource>
<PMID Version="1">10963510</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Occup Med (Lond). 2000 May;50(4):259-63</RefSource>
<PMID Version="1">10912377</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>MMWR Morb Mortal Wkly Rep. 2006 Jul 28;55(29):796-8</RefSource>
<PMID Version="1">16874294</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Phys Act Health. 2009 May;6(3):347-53</RefSource>
<PMID Version="1">19564664</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>MMWR Morb Mortal Wkly Rep. 2000 Jan 14;49(1):11-4</RefSource>
<PMID Version="1">10993567</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Am J Ind Med. 2007 Dec;50(12):940-50</RefSource>
<PMID Version="1">17972253</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Environ Health. 2007 Oct;70(3):32-6</RefSource>
<PMID Version="1">17941401</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Environ Health. 2007 Dec;70(5):43-4, 46</RefSource>
<PMID Version="1">18189039</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000293">Adolescent</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000328">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D017677">Age Distribution</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" Type="Geographic" UI="D000407">Alabama</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002648">Child</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D004651">Employment</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005843">Geography</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D018882">Heat Stress Disorders</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000453">epidemiology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000209">etiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006358">Hot Temperature</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000009">adverse effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015994">Incidence</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008875">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009765">Obesity</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000150">complications</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000453">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009784">Occupational Diseases</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000453">epidemiology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000209">etiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D016273">Occupational Exposure</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D016272">Occupational Health</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000706">statistics &amp; numerical data</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012307">Risk Factors</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D017678">Sex Distribution</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D055815">Young Adult</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<OtherID Source="NLM">NIHMS636725</OtherID>
<OtherID Source="NLM">PMC4211285</OtherID>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25190234</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>05</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>10</Month>
<Day>29</Day>
</DateCompleted>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">1558-3597</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>64</Volume>
<Issue>10</Issue>
<PubDate>
<Year>2014</Year>
<Month>Sep</Month>
<Day>9</Day>
</PubDate>
</JournalIssue>
<Title>Journal of the American College of Cardiology</Title>
<ISOAbbreviation>J. Am. Coll. Cardiol.</ISOAbbreviation>
</Journal>
<ArticleTitle>The relationship of body mass and fat distribution with incident hypertension: observations from the Dallas Heart Study.</ArticleTitle>
<Pagination>
<MedlinePgn>997-1002</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jacc.2014.05.057</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0735-1097(14)04332-0</ELocationID>
<Abstract>
<AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Obesity has been linked to the development of hypertension, but whether total adiposity or site-specific fat accumulation underpins this relationship is unclear.</AbstractText>
<AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">This study sought to determine the relationship between adipose tissue distribution and incident hypertension.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">Normotensive participants enrolled in the Dallas Heart Study were followed for a median of 7 years for the development of hypertension (systolic blood pressure [SBP] ≥140 mm Hg, diastolic blood pressure ≥90 mm Hg, or initiation of blood pressure medications). Visceral adipose tissue (VAT) and subcutaneous adipose tissue (SAT) was quantified by magnetic resonance imaging and proton-spectroscopic imaging, and lower body fat (LBF) was imaged by dual-energy x-ray absorptiometry. Multivariable relative risk regression was performed to test the association between individual fat depots and incident hypertension, adjusting for age, sex, race/ethnicity, diabetes, smoking, SBP, and body mass index (BMI).</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">Among 903 participants (median age, 40 years; 57% women; 60% nonwhite; median BMI 27.5 kg/m(2)), 230 (25%) developed incident hypertension. In multivariable analyses, higher BMI was significantly associated with incident hypertension (relative risk: 1.24; 95% confidence interval: 1.12 to 1.36, per 1-SD increase). However, when VAT, SAT, and LBF were added to the model, only VAT remained independently associated with incident hypertension (relative risk: 1.22; 95% confidence interval: 1.06 to 1.39, per 1-SD increase).</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Increased visceral adiposity, but not total or subcutaneous adiposity, was robustly associated with incident hypertension. Additional studies will be needed to elucidate the mechanisms behind this association.</AbstractText>
<CopyrightInformation>Copyright © 2014 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Chandra</LastName>
<ForeName>Alvin</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Neeland</LastName>
<ForeName>Ian J</ForeName>
<Initials>IJ</Initials>
<AffiliationInfo>
<Affiliation>Division of Cardiology, University of Texas Southwestern Medical Center, Dallas, Texas.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Berry</LastName>
<ForeName>Jarett D</ForeName>
<Initials>JD</Initials>
<AffiliationInfo>
<Affiliation>Division of Cardiology, University of Texas Southwestern Medical Center, Dallas, Texas; Department of Clinical Sciences, University of Texas Southwestern Medical Center, Dallas, Texas.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Ayers</LastName>
<ForeName>Colby R</ForeName>
<Initials>CR</Initials>
<AffiliationInfo>
<Affiliation>Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas; Department of Clinical Sciences, University of Texas Southwestern Medical Center, Dallas, Texas.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Rohatgi</LastName>
<ForeName>Anand</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Division of Cardiology, University of Texas Southwestern Medical Center, Dallas, Texas.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Das</LastName>
<ForeName>Sandeep R</ForeName>
<Initials>SR</Initials>
<AffiliationInfo>
<Affiliation>Division of Cardiology, University of Texas Southwestern Medical Center, Dallas, Texas.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Khera</LastName>
<ForeName>Amit</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Division of Cardiology, University of Texas Southwestern Medical Center, Dallas, Texas.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>McGuire</LastName>
<ForeName>Darren K</ForeName>
<Initials>DK</Initials>
<AffiliationInfo>
<Affiliation>Division of Cardiology, University of Texas Southwestern Medical Center, Dallas, Texas; Department of Clinical Sciences, University of Texas Southwestern Medical Center, Dallas, Texas.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>de Lemos</LastName>
<ForeName>James A</ForeName>
<Initials>JA</Initials>
<AffiliationInfo>
<Affiliation>Division of Cardiology, University of Texas Southwestern Medical Center, Dallas, Texas.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Turer</LastName>
<ForeName>Aslan T</ForeName>
<Initials>AT</Initials>
<AffiliationInfo>
<Affiliation>Division of Cardiology, University of Texas Southwestern Medical Center, Dallas, Texas. Electronic address: aslan.turer@utsouthwestern.edu.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D003160">Comparative Study</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D064888">Observational Study</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>J Am Coll Cardiol</MedlineTA>
<NlmUniqueID>8301365</NlmUniqueID>
<ISSNLinking>0735-1097</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList>
<CommentsCorrections RefType="CommentIn">
<RefSource>J Am Coll Cardiol. 2014 Sep 9;64(10):1003-4</RefSource>
<PMID Version="1">25190235</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000328">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D017677">Age Distribution</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D050218">Body Fat Distribution</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000706">statistics &amp; numerical data</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D015992">Body Mass Index</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015331">Cohort Studies</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015897">Comorbidity</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D016001">Confidence Intervals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005500">Follow-Up Studies</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006973">Hypertension</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000175">diagnosis</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000453">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015994">Incidence</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008875">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015999">Multivariate Analysis</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009765">Obesity</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000175">diagnosis</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000453">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012044">Regression Analysis</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D018570">Risk Assessment</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D017678">Sex Distribution</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D018709">Statistics, Nonparametric</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" Type="Geographic" UI="D013781">Texas</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">body fat distribution</Keyword>
<Keyword MajorTopicYN="N">hypertension</Keyword>
<Keyword MajorTopicYN="N">obesity</Keyword>
<Keyword MajorTopicYN="N">visceral fat</Keyword>
</KeywordList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25190235</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>05</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>10</Month>
<Day>29</Day>
</DateCompleted>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">1558-3597</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>64</Volume>
<Issue>10</Issue>
<PubDate>
<Year>2014</Year>
<Month>Sep</Month>
<Day>9</Day>
</PubDate>
</JournalIssue>
<Title>Journal of the American College of Cardiology</Title>
<ISOAbbreviation>J. Am. Coll. Cardiol.</ISOAbbreviation>
</Journal>
<ArticleTitle>Adiposity and risk for hypertension: does location matter?</ArticleTitle>
<Pagination>
<MedlinePgn>1003-4</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jacc.2014.07.005</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0735-1097(14)04331-9</ELocationID>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Krakoff</LastName>
<ForeName>Lawrence R</ForeName>
<Initials>LR</Initials>
<AffiliationInfo>
<Affiliation>Icahn School of Medicine at Mount Sinai, New York, New York. Electronic address: Lawrence.krakoff@mountsinai.org.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016420">Comment</PublicationType>
<PublicationType UI="D016421">Editorial</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>J Am Coll Cardiol</MedlineTA>
<NlmUniqueID>8301365</NlmUniqueID>
<ISSNLinking>0735-1097</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList>
<CommentsCorrections RefType="CommentOn">
<RefSource>J Am Coll Cardiol. 2014 Sep 9;64(10):997-1002</RefSource>
<PMID Version="1">25190234</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D050218">Body Fat Distribution</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000706">statistics &amp; numerical data</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D015992">Body Mass Index</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006973">Hypertension</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000453">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009765">Obesity</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000453">epidemiology</QualifierName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">magnetic resonance hypertension</Keyword>
<Keyword MajorTopicYN="N">obesity</Keyword>
<Keyword MajorTopicYN="N">retroperitoneum</Keyword>
</KeywordList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25188457</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>05</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>04</Day>
</DateCompleted>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">1085-5629</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>33</Volume>
<Issue>3 Suppl</Issue>
<PubDate>
<Year>2014</Year>
<Month>Jun</Month>
</PubDate>
</JournalIssue>
<Title>Seminars in cutaneous medicine and surgery</Title>
<ISOAbbreviation>Semin Cutan Med Surg</ISOAbbreviation>
</Journal>
<ArticleTitle>Hidradenitis suppurativa: current views on epidemiology, pathogenesis, and pathophysiology.</ArticleTitle>
<Pagination>
<MedlinePgn>S48-50</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.12788/j.sder.0091</ELocationID>
<Abstract>
<AbstractText>Hidradenitis suppurativa (HS) is a disease characterized by chronic follicular occlusion and secondary inflammation of the apocrine glands. The disease is uncommon but not rare. Further epidemiologic study is required to better determine HS prevalence in various populations. Women are affected three times more often than men, although HS tends to be more severe in men. The typical age of onset is in the second and third decades; HS is rare prior to puberty, and the prevalence is lower in older adults. A number of factors (particularly cigarette smoking) and comorbid conditions (especially obesity) are associated with HS, but causative relationships have not been established. </AbstractText>
<CopyrightInformation>2014 published by Frontline Medical Communications.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Micheletti</LastName>
<ForeName>Robert G</ForeName>
<Initials>RG</Initials>
<AffiliationInfo>
<Affiliation>Assistant Professor of Dermatology and Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Semin Cutan Med Surg</MedlineTA>
<NlmUniqueID>9617260</NlmUniqueID>
<ISSNLinking>1085-5629</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D006728">Hormones</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000293">Adolescent</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000328">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D017668">Age of Onset</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000368">Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001424">Bacterial Infections</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002648">Child</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005799">Genes, Dominant</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D017497">Hidradenitis Suppurativa</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000453">epidemiology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000209">etiology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000503">physiopathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006728">Hormones</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000502">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007111">Immunity, Cellular</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008875">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009765">Obesity</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000150">complications</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015995">Prevalence</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012307">Risk Factors</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D017678">Sex Distribution</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012907">Smoking</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000009">adverse effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D055815">Young Adult</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">autosomal dominant inheritance</Keyword>
<Keyword MajorTopicYN="N">cigarette smoking</Keyword>
<Keyword MajorTopicYN="N">comorbidities</Keyword>
<Keyword MajorTopicYN="N">hidradenitis suppurativa</Keyword>
<Keyword MajorTopicYN="N">obesity</Keyword>
</KeywordList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25188459</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>05</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>04</Day>
</DateCompleted>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">1085-5629</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>33</Volume>
<Issue>3 Suppl</Issue>
<PubDate>
<Year>2014</Year>
<Month>Jun</Month>
</PubDate>
</JournalIssue>
<Title>Seminars in cutaneous medicine and surgery</Title>
<ISOAbbreviation>Semin Cutan Med Surg</ISOAbbreviation>
</Journal>
<ArticleTitle>Recognizing and managing comorbidities and complications in hidradenitis suppurativa.</ArticleTitle>
<Pagination>
<MedlinePgn>S54-6</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.12788/j.sder.0093</ELocationID>
<Abstract>
<AbstractText>The list of comorbidities associated with hidradenitis suppurativa (HS) is extensive, although these diseases do not necessarily share a common causality. Among the categories of comorbidities that are observed are obesity, other skin diseases, inflammatory conditions, and genetic disorders. Complications include scarring, restricted movement resulting from scarring and fibrosis in underlying tissue, conditions associated with obstructed lymph drainage, and psychosocial issues. Adverse effects on quality of life are common and may be severe, including unemployment, deterioration of family and other social relationships, and suicidal ideation. Clinical intervention for HS must include consideration and attention to these comorbidities and complications. </AbstractText>
<CopyrightInformation>2014 published by Frontline Medical Communications.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Menter</LastName>
<ForeName>Alan</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Chief, Division of Dermatology, Baylor University Medical Center; Clinical Professor of Dermatology, University of Texas, Southwestern Medical School; Director, Fellowship Program, Baylor Psoriasis Center; Chair, Psoriasis Guidelines Committee, American Academy of Dermatology; Director, Dermatology Residency Program, Baylor University Medical Center, Dallas, TX.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Semin Cutan Med Surg</MedlineTA>
<NlmUniqueID>9617260</NlmUniqueID>
<ISSNLinking>1085-5629</ISSNLinking>
</MedlineJournalInfo>
<SupplMeshList>
<SupplMeshName Type="Disease" UI="C536168">Keratitis, Ichthyosis, and Deafness (KID) Syndrome</SupplMeshName>
</SupplMeshList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000328">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D018771">Arthralgia</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000150">complications</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001168">Arthritis</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000150">complications</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002921">Cicatrix</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000209">etiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D003424">Crohn Disease</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000150">complications</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D003638">Deafness</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000150">complications</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D004314">Down Syndrome</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000150">complications</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005355">Fibrosis</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000209">etiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D017497">Hidradenitis Suppurativa</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000150">complications</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000523">psychology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000628">therapy</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007057">Ichthyosis</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000150">complications</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007634">Keratitis</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000150">complications</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008209">Lymphedema</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000209">etiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008875">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009765">Obesity</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000150">complications</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011788">Quality of Life</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012871">Skin Diseases</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000150">complications</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D055815">Young Adult</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Comorbidities</Keyword>
<Keyword MajorTopicYN="N">dermatologic diseases</Keyword>
<Keyword MajorTopicYN="N">hidradenitis suppurativa</Keyword>
<Keyword MajorTopicYN="N">immune-mediated inflammatory diseases</Keyword>
<Keyword MajorTopicYN="N">obesity</Keyword>
</KeywordList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25071151</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>06</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>11</Day>
</DateCompleted>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1098-5549</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>34</Volume>
<Issue>19</Issue>
<PubDate>
<Year>2014</Year>
<Month>Oct</Month>
<Day>1</Day>
</PubDate>
</JournalIssue>
<Title>Molecular and cellular biology</Title>
<ISOAbbreviation>Mol. Cell. Biol.</ISOAbbreviation>
</Journal>
<ArticleTitle>12-lipoxygenase promotes obesity-induced oxidative stress in pancreatic islets.</ArticleTitle>
<Pagination>
<MedlinePgn>3735-45</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1128/MCB.00157-14</ELocationID>
<Abstract>
<AbstractText>High-fat diets lead to obesity, inflammation, and dysglycemia. 12-Lipoxygenase (12-LO) is activated by high-fat diets and catalyzes the oxygenation of cellular arachidonic acid to form proinflammatory intermediates. We hypothesized that 12-LO in the pancreatic islet is sufficient to cause dysglycemia in the setting of high-fat feeding. To test this, we generated pancreas-specific 12-LO knockout mice and studied their metabolic and molecular adaptations to high-fat diets. Whereas knockout mice and control littermates displayed identical weight gain, body fat distribution, and macrophage infiltration into fat, knockout mice exhibited greater adaptive islet hyperplasia, improved insulin secretion, and complete protection from dysglycemia. At the molecular level, 12-LO deletion resulted in increases in islet antioxidant enzymes Sod1 and Gpx1 in response to high-fat feeding. The absence or inhibition of 12-LO led to increases in nuclear Nrf2, a transcription factor responsible for activation of genes encoding antioxidant enzymes. Our data reveal a novel pathway in which islet 12-LO suppresses antioxidant enzymes and prevents the adaptive islet responses in the setting of high-fat diets. </AbstractText>
<CopyrightInformation>Copyright © 2014, American Society for Microbiology. All Rights Reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Tersey</LastName>
<ForeName>Sarah A</ForeName>
<Initials>SA</Initials>
<AffiliationInfo>
<Affiliation>Department of Pediatrics and Herman B Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, Indiana, USA stersey@iu.edu rmirmira@iu.edu.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Maier</LastName>
<ForeName>Bernhard</ForeName>
<Initials>B</Initials>
<AffiliationInfo>
<Affiliation>Department of Pediatrics and Herman B Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, Indiana, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Nishiki</LastName>
<ForeName>Yurika</ForeName>
<Initials>Y</Initials>
<AffiliationInfo>
<Affiliation>Department of Pediatrics and Herman B Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, Indiana, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Maganti</LastName>
<ForeName>Aarthi V</ForeName>
<Initials>AV</Initials>
<AffiliationInfo>
<Affiliation>Department of Cellular and Integrative Physiology, Indiana University School of Medicine, Indianapolis, Indiana, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Nadler</LastName>
<ForeName>Jerry L</ForeName>
<Initials>JL</Initials>
<AffiliationInfo>
<Affiliation>Department of Medicine and Strelitz Diabetes Center, Eastern Virginia Medical School, Norfolk, Virginia, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Mirmira</LastName>
<ForeName>Raghavendra G</ForeName>
<Initials>RG</Initials>
<AffiliationInfo>
<Affiliation>Department of Pediatrics and Herman B Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, Indiana, USA Department of Medicine, Indiana University School of Medicine, Indianapolis, Indiana, USA Department of Cellular and Integrative Physiology, Indiana University School of Medicine, Indianapolis, Indiana, USA Department of Biochemistry and Molecular Biology, Indiana University School of Medicine, Indianapolis, Indiana, USA stersey@iu.edu rmirmira@iu.edu.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>R01 DK060581</GrantID>
<Acronym>DK</Acronym>
<Agency>NIDDK NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R01 DK080583</GrantID>
<Acronym>DK</Acronym>
<Agency>NIDDK NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R01 HL112605</GrantID>
<Acronym>HL</Acronym>
<Agency>NHLBI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>07</Month>
<Day>28</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Mol Cell Biol</MedlineTA>
<NlmUniqueID>8109087</NlmUniqueID>
<ISSNLinking>0270-7306</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D016207">Cytokines</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D051267">NF-E2-Related Factor 2</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 1.11.1.-</RegistryNumber>
<NameOfSubstance UI="C117216">glutathione peroxidase GPX1</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 1.11.1.9</RegistryNumber>
<NameOfSubstance UI="D005979">Glutathione Peroxidase</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 1.13.11.31</RegistryNumber>
<NameOfSubstance UI="C521960">Alox15 protein, mouse</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 1.13.11.31</RegistryNumber>
<NameOfSubstance UI="D001092">Arachidonate 12-Lipoxygenase</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 1.13.11.33</RegistryNumber>
<NameOfSubstance UI="D001093">Arachidonate 15-Lipoxygenase</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 1.15.1.-</RegistryNumber>
<NameOfSubstance UI="C109808">superoxide dismutase 1</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 1.15.1.1</RegistryNumber>
<NameOfSubstance UI="D013482">Superoxide Dismutase</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000818">Animals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001092">Arachidonate 12-Lipoxygenase</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000235">genetics</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001093">Arachidonate 15-Lipoxygenase</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000235">genetics</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D016207">Cytokines</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D003921">Diabetes Mellitus, Experimental</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D059305">Diet, High-Fat</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000009">adverse effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005786">Gene Expression Regulation</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D018149">Glucose Intolerance</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005979">Glutathione Peroxidase</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006965">Hyperplasia</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D050417">Insulin-Secreting Cells</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007515">Islets of Langerhans</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D051379">Mice</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D018345">Mice, Knockout</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D051267">NF-E2-Related Factor 2</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009765">Obesity</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D018384">Oxidative Stress</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D013482">Superoxide Dismutase</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
</MeshHeadingList>
<OtherID Source="NLM">PMC4187733 [Available on 04/01/15]</OtherID>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25191773</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>06</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>18</Day>
</DateCompleted>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0353-5053</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>26</Volume>
<Issue>3</Issue>
<PubDate>
<Year>2014</Year>
<Month>Sep</Month>
</PubDate>
</JournalIssue>
<Title>Psychiatria Danubina</Title>
<ISOAbbreviation>Psychiatr Danub</ISOAbbreviation>
</Journal>
<ArticleTitle>Clinical correlates of global functioning in obese treatment seeking persons with binge eating disorder.</ArticleTitle>
<Pagination>
<MedlinePgn>256-60</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">In recent years, research has called for an increased emphasis on clinical outcomes that are meaningful to patients with binge eating disorder (BED). This cross-sectional study examined the Global Assessment of Functioning (GAF) and its relation to clinical and demographic factors in BED patients.</AbstractText>
<AbstractText Label="SUBJECTS AND METHODS" NlmCategory="METHODS">Thirty-two patients (28 women and 4 men) with BED (age = 41.1 ± 10.7; body mass index = 38.9 ± 5.8) seeking treatment to a weekly multidisciplinary programme at the UPC KU Leuven, Campus Kortenberg in Belgium, were asked to participate at intake. All participants were assessed with the GAF scale, completed the Eating Disorder Inventory (EDI), the Body Attitude Test (BAT), the Symptoms Checklist-90, the Baecke Physical Activity Questionnaire (BPAQ), and performed a 6 minute walk test.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">The GAF-score (55.9 ± 13.9) was only significantly associated with the BPAQ score (7.0 ± 1.4) (r = 0.383, p = 0.03) and the BAT score (63.9 ± 16.1) (r=-0.443, p = 0.011). The regression model including both of these variables explained 25.3% of the variability in the GAF-score.</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">This study highlights the value of clinicians assessing physical activity and body image in patients with BED. Research is needed to elucidate whether incorporating body image treatments and physical activity in the care of patients with BED can promote global functioning.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Vancampfort</LastName>
<ForeName>Davy</ForeName>
<Initials>D</Initials>
<AffiliationInfo>
<Affiliation>KU Leuven Department of Neurosciences, UPC KU Leuven Campus Kortenberg, Kortenberg, Belgium, Davy.Vancampfort@uc-kortenberg.be.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Probst</LastName>
<ForeName>Michel</ForeName>
<Initials>M</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Adriaens</LastName>
<ForeName>An</ForeName>
<Initials>A</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Pieters</LastName>
<ForeName>Guido</ForeName>
<Initials>G</Initials>
</Author>
<Author ValidYN="Y">
<LastName>De Hert</LastName>
<ForeName>Marc</ForeName>
<Initials>M</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Soundy</LastName>
<ForeName>Andrew</ForeName>
<Initials>A</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Stubbs</LastName>
<ForeName>Brendon</ForeName>
<Initials>B</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Vanderlinden</LastName>
<ForeName>Johan</ForeName>
<Initials>J</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>Croatia</Country>
<MedlineTA>Psychiatr Danub</MedlineTA>
<NlmUniqueID>9424753</NlmUniqueID>
<ISSNLinking>0353-5053</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000203">Activities of Daily Living</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000145">classification</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000523">psychology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000328">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D056912">Binge-Eating Disorder</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000175">diagnosis</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000453">epidemiology</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000523">psychology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015992">Body Mass Index</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D003299">Cooperative Behavior</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D003430">Cross-Sectional Studies</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D033183">Interdisciplinary Communication</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008875">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009043">Motor Activity</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009765">Obesity</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000453">epidemiology</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000523">psychology</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000628">therapy</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D010809">Physical Fitness</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011594">Psychometrics</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000706">statistics &amp; numerical data</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011795">Questionnaires</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">24145235</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>06</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>10</Month>
<Day>30</Day>
</DateCompleted>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Print">1878-8750</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>82</Volume>
<Issue>1-2</Issue>
<PubDate>
<MedlineDate>2014 Jul-Aug</MedlineDate>
</PubDate>
</JournalIssue>
<Title>World neurosurgery</Title>
<ISOAbbreviation>World Neurosurg</ISOAbbreviation>
</Journal>
<ArticleTitle>The impact of obesity on surgeon ratings and patient-reported outcome measures after degenerative cervical spine disease surgery.</ArticleTitle>
<Pagination>
<MedlinePgn>e345-52</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.wneu.2013.09.053</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S1878-8750(13)01369-7</ELocationID>
<Abstract>
<AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">Obesity is a growing public health problem. A considerable number of patients undergoing cervical spine surgery are obese, but the correlation between obesity and surgical outcome is still unclear. In this study, we investigated the impact of body mass index (BMI) on patients' and surgeons' perception of spine surgery outcomes.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">We analyzed a prospectively collected spine surgery registry with patient-reported outcome measures and surgeon ratings. Mixed-effects linear models and linear regression models were applied to investigate the relationship between different World Health Organization obesity classifications and surgical outcome.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 88 patients had surgery for degenerative cervical spine disease, with 97.72% follow-up at 3 months and 94.31% at 6 months postoperatively. Mean BMI was 27.92 ± 7.9 kg/m(2); 28.57% were overweight (BMI 25-29.9), and 31.57% were obese (Class I obesity, BMI 30-34.9). We found a positive correlation between BMI and VAS at 6 months (R = 0.298, P &lt; 0.05) and between BMI and change in Neck Disability Index (R = 0.385, P &lt; 0.01), suggesting that obese patients had less improvement and more pain 6 months postoperatively than nonobese patients. Overweight patients had worse MCS values (R = -0.275, P &lt; 0.05) and obese patients had worse visual analog scale values 6 months after surgery (R = 0.284, P &lt; 0.03). Interestingly, surgeon ratings matched the aforementioned results. Patients with greater BMI had worse surgeon ratings 3 and 6 months postoperatively (R = 0.555, P &lt; 0.05), whereas normal-weight patients had better outcomes when rated from the surgeon's perspective (R = -0.536, P &lt; 0.05).</AbstractText>
<AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Obese patients had worse postoperative patient-reported outcome scores and less overall patient-rated improvement compared with nonobese patients. Patients with BMI &gt;25 reported less improvement after surgery both in the patients' and in the surgeons' perspectives.</AbstractText>
<CopyrightInformation>Copyright © 2014 Elsevier Inc. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Auffinger</LastName>
<ForeName>Brenda</ForeName>
<Initials>B</Initials>
<AffiliationInfo>
<Affiliation>Section of Neurosurgery, The University of Chicago, Chicago, Illinois, USA. Electronic address: bauffinger@surgery.bsd.uchicago.edu.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Lam</LastName>
<ForeName>Sandi</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Baylor College of Medicine, Texas Children's Hospital, Houston, Texas, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Kraninger</LastName>
<ForeName>Jennifer</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>Section of Neurosurgery, The University of Chicago, Chicago, Illinois, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Shen</LastName>
<ForeName>Jingjing</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>Section of Neurosurgery, The University of Chicago, Chicago, Illinois, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Roitberg</LastName>
<ForeName>Ben Z</ForeName>
<Initials>BZ</Initials>
<AffiliationInfo>
<Affiliation>Section of Neurosurgery, The University of Chicago, Chicago, Illinois, USA.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2013</Year>
<Month>10</Month>
<Day>18</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>World Neurosurg</MedlineTA>
<NlmUniqueID>101528275</NlmUniqueID>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList>
<CommentsCorrections RefType="CommentIn">
<RefSource>World Neurosurg. 2014 Jul-Aug;82(1-2):e147-8</RefSource>
<PMID Version="1">24534061</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000328">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000368">Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015992">Body Mass Index</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002574">Cervical Vertebrae</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000601">surgery</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D004185">Disability Evaluation</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D055959">Intervertebral Disc Degeneration</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000523">psychology</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000601">surgery</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D016014">Linear Models</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008875">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D019547">Neck Pain</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000209">etiology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000601">surgery</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009765">Obesity</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000150">complications</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D010147">Pain Measurement</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D063868">Patient Outcome Assessment</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011446">Prospective Studies</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012044">Regression Analysis</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D016896">Treatment Outcome</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Body mass index</Keyword>
<Keyword MajorTopicYN="N">Degenerative cervical spine disease</Keyword>
<Keyword MajorTopicYN="N">Patient-reported outcomes</Keyword>
<Keyword MajorTopicYN="N">Spine surgery outcomes</Keyword>
<Keyword MajorTopicYN="N">Surgeon ratings</Keyword>
</KeywordList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">24534061</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>06</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>10</Month>
<Day>30</Day>
</DateCompleted>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Print">1878-8750</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>82</Volume>
<Issue>1-2</Issue>
<PubDate>
<MedlineDate>2014 Jul-Aug</MedlineDate>
</PubDate>
</JournalIssue>
<Title>World neurosurgery</Title>
<ISOAbbreviation>World Neurosurg</ISOAbbreviation>
</Journal>
<ArticleTitle>Obesity in cervical spine surgery.</ArticleTitle>
<Pagination>
<MedlinePgn>e147-8</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.wneu.2014.02.014</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S1878-8750(14)00144-2</ELocationID>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Witek</LastName>
<ForeName>Alex M</ForeName>
<Initials>AM</Initials>
<AffiliationInfo>
<Affiliation>Department of Neurosurgery, Neurological Institute, Cleveland Clinic, Cleveland, Ohio, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Benzel</LastName>
<ForeName>Edward C</ForeName>
<Initials>EC</Initials>
<AffiliationInfo>
<Affiliation>Department of Neurosurgery, Neurological Institute, Cleveland Clinic, Cleveland, Ohio, USA. Electronic address: benzele@ccf.org.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016420">Comment</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>02</Month>
<Day>15</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>World Neurosurg</MedlineTA>
<NlmUniqueID>101528275</NlmUniqueID>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList>
<CommentsCorrections RefType="CommentOn">
<RefSource>World Neurosurg. 2014 Jul-Aug;82(1-2):e345-52</RefSource>
<PMID Version="1">24145235</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002574">Cervical Vertebrae</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000601">surgery</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D055959">Intervertebral Disc Degeneration</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000601">surgery</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009765">Obesity</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000150">complications</QualifierName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Body mass index</Keyword>
<Keyword MajorTopicYN="N">Degenerative cervical spine disease</Keyword>
<Keyword MajorTopicYN="N">Patient-reported outcomes</Keyword>
<Keyword MajorTopicYN="N">Spine surgery outcomes</Keyword>
<Keyword MajorTopicYN="N">Surgeon ratings</Keyword>
</KeywordList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25195377</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>08</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>09</Month>
<Day>30</Day>
</DateCompleted>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">1438-3276</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>156</Volume>
<Issue>14</Issue>
<PubDate>
<Year>2014</Year>
<Month>Aug</Month>
<Day>21</Day>
</PubDate>
</JournalIssue>
<Title>MMW Fortschritte der Medizin</Title>
<ISOAbbreviation>MMW Fortschr Med</ISOAbbreviation>
</Journal>
<ArticleTitle>[Risk of suicide in smokers. Puff by puff to suicide?].</ArticleTitle>
<Pagination>
<MedlinePgn>6</MedlinePgn>
</Pagination>
<Language>ger</Language>
<PublicationTypeList>
<PublicationType UI="D016433">News</PublicationType>
</PublicationTypeList>
<VernacularTitle>Selbstmordgefahr bei Rauchern. Zug um Zug zum Suizid?</VernacularTitle>
</Article>
<MedlineJournalInfo>
<Country>Germany</Country>
<MedlineTA>MMW Fortschr Med</MedlineTA>
<NlmUniqueID>100893959</NlmUniqueID>
<ISSNLinking>1438-3276</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" Type="Geographic" UI="D001317">Austria</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002423">Cause of Death</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D003924">Diabetes Mellitus, Type 2</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000401">mortality</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006949">Hyperlipidemias</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000401">mortality</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009765">Obesity</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000401">mortality</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012307">Risk Factors</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012907">Smoking</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000009">adverse effects</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000401">mortality</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D013405">Suicide</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25194732</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>08</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>10</Month>
<Day>24</Day>
</DateCompleted>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0236-5383</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>65</Volume>
<Issue>3</Issue>
<PubDate>
<Year>2014</Year>
<Month>Sep</Month>
</PubDate>
</JournalIssue>
<Title>Acta biologica Hungarica</Title>
<ISOAbbreviation>Acta. Biol. Hung.</ISOAbbreviation>
</Journal>
<ArticleTitle>Exaggerated activity of HPA axis in obese rats fed normocaloric liquid nutrition.</ArticleTitle>
<Pagination>
<MedlinePgn>285-93</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1556/ABiol.65.2014.3.5</ELocationID>
<Abstract>
<AbstractText>Experimental and clinical studies have shown alterations in activity of systems responsible for neuroendocrine stress response in obese individuals. Therefore we investigated the effect of palatable normocaloric liquid nutrition (Fresubin) on alterations in activity of the hypothalamic-pituitary-adrenal (HPA) axis in male Wistar rats of different developmental stages. Control rats (CON) received standard pellet chow all the time from weaning (21st day of age) to 150 days. Fresubin was administered throughout the experiment (LN), only in juvenility (from 21st to 90th day of age; LNJ) or only in adulthood (from 90th to 150th day of age; LNA). Body weight and energy intake were periodically monitored. Adrenal gland and fat tissue weight and plasma corticosterone levels (CORT) was determined after sacrification. Fresubin intake induced obesity in LN and LNA rats. In LN and LNA rats were observed elevated serum CORT levels, but only in LN rats with significant twofold increase compared to LNJ rats. However, the weight of adrenal glands did not differ between LN, LNJ and LNA experimental groups. Based on our results, we suggest, that obesity induced by Fresubin in LN and LNA rats is accompanied by increased HPA activity represented by elevated plasma CORT levels in these rats. </AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Vrabcova</LastName>
<ForeName>Michaela</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Comenius University Institute of Histology and Embryology, Faculty of Medicine Sasinkova 4 81108 Bratislava Slovak Republic.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Mikuska</LastName>
<ForeName>Livia</ForeName>
<Initials>L</Initials>
<AffiliationInfo>
<Affiliation>Slovak Academy of Sciences Institute of Experimental Endocrinology Vlarska 3 84215 Bratislava Slovak Republic.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Zeman</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Comenius University Department of Animal Physiology and Ethology Faculty of Natural Sciences Mlynska dolina B2 84215 Bratislava Slovak Republic.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Mravec</LastName>
<ForeName>B</ForeName>
<Initials>B</Initials>
<AffiliationInfo>
<Affiliation>Slovak Academy of Sciences Institute of Experimental Endocrinology Vlarska 3 84215 Bratislava Slovak Republic Comenius University Institute of Physiology, Faculty of Medicine Sasinkova 2 81108 Bratislava Slovak Republic.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>Hungary</Country>
<MedlineTA>Acta Biol Hung</MedlineTA>
<NlmUniqueID>8404358</NlmUniqueID>
<ISSNLinking>0236-5383</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D004044">Dietary Proteins</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C048418">Fresubin</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>WI4X0X7BPJ</RegistryNumber>
<NameOfSubstance UI="D006854">Hydrocortisone</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D050154">Adiposity</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000187">drug effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000284">Administration, Oral</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000367">Age Factors</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000818">Animals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D004044">Dietary Proteins</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000008">administration &amp; dosage</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000633">toxicity</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D002149">Energy Intake</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006854">Hydrocortisone</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000097">blood</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007030">Hypothalamo-Hypophyseal System</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000187">drug effects</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000503">physiopathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009765">Obesity</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000139">chemically induced</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000503">physiopathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D010913">Pituitary-Adrenal System</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000187">drug effects</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000503">physiopathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D051381">Rats</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D017208">Rats, Wistar</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D013997">Time Factors</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015430">Weight Gain</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000187">drug effects</QualifierName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Corticosterone</Keyword>
<Keyword MajorTopicYN="N">Fresubin</Keyword>
<Keyword MajorTopicYN="N">liquid nutrition</Keyword>
<Keyword MajorTopicYN="N">obesity</Keyword>
<Keyword MajorTopicYN="N">rats</Keyword>
</KeywordList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25070058</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>08</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>10</Month>
<Day>30</Day>
</DateCompleted>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1572-0241</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>109</Volume>
<Issue>9</Issue>
<PubDate>
<Year>2014</Year>
<Month>Sep</Month>
</PubDate>
</JournalIssue>
<Title>The American journal of gastroenterology</Title>
<ISOAbbreviation>Am. J. Gastroenterol.</ISOAbbreviation>
</Journal>
<ArticleTitle>Racial differences in the progression to cirrhosis and hepatocellular carcinoma in HCV-infected veterans.</ArticleTitle>
<Pagination>
<MedlinePgn>1427-35</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1038/ajg.2014.214</ELocationID>
<Abstract>
<AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">The race of patients infected with hepatitis C virus (HCV) in the United States may be associated with the risk for cirrhosis and hepatocellular carcinoma (HCC). However, previous studies are too small to provide convincing data regarding the effect of race on cirrhosis and HCC risk after accounting for demographic, clinical, and virological factors.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">We used the Veterans Administration (VA) HCV Clinical Case Registry to identify patients with confirmed viremia between 2000 and 2009 and with at least 1 year of follow-up in the VA. We identified cirrhosis and HCC cases through early 2010. Cox proportional hazard regression models were performed to examine the effect of race on the risk for cirrhosis and HCC while adjusting for patients' age, gender, period of service (World War I/II, Vietnam era, post-Vietnam era), HIV coinfection, HBV coinfection, alcohol abuse, diabetes, body mass index, and antiviral treatment receipt and response.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">There were 149,407 patients with active HCV viremia. Of them, 56.3% were non-Hispanic White (NHW), 36.1% were African American (AA), 6.0% were Hispanic, and 1.6% belonged to other racial groups. After an average follow-up of 5.2 years, 13,099 patients were seen to have a recorded diagnosis of cirrhosis and 3,551 had HCC. Hispanics had the highest annual incidence rates of cirrhosis and HCC (28.8 and 7.8%, respectively), whereas AAs had the lowest rates (13.3% and 3.9%, respectively) compared with NHWs (21.6 and 4.7%, respectively). There were differences among NHW, AA, and Hispanic patients in the rates of HIV infection (2.1, 2.5, and 6.0%, respectively), HCV genotype 1 (50.0, 50.6, and 64.2%, respectively), obesity (28.0, 25.4, and 30.9%, respectively), diabetes (8.7, 16.1, and 16.1%, respectively), and absence of antiviral treatment (81.1, 89.6, and 82.1%, respectively). However, adjusting for differences in demographic and clinical factors did not change the magnitude or direction of the race effect. Compared with NHWs, Hispanic patients had a higher risk of having cirrhosis recorded (adjusted hazard ratio (HR)=1.28, 95% confidence interval (CI)=1.21-1.37) and HCC (1.61, 95% CI=1.44-1.80). In contrast, AAs had a lower risk of cirrhosis (HR=0.58, 95% CI=0.55-0.60) and HCC (0.77, 95% CI=0.71-0.83) compared with NHWs.</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Hispanics with HCV are at a significantly higher risk, whereas AAs are at a considerably lower risk of developing cirrhosis and HCC than are NHWs. These associations persisted even after adjusting for a range of factors including HCV genotype, HCV treatment, diabetes, and body mass index.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>El-Serag</LastName>
<ForeName>Hashem B</ForeName>
<Initials>HB</Initials>
<AffiliationInfo>
<Affiliation>1] Center for Innovations in Quality, Effectiveness and Safety (IQuESt), Michael E. DeBakey Veterans Affairs Medical Center, Houston, Texas, USA [2] Section of Gastroenterology and Hepatology, Department of Medicine, Baylor College of Medicine and Michael E. DeBakey Veterans Affairs Medical Center, Houston, Texas, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Kramer</LastName>
<ForeName>Jennifer</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>1] Center for Innovations in Quality, Effectiveness and Safety (IQuESt), Michael E. DeBakey Veterans Affairs Medical Center, Houston, Texas, USA [2] Section of Health Services Research, Department of Medicine, Baylor College of Medicine, Houston, Texas, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Duan</LastName>
<ForeName>Zhigang</ForeName>
<Initials>Z</Initials>
<AffiliationInfo>
<Affiliation>1] Center for Innovations in Quality, Effectiveness and Safety (IQuESt), Michael E. DeBakey Veterans Affairs Medical Center, Houston, Texas, USA [2] Section of Health Services Research, Department of Medicine, Baylor College of Medicine, Houston, Texas, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Kanwal</LastName>
<ForeName>Fasiha</ForeName>
<Initials>F</Initials>
<AffiliationInfo>
<Affiliation>1] Center for Innovations in Quality, Effectiveness and Safety (IQuESt), Michael E. DeBakey Veterans Affairs Medical Center, Houston, Texas, USA [2] Section of Gastroenterology and Hepatology, Department of Medicine, Baylor College of Medicine and Michael E. DeBakey Veterans Affairs Medical Center, Houston, Texas, USA.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>DK58338</GrantID>
<Acronym>DK</Acronym>
<Agency>NIDDK NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>K24DK-04-107</GrantID>
<Acronym>DK</Acronym>
<Agency>NIDDK NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R01CA 116845</GrantID>
<Acronym>CA</Acronym>
<Agency>NCI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
<PublicationType UI="D013486">Research Support, U.S. Gov't, Non-P.H.S.</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>07</Month>
<Day>29</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Am J Gastroenterol</MedlineTA>
<NlmUniqueID>0421030</NlmUniqueID>
<ISSNLinking>0002-9270</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000998">Antiviral Agents</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000328">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001741">African Americans</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000706">statistics &amp; numerical data</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000998">Antiviral Agents</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000627">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006528">Carcinoma, Hepatocellular</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000208">ethnology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000821">virology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D060085">Coinfection</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000208">ethnology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D003920">Diabetes Mellitus</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000208">ethnology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D044465">European Continental Ancestry Group</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000706">statistics &amp; numerical data</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005500">Follow-Up Studies</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005838">Genotype</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015658">HIV Infections</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000208">ethnology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D016174">Hepacivirus</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000235">genetics</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D019698">Hepatitis C, Chronic</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000150">complications</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000188">drug therapy</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000208">ethnology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006630">Hispanic Americans</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000706">statistics &amp; numerical data</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015994">Incidence</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008103">Liver Cirrhosis</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000208">ethnology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000821">virology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008113">Liver Neoplasms</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000208">ethnology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000821">virology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008875">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009765">Obesity</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000208">ethnology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015995">Prevalence</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012042">Registries</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012307">Risk Factors</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" Type="Geographic" UI="D014481">United States</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000453">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D014728">Veterans</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000706">statistics &amp; numerical data</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25194172</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>08</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>17</Day>
</DateCompleted>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1532-1916</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>28</Volume>
<Issue>4</Issue>
<PubDate>
<Year>2014</Year>
<Month>Aug</Month>
</PubDate>
</JournalIssue>
<Title>Best practice &amp; research. Clinical gastroenterology</Title>
<ISOAbbreviation>Best Pract Res Clin Gastroenterol</ISOAbbreviation>
</Journal>
<ArticleTitle>Obesity and the gastrointestinal tract.</ArticleTitle>
<Pagination>
<MedlinePgn>531-2</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.bpg.2014.07.014</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S1521-6918(14)00092-4</ELocationID>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Mathus-Vliegen</LastName>
<ForeName>E M H</ForeName>
<Initials>EM</Initials>
<AffiliationInfo>
<Affiliation>Department of Gastroenterology &amp; Hepatology, Academic Medical Centre University of Amsterdam, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands. Electronic address: e.mathus-vliegen@amc.uva.nl.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Greve</LastName>
<ForeName>J W M</ForeName>
<Initials>JW</Initials>
<AffiliationInfo>
<Affiliation>Atrium Medical Centre, Henry Dunantstraat 5, 6419 CX Heerlen, The Netherlands; Orbis Medical Centre, Sittard, The Netherlands.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016421">Editorial</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>07</Month>
<Day>24</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Netherlands</Country>
<MedlineTA>Best Pract Res Clin Gastroenterol</MedlineTA>
<NlmUniqueID>101120605</NlmUniqueID>
<ISSNLinking>1521-6918</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D041981">Gastrointestinal Tract</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D009765">Obesity</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25194173</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>08</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>17</Day>
</DateCompleted>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1532-1916</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>28</Volume>
<Issue>4</Issue>
<PubDate>
<Year>2014</Year>
<Month>Aug</Month>
</PubDate>
</JournalIssue>
<Title>Best practice &amp; research. Clinical gastroenterology</Title>
<ISOAbbreviation>Best Pract Res Clin Gastroenterol</ISOAbbreviation>
</Journal>
<ArticleTitle>The aetiology of obesity beyond eating more and exercising less.</ArticleTitle>
<Pagination>
<MedlinePgn>533-44</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.bpg.2014.07.001</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S1521-6918(14)00079-1</ELocationID>
<Abstract>
<AbstractText>Although recent increases in availability of energy dense, processed foods and reductions in institutionally driven physical activity have created an environment that is permissible for obesity to occur, several other factors may contribute to the development of obesity in this context. We review evidence for eleven such factors: endocrine disruptors, intrauterine effects, epigenetics, maternal age, differential fecundity and assortative mating by body mass index, microorganisms, reduction in variability of ambient temperatures, smoking cessation, sleep debt, and pharmaceutical iatrogenesis. Evidence for the role of endocrine disruptors, microorganisms, ambient temperatures, sleep and reproductive factors is accumulating, but additional research is needed to confirm the causative role of these factors in human obesity. However, the role of certain pharmaceuticals and smoking cessation in development of human obesity is clear. Practice points for consideration and future research needed are highlighted for each factor. </AbstractText>
<CopyrightInformation>Copyright © 2014 Elsevier Ltd. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Dhurandhar</LastName>
<ForeName>Emily J</ForeName>
<Initials>EJ</Initials>
<AffiliationInfo>
<Affiliation>Department of Health Behavior, Office of Energetics, Nutrition Obesity Research Center, University of Alabama at Birmingham, 1665 University Blvd, RPHB 227J, Birmingham, AL 35205, USA. Electronic address: edhurand@uab.edu.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Keith</LastName>
<ForeName>Scott W</ForeName>
<Initials>SW</Initials>
<AffiliationInfo>
<Affiliation>Department of Pharmacology and Experimental Therapeutics, Division of Biostatistics, Thomas Jefferson University, 1015 Chestnut St., Suite M100, Phildelphia, PA 19107, USA. Electronic address: scott.keith@jefferson.edu.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016454">Review</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>07</Month>
<Day>11</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Netherlands</Country>
<MedlineTA>Best Pract Res Clin Gastroenterol</MedlineTA>
<NlmUniqueID>101120605</NlmUniqueID>
<ISSNLinking>1521-6918</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001068">Eating Disorders</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000150">complications</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D004734">Energy Metabolism</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015444">Exercise</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000502">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D064307">Microbiota</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009765">Obesity</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000209">etiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012307">Risk Factors</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D057185">Sedentary Lifestyle</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Drug-related side effects and adverse reactions</Keyword>
<Keyword MajorTopicYN="N">Endocrine disruptors</Keyword>
<Keyword MajorTopicYN="N">Epigenomics</Keyword>
<Keyword MajorTopicYN="N">Infection</Keyword>
<Keyword MajorTopicYN="N">Microbiota</Keyword>
<Keyword MajorTopicYN="N">Obesity</Keyword>
<Keyword MajorTopicYN="N">Reproduction</Keyword>
<Keyword MajorTopicYN="N">Sleep</Keyword>
<Keyword MajorTopicYN="N">Smoking</Keyword>
<Keyword MajorTopicYN="N">Temperature</Keyword>
</KeywordList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25194174</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>08</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>17</Day>
</DateCompleted>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1532-1916</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>28</Volume>
<Issue>4</Issue>
<PubDate>
<Year>2014</Year>
<Month>Aug</Month>
</PubDate>
</JournalIssue>
<Title>Best practice &amp; research. Clinical gastroenterology</Title>
<ISOAbbreviation>Best Pract Res Clin Gastroenterol</ISOAbbreviation>
</Journal>
<ArticleTitle>Adipose tissues as endocrine target organs.</ArticleTitle>
<Pagination>
<MedlinePgn>545-58</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.bpg.2014.07.002</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S1521-6918(14)00080-8</ELocationID>
<Abstract>
<AbstractText>In the context of obesity, white adipocyte hypertrophy and adipose tissue macrophage infiltration result in the production of pro-inflammatory adipocytokines inducing insulin resistance locally but also in distant organs and contributing to low grade inflammatory status associated with the metabolic syndrome. Visceral adipose tissue is believed to play a prominent role. Brown and beige adipose tissues are capable of energy dissipation, but also of cytokine production and their role in dysmetabolic syndrome is emerging. This review focuses on metabolic and inflammatory changes in these adipose depots and contribution to metabolic syndrome. Also we will review surgical and pharmacological procedures to target adiposity as therapeutic interventions to treat obesity-associated disorders. </AbstractText>
<CopyrightInformation>Copyright © 2014 Elsevier Ltd. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Lanthier</LastName>
<ForeName>Nicolas</ForeName>
<Initials>N</Initials>
<AffiliationInfo>
<Affiliation>Laboratoire de Gastroentérologie et Hépatologie, Institut de Recherche Expérimentale et Clinique, Université catholique de Louvain, Brussels, Belgium; Service d'Hépato-Gastroentérologie, Cliniques Universitaires Saint-Luc, Université catholique de Louvain, Brussels, Belgium. Electronic address: Nicolas.Lanthier@uclouvain.be.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Leclercq</LastName>
<ForeName>Isabelle A</ForeName>
<Initials>IA</Initials>
<AffiliationInfo>
<Affiliation>Laboratoire de Gastroentérologie et Hépatologie, Institut de Recherche Expérimentale et Clinique, Université catholique de Louvain, Brussels, Belgium; Service d'Hépato-Gastroentérologie, Cliniques Universitaires Saint-Luc, Université catholique de Louvain, Brussels, Belgium. Electronic address: Isabelle.Leclercq@uclouvain.be.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016454">Review</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>07</Month>
<Day>11</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Netherlands</Country>
<MedlineTA>Best Pract Res Clin Gastroenterol</MedlineTA>
<NlmUniqueID>101120605</NlmUniqueID>
<ISSNLinking>1521-6918</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000273">Adipose Tissue</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000502">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D004703">Endocrine System</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008264">Macrophages</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000502">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D024821">Metabolic Syndrome X</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009765">Obesity</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Adipose tissue macrophage</Keyword>
<Keyword MajorTopicYN="N">Beige adipose tissue</Keyword>
<Keyword MajorTopicYN="N">Brown adipose tissue</Keyword>
<Keyword MajorTopicYN="N">Diabetes</Keyword>
<Keyword MajorTopicYN="N">Insulin</Keyword>
<Keyword MajorTopicYN="N">Metabolic syndrome</Keyword>
<Keyword MajorTopicYN="N">Obesity</Keyword>
<Keyword MajorTopicYN="N">Subcutaneous adipose tissue</Keyword>
<Keyword MajorTopicYN="N">Visceral adipose tissue</Keyword>
</KeywordList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25194175</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>08</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>17</Day>
</DateCompleted>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1532-1916</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>28</Volume>
<Issue>4</Issue>
<PubDate>
<Year>2014</Year>
<Month>Aug</Month>
</PubDate>
</JournalIssue>
<Title>Best practice &amp; research. Clinical gastroenterology</Title>
<ISOAbbreviation>Best Pract Res Clin Gastroenterol</ISOAbbreviation>
</Journal>
<ArticleTitle>The gut-brain axis in obesity.</ArticleTitle>
<Pagination>
<MedlinePgn>559-71</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.bpg.2014.07.003</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S1521-6918(14)00081-X</ELocationID>
<Abstract>
<AbstractText>Currently the only effective treatment for morbid obesity with a proven mortality benefit is surgical intervention. The underlying mechanisms of these surgical techniques are unclear, but alterations in circulating gut hormone levels have been demonstrated to be at least one contributing factor. Gut hormones seem to communicate information from the gastrointestinal tract to the regulatory appetite centres within the central nervous system (CNS) via the so-called 'Gut-Brain-Axis'. Such information may be transferred to the CNS either via vagal or non-vagal afferent nerve signalling or directly via blood circulation. Complex neural networks, distributed throughout the forebrain and brainstem, are in control of feeding and energy homoeostasis. This article aims to review how appetite is potentially regulated by these gastrointestinal hormones. Identification of the underlying mechanisms of appetite and weight control may pave the way to develop better surgical techniques and new therapies in the future. </AbstractText>
<CopyrightInformation>Copyright © 2014 Elsevier Ltd. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Buhmann</LastName>
<ForeName>Helena</ForeName>
<Initials>H</Initials>
<AffiliationInfo>
<Affiliation>Institute of Veterinary Physiology, Vetsuisse Faculty, University of Zurich, Switzerland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>le Roux</LastName>
<ForeName>Carel W</ForeName>
<Initials>CW</Initials>
<AffiliationInfo>
<Affiliation>Diabetes Complications Research Centre, Conway Institute, School of Medicine and Medical Sciences, University College Dublin, Ireland; Gastrosurgical Laboratory, University of Gothenburg, Sweden.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Bueter</LastName>
<ForeName>Marco</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Department of Surgery, Division of Visceral and Transplantation Surgery, University Hospital Zurich, Zurich, Switzerland; Center of Integrative Human Physiology, University of Zurich, Zurich, Switzerland. Electronic address: marco.bueter@usz.ch.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
<PublicationType UI="D016454">Review</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>07</Month>
<Day>11</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Netherlands</Country>
<MedlineTA>Best Pract Res Clin Gastroenterol</MedlineTA>
<NlmUniqueID>101120605</NlmUniqueID>
<ISSNLinking>1521-6918</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D005768">Gastrointestinal Hormones</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001069">Appetite Regulation</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000502">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001921">Brain</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005768">Gastrointestinal Hormones</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D041981">Gastrointestinal Tract</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000502">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009765">Obesity</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Appetite</Keyword>
<Keyword MajorTopicYN="N">Gastrointestinal hormones</Keyword>
<Keyword MajorTopicYN="N">Glucagon-like-peptide 1 (GLP-1)</Keyword>
<Keyword MajorTopicYN="N">Hypothalamus</Keyword>
<Keyword MajorTopicYN="N">Obesity</Keyword>
</KeywordList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25194176</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>08</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>17</Day>
</DateCompleted>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1532-1916</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>28</Volume>
<Issue>4</Issue>
<PubDate>
<Year>2014</Year>
<Month>Aug</Month>
</PubDate>
</JournalIssue>
<Title>Best practice &amp; research. Clinical gastroenterology</Title>
<ISOAbbreviation>Best Pract Res Clin Gastroenterol</ISOAbbreviation>
</Journal>
<ArticleTitle>Bile acids, obesity, and the metabolic syndrome.</ArticleTitle>
<Pagination>
<MedlinePgn>573-83</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.bpg.2014.07.004</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S1521-6918(14)00082-1</ELocationID>
<Abstract>
<AbstractText>Bile acids are increasingly recognized as key regulators of systemic metabolism. While bile acids have long been known to play important and direct roles in nutrient absorption, bile acids also serve as signalling molecules. Bile acid interactions with the nuclear hormone receptor farnesoid X receptor (FXR) and the membrane receptor G-protein-coupled bile acid receptor 5 (TGR5) can regulate incretin hormone and fibroblast growth factor 19 (FGF19) secretion, cholesterol metabolism, and systemic energy expenditure. Bile acid levels and distribution are altered in type 2 diabetes and increased following bariatric procedures, in parallel with reduced body weight and improved insulin sensitivity and glycaemic control. Thus, modulation of bile acid levels and signalling, using bile acid binding resins, TGR5 agonists, and FXR agonists, may serve as a potent therapeutic approach for the treatment of obesity, type 2 diabetes, and other components of the metabolic syndrome in humans. </AbstractText>
<CopyrightInformation>Copyright © 2014 Elsevier Ltd. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Ma</LastName>
<ForeName>Huijuan</ForeName>
<Initials>H</Initials>
<AffiliationInfo>
<Affiliation>Department of Endocrinology and Metabolism, Hebei General Hospital, Shijiazhuang, Hebei 050051, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Patti</LastName>
<ForeName>Mary Elizabeth</ForeName>
<Initials>ME</Initials>
<AffiliationInfo>
<Affiliation>Research Division, Joslin Diabetes Center, and Harvard Medical School, Boston, MA 02215, USA. Electronic address: Mary.Elizabeth.Patti@joslin.harvard.edu.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>P30 DK036836</GrantID>
<Acronym>DK</Acronym>
<Agency>NIDDK NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>P30DK036836</GrantID>
<Acronym>DK</Acronym>
<Agency>NIDDK NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
<PublicationType UI="D016454">Review</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>07</Month>
<Day>11</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Netherlands</Country>
<MedlineTA>Best Pract Res Clin Gastroenterol</MedlineTA>
<NlmUniqueID>101120605</NlmUniqueID>
<ISSNLinking>1521-6918</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D001647">Bile Acids and Salts</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C117476">FGF19 protein, human</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C473772">GPBAR1 protein, human</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D043562">Receptors, G-Protein-Coupled</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C091671">XCR1 protein, human</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>62031-54-3</RegistryNumber>
<NameOfSubstance UI="D005346">Fibroblast Growth Factors</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000818">Animals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001647">Bile Acids and Salts</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D003924">Diabetes Mellitus, Type 2</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D004734">Energy Metabolism</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005346">Fibroblast Growth Factors</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D024821">Metabolic Syndrome X</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009765">Obesity</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D043562">Receptors, G-Protein-Coupled</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015398">Signal Transduction</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<OtherID Source="NLM">NIHMS618338 [Available on 08/01/15]</OtherID>
<OtherID Source="NLM">PMC4159616 [Available on 08/01/15]</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Bile acids</Keyword>
<Keyword MajorTopicYN="N">FXR</Keyword>
<Keyword MajorTopicYN="N">Insulin resistance</Keyword>
<Keyword MajorTopicYN="N">Obesity</Keyword>
<Keyword MajorTopicYN="N">TGR5</Keyword>
</KeywordList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25194177</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>08</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>17</Day>
</DateCompleted>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1532-1916</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>28</Volume>
<Issue>4</Issue>
<PubDate>
<Year>2014</Year>
<Month>Aug</Month>
</PubDate>
</JournalIssue>
<Title>Best practice &amp; research. Clinical gastroenterology</Title>
<ISOAbbreviation>Best Pract Res Clin Gastroenterol</ISOAbbreviation>
</Journal>
<ArticleTitle>Gut microbiota and obesity: role in aetiology and potential therapeutic target.</ArticleTitle>
<Pagination>
<MedlinePgn>585-97</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.bpg.2014.07.005</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S1521-6918(14)00083-3</ELocationID>
<Abstract>
<AbstractText>Obesity is epidemic; chronic energy surplus is clearly important in obesity development but other factors are at play. Indigenous gut microbiota are implicated in the aetiopathogenesis of obesity and obesity-related disorders. Evidence from murine models initially suggested a role for the gut microbiota in weight regulation and the microbiota has been shown to contribute to the low grade inflammation that characterises obesity. The microbiota and its metabolites mediate some of the alterations of the microbiota-gut-brain axis, the endocannabinoid system, and bile acid metabolism, found in obesity-related disorders. Modulation of the gut microbiota is an attractive proposition for prevention or treatment of obesity, particularly as traditional measures have been sub-optimal. </AbstractText>
<CopyrightInformation>Copyright © 2014 Elsevier Ltd. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Moran</LastName>
<ForeName>Carthage P</ForeName>
<Initials>CP</Initials>
<AffiliationInfo>
<Affiliation>Dept. Medicine and Alimentary Pharmabiotic Centre, University College Cork, National University of Ireland, Cork, Ireland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Shanahan</LastName>
<ForeName>Fergus</ForeName>
<Initials>F</Initials>
<AffiliationInfo>
<Affiliation>Dept. Medicine and Alimentary Pharmabiotic Centre, University College Cork, National University of Ireland, Cork, Ireland. Electronic address: f.shanahan@ucc.ie.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
<PublicationType UI="D016454">Review</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>07</Month>
<Day>11</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Netherlands</Country>
<MedlineTA>Best Pract Res Clin Gastroenterol</MedlineTA>
<NlmUniqueID>101120605</NlmUniqueID>
<ISSNLinking>1521-6918</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000818">Animals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D041981">Gastrointestinal Tract</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000382">microbiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D064307">Microbiota</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009765">Obesity</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000382">microbiology</QualifierName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Bile acids</Keyword>
<Keyword MajorTopicYN="N">Endocannabinoids</Keyword>
<Keyword MajorTopicYN="N">Microbiota</Keyword>
<Keyword MajorTopicYN="N">Obesity</Keyword>
</KeywordList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25194178</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>08</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>17</Day>
</DateCompleted>
<DateRevised>
<Year>2014</Year>
<Month>11</Month>
<Day>20</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1532-1916</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>28</Volume>
<Issue>4</Issue>
<PubDate>
<Year>2014</Year>
<Month>Aug</Month>
</PubDate>
</JournalIssue>
<Title>Best practice &amp; research. Clinical gastroenterology</Title>
<ISOAbbreviation>Best Pract Res Clin Gastroenterol</ISOAbbreviation>
</Journal>
<ArticleTitle>Mechanisms behind the link between obesity and gastrointestinal cancers.</ArticleTitle>
<Pagination>
<MedlinePgn>599-610</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.bpg.2014.07.006</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S1521-6918(14)00084-5</ELocationID>
<Abstract>
<AbstractText>Obesity and obesity-related disorders such as non-alcoholic fatty liver disease (NAFLD), metabolic syndrome and type 2 diabetes exhibit an increased risk of developing various gastrointestinal cancers. These malignancies include mainly esophageal, gastric, colorectal, pancreatic and hepatocellular carcinoma. Whereas underlying pathomechanisms remain unclear, chronic inflammation accompanying obesity has evolved in the last years as a crucial contributing factor. Obesity is also commonly characterized by inflammation in the organ where those cancers appear. Various pathways might participate involving rather diverse components such as innate immunity, (adipo)-cytokines such as adiponectin or leptin, insulin, insulin-like growth factors, the gut's microbiota and others. An imbalance in these systems could substantially contribute to chronic inflammation and subsequent cancer development. Future studies have to elucidate in more detail underlying mechanisms in the development of obesity-related carcinogensis and potential therapeutic strategies besides weight loss. </AbstractText>
<CopyrightInformation>Copyright © 2014 Elsevier Ltd. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Tilg</LastName>
<ForeName>Herbert</ForeName>
<Initials>H</Initials>
<AffiliationInfo>
<Affiliation>Department of Internal Medicine I, Gastroenterology, Endocrinology &amp; Metabolism, Medical University Innsbruck, Austria. Electronic address: herbert.tilg@i-med.ac.at.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Moschen</LastName>
<ForeName>Alexander R</ForeName>
<Initials>AR</Initials>
<AffiliationInfo>
<Affiliation>Department of Internal Medicine I, Gastroenterology, Endocrinology &amp; Metabolism, Medical University Innsbruck, Austria.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016454">Review</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>07</Month>
<Day>11</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Netherlands</Country>
<MedlineTA>Best Pract Res Clin Gastroenterol</MedlineTA>
<NlmUniqueID>101120605</NlmUniqueID>
<ISSNLinking>1521-6918</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D003924">Diabetes Mellitus, Type 2</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000150">complications</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005234">Fatty Liver</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000150">complications</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005770">Gastrointestinal Neoplasms</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000209">etiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D024821">Metabolic Syndrome X</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000150">complications</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D065626">Non-alcoholic Fatty Liver Disease</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009765">Obesity</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000150">complications</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012307">Risk Factors</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Adipocytokines</Keyword>
<Keyword MajorTopicYN="N">Colorectal carcinoma</Keyword>
<Keyword MajorTopicYN="N">Cytokines</Keyword>
<Keyword MajorTopicYN="N">Esophageal cancer</Keyword>
<Keyword MajorTopicYN="N">Hepatocellular carcinoma</Keyword>
<Keyword MajorTopicYN="N">Inflammation</Keyword>
</KeywordList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25194179</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>08</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>17</Day>
</DateCompleted>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1532-1916</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>28</Volume>
<Issue>4</Issue>
<PubDate>
<Year>2014</Year>
<Month>Aug</Month>
</PubDate>
</JournalIssue>
<Title>Best practice &amp; research. Clinical gastroenterology</Title>
<ISOAbbreviation>Best Pract Res Clin Gastroenterol</ISOAbbreviation>
</Journal>
<ArticleTitle>Gastro-oesophageal reflux disease and obesity: pathogenesis and response to treatment.</ArticleTitle>
<Pagination>
<MedlinePgn>611-22</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.bpg.2014.07.012</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S1521-6918(14)00090-0</ELocationID>
<Abstract>
<AbstractText>The link between obesity and GERD is clear on all measures of the disease: clinical symptoms, erosive oesophagitis, acid esophageal exposure, and complications. The pathogenesis of this link may be due to general factors such as visceral adiposity, oestrogen levels, or decrease of Helicobacter pylori infection with increased gastric acid secretion. Increased abdominal pressure leads to disruption of the esophago-gastric junction and hiatal hernia, and esophageal motility may be modified by obesity. Weight loss does improve GERD, but lifestyle modifications and diet are usually insufficient in the long-term for morbid obesity. GERD and hiatal hernia are key issues in bariatric surgery, and are widely discussed because of important implications. It is not currently certain which procedure should be favoured in case of GERD; yet gastric bypass offers the best guarantee of success. Hiatal hernia repair is also deemed necessary by some authors at the same time of the bariatric surgery. Minimally invasive techniques pose a new challenge to this issue, both technically and theoretically. </AbstractText>
<CopyrightInformation>Copyright © 2014 Elsevier Ltd. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Mion</LastName>
<ForeName>François</ForeName>
<Initials>F</Initials>
<AffiliationInfo>
<Affiliation>Hospices Civils de Lyon, Digestive Physiology, University Lyon 1, Physiology Department, INSERM U1032, LabTau, France. Electronic address: francois.mion@chu-lyon.fr.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Dargent</LastName>
<ForeName>Jérôme</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>Polyclinique de Lyon-Nord Rillieux, 941 Rue capitaine Julien, 69140 Rillieux-la-pape, France. Electronic address: jerome.dargent@polyclinique-rillieux.fr.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016454">Review</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>07</Month>
<Day>21</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Netherlands</Country>
<MedlineTA>Best Pract Res Clin Gastroenterol</MedlineTA>
<NlmUniqueID>101120605</NlmUniqueID>
<ISSNLinking>1521-6918</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D050110">Bariatric Surgery</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005764">Gastroesophageal Reflux</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000175">diagnosis</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000209">etiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009765">Obesity</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000150">complications</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000628">therapy</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015431">Weight Loss</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Bariatric surgery</Keyword>
<Keyword MajorTopicYN="N">Esophago-gastric junction</Keyword>
<Keyword MajorTopicYN="N">Gastric banding</Keyword>
<Keyword MajorTopicYN="N">Gastric bypass</Keyword>
<Keyword MajorTopicYN="N">Helicobacter pylori</Keyword>
<Keyword MajorTopicYN="N">Manometry</Keyword>
<Keyword MajorTopicYN="N">Sleeve gastrectomy</Keyword>
</KeywordList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25194180</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>08</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>17</Day>
</DateCompleted>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1532-1916</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>28</Volume>
<Issue>4</Issue>
<PubDate>
<Year>2014</Year>
<Month>Aug</Month>
</PubDate>
</JournalIssue>
<Title>Best practice &amp; research. Clinical gastroenterology</Title>
<ISOAbbreviation>Best Pract Res Clin Gastroenterol</ISOAbbreviation>
</Journal>
<ArticleTitle>Obesity and the risk and prognosis of gallstone disease and pancreatitis.</ArticleTitle>
<Pagination>
<MedlinePgn>623-35</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.bpg.2014.07.013</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S1521-6918(14)00091-2</ELocationID>
<Abstract>
<AbstractText>Obesity is a risk factor for the formation of cholesterol gallstones and exposes patients to increased risk of gallstone-related complications and cholecystectomy. Rapid weight loss achieved by very low calorie diets or bariatric surgery is also a risk factor for cholelithiasis in obese patients, and therapy should take into account the higher prevalence of gallstones, the possibility of more frequent complications and the need for prophylactic treatment with oral ursodeoxycholic acid during weight loss. Obesity is also frequent in children and adolescents, and the burden of cholesterol cholelithiasis is increasing in this population. The chance to develop acute pancreatitis and the severity of the disease are higher in obese subjects because of specific pathogenic factors, including supersaturated bile and crystal formation, rapid weight loss, and visceral obesity. All health policies aimed at reducing the incidence of obesity worldwide will decrease the incidence of gallstones and gallstone-related complications. The pathophysiological scenarios and the therapeutic implications for obesity, gallstone disease, and pancreatitis are discussed. </AbstractText>
<CopyrightInformation>Copyright © 2014 Elsevier Ltd. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Bonfrate</LastName>
<ForeName>Leonilde</ForeName>
<Initials>L</Initials>
<AffiliationInfo>
<Affiliation>Residency Programme in Internal Medicine, University of Bari Medical School, 70124 Bari, Italy. Electronic address: leonilde.bonfrate@uniba.it.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Wang</LastName>
<ForeName>David Q-H</ForeName>
<Initials>DQ</Initials>
<AffiliationInfo>
<Affiliation>Department of Internal Medicine, Division of Gastroenterology and Hepatology, Saint Louis University School of Medicine, St. Louis, MO 63104, USA. Electronic address: dwang15@slu.edu.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Garruti</LastName>
<ForeName>Gabriella</ForeName>
<Initials>G</Initials>
<AffiliationInfo>
<Affiliation>Department of Emergency and Organ Transplants, Section of Endocrinology, Andrology and Metabolic Diseases, University of Bari Medical School, 70124 Bari, Italy. Electronic address: gabriella.garruti@uniba.it.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Portincasa</LastName>
<ForeName>Piero</ForeName>
<Initials>P</Initials>
<AffiliationInfo>
<Affiliation>Department of Biomedical Sciences and Human Oncology, Clinica Medica "A. Murri", University of Bari Medical School, Piazza Giulio Cesare 11, 70124 Bari, Italy. Electronic address: piero.portincasa@uniba.it.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>DK73917</GrantID>
<Acronym>DK</Acronym>
<Agency>NIDDK NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
<PublicationType UI="D016454">Review</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>07</Month>
<Day>22</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Netherlands</Country>
<MedlineTA>Best Pract Res Clin Gastroenterol</MedlineTA>
<NlmUniqueID>101120605</NlmUniqueID>
<ISSNLinking>1521-6918</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002763">Cholecystectomy</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002769">Cholelithiasis</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000209">etiology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000601">surgery</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009765">Obesity</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000150">complications</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D010195">Pancreatitis</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000209">etiology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000601">surgery</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011379">Prognosis</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012307">Risk Factors</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Bariatric surgery</Keyword>
<Keyword MajorTopicYN="N">Cholecystectomy</Keyword>
<Keyword MajorTopicYN="N">Cholesterol</Keyword>
<Keyword MajorTopicYN="N">Gallbladder motility</Keyword>
<Keyword MajorTopicYN="N">Metabolic syndrome</Keyword>
<Keyword MajorTopicYN="N">Rapid weight loss</Keyword>
</KeywordList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25194181</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>08</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>17</Day>
</DateCompleted>
<DateRevised>
<Year>2014</Year>
<Month>11</Month>
<Day>20</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1532-1916</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>28</Volume>
<Issue>4</Issue>
<PubDate>
<Year>2014</Year>
<Month>Aug</Month>
</PubDate>
</JournalIssue>
<Title>Best practice &amp; research. Clinical gastroenterology</Title>
<ISOAbbreviation>Best Pract Res Clin Gastroenterol</ISOAbbreviation>
</Journal>
<ArticleTitle>Non-alcoholic fatty liver disease, obesity and the metabolic syndrome.</ArticleTitle>
<Pagination>
<MedlinePgn>637-53</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.bpg.2014.07.008</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S1521-6918(14)00086-9</ELocationID>
<Abstract>
<AbstractText>Nonalcoholic fatty liver disease (NAFLD) is now recognized as the most common cause of chronic liver disease worldwide. Its prevalence has increased to more than 30% of adults in developed countries and its incidence is still rising. The majority of patients with NAFLD have simple steatosis but in up to one third of patients, NAFLD progresses to its more severe form nonalcoholic steatohepatitis (NASH). NASH is characterized by liver inflammation and injury thereby determining the risk to develop liver fibrosis and cancer. NAFLD is considered the hepatic manifestation of the metabolic syndrome. However, the liver is not only a passive target but affects the pathogenesis of the metabolic syndrome and its complications. Conversely, pathophysiological changes in other organs such as in the adipose tissue, the intestinal barrier or the immune system have been identified as triggers and promoters of NAFLD progression. This article details the pathogenesis of NAFLD along with the current state of its diagnosis and treatment. </AbstractText>
<CopyrightInformation>Copyright © 2014 Elsevier Ltd. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Dietrich</LastName>
<ForeName>Peter</ForeName>
<Initials>P</Initials>
<AffiliationInfo>
<Affiliation>Institute of Pathology, University Regensburg, 93053 Regensburg, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Hellerbrand</LastName>
<ForeName>Claus</ForeName>
<Initials>C</Initials>
<AffiliationInfo>
<Affiliation>Department of Internal Medicine I, University Hospital Regensburg, 93053 Regensburg, Germany. Electronic address: claus.hellerbrand@ukr.de.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016454">Review</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>07</Month>
<Day>11</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Netherlands</Country>
<MedlineTA>Best Pract Res Clin Gastroenterol</MedlineTA>
<NlmUniqueID>101120605</NlmUniqueID>
<ISSNLinking>1521-6918</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000818">Animals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005234">Fatty Liver</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000175">diagnosis</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000209">etiology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000628">therapy</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007333">Insulin Resistance</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D024821">Metabolic Syndrome X</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000150">complications</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D065626">Non-alcoholic Fatty Liver Disease</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009765">Obesity</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000150">complications</QualifierName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Metabolic syndrome</Keyword>
<Keyword MajorTopicYN="N">Nonalcoholic fatty liver disease (NAFLD)</Keyword>
<Keyword MajorTopicYN="N">Nonalcoholic steatohepatitis (NASH)</Keyword>
</KeywordList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25194182</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>08</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>17</Day>
</DateCompleted>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1532-1916</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>28</Volume>
<Issue>4</Issue>
<PubDate>
<Year>2014</Year>
<Month>Aug</Month>
</PubDate>
</JournalIssue>
<Title>Best practice &amp; research. Clinical gastroenterology</Title>
<ISOAbbreviation>Best Pract Res Clin Gastroenterol</ISOAbbreviation>
</Journal>
<ArticleTitle>The risk of colonic adenomas and colonic cancer in obesity.</ArticleTitle>
<Pagination>
<MedlinePgn>655-63</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.bpg.2014.07.007</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S1521-6918(14)00085-7</ELocationID>
<Abstract>
<AbstractText>Increasing body fatness has been associated with an increased burden from colorectal cancer. An increased susceptibility spanning the entire continuum from precancerous adenomatous polyps to the development of colorectal cancer, poor outcome with treatment, and reduced survival when compared to those with normal body weight has been described. It is unknown which age period and which degree and duration of excess weight are associated with increased colorectal cancer risk. It is uncertain whether weight loss can reverse this risk. If it can, how long will the new lower or normal weight be maintained to effect enduring risk reduction? Furthermore, it is controversial whether the increased burden of colorectal cancer warrants earlier and/or more frequent screening for obese persons. This article reviews the relationship between obesity and colorectal neoplasia, explores the postulated mechanism of carcinogenesis, discusses interventions to reduce the burden of disease, and suggests future directions of research. </AbstractText>
<CopyrightInformation>Copyright © 2014 Elsevier Ltd. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Laiyemo</LastName>
<ForeName>Adeyinka O</ForeName>
<Initials>AO</Initials>
<AffiliationInfo>
<Affiliation>Division of Gastroenterology, Department of Medicine, Howard University College of Medicine, 2041 Georgia Avenue, NW, Washington, DC 20060, USA. Electronic address: adeyinka.laiyemo@howard.edu.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>KL2 TR000102</GrantID>
<Acronym>TR</Acronym>
<Agency>NCATS NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>KL2TR000102-04</GrantID>
<Acronym>TR</Acronym>
<Agency>NCATS NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>UL1RT000101</GrantID>
<Agency>PHS HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>Z99 CA999999</GrantID>
<Acronym>CA</Acronym>
<Agency>NCI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
<PublicationType UI="D016454">Review</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>07</Month>
<Day>10</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Netherlands</Country>
<MedlineTA>Best Pract Res Clin Gastroenterol</MedlineTA>
<NlmUniqueID>101120605</NlmUniqueID>
<ISSNLinking>1521-6918</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D018256">Adenomatous Polyps</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000209">etiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015992">Body Mass Index</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D003110">Colonic Neoplasms</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000209">etiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015179">Colorectal Neoplasms</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000209">etiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009765">Obesity</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000150">complications</QualifierName>
</MeshHeading>
</MeshHeadingList>
<OtherID Source="NLM">NIHMS618341 [Available on 08/01/15]</OtherID>
<OtherID Source="NLM">PMC4159619 [Available on 08/01/15]</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Adenomatous polyps</Keyword>
<Keyword MajorTopicYN="N">Body mass index</Keyword>
<Keyword MajorTopicYN="N">Colonic neoplasm</Keyword>
<Keyword MajorTopicYN="N">Colorectal cancer</Keyword>
<Keyword MajorTopicYN="N">Obesity</Keyword>
</KeywordList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25194183</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>08</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>17</Day>
</DateCompleted>
<DateRevised>
<Year>2014</Year>
<Month>11</Month>
<Day>20</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1532-1916</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>28</Volume>
<Issue>4</Issue>
<PubDate>
<Year>2014</Year>
<Month>Aug</Month>
</PubDate>
</JournalIssue>
<Title>Best practice &amp; research. Clinical gastroenterology</Title>
<ISOAbbreviation>Best Pract Res Clin Gastroenterol</ISOAbbreviation>
</Journal>
<ArticleTitle>Medical treatment of obesity: the past, the present and the future.</ArticleTitle>
<Pagination>
<MedlinePgn>665-84</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.bpg.2014.07.015</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S1521-6918(14)00093-6</ELocationID>
<Abstract>
<AbstractText>Medications for the treatment of obesity began to appear in the late 19th and early 20th century. Amphetamine-addiction led to the search for similar drugs without addictive properties. Four sympathomimetic drugs currently approved in the US arose from this search, but may not be approved elsewhere. When noradrenergic drugs were combined with serotonergic drugs, additional weight loss was induced. At present there are three drugs (orlistat, phentermine/topiramate and lorcaserin) approved for long-term use and four sympathomimetic drugs approved by the US FDA for short-term treatment of obesity. Leptin produced in fat cells and glucagon-like peptide-1, a gastrointestinal hormone, provide a new molecular basis for treatment of obesity. New classes of agents acting on the melanocortin system in the brain or mimicking GLP-1 have been tried with variable success. Combination therapy can substantially increase weight loss; a promising approach for the future. </AbstractText>
<CopyrightInformation>Copyright © 2014 Elsevier Ltd. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Bray</LastName>
<ForeName>George A</ForeName>
<Initials>GA</Initials>
<AffiliationInfo>
<Affiliation>6400 Perkins Road, Baton Rouge, LA 70808, USA. Electronic address: brayga@pbrc.edu.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016454">Review</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>08</Month>
<Day>08</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Netherlands</Country>
<MedlineTA>Best Pract Res Clin Gastroenterol</MedlineTA>
<NlmUniqueID>101120605</NlmUniqueID>
<ISSNLinking>1521-6918</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D019440">Anti-Obesity Agents</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D001552">Benzazepines</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D007783">Lactones</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0H73WJJ391</RegistryNumber>
<NameOfSubstance UI="C052342">topiramate</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>30237-26-4</RegistryNumber>
<NameOfSubstance UI="D005632">Fructose</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>637E494O0Z</RegistryNumber>
<NameOfSubstance UI="C506658">lorcaserin</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>95M8R751W8</RegistryNumber>
<NameOfSubstance UI="C055122">orlistat</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>C045TQL4WP</RegistryNumber>
<NameOfSubstance UI="D010645">Phentermine</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D019440">Anti-Obesity Agents</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000627">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001552">Benzazepines</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000627">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D004359">Drug Therapy, Combination</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005632">Fructose</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000031">analogs &amp; derivatives</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000627">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007783">Lactones</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000627">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009765">Obesity</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000188">drug therapy</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D010645">Phentermine</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000627">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015431">Weight Loss</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Combination therapy</Keyword>
<Keyword MajorTopicYN="N">Glucagon-like peptide-1 agonists</Keyword>
<Keyword MajorTopicYN="N">Orlistat</Keyword>
<Keyword MajorTopicYN="N">Serotonergic drugs</Keyword>
<Keyword MajorTopicYN="N">Sympathomimetic drugs</Keyword>
</KeywordList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25194184</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>08</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>17</Day>
</DateCompleted>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1532-1916</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>28</Volume>
<Issue>4</Issue>
<PubDate>
<Year>2014</Year>
<Month>Aug</Month>
</PubDate>
</JournalIssue>
<Title>Best practice &amp; research. Clinical gastroenterology</Title>
<ISOAbbreviation>Best Pract Res Clin Gastroenterol</ISOAbbreviation>
</Journal>
<ArticleTitle>Endoscopic treatment: the past, the present and the future.</ArticleTitle>
<Pagination>
<MedlinePgn>685-702</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.bpg.2014.07.009</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S1521-6918(14)00087-0</ELocationID>
<Abstract>
<AbstractText>The obesity epidemic asks for an active involvement of gastroenterologists: many of the co-morbidities associated with obesity involve the gastrointestinal tract; a small proportion of obese patients will need bariatric surgery and may suffer from surgical complications that may be solved by minimally invasive endoscopic techniques; and finally, the majority will not be eligible for bariatric surgery and will need some other form of treatment. The first approach should consist of an energy-restricted diet, physical exercise and behaviour modification, followed by pharmacotherapy. For patients who do not respond to medical therapy but are not or not yet surgical candidates, an endoscopic treatment might look attractive. So, endoscopic bariatric therapy has a role to play either as an alternative or adjunct to medical treatment. The different endoscopic modalities may vary in mechanisms of action: by gastric distension and space occupation, delayed gastric emptying, gastric restriction and decreased distensibility, impaired gastric accommodation, stimulation of antroduodenal receptors, or by duodenal exclusion and malabsorption. These treatments will be discussed into detail. </AbstractText>
<CopyrightInformation>Copyright © 2014 Elsevier Ltd. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Mathus-Vliegen</LastName>
<ForeName>E M H</ForeName>
<Initials>EM</Initials>
<AffiliationInfo>
<Affiliation>Academic Medical Centre, University of Amsterdam, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands. Electronic address: e.mathus-vliegen@amc.uva.nl.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016454">Review</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>07</Month>
<Day>11</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Netherlands</Country>
<MedlineTA>Best Pract Res Clin Gastroenterol</MedlineTA>
<NlmUniqueID>101120605</NlmUniqueID>
<ISSNLinking>1521-6918</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D050110">Bariatric Surgery</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000639">trends</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005773">Gastroscopy</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000639">trends</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009765">Obesity</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000601">surgery</QualifierName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Aspire bariatrics system</Keyword>
<Keyword MajorTopicYN="N">Botulinum toxin A</Keyword>
<Keyword MajorTopicYN="N">Duodenojejunal bypass liner</Keyword>
<Keyword MajorTopicYN="N">Duodenojejunal bypass sleeve</Keyword>
<Keyword MajorTopicYN="N">Endoscopy</Keyword>
<Keyword MajorTopicYN="N">Gastric bubble</Keyword>
<Keyword MajorTopicYN="N">Gastric stapling</Keyword>
<Keyword MajorTopicYN="N">Gastric suturing</Keyword>
<Keyword MajorTopicYN="N">Intragastric balloons</Keyword>
</KeywordList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">24853237</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>08</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>03</Day>
</DateCompleted>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1542-4863</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>64</Volume>
<Issue>5</Issue>
<PubDate>
<MedlineDate>2014 Sep-Oct</MedlineDate>
</PubDate>
</JournalIssue>
<Title>CA: a cancer journal for clinicians</Title>
<ISOAbbreviation>CA Cancer J Clin</ISOAbbreviation>
</Journal>
<ArticleTitle>Obesity and economic environments.</ArticleTitle>
<Pagination>
<MedlinePgn>337-50</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.3322/caac.21237</ELocationID>
<Abstract>
<AbstractText>This review summarizes current understanding of economic factors during the obesity epidemic and dispels some widely held, but incorrect, beliefs. Rising obesity rates coincided with increases in leisure time (rather than increased work hours), increased fruit and vegetable availability (rather than a decline in healthier foods), and increased exercise uptake. As a share of disposable income, Americans now have the cheapest food available in history, which fueled the obesity epidemic. Weight gain was surprisingly similar across sociodemographic groups or geographic areas, rather than specific to some groups (at every point in time; however, there are clear disparities). It suggests that if one wants to understand the role of the environment in the obesity epidemic, one needs to understand changes over time affecting all groups, not differences between subgroups at a given time. Although economic and technological changes in the environment drove the obesity epidemic, the evidence for effective economic policies to prevent obesity remains limited. Taxes on foods with low nutritional value could nudge behavior toward healthier diets, as could subsidies/discounts for healthier foods. However, even a large price change for healthy foods could close only part of the gap between dietary guidelines and actual food consumption. Political support has been lacking for even moderate price interventions in the United States and this may continue until the role of environmental factors is accepted more widely. As opinion leaders, clinicians play an important role in shaping the understanding of the causes of obesity.</AbstractText>
<CopyrightInformation>© 2014 American Cancer Society.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Sturm</LastName>
<ForeName>Roland</ForeName>
<Initials>R</Initials>
<AffiliationInfo>
<Affiliation>Senior Economist, RAND Corporation, Santa Monica, CA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>An</LastName>
<ForeName>Ruopeng</ForeName>
<Initials>R</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>R01 HD057193</GrantID>
<Acronym>HD</Acronym>
<Agency>NICHD NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R03 CA173040</GrantID>
<Acronym>CA</Acronym>
<Agency>NCI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R21 CA161287</GrantID>
<Acronym>CA</Acronym>
<Agency>NCI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
<PublicationType UI="D016454">Review</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>05</Month>
<Day>22</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>CA Cancer J Clin</MedlineTA>
<NlmUniqueID>0370647</NlmUniqueID>
<ISSNLinking>0007-9235</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D004777">Environment</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D058872">Epidemics</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000517">prevention &amp; control</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015444">Exercise</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005510">Food Habits</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005523">Food Supply</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000191">economics</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005638">Fruit</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000191">economics</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006291">Health Policy</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000331">legislation &amp; jurisprudence</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007899">Leisure Activities</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009765">Obesity</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000453">epidemiology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000209">etiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D012959">Socioeconomic Factors</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" Type="Geographic" UI="D014481">United States</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000453">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D014675">Vegetables</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000191">economics</QualifierName>
</MeshHeading>
</MeshHeadingList>
<OtherID Source="NLM">NIHMS594673 [Available on 09/10/15]</OtherID>
<OtherID Source="NLM">PMC4159423 [Available on 09/10/15]</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">body weight</Keyword>
<Keyword MajorTopicYN="N">diet</Keyword>
<Keyword MajorTopicYN="N">economic environment</Keyword>
<Keyword MajorTopicYN="N">food</Keyword>
<Keyword MajorTopicYN="N">obesity</Keyword>
<Keyword MajorTopicYN="N">physical activity</Keyword>
<Keyword MajorTopicYN="N">policy</Keyword>
<Keyword MajorTopicYN="N">price</Keyword>
</KeywordList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">24692151</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>08</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>18</Day>
</DateCompleted>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1097-0215</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>135</Volume>
<Issue>10</Issue>
<PubDate>
<Year>2014</Year>
<Month>Nov</Month>
<Day>15</Day>
</PubDate>
</JournalIssue>
<Title>International journal of cancer. Journal international du cancer</Title>
<ISOAbbreviation>Int. J. Cancer</ISOAbbreviation>
</Journal>
<ArticleTitle>Risk factors for cancers of unknown primary site: Results from the prospective EPIC cohort.</ArticleTitle>
<Pagination>
<MedlinePgn>2475-81</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1002/ijc.28874</ELocationID>
<Abstract>
<AbstractText>Cancer of unknown primary site (CUP) may be called an "orphan" disease, as it is diagnosed when metastases are detected while the primary tumor typically remains undetected, and because little research has been done on its primary causes. So far, few epidemiological studies, if any, have addressed possible risk factors for CUP. We analyzed data from the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort (N=476,940). During prospective follow-up, a total of 651 cases of incident cases of CUP were detected (ICD-O-2 code C809). Proportional hazards models were conducted to examine the associations of lifetime history of smoking habits, alcohol consumption, levels of education and anthropometric indices of adiposity with risk of being diagnosed with CUP. Risk of being diagnosed with CUP was strongly related to smoking, with a relative risk of 3.66 [95% C.I., 2.24-5.97] for current, heavy smokers (26+ cigarettes/day) compared to never smokers (adjusted for alcohol consumption, body mass index, waist circumference and level of education) and a relative risk of 5.12 [3.09-8.47] for cases with CUP who died within 12 months. For alcohol consumption and level of education, weaker associations were observed but attenuated and no longer statistically significant after adjusting for smoking and indices of obesity. Finally, risk of CUP was increased by approximately 30 per cent for subjects in the highest versus lowest quartiles of waist circumference. Our analyses provide further documentation, in addition to autopsy studies, that a substantial proportion of cancers of unknown primary site may have their origin in smoking-related tumors, in particular.</AbstractText>
<CopyrightInformation>© 2014 UICC.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Kaaks</LastName>
<ForeName>Rudolf</ForeName>
<Initials>R</Initials>
<AffiliationInfo>
<Affiliation>Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Sookthai</LastName>
<ForeName>Disorn</ForeName>
<Initials>D</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Hemminki</LastName>
<ForeName>Kari</ForeName>
<Initials>K</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Krämer</LastName>
<ForeName>Alwin</ForeName>
<Initials>A</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Boeing</LastName>
<ForeName>Heiner</ForeName>
<Initials>H</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Wirfält</LastName>
<ForeName>Elisabet</ForeName>
<Initials>E</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Weiderpass</LastName>
<ForeName>Elisabete</ForeName>
<Initials>E</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Overvad</LastName>
<ForeName>Kim</ForeName>
<Initials>K</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Tjønneland</LastName>
<ForeName>Anne</ForeName>
<Initials>A</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Olsen</LastName>
<ForeName>Anja</ForeName>
<Initials>A</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Peeters</LastName>
<ForeName>Petra H</ForeName>
<Initials>PH</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Bueno-de-Mesquita</LastName>
<ForeName>H B</ForeName>
<Initials>HB</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Panico</LastName>
<ForeName>Salvatore</ForeName>
<Initials>S</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Pala</LastName>
<ForeName>Valeria</ForeName>
<Initials>V</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Vineis</LastName>
<ForeName>Paolo</ForeName>
<Initials>P</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Quirós</LastName>
<ForeName>J Ramón</ForeName>
<Initials>JR</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Ardanaz</LastName>
<ForeName>Eva</ForeName>
<Initials>E</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Sánchez</LastName>
<ForeName>María-José</ForeName>
<Initials>MJ</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Chirlaque</LastName>
<ForeName>Maria-Dolores</ForeName>
<Initials>MD</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Larrañaga</LastName>
<ForeName>Nerea</ForeName>
<Initials>N</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Brennan</LastName>
<ForeName>Paul</ForeName>
<Initials>P</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Trichopoulos</LastName>
<ForeName>Dimitrios</ForeName>
<Initials>D</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Trichopoulou</LastName>
<ForeName>Antonia</ForeName>
<Initials>A</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Lagiou</LastName>
<ForeName>Pagona</ForeName>
<Initials>P</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Hallmans</LastName>
<ForeName>Göran</ForeName>
<Initials>G</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Khaw</LastName>
<ForeName>Kay-Tee</ForeName>
<Initials>KT</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Key</LastName>
<ForeName>Timothy J</ForeName>
<Initials>TJ</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Riboli</LastName>
<ForeName>Elio</ForeName>
<Initials>E</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Canzian</LastName>
<ForeName>Federico</ForeName>
<Initials>F</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>14136</GrantID>
<Agency>Cancer Research UK</Agency>
<Country>United Kingdom</Country>
</Grant>
<Grant>
<GrantID>16491</GrantID>
<Agency>Cancer Research UK</Agency>
<Country>United Kingdom</Country>
</Grant>
<Grant>
<GrantID>G1000143</GrantID>
<Agency>Medical Research Council</Agency>
<Country>United Kingdom</Country>
</Grant>
<Grant>
<Agency>Cancer Research UK</Agency>
<Country>United Kingdom</Country>
</Grant>
<Grant>
<Agency>Medical Research Council</Agency>
<Country>United Kingdom</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016448">Multicenter Study</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>04</Month>
<Day>10</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Int J Cancer</MedlineTA>
<NlmUniqueID>0042124</NlmUniqueID>
<ISSNLinking>0020-7136</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000328">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000368">Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000369">Aged, 80 and over</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000428">Alcohol Drinking</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000009">adverse effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005500">Follow-Up Studies</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008875">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009382">Neoplasms, Unknown Primary</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000453">epidemiology</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000209">etiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009752">Nutritional Status</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009765">Obesity</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000150">complications</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011379">Prognosis</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011446">Prospective Studies</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012307">Risk Factors</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012907">Smoking</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000009">adverse effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D055105">Waist Circumference</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D049629">Waist-Hip Ratio</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D055815">Young Adult</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">alcohol</Keyword>
<Keyword MajorTopicYN="N">cancer of unknown primary site (CUP)</Keyword>
<Keyword MajorTopicYN="N">obesity</Keyword>
<Keyword MajorTopicYN="N">prospective cohort study</Keyword>
<Keyword MajorTopicYN="N">smoking</Keyword>
<Keyword MajorTopicYN="N">waist circumference</Keyword>
</KeywordList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25112857</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>08</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>10</Month>
<Day>27</Day>
</DateCompleted>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1759-4820</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>11</Volume>
<Issue>9</Issue>
<PubDate>
<Year>2014</Year>
<Month>Sep</Month>
</PubDate>
</JournalIssue>
<Title>Nature reviews. Urology</Title>
<ISOAbbreviation>Nat Rev Urol</ISOAbbreviation>
</Journal>
<ArticleTitle>Prostate cancer: Is active surveillance safe for obese patients?</ArticleTitle>
<Pagination>
<MedlinePgn>489-90</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1038/nrurol.2014.207</ELocationID>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Freedland</LastName>
<ForeName>Stephen</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Duke University, 571 Research Drive, MSRB 475, Durham, NC 27710, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Mucci</LastName>
<ForeName>Lorelei</ForeName>
<Initials>L</Initials>
<AffiliationInfo>
<Affiliation>Harvard School of Public Health, 677 Huntington Avenue, 9th Floor, Boston, MA 02115, USA.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>08</Month>
<Day>12</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>England</Country>
<MedlineTA>Nat Rev Urol</MedlineTA>
<NlmUniqueID>101500082</NlmUniqueID>
<ISSNLinking>1759-4812</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>EC 3.4.21.77</RegistryNumber>
<NameOfSubstance UI="D017430">Prostate-Specific Antigen</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001706">Biopsy</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D051517">Digital Rectal Examination</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D055088">Early Detection of Cancer</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009765">Obesity</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000150">complications</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D017430">Prostate-Specific Antigen</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000097">blood</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011471">Prostatic Neoplasms</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000150">complications</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000175">diagnosis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012306">Risk</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25199398</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>09</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>10</Month>
<Day>20</Day>
</DateCompleted>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0929-0273</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>21</Volume>
<Issue>4</Issue>
<PubDate>
<Year>2014</Year>
<Month>Sep</Month>
</PubDate>
</JournalIssue>
<Title>European journal of health law</Title>
<ISOAbbreviation>Eur J Health Law</ISOAbbreviation>
</Journal>
<ArticleTitle>Stigmatisation as a public health tool against obesity--a health and human rights perspective.</ArticleTitle>
<Pagination>
<MedlinePgn>365-86</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>The right to health is recognised in human rights law and is also part of the catalogue of patients' rights. It imposes a duty on governments to put in place a system of health protection making it possible for individuals to enjoy the highest attainable standard of health. However, disease patterns are constantly changing, and more and more attention is being paid to so-called lifestyle diseases. Individuals may expose themselves to health threats due to personal choices like eating and smoking habits, and this raises the issue of the individual's obligation with regard to ill health. Hence, is there not only a right to health but also a duty to be healthy? Using obesity as an example, and based on a cross-disciplinary research project, the article analyses selected European and national public health policy papers to see how individual rights and duties are framed and to analyse the use of stigmatisation as a public-health strategy from a health and human rights perspective.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Hartlev</LastName>
<ForeName>Mette</ForeName>
<Initials>M</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>Netherlands</Country>
<MedlineTA>Eur J Health Law</MedlineTA>
<NlmUniqueID>9431861</NlmUniqueID>
<ISSNLinking>0929-0273</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006806">Human Rights</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000331">legislation &amp; jurisprudence</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009765">Obesity</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000517">prevention &amp; control</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011287">Prejudice</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000331">legislation &amp; jurisprudence</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011634">Public Health</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011640">Public Policy</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D057545">Social Stigma</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25200051</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>09</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>10</Month>
<Day>27</Day>
</DateCompleted>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">1524-4539</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>130</Volume>
<Issue>11 Suppl 1</Issue>
<PubDate>
<Year>2014</Year>
<Month>Sep</Month>
<Day>9</Day>
</PubDate>
</JournalIssue>
<Title>Circulation</Title>
<ISOAbbreviation>Circulation</ISOAbbreviation>
</Journal>
<ArticleTitle>Prevalence and long-term outcome of aortic prosthesis-patient mismatch in patients with paradoxical low-flow severe aortic stenosis.</ArticleTitle>
<Pagination>
<MedlinePgn>S25-31</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1161/CIRCULATIONAHA.113.007819</ELocationID>
<Abstract>
<AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Patients with severe aortic stenosis (AS) and paradoxical low flow (PLF) have worse outcome compared with those with normal flow. Furthermore, prosthesis-patient mismatch (PPM) after aortic valve replacement is a predictor of reduced survival. However, the prevalence and prognostic impact of PPM in patients with PLF-AS are unknown. We aimed to analyze the prevalence and long-term survival of PPM in patients with PLF-AS.</AbstractText>
<AbstractText Label="METHODS AND RESULTS" NlmCategory="RESULTS">Between 2000 and 2010, 677 patients with severe AS, preserved left ventricular ejection fraction, and aortic valve replacement were included (74±8 years; 42% women; aortic valve area, 0.69±0.16 cm(2)). A PLF (indexed stroke volume ≤35 mL/m(2)) was found in 26%, and after aortic valve replacement, 54% of patients had PPM, defined as an indexed effective orifice area ≤0.85 cm(2)/m(2). The combined presence of PLF and PPM was found in 15%. Compared with patients with noPLF/noPPM, those with PLF/PPM were significantly older, with more comorbidities. They also received smaller and biological bioprosthesis more often (all P&lt;0.01). Although early mortality was not significantly different between groups, the 10-year survival rate was significantly reduced in case of PLF/PPM compared with noPLF/noPPM (38±9% versus 70±5%; P=0.002), even after multivariable adjustment (hazard ratio, 2.58; 95% confidence interval, 1.5-4.45; P=0.0007).</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">In this large catheterization-based study, the coexistence of PLF-AS before surgery and PPM after surgery is associated with the poorest outcome.</AbstractText>
<CopyrightInformation>© 2014 American Heart Association, Inc.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Mohty</LastName>
<ForeName>Dania</ForeName>
<Initials>D</Initials>
<AffiliationInfo>
<Affiliation>From the CHU Limoges, Hôpital Dupuytren, Service Cardiologie (D.M., C.B., J.M., N.E., P.V., V.A.) and Service de Chirurgie thoracique et cardiovasculaire (E.C., M.L.), Limoges, France; INSERM 1094, Faculté de médecine de Limoges, Limoges, France (D.M., J.M.); and Québec Heart &amp; Lung Institute, Department of Medicine, Laval University, Quebec City, Quebec, Canada (P.P., J.D.). dania.mohty@chu-limoges.fr.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Boulogne</LastName>
<ForeName>Cyrille</ForeName>
<Initials>C</Initials>
<AffiliationInfo>
<Affiliation>From the CHU Limoges, Hôpital Dupuytren, Service Cardiologie (D.M., C.B., J.M., N.E., P.V., V.A.) and Service de Chirurgie thoracique et cardiovasculaire (E.C., M.L.), Limoges, France; INSERM 1094, Faculté de médecine de Limoges, Limoges, France (D.M., J.M.); and Québec Heart &amp; Lung Institute, Department of Medicine, Laval University, Quebec City, Quebec, Canada (P.P., J.D.).</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Magne</LastName>
<ForeName>Julien</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>From the CHU Limoges, Hôpital Dupuytren, Service Cardiologie (D.M., C.B., J.M., N.E., P.V., V.A.) and Service de Chirurgie thoracique et cardiovasculaire (E.C., M.L.), Limoges, France; INSERM 1094, Faculté de médecine de Limoges, Limoges, France (D.M., J.M.); and Québec Heart &amp; Lung Institute, Department of Medicine, Laval University, Quebec City, Quebec, Canada (P.P., J.D.).</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Pibarot</LastName>
<ForeName>Philippe</ForeName>
<Initials>P</Initials>
<AffiliationInfo>
<Affiliation>From the CHU Limoges, Hôpital Dupuytren, Service Cardiologie (D.M., C.B., J.M., N.E., P.V., V.A.) and Service de Chirurgie thoracique et cardiovasculaire (E.C., M.L.), Limoges, France; INSERM 1094, Faculté de médecine de Limoges, Limoges, France (D.M., J.M.); and Québec Heart &amp; Lung Institute, Department of Medicine, Laval University, Quebec City, Quebec, Canada (P.P., J.D.).</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Echahidi</LastName>
<ForeName>Najmeddine</ForeName>
<Initials>N</Initials>
<AffiliationInfo>
<Affiliation>From the CHU Limoges, Hôpital Dupuytren, Service Cardiologie (D.M., C.B., J.M., N.E., P.V., V.A.) and Service de Chirurgie thoracique et cardiovasculaire (E.C., M.L.), Limoges, France; INSERM 1094, Faculté de médecine de Limoges, Limoges, France (D.M., J.M.); and Québec Heart &amp; Lung Institute, Department of Medicine, Laval University, Quebec City, Quebec, Canada (P.P., J.D.).</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Cornu</LastName>
<ForeName>Elisabeth</ForeName>
<Initials>E</Initials>
<AffiliationInfo>
<Affiliation>From the CHU Limoges, Hôpital Dupuytren, Service Cardiologie (D.M., C.B., J.M., N.E., P.V., V.A.) and Service de Chirurgie thoracique et cardiovasculaire (E.C., M.L.), Limoges, France; INSERM 1094, Faculté de médecine de Limoges, Limoges, France (D.M., J.M.); and Québec Heart &amp; Lung Institute, Department of Medicine, Laval University, Quebec City, Quebec, Canada (P.P., J.D.).</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Dumesnil</LastName>
<ForeName>Jean</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>From the CHU Limoges, Hôpital Dupuytren, Service Cardiologie (D.M., C.B., J.M., N.E., P.V., V.A.) and Service de Chirurgie thoracique et cardiovasculaire (E.C., M.L.), Limoges, France; INSERM 1094, Faculté de médecine de Limoges, Limoges, France (D.M., J.M.); and Québec Heart &amp; Lung Institute, Department of Medicine, Laval University, Quebec City, Quebec, Canada (P.P., J.D.).</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Laskar</LastName>
<ForeName>Marc</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>From the CHU Limoges, Hôpital Dupuytren, Service Cardiologie (D.M., C.B., J.M., N.E., P.V., V.A.) and Service de Chirurgie thoracique et cardiovasculaire (E.C., M.L.), Limoges, France; INSERM 1094, Faculté de médecine de Limoges, Limoges, France (D.M., J.M.); and Québec Heart &amp; Lung Institute, Department of Medicine, Laval University, Quebec City, Quebec, Canada (P.P., J.D.).</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Virot</LastName>
<ForeName>Patrice</ForeName>
<Initials>P</Initials>
<AffiliationInfo>
<Affiliation>From the CHU Limoges, Hôpital Dupuytren, Service Cardiologie (D.M., C.B., J.M., N.E., P.V., V.A.) and Service de Chirurgie thoracique et cardiovasculaire (E.C., M.L.), Limoges, France; INSERM 1094, Faculté de médecine de Limoges, Limoges, France (D.M., J.M.); and Québec Heart &amp; Lung Institute, Department of Medicine, Laval University, Quebec City, Quebec, Canada (P.P., J.D.).</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Aboyans</LastName>
<ForeName>Victor</ForeName>
<Initials>V</Initials>
<AffiliationInfo>
<Affiliation>From the CHU Limoges, Hôpital Dupuytren, Service Cardiologie (D.M., C.B., J.M., N.E., P.V., V.A.) and Service de Chirurgie thoracique et cardiovasculaire (E.C., M.L.), Limoges, France; INSERM 1094, Faculté de médecine de Limoges, Limoges, France (D.M., J.M.); and Québec Heart &amp; Lung Institute, Department of Medicine, Laval University, Quebec City, Quebec, Canada (P.P., J.D.).</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<Agency>Canadian Institutes of Health Research</Agency>
<Country>Canada</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Circulation</MedlineTA>
<NlmUniqueID>0147763</NlmUniqueID>
<ISSNLinking>0009-7322</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000368">Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000369">Aged, 80 and over</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001024">Aortic Valve Stenosis</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000453">epidemiology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000503">physiopathology</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000601">surgery</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001281">Atrial Fibrillation</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000453">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001783">Blood Flow Velocity</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006328">Cardiac Catheterization</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015897">Comorbidity</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D003327">Coronary Disease</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000453">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D003920">Diabetes Mellitus</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000453">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D050171">Dyslipidemias</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000453">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D004867">Equipment Design</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D006350">Heart Valve Prosthesis</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D019918">Heart Valve Prosthesis Implantation</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006439">Hemodynamics</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006973">Hypertension</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000453">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009765">Obesity</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000453">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011183">Postoperative Complications</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000401">mortality</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015995">Prevalence</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D013318">Stroke Volume</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D016896">Treatment Outcome</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">aortic valve stenosis</Keyword>
<Keyword MajorTopicYN="N">stroke volume</Keyword>
</KeywordList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">24933102</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>09</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>03</Day>
</DateCompleted>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1095-6859</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>134</Volume>
<Issue>3</Issue>
<PubDate>
<Year>2014</Year>
<Month>Sep</Month>
</PubDate>
</JournalIssue>
<Title>Gynecologic oncology</Title>
<ISOAbbreviation>Gynecol. Oncol.</ISOAbbreviation>
</Journal>
<ArticleTitle>Is bariatric surgery an option for women with gynecologic cancer? Examining weight loss counseling practices and training among gynecologic oncology providers.</ArticleTitle>
<Pagination>
<MedlinePgn>540-5</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ygyno.2014.06.006</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0090-8258(14)01037-3</ELocationID>
<Abstract>
<AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">The objective of this study was to evaluate gynecologic oncology provider (GOP) practices regarding weight loss (WL) counseling, and to assess their willingness to initiate weight loss interventions, specifically bariatric surgery (WLS).</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">Members of the Society of Gynecologic Oncology were invited to complete an online survey of 49 items assessing knowledge, attitudes, and behaviors related to WL counseling.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 454 participants initiated the survey, yielding a response rate of 30%. The majority of respondents (85%) were practicing GOP or fellows. A majority of responders reported that &gt;50% of their patient population is clinically obese (BMI ≥ 30). Only 10% reported having any formal training in WL counseling, most often in medical school or residency. Providers who feel adequate about WL counseling were more likely to offer multiple WL options to their patients (p&lt;.05). Over 90% of responders believe that WLS is an effective WL option and is more effective than self-directed diet and medical management of obesity. Providers who were more comfortable with WL counseling were significantly more likely to recommend WLS (p&lt;.01). Approximately 75% of respondents expressed interest in clinical trials evaluating WLS in obese cancer survivors.</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The present study suggests that GOP appreciate the importance of WL counseling, but often fail to provide it. Our results demonstrate the paucity of formal obesity training in oncology. Providers seem willing to recommend WLS as an option to their patients but also in clinical trials examining gynecologic cancer outcomes in women treated with BS.</AbstractText>
<CopyrightInformation>Copyright © 2014 Elsevier Inc. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Neff</LastName>
<ForeName>Robert</ForeName>
<Initials>R</Initials>
<AffiliationInfo>
<Affiliation>Division of Gynecologic Oncology, The Ohio State University, Columbus, OH, United States.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>McCann</LastName>
<ForeName>Georgia A</ForeName>
<Initials>GA</Initials>
<AffiliationInfo>
<Affiliation>University of Texas Health Sciences at San Antonio, San Antonio, TX, United States.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Carpenter</LastName>
<ForeName>Kristen M</ForeName>
<Initials>KM</Initials>
<AffiliationInfo>
<Affiliation>Department of Psychiatry &amp; Behavioral Health, The Ohio State University, Columbus, OH, United States.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Cohn</LastName>
<ForeName>David E</ForeName>
<Initials>DE</Initials>
<AffiliationInfo>
<Affiliation>Division of Gynecologic Oncology, The Ohio State University, Columbus, OH, United States.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Noria</LastName>
<ForeName>Sabrena</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Division of General and Gastrointestinal Surgery, The Ohio State University, Columbus, OH, United States.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Mikami</LastName>
<ForeName>Dean</ForeName>
<Initials>D</Initials>
<AffiliationInfo>
<Affiliation>Division of General and Gastrointestinal Surgery, The Ohio State University, Columbus, OH, United States.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Needleman</LastName>
<ForeName>Bradley J</ForeName>
<Initials>BJ</Initials>
<AffiliationInfo>
<Affiliation>Division of General and Gastrointestinal Surgery, The Ohio State University, Columbus, OH, United States.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>O'Malley</LastName>
<ForeName>David M</ForeName>
<Initials>DM</Initials>
<AffiliationInfo>
<Affiliation>Division of Gynecologic Oncology, The Ohio State University, Columbus, OH, United States. Electronic address: David.O'Malley@osumc.edu.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>06</Month>
<Day>14</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Gynecol Oncol</MedlineTA>
<NlmUniqueID>0365304</NlmUniqueID>
<ISSNLinking>0090-8258</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000328">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000368">Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D050110">Bariatric Surgery</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D037001">Directive Counseling</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005833">Genital Neoplasms, Female</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000150">complications</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D006176">Gynecology</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D007722">Health Knowledge, Attitudes, Practice</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D008495">Medical Oncology</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008875">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009765">Obesity</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000150">complications</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000601">surgery</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000628">therapy</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D010818">Physician's Practice Patterns</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D015431">Weight Loss</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Endometrial cancer</Keyword>
<Keyword MajorTopicYN="N">Obesity</Keyword>
<Keyword MajorTopicYN="N">Weight loss surgery</Keyword>
<Keyword MajorTopicYN="N">Weight loss training</Keyword>
</KeywordList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25198213</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>09</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>10</Month>
<Day>31</Day>
</DateCompleted>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">1533-7294</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>63</Volume>
<Issue>7</Issue>
<PubDate>
<Year>2014</Year>
<Month>Jul</Month>
</PubDate>
</JournalIssue>
<Title>The Journal of family practice</Title>
<ISOAbbreviation>J Fam Pract</ISOAbbreviation>
</Journal>
<ArticleTitle>Tips for communicating with overweight and obese patients.</ArticleTitle>
<Pagination>
<MedlinePgn>S11-4</MedlinePgn>
</Pagination>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Campos</LastName>
<ForeName>Carlos</ForeName>
<Initials>C</Initials>
<AffiliationInfo>
<Affiliation>Clinical Adjunct Professor, Department of Family Medicine, University of Texas Health Science Center, San Antonio, TX, USA.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>J Fam Pract</MedlineTA>
<NlmUniqueID>7502590</NlmUniqueID>
<ISSNLinking>0094-3509</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000328">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000368">Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D003142">Communication</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008875">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009042">Motivation</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009765">Obesity</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000517">prevention &amp; control</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000523">psychology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D050177">Overweight</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000517">prevention &amp; control</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000523">psychology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D010349">Patient Compliance</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D010817">Physician-Patient Relations</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009626">Terminology as Topic</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25198214</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>09</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>10</Month>
<Day>31</Day>
</DateCompleted>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">1533-7294</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>63</Volume>
<Issue>7</Issue>
<PubDate>
<Year>2014</Year>
<Month>Jul</Month>
</PubDate>
</JournalIssue>
<Title>The Journal of family practice</Title>
<ISOAbbreviation>J Fam Pract</ISOAbbreviation>
</Journal>
<ArticleTitle>Principles and nonpharmacologic management of obesity in adults.</ArticleTitle>
<Pagination>
<MedlinePgn>S15-20</MedlinePgn>
</Pagination>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Kushner</LastName>
<ForeName>Robert F</ForeName>
<Initials>RF</Initials>
<AffiliationInfo>
<Affiliation>Professor of Medicine, Clinical Director, Northwestern Comprehensive Center on Obesity, Northwestern University, Feinberg School of Medicine, Chicago, IL, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Sur</LastName>
<ForeName>Denise K</ForeName>
<Initials>DK</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016454">Review</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>J Fam Pract</MedlineTA>
<NlmUniqueID>7502590</NlmUniqueID>
<ISSNLinking>0094-3509</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000328">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000368">Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015992">Body Mass Index</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001835">Body Weight</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015897">Comorbidity</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D004038">Diet, Reducing</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015444">Exercise</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007899">Leisure Activities</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008019">Life Style</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008875">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009765">Obesity</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000517">prevention &amp; control</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012890">Sleep</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D013315">Stress, Psychological</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000517">prevention &amp; control</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D015431">Weight Loss</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25198215</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>09</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>10</Month>
<Day>31</Day>
</DateCompleted>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">1533-7294</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>63</Volume>
<Issue>7</Issue>
<PubDate>
<Year>2014</Year>
<Month>Jul</Month>
</PubDate>
</JournalIssue>
<Title>The Journal of family practice</Title>
<ISOAbbreviation>J Fam Pract</ISOAbbreviation>
</Journal>
<ArticleTitle>Management of obesity in adults: introduction.</ArticleTitle>
<Pagination>
<MedlinePgn>S1-2</MedlinePgn>
</Pagination>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Brunton</LastName>
<ForeName>Stephen A</ForeName>
<Initials>SA</Initials>
<AffiliationInfo>
<Affiliation>Adjunct Clinical Professor, Department of Family Medicine, University of North Carolina, Chapel Hill, North Carolina; Executive Vice President for Education, Primary Care Education Consortium, Charlotte, NC, USA.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D054711">Introductory Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>J Fam Pract</MedlineTA>
<NlmUniqueID>7502590</NlmUniqueID>
<ISSNLinking>0094-3509</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000328">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000368">Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015994">Incidence</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008875">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009765">Obesity</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000453">epidemiology</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000517">prevention &amp; control</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015995">Prevalence</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" Type="Geographic" UI="D014481">United States</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000453">epidemiology</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25198216</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>09</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>10</Month>
<Day>31</Day>
</DateCompleted>
<DateRevised>
<Year>2014</Year>
<Month>11</Month>
<Day>20</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">1533-7294</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>63</Volume>
<Issue>7</Issue>
<PubDate>
<Year>2014</Year>
<Month>Jul</Month>
</PubDate>
</JournalIssue>
<Title>The Journal of family practice</Title>
<ISOAbbreviation>J Fam Pract</ISOAbbreviation>
</Journal>
<ArticleTitle>The pharmacological and surgical management of adults with obesity.</ArticleTitle>
<Pagination>
<MedlinePgn>S21-6</MedlinePgn>
</Pagination>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Ryan</LastName>
<ForeName>Donna H</ForeName>
<Initials>DH</Initials>
<AffiliationInfo>
<Affiliation>Professor Emerita, Pennington Biomedical Research Center, Baton Rouge, LA, USA.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016454">Review</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>J Fam Pract</MedlineTA>
<NlmUniqueID>7502590</NlmUniqueID>
<ISSNLinking>0094-3509</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D019440">Anti-Obesity Agents</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D001067">Appetite Depressants</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D001552">Benzazepines</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D007783">Lactones</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0H73WJJ391</RegistryNumber>
<NameOfSubstance UI="C052342">topiramate</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>30237-26-4</RegistryNumber>
<NameOfSubstance UI="D005632">Fructose</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>637E494O0Z</RegistryNumber>
<NameOfSubstance UI="C506658">lorcaserin</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>95M8R751W8</RegistryNumber>
<NameOfSubstance UI="C055122">orlistat</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>C045TQL4WP</RegistryNumber>
<NameOfSubstance UI="D010645">Phentermine</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000328">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000368">Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D019440">Anti-Obesity Agents</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000627">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001067">Appetite Depressants</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000627">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D050110">Bariatric Surgery</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001552">Benzazepines</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000627">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005632">Fructose</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000031">analogs &amp; derivatives</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000627">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007783">Lactones</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000627">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008875">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009765">Obesity</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000188">drug therapy</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000601">surgery</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D010645">Phentermine</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000627">therapeutic use</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25198217</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>09</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>10</Month>
<Day>31</Day>
</DateCompleted>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">1533-7294</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>63</Volume>
<Issue>7</Issue>
<PubDate>
<Year>2014</Year>
<Month>Jul</Month>
</PubDate>
</JournalIssue>
<Title>The Journal of family practice</Title>
<ISOAbbreviation>J Fam Pract</ISOAbbreviation>
</Journal>
<ArticleTitle>Evolving directions in obesity management.</ArticleTitle>
<Pagination>
<MedlinePgn>S27-33</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>Over the past decade, treatment for obesity has been limited because of an incomplete understanding of the pathophysiology of obesity, lack of recognition of it as a disease, and limited efficacy of treatment options. Safety concerns related to medical and surgical approaches for obesity have also been a major barrier. The challenging nature of obesity management is reflected in a survey of primary care physicians which indicated that treating patients with obesity can be as difficult as treating patients with nicotine or alcohol dependence. </AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Aronne</LastName>
<ForeName>Louis J</ForeName>
<Initials>LJ</Initials>
<AffiliationInfo>
<Affiliation>Weill Cornell Medical College Medical Director, Center for Weight Management and Metabolic Clinical Research, New York, NY, USA.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016454">Review</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>J Fam Pract</MedlineTA>
<NlmUniqueID>7502590</NlmUniqueID>
<ISSNLinking>0094-3509</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D019440">Anti-Obesity Agents</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D018765">Dopamine Uptake Inhibitors</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D054795">Incretins</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D009292">Narcotic Antagonists</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D018027">Receptors, Glucagon</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C053432">glucagon-like peptide-1 receptor</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>01ZG3TPX31</RegistryNumber>
<NameOfSubstance UI="D016642">Bupropion</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>5S6W795CQM</RegistryNumber>
<NameOfSubstance UI="D009271">Naltrexone</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>839I73S42A</RegistryNumber>
<NameOfSubstance UI="C439759">liraglutide</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>89750-14-1</RegistryNumber>
<NameOfSubstance UI="D052216">Glucagon-Like Peptide 1</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D019440">Anti-Obesity Agents</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000627">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D016642">Bupropion</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000627">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D018765">Dopamine Uptake Inhibitors</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000627">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005544">Forecasting</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D052216">Glucagon-Like Peptide 1</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000031">analogs &amp; derivatives</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000627">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D054795">Incretins</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000627">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009271">Naltrexone</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000627">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009292">Narcotic Antagonists</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000627">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009765">Obesity</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000517">prevention &amp; control</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D018027">Receptors, Glucagon</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000819">agonists</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25198218</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>09</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>10</Month>
<Day>31</Day>
</DateCompleted>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">1533-7294</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>63</Volume>
<Issue>7</Issue>
<PubDate>
<Year>2014</Year>
<Month>Jul</Month>
</PubDate>
</JournalIssue>
<Title>The Journal of family practice</Title>
<ISOAbbreviation>J Fam Pract</ISOAbbreviation>
</Journal>
<ArticleTitle>Pathophysiology, epidemiology, and assessment of obesity in adults.</ArticleTitle>
<Pagination>
<MedlinePgn>S3-S10</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>Obesity is a multifactorial disease that results from a combination of both physiological, genetic, and environmental inputs. Obesity is associated with adverse health consequences, including T2DM, cardiovascular disease, musculoskeletal disorders, obstructive sleep apnea, and many types of cancer. The probability of developing adverse health outcomes can be decreased with maintained weight loss of 5% to 10% of current body weight. Body mass index and waist circumference are 2 key measures of body fat. A wide variety of tools are available to assess obesity-related risk factors and guide management.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Skolnik</LastName>
<ForeName>Neil S</ForeName>
<Initials>NS</Initials>
<AffiliationInfo>
<Affiliation>Associate Director, Family Medicine Residency Program, Abington Memorial Hospital, Abington, Pennsylvania; Professor of Family and Community Medicine, Temple University School of Medicine, Philadelphia, PA, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Ryan</LastName>
<ForeName>Donna H</ForeName>
<Initials>DH</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016454">Review</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>J Fam Pract</MedlineTA>
<NlmUniqueID>7502590</NlmUniqueID>
<ISSNLinking>0094-3509</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000328">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000368">Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015992">Body Mass Index</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002149">Energy Intake</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008875">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D009765">Obesity</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000175">diagnosis</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000453">epidemiology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000503">physiopathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015995">Prevalence</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011320">Primary Health Care</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012307">Risk Factors</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25012272</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>09</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>05</Day>
</DateCompleted>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1095-8673</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>191</Volume>
<Issue>2</Issue>
<PubDate>
<Year>2014</Year>
<Month>Oct</Month>
</PubDate>
</JournalIssue>
<Title>The Journal of surgical research</Title>
<ISOAbbreviation>J. Surg. Res.</ISOAbbreviation>
</Journal>
<ArticleTitle>Reoperative parathyroidectomy: who is at risk and what is the risk?</ArticleTitle>
<Pagination>
<MedlinePgn>256-61</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jss.2014.05.073</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0022-4804(14)00539-3</ELocationID>
<Abstract>
<AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Persistent and recurrent hyperparathyroidism necessitate reoperation, which is associated with increased procedure-specific complication rates. The effect of reoperative parathyroidectomy on more generalized outcomes is poorly understood. We sought to determine patient, provider, and perioperative characteristics associated with reoperation, as well as to determine the associated risks.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">All patients receiving a parathyroidectomy in the American College of Surgeons National Surgical Quality Improvement Program database (2008-2011) were identified. Patients receiving initial parathyroidectomy were compared with those receiving reoperative parathyroidectomy. Descriptive statistics and univariate analyses were performed. Multivariate logistic regression models were developed for significant outcome measures.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">Of 9114 parathyroidectomies performed, 8738 (95.9%) were initial and 376 (4.1%) were reoperative. The annual rate of reoperation was 3.6%-4.8%. Patients undergoing reoperative parathyroidectomy were more likely to be obese (48.5 versus 40.0%, P = 0.009) and American Society of Anesthesiologist class 3 (40.7 versus 30.3%, P = 0.001) than patients undergoing initial parathyroidectomy. There was no difference in gender, age, or race. Reoperations had a longer median operative time (101 minimum, interquartile range [IQR] [74-146] versus 76 [55-105], P &lt;0.001) and a longer postoperative length of stay (median days until discharge 1, IQR [1-1] versus 1, IQR [0-1], P &lt;0.001). No difference was found in the rates of mortality and common postoperative morbidity as measured in NSQIP. Patients undergoing reoperation were more likely to be readmitted within 30 d (12.7 versus 2.6%, P &lt;0.001). After adjusting for confounders, reoperation continued to be significantly associated with readmission (odds ratio 3.82, confidence interval: 1.63-8.97; P = 0.002).</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Obesity and an American Society of Anesthesiologist 3 classification are independently associated with reoperation. Readmission within 30 d is associated with reoperation and is a target for patient education and quality improvement after this procedure.</AbstractText>
<CopyrightInformation>Copyright © 2014 Elsevier Inc. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Kuo</LastName>
<ForeName>Lindsay E</ForeName>
<Initials>LE</Initials>
<AffiliationInfo>
<Affiliation>Department of Surgery, University of Pennsylvania, Philadelphia, Pennsylvania. Electronic address: Lindsay.Kuo@uphs.upenn.edu.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Wachtel</LastName>
<ForeName>Heather</ForeName>
<Initials>H</Initials>
<AffiliationInfo>
<Affiliation>Department of Surgery, University of Pennsylvania, Philadelphia, Pennsylvania.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Fraker</LastName>
<ForeName>Douglas</ForeName>
<Initials>D</Initials>
<AffiliationInfo>
<Affiliation>Department of Surgery, University of Pennsylvania, Philadelphia, Pennsylvania.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Kelz</LastName>
<ForeName>Rachel</ForeName>
<Initials>R</Initials>
<AffiliationInfo>
<Affiliation>Department of Surgery, University of Pennsylvania, Philadelphia, Pennsylvania.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>06</Month>
<Day>02</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>J Surg Res</MedlineTA>
<NlmUniqueID>0376340</NlmUniqueID>
<ISSNLinking>0022-4804</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015331">Cohort Studies</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D016015">Logistic Models</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009765">Obesity</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000150">complications</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D016105">Parathyroidectomy</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000009">adverse effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012086">Reoperation</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012189">Retrospective Studies</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012306">Risk</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">ACS NSQIP</Keyword>
<Keyword MajorTopicYN="N">Morbidity</Keyword>
<Keyword MajorTopicYN="N">Mortality</Keyword>
<Keyword MajorTopicYN="N">Primary hyperparathyroidism</Keyword>
<Keyword MajorTopicYN="N">Readmission rate</Keyword>
<Keyword MajorTopicYN="N">Reoperative parathyroidectomy</Keyword>
</KeywordList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25086906</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>09</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>03</Day>
</DateCompleted>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1546-170X</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>20</Volume>
<Issue>9</Issue>
<PubDate>
<Year>2014</Year>
<Month>Sep</Month>
</PubDate>
</JournalIssue>
<Title>Nature medicine</Title>
<ISOAbbreviation>Nat. Med.</ISOAbbreviation>
</Journal>
<ArticleTitle>Obesity- and aging-induced excess of central transforming growth factor-β potentiates diabetic development via an RNA stress response.</ArticleTitle>
<Pagination>
<MedlinePgn>1001-8</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1038/nm.3616</ELocationID>
<Abstract>
<AbstractText>The brain, in particular the hypothalamus, plays a role in regulating glucose homeostasis; however, it remains unclear whether this organ is causally and etiologically involved in the development of diabetes. Here, we found that hypothalamic transforming growth factor-β (TGF-β) production is excessive under conditions of not only obesity but also aging, which are two general etiological factors of type 2 diabetes. Pharmacological and genetic approaches revealed that central TGF-β excess caused hyperglycemia and glucose intolerance independent of a change in body weight. Further, using cell-specific genetic analyses in vivo, we found that astrocytes and proopiomelanocortin neurons are responsible for the production and prodiabetic effect of central TGF-β, respectively. Mechanistically, TGF-β excess induced a hypothalamic RNA stress response, resulting in accelerated mRNA decay of IκBα, an inhibitor of proinflammatory nuclear factor-κB. These results reveal an atypical, mRNA metabolism-driven hypothalamic nuclear factor-κB activation, a mechanism that links obesity as well as aging to hypothalamic inflammation and ultimately to type 2 diabetes. </AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Yan</LastName>
<ForeName>Jingqi</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>1] Department of Molecular Pharmacology, Albert Einstein College of Medicine, Bronx, New York, USA. [2] Diabetes Research Center, Albert Einstein College of Medicine, Bronx, New York, USA. [3] Institute of Aging, Albert Einstein College of Medicine, Bronx, New York, USA. [4].</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Zhang</LastName>
<ForeName>Hai</ForeName>
<Initials>H</Initials>
<AffiliationInfo>
<Affiliation>1] Department of Molecular Pharmacology, Albert Einstein College of Medicine, Bronx, New York, USA. [2] Diabetes Research Center, Albert Einstein College of Medicine, Bronx, New York, USA. [3] Institute of Aging, Albert Einstein College of Medicine, Bronx, New York, USA. [4].</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Yin</LastName>
<ForeName>Ye</ForeName>
<Initials>Y</Initials>
<AffiliationInfo>
<Affiliation>1] Department of Molecular Pharmacology, Albert Einstein College of Medicine, Bronx, New York, USA. [2] Diabetes Research Center, Albert Einstein College of Medicine, Bronx, New York, USA. [3] Institute of Aging, Albert Einstein College of Medicine, Bronx, New York, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Li</LastName>
<ForeName>Juxue</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>1] Department of Molecular Pharmacology, Albert Einstein College of Medicine, Bronx, New York, USA. [2] Diabetes Research Center, Albert Einstein College of Medicine, Bronx, New York, USA. [3] Institute of Aging, Albert Einstein College of Medicine, Bronx, New York, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Tang</LastName>
<ForeName>Yizhe</ForeName>
<Initials>Y</Initials>
<AffiliationInfo>
<Affiliation>1] Department of Molecular Pharmacology, Albert Einstein College of Medicine, Bronx, New York, USA. [2] Diabetes Research Center, Albert Einstein College of Medicine, Bronx, New York, USA. [3] Institute of Aging, Albert Einstein College of Medicine, Bronx, New York, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Purkayastha</LastName>
<ForeName>Sudarshana</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>1] Department of Molecular Pharmacology, Albert Einstein College of Medicine, Bronx, New York, USA. [2] Diabetes Research Center, Albert Einstein College of Medicine, Bronx, New York, USA. [3] Institute of Aging, Albert Einstein College of Medicine, Bronx, New York, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Li</LastName>
<ForeName>Lianxi</ForeName>
<Initials>L</Initials>
<AffiliationInfo>
<Affiliation>1] Department of Molecular Pharmacology, Albert Einstein College of Medicine, Bronx, New York, USA. [2] Diabetes Research Center, Albert Einstein College of Medicine, Bronx, New York, USA. [3] Institute of Aging, Albert Einstein College of Medicine, Bronx, New York, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Cai</LastName>
<ForeName>Dongsheng</ForeName>
<Initials>D</Initials>
<AffiliationInfo>
<Affiliation>1] Department of Molecular Pharmacology, Albert Einstein College of Medicine, Bronx, New York, USA. [2] Diabetes Research Center, Albert Einstein College of Medicine, Bronx, New York, USA. [3] Institute of Aging, Albert Einstein College of Medicine, Bronx, New York, USA.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>R01 AG031774</GrantID>
<Acronym>AG</Acronym>
<Agency>NIA NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R01 AG031774</GrantID>
<Acronym>AG</Acronym>
<Agency>NIA NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R01 DK 099136</GrantID>
<Acronym>DK</Acronym>
<Agency>NIDDK NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R01 DK078750</GrantID>
<Acronym>DK</Acronym>
<Agency>NIDDK NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R01 DK078750</GrantID>
<Acronym>DK</Acronym>
<Agency>NIDDK NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R01 DK099136</GrantID>
<Acronym>DK</Acronym>
<Agency>NIDDK NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R01 HL113180</GrantID>
<Acronym>HL</Acronym>
<Agency>NHLBI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R01 HL113180</GrantID>
<Acronym>HL</Acronym>
<Agency>NHLBI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>08</Month>
<Day>03</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Nat Med</MedlineTA>
<NlmUniqueID>9502015</NlmUniqueID>
<ISSNLinking>1078-8956</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D016328">NF-kappa B</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D016212">Transforming Growth Factor beta</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>63231-63-0</RegistryNumber>
<NameOfSubstance UI="D012313">RNA</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>66796-54-1</RegistryNumber>
<NameOfSubstance UI="D011333">Pro-Opiomelanocortin</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList>
<CommentsCorrections RefType="CommentIn">
<RefSource>Nat Rev Neurosci. 2014 Sep;15(9):563</RefSource>
<PMID Version="1">25139270</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="CommentIn">
<RefSource>Nat Med. 2014 Sep;20(9):985-7</RefSource>
<PMID Version="1">25198046</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000375">Aging</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000502">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001253">Astrocytes</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D003920">Diabetes Mellitus</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000209">etiology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000503">physiopathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005951">Glucose Tolerance Test</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007031">Hypothalamus</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000503">physiopathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D016328">NF-kappa B</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009765">Obesity</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000503">physiopathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011333">Pro-Opiomelanocortin</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012313">RNA</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D013312">Stress, Physiological</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D016212">Transforming Growth Factor beta</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
</MeshHeadingList>
<OtherID Source="NLM">NIHMS600157 [Available on 03/01/15]</OtherID>
<OtherID Source="NLM">PMC4167789 [Available on 03/01/15]</OtherID>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25198046</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>09</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>03</Day>
</DateCompleted>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">1546-170X</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>20</Volume>
<Issue>9</Issue>
<PubDate>
<Year>2014</Year>
<Month>Sep</Month>
</PubDate>
</JournalIssue>
<Title>Nature medicine</Title>
<ISOAbbreviation>Nat. Med.</ISOAbbreviation>
</Journal>
<ArticleTitle>Atypical transforming growth factor-β signaling in the hypothalamus is linked to diabetes.</ArticleTitle>
<Pagination>
<MedlinePgn>985-7</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1038/nm.3673</ELocationID>
<Abstract>
<AbstractText>Aging and a high-fat diet are predisposing factors for type 2 diabetes. A study in mice suggests that dietary fat and aging lead to atypical transforming growth factor-β1 signaling in the hypothalamus, which disturbs whole-body glucose regulation.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Araujo</LastName>
<ForeName>Eliana P</ForeName>
<Initials>EP</Initials>
<AffiliationInfo>
<Affiliation>Laboratory of Cell Signaling, University of Campinas, Campinas, Brazil.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>de Souza</LastName>
<ForeName>Claudio T</ForeName>
<Initials>CT</Initials>
<AffiliationInfo>
<Affiliation>Laboratory of Exercise Biochemistry and Physiology, Universidade do Sul Catarinense (UNESC), Crisciuma, Brazil.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Velloso</LastName>
<ForeName>Licio A</ForeName>
<Initials>LA</Initials>
<AffiliationInfo>
<Affiliation>Laboratory of Cell Signaling, University of Campinas, Campinas, Brazil.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016420">Comment</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Nat Med</MedlineTA>
<NlmUniqueID>9502015</NlmUniqueID>
<ISSNLinking>1078-8956</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D016212">Transforming Growth Factor beta</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>63231-63-0</RegistryNumber>
<NameOfSubstance UI="D012313">RNA</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList>
<CommentsCorrections RefType="CommentOn">
<RefSource>Nat Med. 2014 Sep;20(9):1001-8</RefSource>
<PMID Version="1">25086906</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000375">Aging</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000502">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D003920">Diabetes Mellitus</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000503">physiopathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009765">Obesity</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000503">physiopathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012313">RNA</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D013312">Stress, Physiological</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D016212">Transforming Growth Factor beta</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25204023</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>09</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>10</Month>
<Day>16</Day>
</DateCompleted>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">1051-5313</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>24</Volume>
<Issue>11</Issue>
<PubDate>
<Year>2014</Year>
<Month>Jul</Month>
</PubDate>
</JournalIssue>
<Title>Harvard heart letter : from Harvard Medical School</Title>
<ISOAbbreviation>Harv Heart Lett</ISOAbbreviation>
</Journal>
<ArticleTitle>Weight-loss surgery for uncontrolled diabetes.</ArticleTitle>
<Pagination>
<MedlinePgn>8</MedlinePgn>
</Pagination>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016433">News</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Harv Heart Lett</MedlineTA>
<NlmUniqueID>9425723</NlmUniqueID>
<ISSNLinking>1051-5313</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>K</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D003924">Diabetes Mellitus, Type 2</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000150">complications</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000601">surgery</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D015390">Gastric Bypass</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009765">Obesity</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000150">complications</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000601">surgery</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D015431">Weight Loss</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25204094</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>10</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>10</Month>
<Day>09</Day>
</DateCompleted>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0033-2674</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>48</Volume>
<Issue>3</Issue>
<PubDate>
<MedlineDate>2014 May-Jun</MedlineDate>
</PubDate>
</JournalIssue>
<Title>Psychiatria polska</Title>
<ISOAbbreviation>Psychiatr. Pol.</ISOAbbreviation>
</Journal>
<ArticleTitle>[Coping with overweight strategies, self-esteem and body-esteem in the context of transactional analysis].</ArticleTitle>
<Pagination>
<MedlinePgn>477-87</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">The aim of this study was to analyze the ego-state of obese people in terms of transactional analysis and to determine the relationship between coping with overweight strategies, Ego-structure, global self-esteem, and body self-esteem levels.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">One-hundred-seventy-one overweight and obese adult females were examined by a general practitioner and a specialist in obesity management. The ego-state, global self-esteem, and body self-esteem were assessed using the Ego State Questionnaire (ESQ), the Coopersmith Self-Esteem Inventory, and the Body-Esteem Scale, respectively.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">Participants were divided into three subgroups: A--no attempts at weight loss currently (35.1%), B--self-attempted weight loss (33.9%), C--professional obesity treatment (31.0%). Age, education level, professional status, marital status, and number of children, along with the onset of being overweight/obese were similar in all subgroups. Subgroups B and C statistically and significantly made frequent attempts at weight loss (p &lt; 0.001) and experienced yo-yo effect (p &lt; 0.001) more than subgroup A. Effective weight loss attempts were observed significantly more often in subgroups C (p &lt; 0.001). Only mean lies scale results were significantly higher in subgroups A and C compared to B (p &lt; 0.05 and p &lt; 0.01, respectively). While self-esteem, sexual attractiveness, weight concern, physical condition and ego-states were similar in all study subgroups.</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Structure of the Ego-states, self-esteem and body-esteem did not influence the strategies of coping with overweight. Self-esteem is related to spontaneous Ego-child and Ego-adult levels, while the sense of sexual attractiveness is affected only by Ego-spontaneous child.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Bak-Sosnowska</LastName>
<ForeName>Monika</ForeName>
<Initials>M</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Naworska</LastName>
<ForeName>Beata</ForeName>
<Initials>B</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Owczarek</LastName>
<ForeName>Aleksander</ForeName>
<Initials>A</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Chudek</LastName>
<ForeName>Jerzy</ForeName>
<Initials>J</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Skrzypulec-Plinta</LastName>
<ForeName>Violetta</ForeName>
<Initials>V</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Olszanecka-Glinianowicz</LastName>
<ForeName>Magdalena</ForeName>
<Initials>M</Initials>
</Author>
</AuthorList>
<Language>pol</Language>
<PublicationTypeList>
<PublicationType UI="D004740">English Abstract</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<VernacularTitle>Strategie radzenia sobie z nadmierna masa ciała oraz szacunek do siebie i własnego ciała w kontekście analizy transakcyjnej.</VernacularTitle>
</Article>
<MedlineJournalInfo>
<Country>Poland</Country>
<MedlineTA>Psychiatr Pol</MedlineTA>
<NlmUniqueID>0103314</NlmUniqueID>
<ISSNLinking>0033-2674</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000223">Adaptation, Psychological</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000328">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001828">Body Image</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000523">psychology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015992">Body Mass Index</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001835">Body Weight</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D004532">Ego</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D015438">Health Behavior</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009765">Obesity</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000523">psychology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D050177">Overweight</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000523">psychology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" Type="Geographic" UI="D011044">Poland</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011795">Questionnaires</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D012649">Self Concept</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D014152">Transactional Analysis</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D055815">Young Adult</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25203878</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>10</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>03</Day>
</DateCompleted>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">1528-1140</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>260</Volume>
<Issue>4</Issue>
<PubDate>
<Year>2014</Year>
<Month>Oct</Month>
</PubDate>
</JournalIssue>
<Title>Annals of surgery</Title>
<ISOAbbreviation>Ann. Surg.</ISOAbbreviation>
</Journal>
<ArticleTitle>Randomized pilot trial of bariatric surgery versus intensive medical weight management on diabetes remission in type 2 diabetic patients who do NOT meet NIH criteria for surgery and the role of soluble RAGE as a novel biomarker of success.</ArticleTitle>
<Pagination>
<MedlinePgn>617-22; discussion 622-4</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1097/SLA.0000000000000919</ELocationID>
<Abstract>
<AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To compare bariatric surgery versus intensive medical weight management (MWM) in patients with type 2 diabetes mellitus (T2DM) who do not meet current National Institutes of Health criteria for bariatric surgery and to assess whether the soluble form of receptor for advanced glycation end products (sRAGE) is a biomarker to identify patients most likely to benefit from surgery.</AbstractText>
<AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">There are few studies comparing surgery to MWM for patients with T2DM and BMI less than 35.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">Fifty-seven patients with T2DM and BMI 30 to 35, who otherwise met the criteria for bariatric surgery were randomized to MWM versus surgery (bypass, sleeve or band, based on patient preference). The primary outcomes assessed at 6 months were change in homeostatic model of insulin resistance (HOMA-IR) and diabetes remission. Secondary outcomes included changes in HbA1c, weight, and sRAGE.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">The surgery group had improved HOMA-IR (-4.6 vs +1.6; P = 0.0004) and higher diabetes remission (65% vs 0%, P &lt; 0.0001) than the MWM group at 6 months. Compared to MWM, the surgery group had lower HbA1c (6.2 vs 7.8, P = 0.002), lower fasting glucose (99.5 vs 157; P = 0.0068), and fewer T2DM medication requirements (20% vs 88%; P &lt; 0.0001) at 6 months. The surgery group lost more weight (7. vs 1.0 BMI decrease, P &lt; 0.0001). Higher baseline sRAGE was associated with better weight loss outcomes (r = -0.641; P = 0.046). There were no mortalities.</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Surgery was very effective short-term in patients with T2DM and BMI 30 to 35. Baseline sRAGE may predict patients most likely to benefit from surgery. These findings need to be confirmed with larger studies.ClinicalTrials.gov ID: NCT01423877.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Parikh</LastName>
<ForeName>Manish</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Departments of *Surgery †Medicine ‡Population Health, NYU School of Medicine/Bellevue Hospital §Department of Medicine, Lincoln Hospital; and ¶MetroPlus Health Plan, Health and Hospitals Corporation, New York City, NY.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Chung</LastName>
<ForeName>Mimi</ForeName>
<Initials>M</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Sheth</LastName>
<ForeName>Sheetal</ForeName>
<Initials>S</Initials>
</Author>
<Author ValidYN="Y">
<LastName>McMacken</LastName>
<ForeName>Michelle</ForeName>
<Initials>M</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Zahra</LastName>
<ForeName>Tasneem</ForeName>
<Initials>T</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Saunders</LastName>
<ForeName>John K</ForeName>
<Initials>JK</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Ude-Welcome</LastName>
<ForeName>Aku</ForeName>
<Initials>A</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Dunn</LastName>
<ForeName>Van</ForeName>
<Initials>V</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Ogedegbe</LastName>
<ForeName>Gbenga</ForeName>
<Initials>G</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Schmidt</LastName>
<ForeName>Ann Marie</ForeName>
<Initials>AM</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Pachter</LastName>
<ForeName>H Leon</ForeName>
<Initials>HL</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<DataBankList CompleteYN="Y">
<DataBank>
<DataBankName>ClinicalTrials.gov</DataBankName>
<AccessionNumberList>
<AccessionNumber>NCT01423877</AccessionNumber>
</AccessionNumberList>
</DataBank>
</DataBankList>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>1UL1RR029893</GrantID>
<Acronym>RR</Acronym>
<Agency>NCRR NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>K12HS019473</GrantID>
<Acronym>HS</Acronym>
<Agency>AHRQ HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D003160">Comparative Study</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016449">Randomized Controlled Trial</PublicationType>
<PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
<PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Ann Surg</MedlineTA>
<NlmUniqueID>0372354</NlmUniqueID>
<ISSNLinking>0003-4932</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D015415">Biological Markers</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D017127">Glycosylation End Products, Advanced</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D006442">Hemoglobin A, Glycosylated</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D011971">Receptors, Immunologic</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C068348">advanced glycosylation end-product receptor</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000328">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D050110">Bariatric Surgery</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015415">Biological Markers</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000032">analysis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015992">Body Mass Index</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D003376">Counseling</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D003924">Diabetes Mellitus, Type 2</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000150">complications</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000628">therapy</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005081">Exercise Therapy</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D017127">Glycosylation End Products, Advanced</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000032">analysis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006442">Hemoglobin A, Glycosylated</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000032">analysis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007333">Insulin Resistance</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008875">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009765">Obesity</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000150">complications</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000601">surgery</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000628">therapy</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D010865">Pilot Projects</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011971">Receptors, Immunologic</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000032">analysis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012074">Remission Induction</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015431">Weight Loss</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25203544</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>10</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>03</Day>
</DateCompleted>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1439-4413</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>139</Volume>
<Issue>38</Issue>
<PubDate>
<Year>2014</Year>
<Month>Sep</Month>
</PubDate>
</JournalIssue>
<Title>Deutsche medizinische Wochenschrift (1946)</Title>
<ISOAbbreviation>Dtsch. Med. Wochenschr.</ISOAbbreviation>
</Journal>
<ArticleTitle>[Do epigenetic factors have an influence on body weight? The era of epigenome-association-studies in adipositas research has begun].</ArticleTitle>
<Pagination>
<MedlinePgn>1866</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1055/s-0033-1353916</ELocationID>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Kovacs</LastName>
<ForeName>Peter</ForeName>
<Initials>P</Initials>
</Author>
</AuthorList>
<Language>ger</Language>
<PublicationTypeList>
<PublicationType UI="D016420">Comment</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<VernacularTitle>Beeinflussen epigenetische Faktoren das Körpergewicht? Die Ära der epigenome-association-studies in der Adipositas hat begonnen.</VernacularTitle>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>09</Month>
<Day>09</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Germany</Country>
<MedlineTA>Dtsch Med Wochenschr</MedlineTA>
<NlmUniqueID>0006723</NlmUniqueID>
<ISSNLinking>0012-0472</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList>
<CommentsCorrections RefType="CommentOn">
<RefSource>Lancet. 2014 Jun 7;383(9933):1990-8</RefSource>
<PMID Version="1">24630777</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D019175">DNA Methylation</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000235">genetics</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009765">Obesity</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000235">genetics</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25121810</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>11</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>10</Day>
</DateCompleted>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1541-0048</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>104</Volume>
<Issue>10</Issue>
<PubDate>
<Year>2014</Year>
<Month>Oct</Month>
</PubDate>
</JournalIssue>
<Title>American journal of public health</Title>
<ISOAbbreviation>Am J Public Health</ISOAbbreviation>
</Journal>
<ArticleTitle>A framework for evaluating the impact of obesity prevention strategies on socioeconomic inequalities in weight.</ArticleTitle>
<Pagination>
<MedlinePgn>e43-50</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.2105/AJPH.2014.302066</ELocationID>
<Abstract>
<AbstractText>We developed a theoretical framework to organize obesity prevention interventions by their likely impact on the socioeconomic gradient of weight. The degree to which an intervention involves individual agency versus structural change influences socioeconomic inequalities in weight. Agentic interventions, such as standalone social marketing, increase socioeconomic inequalities. Structural interventions, such as food procurement policies and restrictions on unhealthy foods in schools, show equal or greater benefit for lower socioeconomic groups. Many obesity prevention interventions belong to the agento-structural types of interventions, and account for the environment in which health behaviors occur, but they require a level of individual agency for behavioral change, including workplace design to encourage exercise and fiscal regulation of unhealthy foods or beverages. Obesity prevention interventions differ in their effectiveness across socioeconomic groups. Limiting further increases in socioeconomic inequalities in obesity requires implementation of structural interventions. Further empirical evaluation, especially of agento-structural type interventions, remains crucial. </AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Backholer</LastName>
<ForeName>Kathryn</ForeName>
<Initials>K</Initials>
<AffiliationInfo>
<Affiliation>Kathryn Backholer, Anna Peeters, and Alison Beauchamp are with the Obesity and Population Health Unit, Baker IDI Heart and Diabetes Institute, Melbourne, Australia. Kylie Ball is with the Centre for Physical Activity and Nutrition Research, Deakin University, Melbourne, Australia. Gavin Turrell is with the School of Public Health and Social Work/Institute of Health and Biomedical Innovation, Queensland University of Technology, Brisbane, Australia. Jane Martin is with the Obesity Policy Coalition, Melbourne, Australia. Julie Woods is with the School of Exercise and Nutrition Science, Deakin University.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Beauchamp</LastName>
<ForeName>Alison</ForeName>
<Initials>A</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Ball</LastName>
<ForeName>Kylie</ForeName>
<Initials>K</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Turrell</LastName>
<ForeName>Gavin</ForeName>
<Initials>G</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Martin</LastName>
<ForeName>Jane</ForeName>
<Initials>J</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Woods</LastName>
<ForeName>Julie</ForeName>
<Initials>J</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Peeters</LastName>
<ForeName>Anna</ForeName>
<Initials>A</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>08</Month>
<Day>14</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Am J Public Health</MedlineTA>
<NlmUniqueID>1254074</NlmUniqueID>
<ISSNLinking>0090-0036</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001837">Body Weights and Measures</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D004777">Environment</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D015438">Health Behavior</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006291">Health Policy</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006293">Health Promotion</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000458">organization &amp; administration</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D054624">Health Status Disparities</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009765">Obesity</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000517">prevention &amp; control</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012959">Socioeconomic Factors</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25210095</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>11</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>06</Day>
</DateCompleted>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1524-4539</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>130</Volume>
<Issue>10</Issue>
<PubDate>
<Year>2014</Year>
<Month>Sep</Month>
<Day>2</Day>
</PubDate>
</JournalIssue>
<Title>Circulation</Title>
<ISOAbbreviation>Circulation</ISOAbbreviation>
</Journal>
<ArticleTitle>Temporal trends in the population attributable risk for cardiovascular disease: the Atherosclerosis Risk in Communities Study.</ArticleTitle>
<Pagination>
<MedlinePgn>820-8</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1161/CIRCULATIONAHA.113.008506</ELocationID>
<Abstract>
<AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The extent to which the relative contributions of traditional cardiovascular risk factors to incident cardiovascular disease (CVD) may have changed over time remains unclear.</AbstractText>
<AbstractText Label="METHODS AND RESULTS" NlmCategory="RESULTS">We studied 13 541 participants (56% women, 26% black) in the Atherosclerosis Risk in Communities Study, aged 52 to 66 years and free of CVD at exams in 1987 through 1989, 1990 through 1992, 1993 through 1995, or 1996 through 1998. At each examination, we estimated the population attributable risks (PAR) of traditional risk factors (hypertension, diabetes mellitus, obesity, hypercholesterolemia, and smoking) for the 10-year incidence of CVD. Overall, the PAR of all risk factors combined appeared to decrease from the late 1980s to the late 1990s (0.58 to 0.53). The combined PAR was higher in women than men in 1987 through 1989 (0.68 versus 0.51, P&lt;0.001) but not by the late 1990s (0.58 versus 0.48, P=0.08). The combined PAR was higher in blacks than whites in the late 1980s (0.67 versus 0.57, P=0.049), and this difference was more pronounced by the late 1990s (0.67 versus 0.48, P=0.002). By the late 1990s, the PAR of hypertension had become higher in women than men (P=0.02) and also appeared higher in blacks than whites (P=0.08). By the late 1990s, the PAR of diabetes mellitus remained higher in women than men (P&lt;0.0001) and in blacks than whites (P&lt;0.0001).</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The contribution to CVD of all traditional risk factors combined is greater in blacks than whites, and this difference may be increasing. The contributions of hypertension and diabetes mellitus remain especially high, in women as well as blacks. These findings underscore the continued need for individual as well as population approaches to CVD risk factor modification.</AbstractText>
<CopyrightInformation>© 2014 American Heart Association, Inc.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Cheng</LastName>
<ForeName>Susan</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>From the Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA (S.C., B.C., A.M.S., D.K.G., H.S., S.D.S.); NMR Group Inc, Somerville, MA (A.W.C.); National Institutes of Health, National Heart, Lung, and Blood Institute, Bethesda, MD (H.N.); the Department of Epidemiology, University of North Carolina, Chapel Hill, NC (W.D.R., G.H.); the Division of Epidemiology and Community Health, University of Minnesota, Minneapolis, MN (A.R.F.); the Welch Center for Prevention, Epidemiology and Clinical Research, Johns Hopkins University, Baltimore, MD (J.C.); and the Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD (J.C.). scheng@rics.bwh.harvard.edu.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Claggett</LastName>
<ForeName>Brian</ForeName>
<Initials>B</Initials>
<AffiliationInfo>
<Affiliation>From the Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA (S.C., B.C., A.M.S., D.K.G., H.S., S.D.S.); NMR Group Inc, Somerville, MA (A.W.C.); National Institutes of Health, National Heart, Lung, and Blood Institute, Bethesda, MD (H.N.); the Department of Epidemiology, University of North Carolina, Chapel Hill, NC (W.D.R., G.H.); the Division of Epidemiology and Community Health, University of Minnesota, Minneapolis, MN (A.R.F.); the Welch Center for Prevention, Epidemiology and Clinical Research, Johns Hopkins University, Baltimore, MD (J.C.); and the Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD (J.C.).</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Correia</LastName>
<ForeName>Andrew W</ForeName>
<Initials>AW</Initials>
<AffiliationInfo>
<Affiliation>From the Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA (S.C., B.C., A.M.S., D.K.G., H.S., S.D.S.); NMR Group Inc, Somerville, MA (A.W.C.); National Institutes of Health, National Heart, Lung, and Blood Institute, Bethesda, MD (H.N.); the Department of Epidemiology, University of North Carolina, Chapel Hill, NC (W.D.R., G.H.); the Division of Epidemiology and Community Health, University of Minnesota, Minneapolis, MN (A.R.F.); the Welch Center for Prevention, Epidemiology and Clinical Research, Johns Hopkins University, Baltimore, MD (J.C.); and the Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD (J.C.).</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Shah</LastName>
<ForeName>Amil M</ForeName>
<Initials>AM</Initials>
<AffiliationInfo>
<Affiliation>From the Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA (S.C., B.C., A.M.S., D.K.G., H.S., S.D.S.); NMR Group Inc, Somerville, MA (A.W.C.); National Institutes of Health, National Heart, Lung, and Blood Institute, Bethesda, MD (H.N.); the Department of Epidemiology, University of North Carolina, Chapel Hill, NC (W.D.R., G.H.); the Division of Epidemiology and Community Health, University of Minnesota, Minneapolis, MN (A.R.F.); the Welch Center for Prevention, Epidemiology and Clinical Research, Johns Hopkins University, Baltimore, MD (J.C.); and the Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD (J.C.).</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Gupta</LastName>
<ForeName>Deepak K</ForeName>
<Initials>DK</Initials>
<AffiliationInfo>
<Affiliation>From the Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA (S.C., B.C., A.M.S., D.K.G., H.S., S.D.S.); NMR Group Inc, Somerville, MA (A.W.C.); National Institutes of Health, National Heart, Lung, and Blood Institute, Bethesda, MD (H.N.); the Department of Epidemiology, University of North Carolina, Chapel Hill, NC (W.D.R., G.H.); the Division of Epidemiology and Community Health, University of Minnesota, Minneapolis, MN (A.R.F.); the Welch Center for Prevention, Epidemiology and Clinical Research, Johns Hopkins University, Baltimore, MD (J.C.); and the Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD (J.C.).</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Skali</LastName>
<ForeName>Hicham</ForeName>
<Initials>H</Initials>
<AffiliationInfo>
<Affiliation>From the Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA (S.C., B.C., A.M.S., D.K.G., H.S., S.D.S.); NMR Group Inc, Somerville, MA (A.W.C.); National Institutes of Health, National Heart, Lung, and Blood Institute, Bethesda, MD (H.N.); the Department of Epidemiology, University of North Carolina, Chapel Hill, NC (W.D.R., G.H.); the Division of Epidemiology and Community Health, University of Minnesota, Minneapolis, MN (A.R.F.); the Welch Center for Prevention, Epidemiology and Clinical Research, Johns Hopkins University, Baltimore, MD (J.C.); and the Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD (J.C.).</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Ni</LastName>
<ForeName>Hanyu</ForeName>
<Initials>H</Initials>
<AffiliationInfo>
<Affiliation>From the Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA (S.C., B.C., A.M.S., D.K.G., H.S., S.D.S.); NMR Group Inc, Somerville, MA (A.W.C.); National Institutes of Health, National Heart, Lung, and Blood Institute, Bethesda, MD (H.N.); the Department of Epidemiology, University of North Carolina, Chapel Hill, NC (W.D.R., G.H.); the Division of Epidemiology and Community Health, University of Minnesota, Minneapolis, MN (A.R.F.); the Welch Center for Prevention, Epidemiology and Clinical Research, Johns Hopkins University, Baltimore, MD (J.C.); and the Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD (J.C.).</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Rosamond</LastName>
<ForeName>Wayne D</ForeName>
<Initials>WD</Initials>
<AffiliationInfo>
<Affiliation>From the Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA (S.C., B.C., A.M.S., D.K.G., H.S., S.D.S.); NMR Group Inc, Somerville, MA (A.W.C.); National Institutes of Health, National Heart, Lung, and Blood Institute, Bethesda, MD (H.N.); the Department of Epidemiology, University of North Carolina, Chapel Hill, NC (W.D.R., G.H.); the Division of Epidemiology and Community Health, University of Minnesota, Minneapolis, MN (A.R.F.); the Welch Center for Prevention, Epidemiology and Clinical Research, Johns Hopkins University, Baltimore, MD (J.C.); and the Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD (J.C.).</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Heiss</LastName>
<ForeName>Gerardo</ForeName>
<Initials>G</Initials>
<AffiliationInfo>
<Affiliation>From the Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA (S.C., B.C., A.M.S., D.K.G., H.S., S.D.S.); NMR Group Inc, Somerville, MA (A.W.C.); National Institutes of Health, National Heart, Lung, and Blood Institute, Bethesda, MD (H.N.); the Department of Epidemiology, University of North Carolina, Chapel Hill, NC (W.D.R., G.H.); the Division of Epidemiology and Community Health, University of Minnesota, Minneapolis, MN (A.R.F.); the Welch Center for Prevention, Epidemiology and Clinical Research, Johns Hopkins University, Baltimore, MD (J.C.); and the Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD (J.C.).</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Folsom</LastName>
<ForeName>Aaron R</ForeName>
<Initials>AR</Initials>
<AffiliationInfo>
<Affiliation>From the Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA (S.C., B.C., A.M.S., D.K.G., H.S., S.D.S.); NMR Group Inc, Somerville, MA (A.W.C.); National Institutes of Health, National Heart, Lung, and Blood Institute, Bethesda, MD (H.N.); the Department of Epidemiology, University of North Carolina, Chapel Hill, NC (W.D.R., G.H.); the Division of Epidemiology and Community Health, University of Minnesota, Minneapolis, MN (A.R.F.); the Welch Center for Prevention, Epidemiology and Clinical Research, Johns Hopkins University, Baltimore, MD (J.C.); and the Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD (J.C.).</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Coresh</LastName>
<ForeName>Josef</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>From the Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA (S.C., B.C., A.M.S., D.K.G., H.S., S.D.S.); NMR Group Inc, Somerville, MA (A.W.C.); National Institutes of Health, National Heart, Lung, and Blood Institute, Bethesda, MD (H.N.); the Department of Epidemiology, University of North Carolina, Chapel Hill, NC (W.D.R., G.H.); the Division of Epidemiology and Community Health, University of Minnesota, Minneapolis, MN (A.R.F.); the Welch Center for Prevention, Epidemiology and Clinical Research, Johns Hopkins University, Baltimore, MD (J.C.); and the Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD (J.C.).</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Solomon</LastName>
<ForeName>Scott D</ForeName>
<Initials>SD</Initials>
<AffiliationInfo>
<Affiliation>From the Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA (S.C., B.C., A.M.S., D.K.G., H.S., S.D.S.); NMR Group Inc, Somerville, MA (A.W.C.); National Institutes of Health, National Heart, Lung, and Blood Institute, Bethesda, MD (H.N.); the Department of Epidemiology, University of North Carolina, Chapel Hill, NC (W.D.R., G.H.); the Division of Epidemiology and Community Health, University of Minnesota, Minneapolis, MN (A.R.F.); the Welch Center for Prevention, Epidemiology and Clinical Research, Johns Hopkins University, Baltimore, MD (J.C.); and the Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD (J.C.).</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>HHSN268201100007C</GrantID>
<Acronym>HL</Acronym>
<Agency>NHLBI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>HHSN268201100008C</GrantID>
<Acronym>HL</Acronym>
<Agency>NHLBI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>HHSN268201100009C</GrantID>
<Acronym>HL</Acronym>
<Agency>NHLBI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>HHSN268201100011C</GrantID>
<Acronym>HL</Acronym>
<Agency>NHLBI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>K08 HL116792</GrantID>
<Acronym>HL</Acronym>
<Agency>NHLBI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>K08-HL-116792</GrantID>
<Acronym>HL</Acronym>
<Agency>NHLBI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>K99 HL107642</GrantID>
<Acronym>HL</Acronym>
<Agency>NHLBI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R00 HL107642</GrantID>
<Acronym>HL</Acronym>
<Agency>NHLBI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R00-HL-107642</GrantID>
<Acronym>HL</Acronym>
<Agency>NHLBI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>08</Month>
<Day>11</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Circulation</MedlineTA>
<NlmUniqueID>0147763</NlmUniqueID>
<ISSNLinking>0009-7322</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D044383">African Continental Ancestry Group</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000368">Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002318">Cardiovascular Diseases</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000453">epidemiology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000208">ethnology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000209">etiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D044469">Continental Population Groups</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D048909">Diabetes Complications</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000150">complications</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000453">epidemiology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000208">ethnology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D044465">European Continental Ancestry Group</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006937">Hypercholesterolemia</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000150">complications</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000453">epidemiology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000208">ethnology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006973">Hypertension</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000150">complications</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000453">epidemiology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000208">ethnology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015994">Incidence</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008875">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009765">Obesity</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000150">complications</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000453">epidemiology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000208">ethnology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012189">Retrospective Studies</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012307">Risk Factors</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012737">Sex Factors</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012907">Smoking</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000009">adverse effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" Type="Geographic" UI="D014481">United States</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000453">epidemiology</QualifierName>
</MeshHeading>
</MeshHeadingList>
<OtherID Source="NLM">NIHMS607925 [Available on 09/02/15]</OtherID>
<OtherID Source="NLM">PMC4161984 [Available on 09/02/15]</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">cardiovascular diseases</Keyword>
<Keyword MajorTopicYN="N">ethnicity</Keyword>
<Keyword MajorTopicYN="N">gender</Keyword>
<Keyword MajorTopicYN="N">prevention</Keyword>
<Keyword MajorTopicYN="N">race</Keyword>
<Keyword MajorTopicYN="N">risk factors</Keyword>
</KeywordList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">24849517</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>11</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>01</Day>
</DateCompleted>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1479-683X</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>171</Volume>
<Issue>4</Issue>
<PubDate>
<Year>2014</Year>
<Month>Oct</Month>
</PubDate>
</JournalIssue>
<Title>European journal of endocrinology / European Federation of Endocrine Societies</Title>
<ISOAbbreviation>Eur. J. Endocrinol.</ISOAbbreviation>
</Journal>
<ArticleTitle>The polycystic ovary syndrome: a position statement from the European Society of Endocrinology.</ArticleTitle>
<Pagination>
<MedlinePgn>P1-29</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1530/EJE-14-0253</ELocationID>
<Abstract>
<AbstractText>Polycystic ovary syndrome (PCOS) is the most common ovarian disorder associated with androgen excess in women, which justifies the growing interest of endocrinologists. Great efforts have been made in the last 2 decades to define the syndrome. The presence of three different definitions for the diagnosis of PCOS reflects the phenotypic heterogeneity of the syndrome. Major criteria are required for the diagnosis, which in turn identifies different phenotypes according to the combination of different criteria. In addition, the relevant impact of metabolic issues, specifically insulin resistance and obesity, on the pathogenesis of PCOS, and the susceptibility to develop earlier than expected glucose intolerance states, including type 2 diabetes, has supported the notion that these aspects should be considered when defining the PCOS phenotype and planning potential therapeutic strategies in an affected subject. This paper offers a critical endocrine and European perspective on the debate on the definition of PCOS and summarises all major aspects related to aetiological factors, including early life events, potentially involved in the development of the disorder. Diagnostic tools of PCOS are also discussed, with emphasis on the laboratory evaluation of androgens and other potential biomarkers of ovarian and metabolic dysfunctions. We have also paid specific attention to the role of obesity, sleep disorders and neuropsychological aspects of PCOS and on the relevant pathogenetic aspects of cardiovascular risk factors. In addition, we have discussed how to target treatment choices based according to the phenotype and individual patient's needs. Finally, we have suggested potential areas of translational and clinical research for the future with specific emphasis on hormonal and metabolic aspects of PCOS. </AbstractText>
<CopyrightInformation>© 2014 European Society of Endocrinology.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Conway</LastName>
<ForeName>Gerard</ForeName>
<Initials>G</Initials>
<AffiliationInfo>
<Affiliation>Department of EndocrinologyUniversity College London Hospitals, 250 Euston Road, London NW1 2BU, UKDepartment of Endocrine Gynaecology and Reproductive MedicineCentre Hospitalier de Lille, Hopital Jeanne de Fiandre, Lille, FranceEndocrine Unit3rd Department of Medicine, University of Athens Medical School, Athens, GreeceDepartment of Endocrinology and NutritionUniversidad de Alcalá and Hospital Universitario Ramón y Cajal and Centro de Investigación Biomédica en Red Diabetes y Enfermedades Metabólicas Asociadas CIBERDEM and Instituto Ramón y Cajal de Investigación Sanitaria IRYCIS, Madrid, SpainImperial College LondonInstitute of Reproductive and Developmental Biology, London, UKDivision of EndocrinologyDepartment of Medical and Surgical Sciences, St. Orsola-Malpighi Hospital, University Alma Mater Studiorum, Via Massarenti 9, 40138 Bologna, ItalyDepartment of EndocrinologySchool of Medicine, Erciyes University, Kayseri, TurkeyClinic for EndocrinologyDiabetes and Metabolic Diseases, School of Medicine, University of Belgrade, Belgrade, SerbiaDepartment of EndocrinologyDiabetes and Metabolic Diseases, Medical Faculty, University Medical Centre, University of Ljubljana, Ljubljana, SloveniaDepartment of EndocrinologyFaculty of Medicine of Porto, Hospital S. Joao, Porto, PortugalInsermFédération d'Endocrinologie, Groupement Hospitalier Est, Hospices Civils de Lyon, Université Lyon-1, Lyon, France andDivision of Endocrinology and MetabolismDepartment of Internal Medicine, Hacettepe University School of Medicine, Ankara, Turkey.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Dewailly</LastName>
<ForeName>Didier</ForeName>
<Initials>D</Initials>
<AffiliationInfo>
<Affiliation>Department of EndocrinologyUniversity College London Hospitals, 250 Euston Road, London NW1 2BU, UKDepartment of Endocrine Gynaecology and Reproductive MedicineCentre Hospitalier de Lille, Hopital Jeanne de Fiandre, Lille, FranceEndocrine Unit3rd Department of Medicine, University of Athens Medical School, Athens, GreeceDepartment of Endocrinology and NutritionUniversidad de Alcalá and Hospital Universitario Ramón y Cajal and Centro de Investigación Biomédica en Red Diabetes y Enfermedades Metabólicas Asociadas CIBERDEM and Instituto Ramón y Cajal de Investigación Sanitaria IRYCIS, Madrid, SpainImperial College LondonInstitute of Reproductive and Developmental Biology, London, UKDivision of EndocrinologyDepartment of Medical and Surgical Sciences, St. Orsola-Malpighi Hospital, University Alma Mater Studiorum, Via Massarenti 9, 40138 Bologna, ItalyDepartment of EndocrinologySchool of Medicine, Erciyes University, Kayseri, TurkeyClinic for EndocrinologyDiabetes and Metabolic Diseases, School of Medicine, University of Belgrade, Belgrade, SerbiaDepartment of EndocrinologyDiabetes and Metabolic Diseases, Medical Faculty, University Medical Centre, University of Ljubljana, Ljubljana, SloveniaDepartment of EndocrinologyFaculty of Medicine of Porto, Hospital S. Joao, Porto, PortugalInsermFédération d'Endocrinologie, Groupement Hospitalier Est, Hospices Civils de Lyon, Université Lyon-1, Lyon, France andDivision of Endocrinology and MetabolismDepartment of Internal Medicine, Hacettepe University School of Medicine, Ankara, Turkey.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Diamanti-Kandarakis</LastName>
<ForeName>Evanthia</ForeName>
<Initials>E</Initials>
<AffiliationInfo>
<Affiliation>Department of EndocrinologyUniversity College London Hospitals, 250 Euston Road, London NW1 2BU, UKDepartment of Endocrine Gynaecology and Reproductive MedicineCentre Hospitalier de Lille, Hopital Jeanne de Fiandre, Lille, FranceEndocrine Unit3rd Department of Medicine, University of Athens Medical School, Athens, GreeceDepartment of Endocrinology and NutritionUniversidad de Alcalá and Hospital Universitario Ramón y Cajal and Centro de Investigación Biomédica en Red Diabetes y Enfermedades Metabólicas Asociadas CIBERDEM and Instituto Ramón y Cajal de Investigación Sanitaria IRYCIS, Madrid, SpainImperial College LondonInstitute of Reproductive and Developmental Biology, London, UKDivision of EndocrinologyDepartment of Medical and Surgical Sciences, St. Orsola-Malpighi Hospital, University Alma Mater Studiorum, Via Massarenti 9, 40138 Bologna, ItalyDepartment of EndocrinologySchool of Medicine, Erciyes University, Kayseri, TurkeyClinic for EndocrinologyDiabetes and Metabolic Diseases, School of Medicine, University of Belgrade, Belgrade, SerbiaDepartment of EndocrinologyDiabetes and Metabolic Diseases, Medical Faculty, University Medical Centre, University of Ljubljana, Ljubljana, SloveniaDepartment of EndocrinologyFaculty of Medicine of Porto, Hospital S. Joao, Porto, PortugalInsermFédération d'Endocrinologie, Groupement Hospitalier Est, Hospices Civils de Lyon, Université Lyon-1, Lyon, France andDivision of Endocrinology and MetabolismDepartment of Internal Medicine, Hacettepe University School of Medicine, Ankara, Turkey.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Escobar-Morreale</LastName>
<ForeName>Héctor F</ForeName>
<Initials>HF</Initials>
<AffiliationInfo>
<Affiliation>Department of EndocrinologyUniversity College London Hospitals, 250 Euston Road, London NW1 2BU, UKDepartment of Endocrine Gynaecology and Reproductive MedicineCentre Hospitalier de Lille, Hopital Jeanne de Fiandre, Lille, FranceEndocrine Unit3rd Department of Medicine, University of Athens Medical School, Athens, GreeceDepartment of Endocrinology and NutritionUniversidad de Alcalá and Hospital Universitario Ramón y Cajal and Centro de Investigación Biomédica en Red Diabetes y Enfermedades Metabólicas Asociadas CIBERDEM and Instituto Ramón y Cajal de Investigación Sanitaria IRYCIS, Madrid, SpainImperial College LondonInstitute of Reproductive and Developmental Biology, London, UKDivision of EndocrinologyDepartment of Medical and Surgical Sciences, St. Orsola-Malpighi Hospital, University Alma Mater Studiorum, Via Massarenti 9, 40138 Bologna, ItalyDepartment of EndocrinologySchool of Medicine, Erciyes University, Kayseri, TurkeyClinic for EndocrinologyDiabetes and Metabolic Diseases, School of Medicine, University of Belgrade, Belgrade, SerbiaDepartment of EndocrinologyDiabetes and Metabolic Diseases, Medical Faculty, University Medical Centre, University of Ljubljana, Ljubljana, SloveniaDepartment of EndocrinologyFaculty of Medicine of Porto, Hospital S. Joao, Porto, PortugalInsermFédération d'Endocrinologie, Groupement Hospitalier Est, Hospices Civils de Lyon, Université Lyon-1, Lyon, France andDivision of Endocrinology and MetabolismDepartment of Internal Medicine, Hacettepe University School of Medicine, Ankara, Turkey.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Franks</LastName>
<ForeName>Stephen</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Department of EndocrinologyUniversity College London Hospitals, 250 Euston Road, London NW1 2BU, UKDepartment of Endocrine Gynaecology and Reproductive MedicineCentre Hospitalier de Lille, Hopital Jeanne de Fiandre, Lille, FranceEndocrine Unit3rd Department of Medicine, University of Athens Medical School, Athens, GreeceDepartment of Endocrinology and NutritionUniversidad de Alcalá and Hospital Universitario Ramón y Cajal and Centro de Investigación Biomédica en Red Diabetes y Enfermedades Metabólicas Asociadas CIBERDEM and Instituto Ramón y Cajal de Investigación Sanitaria IRYCIS, Madrid, SpainImperial College LondonInstitute of Reproductive and Developmental Biology, London, UKDivision of EndocrinologyDepartment of Medical and Surgical Sciences, St. Orsola-Malpighi Hospital, University Alma Mater Studiorum, Via Massarenti 9, 40138 Bologna, ItalyDepartment of EndocrinologySchool of Medicine, Erciyes University, Kayseri, TurkeyClinic for EndocrinologyDiabetes and Metabolic Diseases, School of Medicine, University of Belgrade, Belgrade, SerbiaDepartment of EndocrinologyDiabetes and Metabolic Diseases, Medical Faculty, University Medical Centre, University of Ljubljana, Ljubljana, SloveniaDepartment of EndocrinologyFaculty of Medicine of Porto, Hospital S. Joao, Porto, PortugalInsermFédération d'Endocrinologie, Groupement Hospitalier Est, Hospices Civils de Lyon, Université Lyon-1, Lyon, France andDivision of Endocrinology and MetabolismDepartment of Internal Medicine, Hacettepe University School of Medicine, Ankara, Turkey.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Gambineri</LastName>
<ForeName>Alessandra</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Department of EndocrinologyUniversity College London Hospitals, 250 Euston Road, London NW1 2BU, UKDepartment of Endocrine Gynaecology and Reproductive MedicineCentre Hospitalier de Lille, Hopital Jeanne de Fiandre, Lille, FranceEndocrine Unit3rd Department of Medicine, University of Athens Medical School, Athens, GreeceDepartment of Endocrinology and NutritionUniversidad de Alcalá and Hospital Universitario Ramón y Cajal and Centro de Investigación Biomédica en Red Diabetes y Enfermedades Metabólicas Asociadas CIBERDEM and Instituto Ramón y Cajal de Investigación Sanitaria IRYCIS, Madrid, SpainImperial College LondonInstitute of Reproductive and Developmental Biology, London, UKDivision of EndocrinologyDepartment of Medical and Surgical Sciences, St. Orsola-Malpighi Hospital, University Alma Mater Studiorum, Via Massarenti 9, 40138 Bologna, ItalyDepartment of EndocrinologySchool of Medicine, Erciyes University, Kayseri, TurkeyClinic for EndocrinologyDiabetes and Metabolic Diseases, School of Medicine, University of Belgrade, Belgrade, SerbiaDepartment of EndocrinologyDiabetes and Metabolic Diseases, Medical Faculty, University Medical Centre, University of Ljubljana, Ljubljana, SloveniaDepartment of EndocrinologyFaculty of Medicine of Porto, Hospital S. Joao, Porto, PortugalInsermFédération d'Endocrinologie, Groupement Hospitalier Est, Hospices Civils de Lyon, Université Lyon-1, Lyon, France andDivision of Endocrinology and MetabolismDepartment of Internal Medicine, Hacettepe University School of Medicine, Ankara, Turkey.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Kelestimur</LastName>
<ForeName>Fahrettin</ForeName>
<Initials>F</Initials>
<AffiliationInfo>
<Affiliation>Department of EndocrinologyUniversity College London Hospitals, 250 Euston Road, London NW1 2BU, UKDepartment of Endocrine Gynaecology and Reproductive MedicineCentre Hospitalier de Lille, Hopital Jeanne de Fiandre, Lille, FranceEndocrine Unit3rd Department of Medicine, University of Athens Medical School, Athens, GreeceDepartment of Endocrinology and NutritionUniversidad de Alcalá and Hospital Universitario Ramón y Cajal and Centro de Investigación Biomédica en Red Diabetes y Enfermedades Metabólicas Asociadas CIBERDEM and Instituto Ramón y Cajal de Investigación Sanitaria IRYCIS, Madrid, SpainImperial College LondonInstitute of Reproductive and Developmental Biology, London, UKDivision of EndocrinologyDepartment of Medical and Surgical Sciences, St. Orsola-Malpighi Hospital, University Alma Mater Studiorum, Via Massarenti 9, 40138 Bologna, ItalyDepartment of EndocrinologySchool of Medicine, Erciyes University, Kayseri, TurkeyClinic for EndocrinologyDiabetes and Metabolic Diseases, School of Medicine, University of Belgrade, Belgrade, SerbiaDepartment of EndocrinologyDiabetes and Metabolic Diseases, Medical Faculty, University Medical Centre, University of Ljubljana, Ljubljana, SloveniaDepartment of EndocrinologyFaculty of Medicine of Porto, Hospital S. Joao, Porto, PortugalInsermFédération d'Endocrinologie, Groupement Hospitalier Est, Hospices Civils de Lyon, Université Lyon-1, Lyon, France andDivision of Endocrinology and MetabolismDepartment of Internal Medicine, Hacettepe University School of Medicine, Ankara, Turkey.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Macut</LastName>
<ForeName>Djuro</ForeName>
<Initials>D</Initials>
<AffiliationInfo>
<Affiliation>Department of EndocrinologyUniversity College London Hospitals, 250 Euston Road, London NW1 2BU, UKDepartment of Endocrine Gynaecology and Reproductive MedicineCentre Hospitalier de Lille, Hopital Jeanne de Fiandre, Lille, FranceEndocrine Unit3rd Department of Medicine, University of Athens Medical School, Athens, GreeceDepartment of Endocrinology and NutritionUniversidad de Alcalá and Hospital Universitario Ramón y Cajal and Centro de Investigación Biomédica en Red Diabetes y Enfermedades Metabólicas Asociadas CIBERDEM and Instituto Ramón y Cajal de Investigación Sanitaria IRYCIS, Madrid, SpainImperial College LondonInstitute of Reproductive and Developmental Biology, London, UKDivision of EndocrinologyDepartment of Medical and Surgical Sciences, St. Orsola-Malpighi Hospital, University Alma Mater Studiorum, Via Massarenti 9, 40138 Bologna, ItalyDepartment of EndocrinologySchool of Medicine, Erciyes University, Kayseri, TurkeyClinic for EndocrinologyDiabetes and Metabolic Diseases, School of Medicine, University of Belgrade, Belgrade, SerbiaDepartment of EndocrinologyDiabetes and Metabolic Diseases, Medical Faculty, University Medical Centre, University of Ljubljana, Ljubljana, SloveniaDepartment of EndocrinologyFaculty of Medicine of Porto, Hospital S. Joao, Porto, PortugalInsermFédération d'Endocrinologie, Groupement Hospitalier Est, Hospices Civils de Lyon, Université Lyon-1, Lyon, France andDivision of Endocrinology and MetabolismDepartment of Internal Medicine, Hacettepe University School of Medicine, Ankara, Turkey.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Micic</LastName>
<ForeName>Dragan</ForeName>
<Initials>D</Initials>
<AffiliationInfo>
<Affiliation>Department of EndocrinologyUniversity College London Hospitals, 250 Euston Road, London NW1 2BU, UKDepartment of Endocrine Gynaecology and Reproductive MedicineCentre Hospitalier de Lille, Hopital Jeanne de Fiandre, Lille, FranceEndocrine Unit3rd Department of Medicine, University of Athens Medical School, Athens, GreeceDepartment of Endocrinology and NutritionUniversidad de Alcalá and Hospital Universitario Ramón y Cajal and Centro de Investigación Biomédica en Red Diabetes y Enfermedades Metabólicas Asociadas CIBERDEM and Instituto Ramón y Cajal de Investigación Sanitaria IRYCIS, Madrid, SpainImperial College LondonInstitute of Reproductive and Developmental Biology, London, UKDivision of EndocrinologyDepartment of Medical and Surgical Sciences, St. Orsola-Malpighi Hospital, University Alma Mater Studiorum, Via Massarenti 9, 40138 Bologna, ItalyDepartment of EndocrinologySchool of Medicine, Erciyes University, Kayseri, TurkeyClinic for EndocrinologyDiabetes and Metabolic Diseases, School of Medicine, University of Belgrade, Belgrade, SerbiaDepartment of EndocrinologyDiabetes and Metabolic Diseases, Medical Faculty, University Medical Centre, University of Ljubljana, Ljubljana, SloveniaDepartment of EndocrinologyFaculty of Medicine of Porto, Hospital S. Joao, Porto, PortugalInsermFédération d'Endocrinologie, Groupement Hospitalier Est, Hospices Civils de Lyon, Université Lyon-1, Lyon, France andDivision of Endocrinology and MetabolismDepartment of Internal Medicine, Hacettepe University School of Medicine, Ankara, Turkey.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Pasquali</LastName>
<ForeName>Renato</ForeName>
<Initials>R</Initials>
<AffiliationInfo>
<Affiliation>Department of EndocrinologyUniversity College London Hospitals, 250 Euston Road, London NW1 2BU, UKDepartment of Endocrine Gynaecology and Reproductive MedicineCentre Hospitalier de Lille, Hopital Jeanne de Fiandre, Lille, FranceEndocrine Unit3rd Department of Medicine, University of Athens Medical School, Athens, GreeceDepartment of Endocrinology and NutritionUniversidad de Alcalá and Hospital Universitario Ramón y Cajal and Centro de Investigación Biomédica en Red Diabetes y Enfermedades Metabólicas Asociadas CIBERDEM and Instituto Ramón y Cajal de Investigación Sanitaria IRYCIS, Madrid, SpainImperial College LondonInstitute of Reproductive and Developmental Biology, London, UKDivision of EndocrinologyDepartment of Medical and Surgical Sciences, St. Orsola-Malpighi Hospital, University Alma Mater Studiorum, Via Massarenti 9, 40138 Bologna, ItalyDepartment of EndocrinologySchool of Medicine, Erciyes University, Kayseri, TurkeyClinic for EndocrinologyDiabetes and Metabolic Diseases, School of Medicine, University of Belgrade, Belgrade, SerbiaDepartment of EndocrinologyDiabetes and Metabolic Diseases, Medical Faculty, University Medical Centre, University of Ljubljana, Ljubljana, SloveniaDepartment of EndocrinologyFaculty of Medicine of Porto, Hospital S. Joao, Porto, PortugalInsermFédération d'Endocrinologie, Groupement Hospitalier Est, Hospices Civils de Lyon, Université Lyon-1, Lyon, France andDivision of Endocrinology and MetabolismDepartment of Internal Medicine, Hacettepe University School of Medicine, Ankara, Turkey renato.pasquali@unibo.it.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Pfeifer</LastName>
<ForeName>Marija</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Department of EndocrinologyUniversity College London Hospitals, 250 Euston Road, London NW1 2BU, UKDepartment of Endocrine Gynaecology and Reproductive MedicineCentre Hospitalier de Lille, Hopital Jeanne de Fiandre, Lille, FranceEndocrine Unit3rd Department of Medicine, University of Athens Medical School, Athens, GreeceDepartment of Endocrinology and NutritionUniversidad de Alcalá and Hospital Universitario Ramón y Cajal and Centro de Investigación Biomédica en Red Diabetes y Enfermedades Metabólicas Asociadas CIBERDEM and Instituto Ramón y Cajal de Investigación Sanitaria IRYCIS, Madrid, SpainImperial College LondonInstitute of Reproductive and Developmental Biology, London, UKDivision of EndocrinologyDepartment of Medical and Surgical Sciences, St. Orsola-Malpighi Hospital, University Alma Mater Studiorum, Via Massarenti 9, 40138 Bologna, ItalyDepartment of EndocrinologySchool of Medicine, Erciyes University, Kayseri, TurkeyClinic for EndocrinologyDiabetes and Metabolic Diseases, School of Medicine, University of Belgrade, Belgrade, SerbiaDepartment of EndocrinologyDiabetes and Metabolic Diseases, Medical Faculty, University Medical Centre, University of Ljubljana, Ljubljana, SloveniaDepartment of EndocrinologyFaculty of Medicine of Porto, Hospital S. Joao, Porto, PortugalInsermFédération d'Endocrinologie, Groupement Hospitalier Est, Hospices Civils de Lyon, Université Lyon-1, Lyon, France andDivision of Endocrinology and MetabolismDepartment of Internal Medicine, Hacettepe University School of Medicine, Ankara, Turkey.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Pignatelli</LastName>
<ForeName>Duarte</ForeName>
<Initials>D</Initials>
<AffiliationInfo>
<Affiliation>Department of EndocrinologyUniversity College London Hospitals, 250 Euston Road, London NW1 2BU, UKDepartment of Endocrine Gynaecology and Reproductive MedicineCentre Hospitalier de Lille, Hopital Jeanne de Fiandre, Lille, FranceEndocrine Unit3rd Department of Medicine, University of Athens Medical School, Athens, GreeceDepartment of Endocrinology and NutritionUniversidad de Alcalá and Hospital Universitario Ramón y Cajal and Centro de Investigación Biomédica en Red Diabetes y Enfermedades Metabólicas Asociadas CIBERDEM and Instituto Ramón y Cajal de Investigación Sanitaria IRYCIS, Madrid, SpainImperial College LondonInstitute of Reproductive and Developmental Biology, London, UKDivision of EndocrinologyDepartment of Medical and Surgical Sciences, St. Orsola-Malpighi Hospital, University Alma Mater Studiorum, Via Massarenti 9, 40138 Bologna, ItalyDepartment of EndocrinologySchool of Medicine, Erciyes University, Kayseri, TurkeyClinic for EndocrinologyDiabetes and Metabolic Diseases, School of Medicine, University of Belgrade, Belgrade, SerbiaDepartment of EndocrinologyDiabetes and Metabolic Diseases, Medical Faculty, University Medical Centre, University of Ljubljana, Ljubljana, SloveniaDepartment of EndocrinologyFaculty of Medicine of Porto, Hospital S. Joao, Porto, PortugalInsermFédération d'Endocrinologie, Groupement Hospitalier Est, Hospices Civils de Lyon, Université Lyon-1, Lyon, France andDivision of Endocrinology and MetabolismDepartment of Internal Medicine, Hacettepe University School of Medicine, Ankara, Turkey.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Pugeat</LastName>
<ForeName>Michel</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Department of EndocrinologyUniversity College London Hospitals, 250 Euston Road, London NW1 2BU, UKDepartment of Endocrine Gynaecology and Reproductive MedicineCentre Hospitalier de Lille, Hopital Jeanne de Fiandre, Lille, FranceEndocrine Unit3rd Department of Medicine, University of Athens Medical School, Athens, GreeceDepartment of Endocrinology and NutritionUniversidad de Alcalá and Hospital Universitario Ramón y Cajal and Centro de Investigación Biomédica en Red Diabetes y Enfermedades Metabólicas Asociadas CIBERDEM and Instituto Ramón y Cajal de Investigación Sanitaria IRYCIS, Madrid, SpainImperial College LondonInstitute of Reproductive and Developmental Biology, London, UKDivision of EndocrinologyDepartment of Medical and Surgical Sciences, St. Orsola-Malpighi Hospital, University Alma Mater Studiorum, Via Massarenti 9, 40138 Bologna, ItalyDepartment of EndocrinologySchool of Medicine, Erciyes University, Kayseri, TurkeyClinic for EndocrinologyDiabetes and Metabolic Diseases, School of Medicine, University of Belgrade, Belgrade, SerbiaDepartment of EndocrinologyDiabetes and Metabolic Diseases, Medical Faculty, University Medical Centre, University of Ljubljana, Ljubljana, SloveniaDepartment of EndocrinologyFaculty of Medicine of Porto, Hospital S. Joao, Porto, PortugalInsermFédération d'Endocrinologie, Groupement Hospitalier Est, Hospices Civils de Lyon, Université Lyon-1, Lyon, France andDivision of Endocrinology and MetabolismDepartment of Internal Medicine, Hacettepe University School of Medicine, Ankara, Turkey.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Yildiz</LastName>
<ForeName>Bulent O</ForeName>
<Initials>BO</Initials>
<AffiliationInfo>
<Affiliation>Department of EndocrinologyUniversity College London Hospitals, 250 Euston Road, London NW1 2BU, UKDepartment of Endocrine Gynaecology and Reproductive MedicineCentre Hospitalier de Lille, Hopital Jeanne de Fiandre, Lille, FranceEndocrine Unit3rd Department of Medicine, University of Athens Medical School, Athens, GreeceDepartment of Endocrinology and NutritionUniversidad de Alcalá and Hospital Universitario Ramón y Cajal and Centro de Investigación Biomédica en Red Diabetes y Enfermedades Metabólicas Asociadas CIBERDEM and Instituto Ramón y Cajal de Investigación Sanitaria IRYCIS, Madrid, SpainImperial College LondonInstitute of Reproductive and Developmental Biology, London, UKDivision of EndocrinologyDepartment of Medical and Surgical Sciences, St. Orsola-Malpighi Hospital, University Alma Mater Studiorum, Via Massarenti 9, 40138 Bologna, ItalyDepartment of EndocrinologySchool of Medicine, Erciyes University, Kayseri, TurkeyClinic for EndocrinologyDiabetes and Metabolic Diseases, School of Medicine, University of Belgrade, Belgrade, SerbiaDepartment of EndocrinologyDiabetes and Metabolic Diseases, Medical Faculty, University Medical Centre, University of Ljubljana, Ljubljana, SloveniaDepartment of EndocrinologyFaculty of Medicine of Porto, Hospital S. Joao, Porto, PortugalInsermFédération d'Endocrinologie, Groupement Hospitalier Est, Hospices Civils de Lyon, Université Lyon-1, Lyon, France andDivision of Endocrinology and MetabolismDepartment of Internal Medicine, Hacettepe University School of Medicine, Ankara, Turkey.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<CollectiveName>ESE PCOS Special Interest Group</CollectiveName>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D017065">Practice Guideline</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
<PublicationType UI="D016454">Review</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>05</Month>
<Day>21</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>England</Country>
<MedlineTA>Eur J Endocrinol</MedlineTA>
<NlmUniqueID>9423848</NlmUniqueID>
<ISSNLinking>0804-4643</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000728">Androgens</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D015415">Biological Markers</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D012739">Gonadal Steroid Hormones</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D007004">Hypoglycemic Agents</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>3XMK78S47O</RegistryNumber>
<NameOfSubstance UI="D013739">Testosterone</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>IY9XDZ35W2</RegistryNumber>
<NameOfSubstance UI="D005947">Glucose</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000728">Androgens</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D050110">Bariatric Surgery</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015415">Biological Markers</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000097">blood</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001823">Body Composition</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002318">Cardiovascular Diseases</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000209">etiology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000517">prevention &amp; control</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D003210">Concept Formation</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005947">Glucose</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D018149">Glucose Intolerance</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000209">etiology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012739">Gonadal Steroid Hormones</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007004">Hypoglycemic Agents</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000627">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007247">Infertility, Female</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000209">etiology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000628">therapy</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007333">Insulin Resistance</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015227">Lipid Peroxidation</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009765">Obesity</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000150">complications</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000209">etiology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000628">therapy</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D010053">Ovary</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000378">metabolism</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000473">pathology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000736">ultrasonography</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D010641">Phenotype</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D011085">Polycystic Ovary Syndrome</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000150">complications</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000175">diagnosis</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000209">etiology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000523">psychology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000628">therapy</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011788">Quality of Life</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D040242">Risk Reduction Behavior</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D013739">Testosterone</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25211791</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>12</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>10</Month>
<Day>30</Day>
</DateCompleted>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0032-6518</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>258</Volume>
<Issue>1773</Issue>
<PubDate>
<MedlineDate>2014 Jul-Aug</MedlineDate>
</PubDate>
</JournalIssue>
<Title>The Practitioner</Title>
<ISOAbbreviation>Practitioner</ISOAbbreviation>
</Journal>
<ArticleTitle>Improving outcomes for patients with obesity.</ArticleTitle>
<Pagination>
<MedlinePgn>29-31, 3</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>In England there has been a sharp increase in the prevalence of overweight and obesity in adults. In 1993 58% of men and 49% of women were classified as overweight or obese compared with 65% and 58% respectively in 2011; 24% of men and 26% of women were classed as obese in 2011. Body mass index (BMI) is the most commonly used measure to classify people into weight categories. While the use of BMI has limitations, as it does not take into account the difference between muscle and fat, it is a good quick indicator of increased risks. Obesity increases the risk of hypertension, coronary heart disease, deep vein thrombosis and pulmonary embolism. It is also associated with an increased risk of certain cancers. Obesity is an important risk factor for non-alcoholic fatty liver disease which if left untreated can progress to severe forms of liver disease, such as non-alcoholic steatohepatitis, fibrosis and cirrhosis. The risk of sleep apnoea is raised in obese individuals as is that for gastro-oesophageal reflux and gallstones, stress incontinence in women and erectile dysfunction in men. Lifestyle weight management programmes should be multicomponent, developed by a multidisciplinary team, and delivered by individuals who have undergone appropriate training. They should focus on long-term weight loss and prevention of weight regain and continue for a minimum of three months. Effective programmes include setting dietary targets, such as specific reductions in energy intake. Other options that GPs and practice nurses might offer within the practice, over and above referral to lifestyle programmes, include help with intermittent or regular motivational support, and/or drug therapy.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Jolly</LastName>
<ForeName>Kate</ForeName>
<Initials>K</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Chambers</LastName>
<ForeName>Ruth</ForeName>
<Initials>R</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>England</Country>
<MedlineTA>Practitioner</MedlineTA>
<NlmUniqueID>0404245</NlmUniqueID>
<ISSNLinking>0032-6518</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000328">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015992">Body Mass Index</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009765">Obesity</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000150">complications</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000453">epidemiology</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000628">therapy</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015431">Weight Loss</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25211929</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>12</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>10</Month>
<Day>01</Day>
</DateCompleted>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">1728-2985</ISSN>
<JournalIssue CitedMedium="Print">
<Issue>3</Issue>
<PubDate>
<MedlineDate>2014 May-Jun</MedlineDate>
</PubDate>
</JournalIssue>
<Title>Urologii͡a (Moscow, Russia : 1999)</Title>
<ISOAbbreviation>Urologiia</ISOAbbreviation>
</Journal>
<ArticleTitle>[Features of endoscopic surgical treatment of urolithiasis in overweight patients].</ArticleTitle>
<Pagination>
<MedlinePgn>59-62</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>The article presents the results of endoscopic and nephrolithotripsy and ureterolithotripsy in 73 overweight patients (body mass index of over 30 kg/m2) with kidney stones and urinary tract infections of different locations compared with 30 patients without obesity. The features of choice of tactics of surgical treatment and access, possible complications and their prevention are described.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Teodorovich</LastName>
<ForeName>O V</ForeName>
<Initials>OV</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Borisenko</LastName>
<ForeName>G G</ForeName>
<Initials>GG</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Shatokhin</LastName>
<ForeName>M N</ForeName>
<Initials>MN</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Davlatbiev</LastName>
<ForeName>S A</ForeName>
<Initials>SA</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Naryshkin</LastName>
<ForeName>S A</ForeName>
<Initials>SA</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Dalgatov</LastName>
<ForeName>Sh Iu</ForeName>
<Initials>ShIu</Initials>
</Author>
</AuthorList>
<Language>rus</Language>
<PublicationTypeList>
<PublicationType UI="D004740">English Abstract</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>Russia (Federation)</Country>
<MedlineTA>Urologiia</MedlineTA>
<NlmUniqueID>100900900</NlmUniqueID>
<ISSNLinking>1728-2985</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000328">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000368">Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D004724">Endoscopy</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008875">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D053040">Nephrolithiasis</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000150">complications</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000601">surgery</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009765">Obesity</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000150">complications</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000601">surgery</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D053039">Ureterolithiasis</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000150">complications</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000601">surgery</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">24920290</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>12</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>01</Day>
</DateCompleted>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1479-683X</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>171</Volume>
<Issue>4</Issue>
<PubDate>
<Year>2014</Year>
<Month>Oct</Month>
</PubDate>
</JournalIssue>
<Title>European journal of endocrinology / European Federation of Endocrine Societies</Title>
<ISOAbbreviation>Eur. J. Endocrinol.</ISOAbbreviation>
</Journal>
<ArticleTitle>Endocrinology and Adolescence: aerobic exercise reduces insulin resistance markers in obese youth: a meta-analysis of randomized controlled trials.</ArticleTitle>
<Pagination>
<MedlinePgn>R163-71</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1530/EJE-14-0291</ELocationID>
<Abstract>
<AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">The purpose of this meta-analysis was to examine the evidence for the effectiveness of aerobic exercise interventions on reducing insulin resistance markers in obese children and/or adolescents. A secondary outcome was change in percentage of body fat.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">A computerized search was made from seven databases: CINAHL, Cochrane Central Register of Controlled Trials, EMBASE, ERIC, MEDLINE, PsycINFO, and Science Citation Index. The analysis was restricted to randomized controlled trials that examined the effect of aerobic exercise on insulin resistance markers in obese youth. Two independent reviewers screened studies and extracted data. Effect sizes (ES) and 95% confidence interval (CI) were calculated, and the heterogeneity of the studies was estimated using Cochran's Q-statistic.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">Nine studies were selected for meta-analysis as they fulfilled the inclusion criteria (n=367). Aerobic exercise interventions resulted in decreases in fasting glucose (ES=-0.39; low heterogeneity) and insulin (ES=-0.40; low heterogeneity) and in percentage of body fat (ES=-0.35; low heterogeneity). These improvements were specifically accentuated in adolescents (only in fasting insulin), or through programs lasting more than 12 weeks, three sessions per week, and over 60 min of aerobic exercise per session.</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">This meta-analysis provides insights into the effectiveness of aerobic exercise interventions on insulin resistance markers in the obese youth population.</AbstractText>
<CopyrightInformation>© 2014 European Society of Endocrinology.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>García-Hermoso</LastName>
<ForeName>Antonio</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Facultad de Ciencias de la SaludUniversidad Autónoma de Chile, Talca, ChileAFIDES Research GroupFacultad de Ciencias del Deporte, Universidad de Extremadura, Cáceres, SpainSocial and Health Care Research CenterUniversity of Castilla-La Mancha, Edificio Melchor Cano, Centro de Estudios Socio-Sanitarios, Santa Teresa Jornet s/n, 16071 Cuenca, SpainSchool of EducationUniversity of Castilla-La Mancha, Ciudad Real, Spain.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Saavedra</LastName>
<ForeName>Jose M</ForeName>
<Initials>JM</Initials>
<AffiliationInfo>
<Affiliation>Facultad de Ciencias de la SaludUniversidad Autónoma de Chile, Talca, ChileAFIDES Research GroupFacultad de Ciencias del Deporte, Universidad de Extremadura, Cáceres, SpainSocial and Health Care Research CenterUniversity of Castilla-La Mancha, Edificio Melchor Cano, Centro de Estudios Socio-Sanitarios, Santa Teresa Jornet s/n, 16071 Cuenca, SpainSchool of EducationUniversity of Castilla-La Mancha, Ciudad Real, Spain.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Escalante</LastName>
<ForeName>Yolanda</ForeName>
<Initials>Y</Initials>
<AffiliationInfo>
<Affiliation>Facultad de Ciencias de la SaludUniversidad Autónoma de Chile, Talca, ChileAFIDES Research GroupFacultad de Ciencias del Deporte, Universidad de Extremadura, Cáceres, SpainSocial and Health Care Research CenterUniversity of Castilla-La Mancha, Edificio Melchor Cano, Centro de Estudios Socio-Sanitarios, Santa Teresa Jornet s/n, 16071 Cuenca, SpainSchool of EducationUniversity of Castilla-La Mancha, Ciudad Real, Spain.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Sánchez-López</LastName>
<ForeName>Mairena</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Facultad de Ciencias de la SaludUniversidad Autónoma de Chile, Talca, ChileAFIDES Research GroupFacultad de Ciencias del Deporte, Universidad de Extremadura, Cáceres, SpainSocial and Health Care Research CenterUniversity of Castilla-La Mancha, Edificio Melchor Cano, Centro de Estudios Socio-Sanitarios, Santa Teresa Jornet s/n, 16071 Cuenca, SpainSchool of EducationUniversity of Castilla-La Mancha, Ciudad Real, Spain Facultad de Ciencias de la SaludUniversidad Autónoma de Chile, Talca, ChileAFIDES Research GroupFacultad de Ciencias del Deporte, Universidad de Extremadura, Cáceres, SpainSocial and Health Care Research CenterUniversity of Castilla-La Mancha, Edificio Melchor Cano, Centro de Estudios Socio-Sanitarios, Santa Teresa Jornet s/n, 16071 Cuenca, SpainSchool of EducationUniversity of Castilla-La Mancha, Ciudad Real, Spain.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Martínez-Vizcaíno</LastName>
<ForeName>Vicente</ForeName>
<Initials>V</Initials>
<AffiliationInfo>
<Affiliation>Facultad de Ciencias de la SaludUniversidad Autónoma de Chile, Talca, ChileAFIDES Research GroupFacultad de Ciencias del Deporte, Universidad de Extremadura, Cáceres, SpainSocial and Health Care Research CenterUniversity of Castilla-La Mancha, Edificio Melchor Cano, Centro de Estudios Socio-Sanitarios, Santa Teresa Jornet s/n, 16071 Cuenca, SpainSchool of EducationUniversity of Castilla-La Mancha, Ciudad Real, Spain Vicente.Martinez@uclm.es.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D017418">Meta-Analysis</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>06</Month>
<Day>11</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>England</Country>
<MedlineTA>Eur J Endocrinol</MedlineTA>
<NlmUniqueID>9423848</NlmUniqueID>
<ISSNLinking>0804-4643</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D015415">Biological Markers</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D001786">Blood Glucose</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D007328">Insulin</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D000273">Adipose Tissue</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000293">Adolescent</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015982">Bias (Epidemiology)</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015415">Biological Markers</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000097">blood</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001786">Blood Glucose</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D001823">Body Composition</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002648">Child</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D015444">Exercise</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007328">Insulin</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000097">blood</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D007333">Insulin Resistance</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009765">Obesity</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000097">blood</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000378">metabolism</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000628">therapy</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D016032">Randomized Controlled Trials as Topic</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25214234</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>12</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>01</Day>
</DateCompleted>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">1479-683X</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>171</Volume>
<Issue>4</Issue>
<PubDate>
<Year>2014</Year>
<Month>Oct</Month>
</PubDate>
</JournalIssue>
<Title>European journal of endocrinology / European Federation of Endocrine Societies</Title>
<ISOAbbreviation>Eur. J. Endocrinol.</ISOAbbreviation>
</Journal>
<ArticleTitle>Mechanisms in endocrinology: the crosstalk between thyroid gland and adipose tissue: signal integration in health and disease.</ArticleTitle>
<Pagination>
<MedlinePgn>R137-52</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1530/EJE-14-0067</ELocationID>
<Abstract>
<AbstractText>Obesity and thyroid diseases are common disorders in the general population and they frequently occur in single individuals. Alongside a chance association, a direct relationship between 'thyroid and obesity' has been hypothesized. Thyroid hormone is an important determinant of energy expenditure and contributes to appetite regulation, while hormones and cytokines from the adipose tissue act on the CNS to inform on the quantity of energy stores. A continuous interaction between the thyroid hormone and regulatory mechanisms localized in adipose tissue and brain is important for human body weight control and maintenance of optimal energy balance. Whether obesity has a pathogenic role in thyroid disease remains largely a matter of investigation. This review highlights the complexity in the identification of thyroid hormone deficiency in obese patients. Regardless of the importance of treating subclinical and overt hypothyroidism, at present there is no evidence to recommend pharmacological correction of the isolated hyperthyrotropinemia often encountered in obese patients. While thyroid hormones are not indicated as anti-obesity drugs, preclinical studies suggest that thyromimetic drugs, by targeting selected receptors, might be useful in the treatment of obesity and dyslipidemia. </AbstractText>
<CopyrightInformation>© 2014 European Society of Endocrinology.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Santini</LastName>
<ForeName>Ferruccio</ForeName>
<Initials>F</Initials>
<AffiliationInfo>
<Affiliation>Endocrinology UnitObesity Center, University Hospital of Pisa, Pisa, ItalyDepartment of Translational MedicineUniversity of Piemonte Orientale, Novara, ItalyDivision of General MedicineI.R.C.C.S. Istituto Auxologico Italiano, Verbania, ItalyUnit of Internal Medicine and EndocrinologyFondazione Salvatore Maugeri I.R.C.C.S., University of Pavia, Pavia, ItalyDepartment of Clinical Medicine and SurgeryUniversity of Naples Federico II, Via S. Pansini 5, 80131 Naples, Italy.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Marzullo</LastName>
<ForeName>Paolo</ForeName>
<Initials>P</Initials>
<AffiliationInfo>
<Affiliation>Endocrinology UnitObesity Center, University Hospital of Pisa, Pisa, ItalyDepartment of Translational MedicineUniversity of Piemonte Orientale, Novara, ItalyDivision of General MedicineI.R.C.C.S. Istituto Auxologico Italiano, Verbania, ItalyUnit of Internal Medicine and EndocrinologyFondazione Salvatore Maugeri I.R.C.C.S., University of Pavia, Pavia, ItalyDepartment of Clinical Medicine and SurgeryUniversity of Naples Federico II, Via S. Pansini 5, 80131 Naples, Italy Endocrinology UnitObesity Center, University Hospital of Pisa, Pisa, ItalyDepartment of Translational MedicineUniversity of Piemonte Orientale, Novara, ItalyDivision of General MedicineI.R.C.C.S. Istituto Auxologico Italiano, Verbania, ItalyUnit of Internal Medicine and EndocrinologyFondazione Salvatore Maugeri I.R.C.C.S., University of Pavia, Pavia, ItalyDepartment of Clinical Medicine and SurgeryUniversity of Naples Federico II, Via S. Pansini 5, 80131 Naples, Italy.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Rotondi</LastName>
<ForeName>Mario</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Endocrinology UnitObesity Center, University Hospital of Pisa, Pisa, ItalyDepartment of Translational MedicineUniversity of Piemonte Orientale, Novara, ItalyDivision of General MedicineI.R.C.C.S. Istituto Auxologico Italiano, Verbania, ItalyUnit of Internal Medicine and EndocrinologyFondazione Salvatore Maugeri I.R.C.C.S., University of Pavia, Pavia, ItalyDepartment of Clinical Medicine and SurgeryUniversity of Naples Federico II, Via S. Pansini 5, 80131 Naples, Italy.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Ceccarini</LastName>
<ForeName>Giovanni</ForeName>
<Initials>G</Initials>
<AffiliationInfo>
<Affiliation>Endocrinology UnitObesity Center, University Hospital of Pisa, Pisa, ItalyDepartment of Translational MedicineUniversity of Piemonte Orientale, Novara, ItalyDivision of General MedicineI.R.C.C.S. Istituto Auxologico Italiano, Verbania, ItalyUnit of Internal Medicine and EndocrinologyFondazione Salvatore Maugeri I.R.C.C.S., University of Pavia, Pavia, ItalyDepartment of Clinical Medicine and SurgeryUniversity of Naples Federico II, Via S. Pansini 5, 80131 Naples, Italy.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Pagano</LastName>
<ForeName>Loredana</ForeName>
<Initials>L</Initials>
<AffiliationInfo>
<Affiliation>Endocrinology UnitObesity Center, University Hospital of Pisa, Pisa, ItalyDepartment of Translational MedicineUniversity of Piemonte Orientale, Novara, ItalyDivision of General MedicineI.R.C.C.S. Istituto Auxologico Italiano, Verbania, ItalyUnit of Internal Medicine and EndocrinologyFondazione Salvatore Maugeri I.R.C.C.S., University of Pavia, Pavia, ItalyDepartment of Clinical Medicine and SurgeryUniversity of Naples Federico II, Via S. Pansini 5, 80131 Naples, Italy.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Ippolito</LastName>
<ForeName>Serena</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Endocrinology UnitObesity Center, University Hospital of Pisa, Pisa, ItalyDepartment of Translational MedicineUniversity of Piemonte Orientale, Novara, ItalyDivision of General MedicineI.R.C.C.S. Istituto Auxologico Italiano, Verbania, ItalyUnit of Internal Medicine and EndocrinologyFondazione Salvatore Maugeri I.R.C.C.S., University of Pavia, Pavia, ItalyDepartment of Clinical Medicine and SurgeryUniversity of Naples Federico II, Via S. Pansini 5, 80131 Naples, Italy.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Chiovato</LastName>
<ForeName>Luca</ForeName>
<Initials>L</Initials>
<AffiliationInfo>
<Affiliation>Endocrinology UnitObesity Center, University Hospital of Pisa, Pisa, ItalyDepartment of Translational MedicineUniversity of Piemonte Orientale, Novara, ItalyDivision of General MedicineI.R.C.C.S. Istituto Auxologico Italiano, Verbania, ItalyUnit of Internal Medicine and EndocrinologyFondazione Salvatore Maugeri I.R.C.C.S., University of Pavia, Pavia, ItalyDepartment of Clinical Medicine and SurgeryUniversity of Naples Federico II, Via S. Pansini 5, 80131 Naples, Italy.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Biondi</LastName>
<ForeName>Bernadette</ForeName>
<Initials>B</Initials>
<AffiliationInfo>
<Affiliation>Endocrinology UnitObesity Center, University Hospital of Pisa, Pisa, ItalyDepartment of Translational MedicineUniversity of Piemonte Orientale, Novara, ItalyDivision of General MedicineI.R.C.C.S. Istituto Auxologico Italiano, Verbania, ItalyUnit of Internal Medicine and EndocrinologyFondazione Salvatore Maugeri I.R.C.C.S., University of Pavia, Pavia, ItalyDepartment of Clinical Medicine and SurgeryUniversity of Naples Federico II, Via S. Pansini 5, 80131 Naples, Italy bebiondi@unina.it bebiondi@libero.it.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016454">Review</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>England</Country>
<MedlineTA>Eur J Endocrinol</MedlineTA>
<NlmUniqueID>9423848</NlmUniqueID>
<ISSNLinking>0804-4643</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D019440">Anti-Obesity Agents</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D020738">Leptin</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D013963">Thyroid Hormones</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>9002-71-5</RegistryNumber>
<NameOfSubstance UI="D013972">Thyrotropin</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000273">Adipose Tissue</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000818">Animals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D019440">Anti-Obesity Agents</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000494">pharmacology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000627">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D015551">Autoimmunity</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001835">Body Weight</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002149">Energy Intake</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D004734">Energy Metabolism</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D025461">Feedback, Physiological</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005510">Food Habits</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007037">Hypothyroidism</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000209">etiology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D020738">Leptin</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" Type="Geographic" UI="D009656">North America</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000453">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009765">Obesity</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000150">complications</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000188">drug therapy</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000453">epidemiology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000276">immunology</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D016032">Randomized Controlled Trials as Topic</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D013961">Thyroid Gland</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000276">immunology</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D013963">Thyroid Hormones</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000276">immunology</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000378">metabolism</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000494">pharmacology</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000627">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D013964">Thyroid Neoplasms</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000453">epidemiology</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000209">etiology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D013967">Thyroiditis, Autoimmune</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000209">etiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D013972">Thyrotropin</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000097">blood</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25211047</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>12</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>06</Day>
</DateCompleted>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">1536-5964</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>93</Volume>
<Issue>12</Issue>
<PubDate>
<Year>2014</Year>
<Month>Sep</Month>
</PubDate>
</JournalIssue>
<Title>Medicine</Title>
<ISOAbbreviation>Medicine (Baltimore)</ISOAbbreviation>
</Journal>
<ArticleTitle>Early myocardial deformation changes in hypercholesterolemic and obese children and adolescents: a 2D and 3D speckle tracking echocardiography study.</ArticleTitle>
<Pagination>
<MedlinePgn>e71</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1097/MD.0000000000000071</ELocationID>
<Abstract>
<AbstractText>Dyslipidemia and obesity are considered strong risk factors for premature atherosclerotic cardiovascular disease and increased morbidity and mortality and may have a negative impact on myocardial function.Our purpose was to assess the presence of early myocardial deformation abnormalities in dyslipidemic children free from other cardiovascular risk factors, using 2-dimensional speckle tracking echocardiography (2DSTE) and 3-dimensional speckle tracking echocardiography (3DSTE).We studied 80 consecutive nonselected patients (6-18 years of age) with hypercholesterolemia (low-density lipoprotein [LDL] cholesterol levels &gt;95th percentile for age and sex). Forty of them had normal weight and 40 were obese (body mass index &gt;95th percentile for age and sex). Forty healthy age-matched children were selected as controls. Left ventricular (LV) global longitudinal, circumferential, and radial strains were calculated by 2DSTE and 3DSTE. Global area strain (GAS) was calculated by 3DSTE as percentage of variation in surface area defined by the longitudinal and circumferential strain vectors. Right ventricular (RV) global and free-wall longitudinal strain and LV and RV diastolic strain rate parameters were obtained. Data analysis was performed offline.LV global longitudinal strain and GAS were lower in normal-weight and obese dyslipidemic children compared with normal controls and reduced in obese patients compared with normal-weight dyslipidemic children. LV early diastolic strain rate was lower compared with normals. RV global and free-wall longitudinal strain was significantly reduced in obese patients when compared with the control group. A significant inverse correlation was found between LV strain, LDL cholesterol levels, and body mass index.2DSTE and 3DSTE show LV longitudinal strain and GAS changes in dyslipidemic children and adolescents free from other cardiovascular risk factors or structural cardiac abnormalities. Obesity causes an additive adverse effect on LV strain parameters and RV strain impairment. </AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Vitarelli</LastName>
<ForeName>Antonio</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Department of Cardiology (AV, LC, RA, YC, FaM); Department of Pediatrics (FrM, EM, CC, CZ); and Department of Medicine (SR, MV, SDC), Sapienza University, Rome, Italy.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Martino</LastName>
<ForeName>Francesco</ForeName>
<Initials>F</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Capotosto</LastName>
<ForeName>Lidia</ForeName>
<Initials>L</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Martino</LastName>
<ForeName>Eliana</ForeName>
<Initials>E</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Colantoni</LastName>
<ForeName>Chiara</ForeName>
<Initials>C</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Ashurov</LastName>
<ForeName>Rasul</ForeName>
<Initials>R</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Ricci</LastName>
<ForeName>Serafino</ForeName>
<Initials>S</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Conde</LastName>
<ForeName>Ysabel</ForeName>
<Initials>Y</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Maramao</LastName>
<ForeName>Fabio</ForeName>
<Initials>F</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Vitarelli</LastName>
<ForeName>Massimo</ForeName>
<Initials>M</Initials>
</Author>
<Author ValidYN="Y">
<LastName>De Chiara</LastName>
<ForeName>Stefania</ForeName>
<Initials>S</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Zanoni</LastName>
<ForeName>Cristina</ForeName>
<Initials>C</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Medicine (Baltimore)</MedlineTA>
<NlmUniqueID>2985248R</NlmUniqueID>
<ISSNLinking>0025-7974</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D008078">Cholesterol, LDL</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000293">Adolescent</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015992">Body Mass Index</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D016022">Case-Control Studies</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002648">Child</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008078">Cholesterol, LDL</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000097">blood</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015897">Comorbidity</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D004452">Echocardiography</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D019560">Echocardiography, Three-Dimensional</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006352">Heart Ventricles</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000736">ultrasonography</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006937">Hypercholesterolemia</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000097">blood</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000150">complications</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009206">Myocardium</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009765">Obesity</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000150">complications</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25214611</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>12</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>10</Month>
<Day>03</Day>
</DateCompleted>
<DateRevised>
<Year>2014</Year>
<Month>11</Month>
<Day>20</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">1095-9203</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>345</Volume>
<Issue>6202</Issue>
<PubDate>
<Year>2014</Year>
<Month>Sep</Month>
<Day>12</Day>
</PubDate>
</JournalIssue>
<Title>Science (New York, N.Y.)</Title>
<ISOAbbreviation>Science</ISOAbbreviation>
</Journal>
<ArticleTitle>The state of global health in 2014.</ArticleTitle>
<Pagination>
<MedlinePgn>1275-8</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1126/science.1257099</ELocationID>
<Abstract>
<AbstractText>The global health landscape looks more promising than ever, although progress has been uneven. Here, we describe the current global burden of disease throughout the life cycle, highlighting regional differences in the unfinished agenda of communicable diseases and reproductive, maternal, and child health and the additive burden of emerging noncommunicable diseases and injuries. Understanding this changing landscape is an essential starting point for effective allocation of both domestic and international resources for health. </AbstractText>
<CopyrightInformation>Copyright © 2014, American Association for the Advancement of Science.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Sepúlveda</LastName>
<ForeName>Jaime</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>Global Health Sciences, University of California (UC) San Francisco, San Francisco, CA, USA. sepulvedaj@globalhealth.ucsf.edu.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Murray</LastName>
<ForeName>Christopher</ForeName>
<Initials>C</Initials>
<AffiliationInfo>
<Affiliation>Institute for Health Metrics and Evaluation (IHME), University of Washington, Seattle, WA, USA.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Science</MedlineTA>
<NlmUniqueID>0404511</NlmUniqueID>
<ISSNLinking>0036-8075</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000293">Adolescent</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000328">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000367">Age Factors</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000368">Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002648">Child</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002669">Child Welfare</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000639">trends</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002675">Child, Preschool</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D003141">Communicable Diseases</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000453">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D017281">Cost of Illness</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D003920">Diabetes Mellitus</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000453">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D004630">Emergencies</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000453">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D014943">Global Health</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000639">trends</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007223">Infant</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007231">Infant, Newborn</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008429">Maternal Welfare</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000639">trends</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008875">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009765">Obesity</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000453">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015995">Prevalence</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D060728">Reproductive Health</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000639">trends</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D014947">Wounds and Injuries</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000453">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D055815">Young Adult</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">24861033</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>13</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>07</Day>
</DateCompleted>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1573-2568</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>59</Volume>
<Issue>10</Issue>
<PubDate>
<Year>2014</Year>
<Month>Oct</Month>
</PubDate>
</JournalIssue>
<Title>Digestive diseases and sciences</Title>
<ISOAbbreviation>Dig. Dis. Sci.</ISOAbbreviation>
</Journal>
<ArticleTitle>Serum alanine aminotransferase independently correlates with intrahepatic triglyceride contents in obese subjects.</ArticleTitle>
<Pagination>
<MedlinePgn>2470-6</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1007/s10620-014-3214-3</ELocationID>
<Abstract>
<AbstractText Label="BACKGROUND AND AIM" NlmCategory="OBJECTIVE">Liver enzymes including serum alanine aminotransferase (ALT), aspartate aminotransferase (AST) and gamma-glutamyltransferase (GGT) are well recognized as surrogate makers reflecting non-alcoholic fatty liver disease (NAFLD). However, the associations of serum ALT, AST and GGT with hepatic lipid contents are not well established. The aim of this study was to investigate the relationship between liver enzymes and intrahepatic triglyceride (IHTG) contents, and explore the feasibility in using liver enzymes to reflect accumulation of IHTG in obese subjects.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">A cross-sectional analysis was conducted in 475 obese adults aged 40-65 years. Anthropometric parameters and blood biochemical indexes including liver enzymes, glucose and lipid profiles were measured. The liver triglyceride contents of subjects were determined by (1)H-MRS.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">Serum ALT, AST and GGT were positively correlated with IHTG contents (p &lt; 0.01). Serum ALT, AST and GGT levels at the highest quartile of IHTG contents were significantly elevated as compared with those in the lowest quartile (p &lt; 0.01). Multivariate linear regression analysis demonstrated that serum ALT, but not AST or GGT was independently associated with IHTG contents. By logistic regression analysis, the odds ratio for higher IHTG contents was increased by 1.464 times/1 SD increase in serum ALT level after adjusting for multiple confounding factors [OR (95% CI) 2.464 (1.584-3.834)]. However, these relationships could not be observed between serum AST or GGT with IHTG contents.</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Serum ALT level is independently correlated with the hepatic triglyceride contents in obese subjects and more appropriate to be used as a predictor for the degree of NAFLD rather than AST and GGT.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Chen</LastName>
<ForeName>Zheng</ForeName>
<Initials>Z</Initials>
<AffiliationInfo>
<Affiliation>Department of Endocrinology and Metabolism, Xiamen Diabetes Institute, The First Hospital of Xiamen, Xiamen University, 55 Zhenhai Road, Xiamen, 361003, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Han</LastName>
<ForeName>Cheng-Kun</ForeName>
<Initials>CK</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Pan</LastName>
<ForeName>Ling-Ling</ForeName>
<Initials>LL</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Zhang</LastName>
<ForeName>Hui-Jie</ForeName>
<Initials>HJ</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Ma</LastName>
<ForeName>Zhi-Min</ForeName>
<Initials>ZM</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Huang</LastName>
<ForeName>Zhu-Feng</ForeName>
<Initials>ZF</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Chen</LastName>
<ForeName>Shi</ForeName>
<Initials>S</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Zhuang</LastName>
<ForeName>Xiong-Jie</ForeName>
<Initials>XJ</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Li</LastName>
<ForeName>Zhi-Bin</ForeName>
<Initials>ZB</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Li</LastName>
<ForeName>Xiao-Ying</ForeName>
<Initials>XY</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Li</LastName>
<ForeName>Xue-Jun</ForeName>
<Initials>XJ</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Yang</LastName>
<ForeName>Shu-Yu</ForeName>
<Initials>SY</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>05</Month>
<Day>27</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Dig Dis Sci</MedlineTA>
<NlmUniqueID>7902782</NlmUniqueID>
<ISSNLinking>0163-2116</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>EC 2.6.1.2</RegistryNumber>
<NameOfSubstance UI="D000410">Alanine Transaminase</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000410">Alanine Transaminase</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000097">blood</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008099">Liver</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000737">chemistry</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008875">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009765">Obesity</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000097">blood</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25219172</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>15</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>10</Month>
<Day>09</Day>
</DateCompleted>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0025-7206</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>91</Volume>
<Issue>4</Issue>
<PubDate>
<Year>2014</Year>
<Month>Feb</Month>
<Day>25</Day>
</PubDate>
</JournalIssue>
<Title>Medical economics</Title>
<ISOAbbreviation>Med Econ</ISOAbbreviation>
</Journal>
<ArticleTitle>Obesity's growing threat. While the adult obesity rate went up again in 2013, associated health problems could explode in the next 10 years unless patients and physicians take action.</ArticleTitle>
<Pagination>
<MedlinePgn>36, 38-41</MedlinePgn>
</Pagination>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Zamosky</LastName>
<ForeName>Lisa</ForeName>
<Initials>L</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Med Econ</MedlineTA>
<NlmUniqueID>2985239R</NlmUniqueID>
<ISSNLinking>0025-7206</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>H</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000328">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000368">Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D017281">Cost of Illness</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008875">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009765">Obesity</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000150">complications</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000178">diet therapy</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000191">economics</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000453">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015995">Prevalence</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" Type="Geographic" UI="D014481">United States</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000453">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D055815">Young Adult</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25219706</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>15</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>18</Day>
</DateCompleted>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">1097-6787</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>71</Volume>
<Issue>4</Issue>
<PubDate>
<Year>2014</Year>
<Month>Oct</Month>
</PubDate>
</JournalIssue>
<Title>Journal of the American Academy of Dermatology</Title>
<ISOAbbreviation>J. Am. Acad. Dermatol.</ISOAbbreviation>
</Journal>
<ArticleTitle>Comments on "Diet and psoriasis, Part I: Impact of weight loss interventions".</ArticleTitle>
<Pagination>
<MedlinePgn>829</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jaad.2014.05.072</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0190-9622(14)01613-2</ELocationID>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Cazzaniga</LastName>
<ForeName>Simone</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Centro Studi Gruppo Italiano Studi Epidemiologici in Dermatologia (GISED), Bergamo, Italy.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Conti</LastName>
<ForeName>Andrea</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Department of Dermatology, Azienda Ospedaliero-Universitaria-Policlinico, Modena, Italy.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Naldi</LastName>
<ForeName>Luigi</ForeName>
<Initials>L</Initials>
<AffiliationInfo>
<Affiliation>Centro Studi Gruppo Italiano Studi Epidemiologici in Dermatologia (GISED), Bergamo, Italy; Azienda Ospedaliera Papa Giovanni XXIII, Bergamo, Italy. Electronic address: luigi.naldi@gised.it.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<CollectiveName>Psoriasis Emilia Romagna Study Group</CollectiveName>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016420">Comment</PublicationType>
<PublicationType UI="D016422">Letter</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>J Am Acad Dermatol</MedlineTA>
<NlmUniqueID>7907132</NlmUniqueID>
<ISSNLinking>0190-9622</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList>
<CommentsCorrections RefType="CommentOn">
<RefSource>J Am Acad Dermatol. 2014 Jul;71(1):133-40</RefSource>
<PMID Version="1">24709272</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009765">Obesity</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000178">diet therapy</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000453">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011565">Psoriasis</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000453">epidemiology</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000517">prevention &amp; control</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D015431">Weight Loss</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">24848780</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>15</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>18</Day>
</DateCompleted>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1532-8406</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>29</Volume>
<Issue>9</Issue>
<PubDate>
<Year>2014</Year>
<Month>Sep</Month>
</PubDate>
</JournalIssue>
<Title>The Journal of arthroplasty</Title>
<ISOAbbreviation>J Arthroplasty</ISOAbbreviation>
</Journal>
<ArticleTitle>Trends in same-day bilateral total knee arthroplasty.</ArticleTitle>
<Pagination>
<MedlinePgn>1713-6</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.arth.2014.04.021</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0883-5403(14)00263-0</ELocationID>
<Abstract>
<AbstractText>Between 2000 and 2009 demographics, comorbidity, complications, and 30-day mortality following same-day BTKA (SBTKA) in two high-volume institutions were obtained. Two 5-year periods were created to facilitate trend analysis. The percentage of SBTKA decreased by 36.2% in the latter period. A decline in mean age reflected mainly by a 50% decrease in patients &gt;75 years was observed. The average LOS decreased (5.7 vs. 4.5 days). Overall, selected patients were healthier in the second period. The prevalence of CAD and obesity decreased, whereas hypercholesteremia increased. The overall complication rate decreased by 55.5%; reduction in cardiac adverse events and acute posthemorrhagic anemia was observed. The rate of PE and 30-day mortality was unchanged with time. A need for more selective preoperative screening for potential candidates of SBTKAs is indicated.</AbstractText>
<CopyrightInformation>Copyright © 2014 Elsevier Inc. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Poultsides</LastName>
<ForeName>Lazaros A</ForeName>
<Initials>LA</Initials>
<AffiliationInfo>
<Affiliation>Department of Orthopaedic Surgery, Division of Adult Reconstruction and Joint Replacement, Hospital for Special Surgery, Weill Medical College of Cornell University, New York, New York.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Rasouli</LastName>
<ForeName>Mohammad R</ForeName>
<Initials>MR</Initials>
<AffiliationInfo>
<Affiliation>Rothman Institute of Orthopaedics, Thomas Jefferson University Hospital, Philadelphia, Pennsylvania.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Maltenfort</LastName>
<ForeName>Mitchell G</ForeName>
<Initials>MG</Initials>
<AffiliationInfo>
<Affiliation>Rothman Institute of Orthopaedics, Thomas Jefferson University Hospital, Philadelphia, Pennsylvania.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Parvizi</LastName>
<ForeName>Javad</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>Rothman Institute of Orthopaedics, Thomas Jefferson University Hospital, Philadelphia, Pennsylvania.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Memtsoudis</LastName>
<ForeName>Stavros G</ForeName>
<Initials>SG</Initials>
<AffiliationInfo>
<Affiliation>Department of Anesthesiology, Hospital for Special Surgery, Weill Medical College of Cornell University, New York, New York.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Sculco</LastName>
<ForeName>Thomas P</ForeName>
<Initials>TP</Initials>
<AffiliationInfo>
<Affiliation>Department of Orthopaedic Surgery, Division of Adult Reconstruction and Joint Replacement, Hospital for Special Surgery, Weill Medical College of Cornell University, New York, New York.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>04</Month>
<Day>24</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>J Arthroplasty</MedlineTA>
<NlmUniqueID>8703515</NlmUniqueID>
<ISSNLinking>0883-5403</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000293">Adolescent</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000328">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D017677">Age Distribution</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000368">Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000369">Aged, 80 and over</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000740">Anemia</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000401">mortality</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D019645">Arthroplasty, Replacement, Knee</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000009">adverse effects</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000401">mortality</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000639">trends</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015897">Comorbidity</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D003324">Coronary Artery Disease</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000453">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D003920">Diabetes Mellitus</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000453">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008875">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009765">Obesity</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000453">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D017063">Outcome Assessment (Health Care)</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D018579">Patient Selection</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011183">Postoperative Complications</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000401">mortality</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015995">Prevalence</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012307">Risk Factors</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D016896">Treatment Outcome</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D055815">Young Adult</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">bilateral total knee arthroplasty</Keyword>
<Keyword MajorTopicYN="N">morbidity</Keyword>
<Keyword MajorTopicYN="N">mortality</Keyword>
<Keyword MajorTopicYN="N">same-day bilateral total knee arthroplasty</Keyword>
<Keyword MajorTopicYN="N">total knee arthroplasty</Keyword>
<Keyword MajorTopicYN="N">trend analysis</Keyword>
</KeywordList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">24851795</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>15</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>18</Day>
</DateCompleted>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1532-8406</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>29</Volume>
<Issue>9</Issue>
<PubDate>
<Year>2014</Year>
<Month>Sep</Month>
</PubDate>
</JournalIssue>
<Title>The Journal of arthroplasty</Title>
<ISOAbbreviation>J Arthroplasty</ISOAbbreviation>
</Journal>
<ArticleTitle>Impact of metabolic syndrome on perioperative complication rates after total joint arthroplasty surgery.</ArticleTitle>
<Pagination>
<MedlinePgn>1842-5</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.arth.2014.04.009</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0883-5403(14)00240-X</ELocationID>
<Abstract>
<AbstractText>This study investigated the impact of metabolic syndrome (MetS) on perioperative and postoperative complication rates: the results of a cohort of 168 total hip and knee arthroplasties, 63 of normal weight, 105 with obesity without risk factors for metabolic syndrome and 39 with obesity and other factors that classify them with metabolic syndrome. Patients with metabolic syndrome were more likely to have complications than those without metabolic syndrome (P=0.0156). Perioperative and postoperative complication rates for the MetS and control groups were 35.9% and 16.3%, respectively. Elevated BMI was the element of MetS that had the largest impact on post-surgical complication rates, and this was statistically significant (P=0.0028). The presence of MetS in patients undergoing total joint arthroplasty has a significant impact on surgical complication rates. This cannot be attributed to the BMI component alone, and may help guide efforts of patient optimization prior to total joint arthroplasty. </AbstractText>
<CopyrightInformation>Copyright © 2014 Elsevier Inc. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Gage</LastName>
<ForeName>Mark J</ForeName>
<Initials>MJ</Initials>
<AffiliationInfo>
<Affiliation>Department of Orthopaedic Surgery, NYU Hospital for Joint Diseases, New York, New York.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Schwarzkopf</LastName>
<ForeName>Ran</ForeName>
<Initials>R</Initials>
<AffiliationInfo>
<Affiliation>Department Of Orthopaedic Surgery, University of California Irvine, Orange, California.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Abrouk</LastName>
<ForeName>Michael</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Department Of Orthopaedic Surgery, University of California Irvine, Orange, California.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Slover</LastName>
<ForeName>James D</ForeName>
<Initials>JD</Initials>
<AffiliationInfo>
<Affiliation>Department of Orthopaedic Surgery, NYU Hospital for Joint Diseases, New York, New York.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>04</Month>
<Day>13</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>J Arthroplasty</MedlineTA>
<NlmUniqueID>8703515</NlmUniqueID>
<ISSNLinking>0883-5403</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000293">Adolescent</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000328">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000368">Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000369">Aged, 80 and over</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D019644">Arthroplasty, Replacement, Hip</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000009">adverse effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D019645">Arthroplasty, Replacement, Knee</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000009">adverse effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015992">Body Mass Index</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D048909">Diabetes Complications</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000453">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D050171">Dyslipidemias</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000150">complications</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000453">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006973">Hypertension</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000150">complications</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000453">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D024821">Metabolic Syndrome X</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000150">complications</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000453">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008875">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009765">Obesity</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000150">complications</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000453">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011183">Postoperative Complications</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000453">epidemiology</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000209">etiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015995">Prevalence</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012189">Retrospective Studies</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012307">Risk Factors</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D055815">Young Adult</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">complications</Keyword>
<Keyword MajorTopicYN="N">diabetes mellitus</Keyword>
<Keyword MajorTopicYN="N">metabolic syndrome</Keyword>
<Keyword MajorTopicYN="N">obesity</Keyword>
<Keyword MajorTopicYN="N">total joint arthroplasty</Keyword>
</KeywordList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">24890992</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>15</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>18</Day>
</DateCompleted>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1532-8406</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>29</Volume>
<Issue>9</Issue>
<PubDate>
<Year>2014</Year>
<Month>Sep</Month>
</PubDate>
</JournalIssue>
<Title>The Journal of arthroplasty</Title>
<ISOAbbreviation>J Arthroplasty</ISOAbbreviation>
</Journal>
<ArticleTitle>The effect of obesity on the clinical, functional and radiological outcome of cementless total hip replacement: a case-matched study with a minimum 10-year follow-up.</ArticleTitle>
<Pagination>
<MedlinePgn>1758-62</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.arth.2014.04.033</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0883-5403(14)00291-5</ELocationID>
<Abstract>
<AbstractText>1420 primary cementless THRs with a minimum follow-up of 10-years were stratified according to BMI: non-obese (BMI&lt;30kg/m(2)) and obese (BMI≥30kg/m(2)). Median age at surgery was younger in obese patients (P&lt;0.001). We case-matched 82 THRs in obese patients with 162 THRs in non-obese patients. No difference between groups was found in improvement in HHS (P=0.668), satisfaction with surgery (P=0.644), range of movement, prosthesis orientation, or radiological loosening. The obese cohort was further separated into those with a BMI below and above 35. No difference was found between groups in improvement in HHS, satisfaction with surgery, component orientation, or radiological loosening. There was no difference in the incidence of post-operative complications between obese and non-obese patients. After 10-years, the results of THR are not compromised by obesity. </AbstractText>
<CopyrightInformation>Copyright © 2014 Elsevier Inc. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Tai</LastName>
<ForeName>Stephen M</ForeName>
<Initials>SM</Initials>
<AffiliationInfo>
<Affiliation>Specialist Orthopaedic Group, Mater Clinic Suite 1.08, North Sydney, New South Wales, Australia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Imbuldeniya</LastName>
<ForeName>Arjuna M</ForeName>
<Initials>AM</Initials>
<AffiliationInfo>
<Affiliation>Specialist Orthopaedic Group, Mater Clinic Suite 1.08, North Sydney, New South Wales, Australia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Munir</LastName>
<ForeName>Selin</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Specialist Orthopaedic Group, Mater Clinic Suite 1.08, North Sydney, New South Wales, Australia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Walter</LastName>
<ForeName>William L</ForeName>
<Initials>WL</Initials>
<AffiliationInfo>
<Affiliation>Specialist Orthopaedic Group, Mater Clinic Suite 1.08, North Sydney, New South Wales, Australia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Walter</LastName>
<ForeName>William K</ForeName>
<Initials>WK</Initials>
<AffiliationInfo>
<Affiliation>Specialist Orthopaedic Group, Mater Clinic Suite 1.08, North Sydney, New South Wales, Australia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Zicat</LastName>
<ForeName>Bernard A</ForeName>
<Initials>BA</Initials>
<AffiliationInfo>
<Affiliation>Specialist Orthopaedic Group, Mater Clinic Suite 1.08, North Sydney, New South Wales, Australia.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>05</Month>
<Day>04</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>J Arthroplasty</MedlineTA>
<NlmUniqueID>8703515</NlmUniqueID>
<ISSNLinking>0883-5403</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000368">Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000369">Aged, 80 and over</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D019644">Arthroplasty, Replacement, Hip</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D015992">Body Mass Index</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D016022">Case-Control Studies</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D004204">Dislocations</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000209">etiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005265">Femoral Neck Fractures</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000209">etiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005500">Follow-Up Studies</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008875">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009765">Obesity</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000150">complications</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015207">Osteoarthritis, Hip</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000150">complications</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000601">surgery</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D017060">Patient Satisfaction</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011475">Prosthesis Failure</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000209">etiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D013530">Surgical Wound Infection</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000209">etiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D016896">Treatment Outcome</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">BMI</Keyword>
<Keyword MajorTopicYN="N">arthroplasty</Keyword>
<Keyword MajorTopicYN="N">hip</Keyword>
<Keyword MajorTopicYN="N">long term</Keyword>
<Keyword MajorTopicYN="N">obesity</Keyword>
<Keyword MajorTopicYN="N">outcome</Keyword>
</KeywordList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25223161</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>16</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>10</Month>
<Day>27</Day>
</DateCompleted>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">1078-6767</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>40</Volume>
<Issue>3</Issue>
<PubDate>
<Year>2014</Year>
<Season>Spring</Season>
</PubDate>
</JournalIssue>
<Title>Journal of health care finance</Title>
<ISOAbbreviation>J Health Care Finance</ISOAbbreviation>
</Journal>
<ArticleTitle>Health policies and intervention strategies: a description of current issues and approaches to care of the public health and health care system in the United Arab emirates.</ArticleTitle>
<Pagination>
<MedlinePgn>86-100</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>The demographic factors of the United Arab Emirates (UAE) have changed drastically within one generation. This is evident in how quickly it has moved from a developing nation, where fishing was once the main source of income, to a country that is quite developed, competing on a global level. From one perspective, socio-economic progress has brought many benefits to the population. These include improved education, better access to health care, and safe drinking water. However, on the other hand, economic development has been the cause for changes in lifestyles, eating habits, and traditional societal and family structures. Over time, these changes have added up, creating an unprecedented impact on the population's health. This impact has crept up onto the society until suddenly a notable epidemic has become recognized in the country. According to the UAE Ministry of Health, 19.5 percent of the UAE population has diabetes, making it the second highest rate in the world. The structure and responsibilities of the current UAE health care systems along with other cultural factors were investigated in order to determine their impact on the growing epidemic.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Mosaad</LastName>
<ForeName>Aliye T</ForeName>
<Initials>AT</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Younis</LastName>
<ForeName>Mustafa Z</ForeName>
<Initials>MZ</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>J Health Care Finance</MedlineTA>
<NlmUniqueID>9503024</NlmUniqueID>
<ISSNLinking>1078-6767</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000293">Adolescent</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000328">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000368">Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000369">Aged, 80 and over</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000375">Aging</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002648">Child</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002675">Child, Preschool</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D003695">Delivery of Health Care</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000458">organization &amp; administration</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000592">standards</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D003920">Diabetes Mellitus</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000453">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007722">Health Knowledge, Attitudes, Practice</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D006291">Health Policy</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007223">Infant</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008393">Marriage</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000639">trends</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008875">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009765">Obesity</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000453">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D017149">Private Sector</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D011634">Public Health</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" Type="Geographic" UI="D014479">United Arab Emirates</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000453">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D055815">Young Adult</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25038148</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>16</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>06</Day>
</DateCompleted>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1522-1539</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>307</Volume>
<Issue>6</Issue>
<PubDate>
<Year>2014</Year>
<Month>Sep</Month>
<Day>15</Day>
</PubDate>
</JournalIssue>
<Title>American journal of physiology. Heart and circulatory physiology</Title>
<ISOAbbreviation>Am. J. Physiol. Heart Circ. Physiol.</ISOAbbreviation>
</Journal>
<ArticleTitle>Exercise-mediated vasodilation in human obesity and metabolic syndrome: effect of acute ascorbic acid infusion.</ArticleTitle>
<Pagination>
<MedlinePgn>H840-7</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1152/ajpheart.00312.2014</ELocationID>
<Abstract>
<AbstractText>We tested the hypothesis that infusion of ascorbic acid (AA), a potent antioxidant, would alter vasodilator responses to exercise in human obesity and metabolic syndrome (MetSyn). Forearm blood flow (FBF, Doppler ultrasound) was measured in lean, obese, and MetSyn adults (n = 39, 32 ± 2 yr). A brachial artery catheter was inserted for blood pressure monitoring and local infusion of AA. FBF was measured during dynamic handgrip exercise (15% maximal effort) with and without AA infusion. To account for group differences in blood pressure and forearm size, and to assess vasodilation, forearm vascular conductance (FVC = FBF/mean arterial blood pressure/lean forearm mass) was calculated. We examined the time to achieve steady-state FVC (mean response time, MRT) and the rise in FVC from rest to steady-state exercise (Δ, exercise - rest) before and during acute AA infusion. The MRT (P = 0.26) and steady-state vasodilator responses to exercise (ΔFVC, P = 0.31) were not different between groups. Intra-arterial infusion of AA resulted in a significant increase in plasma total antioxidant capacity (174 ± 37%). AA infusion did not alter MRT or steady-state FVC in any group (P = 0.90 and P = 0.85, respectively). Interestingly, higher levels of C-reactive protein predicted longer MRT (r = 0.52, P &lt; 0.01) and a greater reduction in MRT with AA infusion (r = -0.43, P = 0.02). We concluded that AA infusion during moderate-intensity, rhythmic forearm exercise does not alter the time course or magnitude of exercise-mediated vasodilation in groups of young lean, obese, or MetSyn adults. However, systemic inflammation may limit the MRT to exercise, which can be improved with AA. </AbstractText>
<CopyrightInformation>Copyright © 2014 the American Physiological Society.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Limberg</LastName>
<ForeName>Jacqueline K</ForeName>
<Initials>JK</Initials>
<AffiliationInfo>
<Affiliation>Department of Kinesiology, School of Education, University of Wisconsin, and.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Kellawan</LastName>
<ForeName>J Mikhail</ForeName>
<Initials>JM</Initials>
<AffiliationInfo>
<Affiliation>Department of Kinesiology, School of Education, University of Wisconsin, and.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Harrell</LastName>
<ForeName>John W</ForeName>
<Initials>JW</Initials>
<AffiliationInfo>
<Affiliation>Department of Kinesiology, School of Education, University of Wisconsin, and.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Johansson</LastName>
<ForeName>Rebecca E</ForeName>
<Initials>RE</Initials>
<AffiliationInfo>
<Affiliation>Department of Kinesiology, School of Education, University of Wisconsin, and.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Eldridge</LastName>
<ForeName>Marlowe W</ForeName>
<Initials>MW</Initials>
<AffiliationInfo>
<Affiliation>Departments of Pediatrics and.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Proctor</LastName>
<ForeName>Lester T</ForeName>
<Initials>LT</Initials>
<AffiliationInfo>
<Affiliation>Anesthesiology, School of Medicine and Public Health, University of Wisconsin Hospital and Clinics, Madison, Wisconsin.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Sebranek</LastName>
<ForeName>Joshua J</ForeName>
<Initials>JJ</Initials>
<AffiliationInfo>
<Affiliation>Anesthesiology, School of Medicine and Public Health, University of Wisconsin Hospital and Clinics, Madison, Wisconsin.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Schrage</LastName>
<ForeName>William G</ForeName>
<Initials>WG</Initials>
<AffiliationInfo>
<Affiliation>Department of Kinesiology, School of Education, University of Wisconsin, and wschrage@education.wisc.edu.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>HL091397</GrantID>
<Acronym>HL</Acronym>
<Agency>NHLBI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>HL105820</GrantID>
<Acronym>HL</Acronym>
<Agency>NHLBI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D018848">Controlled Clinical Trial</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>07</Month>
<Day>18</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Am J Physiol Heart Circ Physiol</MedlineTA>
<NlmUniqueID>100901228</NlmUniqueID>
<ISSNLinking>0363-6135</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000975">Antioxidants</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D015415">Biological Markers</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D018836">Inflammation Mediators</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>9007-41-4</RegistryNumber>
<NameOfSubstance UI="D002097">C-Reactive Protein</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>PQ6CK8PD0R</RegistryNumber>
<NameOfSubstance UI="D001205">Ascorbic Acid</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000293">Adolescent</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000328">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000975">Antioxidants</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000008">administration &amp; dosage</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D062186">Arterial Pressure</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001205">Ascorbic Acid</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000008">administration &amp; dosage</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015415">Biological Markers</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000097">blood</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001783">Blood Flow Velocity</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001916">Brachial Artery</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000187">drug effects</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000503">physiopathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002097">C-Reactive Protein</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D015444">Exercise</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005542">Forearm</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000098">blood supply</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D018836">Inflammation Mediators</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000097">blood</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007261">Infusions, Intra-Arterial</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D024821">Metabolic Syndrome X</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000097">blood</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000175">diagnosis</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000503">physiopathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009765">Obesity</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000097">blood</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000175">diagnosis</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000503">physiopathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012039">Regional Blood Flow</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D013997">Time Factors</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D014664">Vasodilation</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000187">drug effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D055815">Young Adult</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<OtherID Source="NLM">PMC4166748 [Available on 09/15/15]</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">antioxidant</Keyword>
<Keyword MajorTopicYN="N">blood flow</Keyword>
<Keyword MajorTopicYN="N">reactive oxygen species</Keyword>
</KeywordList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25009214</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>16</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>06</Day>
</DateCompleted>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1522-1490</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>307</Volume>
<Issue>6</Issue>
<PubDate>
<Year>2014</Year>
<Month>Sep</Month>
<Day>15</Day>
</PubDate>
</JournalIssue>
<Title>American journal of physiology. Regulatory, integrative and comparative physiology</Title>
<ISOAbbreviation>Am. J. Physiol. Regul. Integr. Comp. Physiol.</ISOAbbreviation>
</Journal>
<ArticleTitle>Effect of antigen sensitization and challenge on oscillatory mechanics of the lung and pulmonary inflammation in obese carboxypeptidase E-deficient mice.</ArticleTitle>
<Pagination>
<MedlinePgn>R621-33</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1152/ajpregu.00205.2014</ELocationID>
<Abstract>
<AbstractText>Atopic, obese asthmatics exhibit airway obstruction with variable degrees of eosinophilic airway inflammation. We previously reported that mice obese as a result of a genetic deficiency in either leptin (ob/ob mice) or the long isoform of the leptin receptor (db/db mice) exhibit enhanced airway obstruction in the presence of decreased numbers of bronchoalveolar lavage fluid (BALF) eosinophils compared with lean, wild-type mice following antigen (ovalbumin; OVA) sensitization and challenge. To determine whether the genetic modality of obesity induction influences the development of OVA-induced airway obstruction and OVA-induced pulmonary inflammation, we examined indices of these sequelae in mice obese as a result of a genetic deficiency in carboxypeptidase E, an enzyme that processes prohormones and proneuropeptides involved in satiety and energy expenditure (Cpe(fat) mice). Accordingly, Cpe(fat) and lean, wild-type (C57BL/6) mice were sensitized to OVA and then challenged with either aerosolized PBS or OVA. Compared with genotype-matched, OVA-sensitized and PBS-challenged mice, OVA sensitization and challenge elicited airway obstruction and increased BALF eosinophils, macrophages, neutrophils, IL-4, IL-13, IL-18, and chemerin. However, OVA challenge enhanced airway obstruction and pulmonary inflammation in Cpe(fat) compared with wild-type mice. These results demonstrate that OVA sensitization and challenge enhance airway obstruction in obese mice regardless of the genetic basis of obesity, whereas the degree of OVA-induced pulmonary inflammation is dependent on the genetic modality of obesity induction. These results have important implications for animal models of asthma, as modeling the pulmonary phenotypes for subpopulations of atopic, obese asthmatics critically depends on selecting the appropriate mouse model. </AbstractText>
<CopyrightInformation>Copyright © 2014 the American Physiological Society.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Dahm</LastName>
<ForeName>Paul H</ForeName>
<Initials>PH</Initials>
<AffiliationInfo>
<Affiliation>Division of Critical Care Medicine, Department of Pediatrics, The University of Texas Medical School at Houston, Houston, Texas;</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Richards</LastName>
<ForeName>Jeremy B</ForeName>
<Initials>JB</Initials>
<AffiliationInfo>
<Affiliation>Division of Pulmonary, Critical Care, and Sleep Medicine, Department of Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts;</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Karmouty-Quintana</LastName>
<ForeName>Harry</ForeName>
<Initials>H</Initials>
<AffiliationInfo>
<Affiliation>Department of Biochemistry and Molecular Biology, The University of Texas Medical School at Houston, Houston, Texas;</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Cromar</LastName>
<ForeName>Kevin R</ForeName>
<Initials>KR</Initials>
<AffiliationInfo>
<Affiliation>Department of Environmental Medicine, New York University School of Medicine, Tuxedo, New York;</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Sur</LastName>
<ForeName>Sanjiv</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Division of Allergy and Immunology, Department of Internal Medicine, The University of Texas Medical Branch at Galveston School of Medicine, Galveston, Texas;</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Price</LastName>
<ForeName>Roger E</ForeName>
<Initials>RE</Initials>
<AffiliationInfo>
<Affiliation>Comparative Pathology Laboratory, Center for Comparative Medicine, Baylor College of Medicine, Houston, Texas;</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Malik</LastName>
<ForeName>Farhan</ForeName>
<Initials>F</Initials>
<AffiliationInfo>
<Affiliation>Division of Critical Care Medicine, Department of Pediatrics, The University of Texas Medical School at Houston, Houston, Texas;</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Spencer</LastName>
<ForeName>Chantal Y</ForeName>
<Initials>CY</Initials>
<AffiliationInfo>
<Affiliation>Pediatric Pulmonary Section, Department of Pediatrics, Baylor College of Medicine, Houston, Texas; and.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Barreno</LastName>
<ForeName>Ramon X</ForeName>
<Initials>RX</Initials>
<AffiliationInfo>
<Affiliation>Division of Critical Care Medicine, Department of Pediatrics, The University of Texas Medical School at Houston, Houston, Texas;</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Hashmi</LastName>
<ForeName>Syed S</ForeName>
<Initials>SS</Initials>
<AffiliationInfo>
<Affiliation>Pediatric Research Center, Department of Pediatrics, The University of Texas Medical School at Houston, Houston, Texas.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Blackburn</LastName>
<ForeName>Michael R</ForeName>
<Initials>MR</Initials>
<AffiliationInfo>
<Affiliation>Department of Biochemistry and Molecular Biology, The University of Texas Medical School at Houston, Houston, Texas;</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Haque</LastName>
<ForeName>Ikram U</ForeName>
<Initials>IU</Initials>
<AffiliationInfo>
<Affiliation>Division of Critical Care Medicine, Department of Pediatrics, The University of Texas Medical School at Houston, Houston, Texas;</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Johnston</LastName>
<ForeName>Richard A</ForeName>
<Initials>RA</Initials>
<AffiliationInfo>
<Affiliation>Division of Critical Care Medicine, Department of Pediatrics, The University of Texas Medical School at Houston, Houston, Texas; Pediatric Research Center, Department of Pediatrics, The University of Texas Medical School at Houston, Houston, Texas Richard.A.Johnston@uth.tmc.edu.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>R03AI107432</GrantID>
<Acronym>AI</Acronym>
<Agency>NIAID NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R03ES022378</GrantID>
<Acronym>ES</Acronym>
<Agency>NIEHS NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>07</Month>
<Day>09</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Am J Physiol Regul Integr Comp Physiol</MedlineTA>
<NlmUniqueID>100901230</NlmUniqueID>
<ISSNLinking>0363-6119</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000941">Antigens</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D015415">Biological Markers</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D007136">Immunoglobulins</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D018836">Inflammation Mediators</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>9006-59-1</RegistryNumber>
<NameOfSubstance UI="D010047">Ovalbumin</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 3.4.17.10</RegistryNumber>
<NameOfSubstance UI="D043423">Carboxypeptidase H</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000402">Airway Obstruction</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000201">enzymology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000235">genetics</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000276">immunology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000503">physiopathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000403">Airway Resistance</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000818">Animals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D000941">Antigens</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015415">Biological Markers</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000097">blood</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001992">Bronchoalveolar Lavage Fluid</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000166">cytology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000276">immunology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D043423">Carboxypeptidase H</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000172">deficiency</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000235">genetics</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D004195">Disease Models, Animal</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005838">Genotype</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007136">Immunoglobulins</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000097">blood</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D018836">Inflammation Mediators</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000097">blood</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008168">Lung</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000201">enzymology</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000276">immunology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000503">physiopathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D051379">Mice</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008810">Mice, Inbred C57BL</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D018345">Mice, Knockout</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009765">Obesity</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000097">blood</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000201">enzymology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000235">genetics</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000276">immunology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000503">physiopathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D010047">Ovalbumin</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D010641">Phenotype</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011014">Pneumonia</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000097">blood</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000201">enzymology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000235">genetics</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000276">immunology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000503">physiopathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D013997">Time Factors</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<OtherID Source="NLM">PMC4166760 [Available on 09/15/15]</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">asthma</Keyword>
<Keyword MajorTopicYN="N">atopic</Keyword>
<Keyword MajorTopicYN="N">eosinophil</Keyword>
<Keyword MajorTopicYN="N">interleukin-13</Keyword>
<Keyword MajorTopicYN="N">ovalbumin</Keyword>
</KeywordList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25222388</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>16</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>12</Day>
</DateCompleted>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">1539-3704</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>161</Volume>
<Issue>6</Issue>
<PubDate>
<Year>2014</Year>
<Month>Sep</Month>
<Day>16</Day>
</PubDate>
</JournalIssue>
<Title>Annals of internal medicine</Title>
<ISOAbbreviation>Ann. Intern. Med.</ISOAbbreviation>
</Journal>
<ArticleTitle>Nonsurgical management of urinary incontinence in women: a clinical practice guideline from the American College of Physicians.</ArticleTitle>
<Pagination>
<MedlinePgn>429-40</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.7326/M13-2410</ELocationID>
<Abstract>
<AbstractText Label="DESCRIPTION" NlmCategory="METHODS">The American College of Physicians (ACP) developed this guideline to present the evidence and provide clinical recommendations on the nonsurgical management of urinary incontinence (UI) in women.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">This guideline is based on published English-language literature on nonsurgical management of UI in women from 1990 through December 2013 that was identified using MEDLINE, the Cochrane Library, Scirus, and Google Scholar. The outcomes evaluated for this guideline include continence, improvement in UI, quality of life, adverse effects, and discontinuation due to adverse effects. It grades the evidence and recommendations by using ACP's guideline grading system. The target audience is all clinicians, and the target patient population is all women with UI.</AbstractText>
<AbstractText Label="RECOMMENDATION 1" NlmCategory="UNASSIGNED">ACP recommends first-line treatment with pelvic floor muscle training in women with stress UI. (Grade: strong recommendation, high-quality evidence).</AbstractText>
<AbstractText Label="RECOMMENDATION 2" NlmCategory="UNASSIGNED">ACP recommends bladder training in women with urgency UI. (Grade: strong recommendation, moderate-quality evidence).</AbstractText>
<AbstractText Label="RECOMMENDATION 3" NlmCategory="UNASSIGNED">ACP recommends pelvic floor muscle training with bladder training in women with mixed UI. (Grade: strong recommendation, moderate-quality evidence).</AbstractText>
<AbstractText Label="RECOMMENDATION 4" NlmCategory="UNASSIGNED">ACP recommends against treatment with systemic pharmacologic therapy for stress UI. (Grade: strong recommendation, low-quality evidence).</AbstractText>
<AbstractText Label="RECOMMENDATION 5" NlmCategory="UNASSIGNED">ACP recommends pharmacologic treatment in women with urgency UI if bladder training was unsuccessful. Clinicians should base the choice of pharmacologic agents on tolerability, adverse effect profile, ease of use, and cost of medication. (Grade: strong recommendation, high-quality evidence).</AbstractText>
<AbstractText Label="RECOMMENDATION 6" NlmCategory="UNASSIGNED">ACP recommends weight loss and exercise for obese women with UI. (Grade: strong recommendation, moderate-quality evidence).</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Qaseem</LastName>
<ForeName>Amir</ForeName>
<Initials>A</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Dallas</LastName>
<ForeName>Paul</ForeName>
<Initials>P</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Forciea</LastName>
<ForeName>Mary Ann</ForeName>
<Initials>MA</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Starkey</LastName>
<ForeName>Melissa</ForeName>
<Initials>M</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Denberg</LastName>
<ForeName>Thomas D</ForeName>
<Initials>TD</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Shekelle</LastName>
<ForeName>Paul</ForeName>
<Initials>P</Initials>
</Author>
<Author ValidYN="Y">
<CollectiveName>Clinical Guidelines Committee of the American College of Physicians</CollectiveName>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>1 K23 DK080227</GrantID>
<Acronym>DK</Acronym>
<Agency>NIDDK NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>5RC1EB010649</GrantID>
<Acronym>EB</Acronym>
<Agency>NIBIB NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D017065">Practice Guideline</PublicationType>
<PublicationType UI="D057666">Research Support, American Recovery and Reinvestment Act</PublicationType>
<PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Ann Intern Med</MedlineTA>
<NlmUniqueID>0372351</NlmUniqueID>
<ISSNLinking>0003-4819</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList>
<CommentsCorrections RefType="SummaryForPatientsIn">
<RefSource>Ann Intern Med. 2014 Sep 16;161(6):I-34</RefSource>
<PMID Version="1">25222408</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001521">Behavior Therapy</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001676">Biofeedback, Psychology</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D004576">Electromyography</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005081">Exercise Therapy</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009765">Obesity</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000150">complications</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000628">therapy</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D017773">Pelvic Floor</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011788">Quality of Life</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001743">Urinary Bladder</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D014549">Urinary Incontinence</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000150">complications</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000175">diagnosis</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000188">drug therapy</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000628">therapy</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015431">Weight Loss</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<InvestigatorList>
<Investigator ValidYN="Y">
<LastName>Shekelle</LastName>
<ForeName>Paul</ForeName>
<Initials>P</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Barry</LastName>
<ForeName>Michael J</ForeName>
<Initials>MJ</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Chou</LastName>
<ForeName>Roger</ForeName>
<Initials>R</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Cooke</LastName>
<ForeName>Molly</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Dallas</LastName>
<ForeName>Paul</ForeName>
<Initials>P</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Denberg</LastName>
<ForeName>Thomas D</ForeName>
<Initials>TD</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Fitterman</LastName>
<ForeName>Nick</ForeName>
<Initials>N</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Forciea</LastName>
<ForeName>Mary Ann</ForeName>
<Initials>MA</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Harris</LastName>
<ForeName>Russell P</ForeName>
<Initials>RP</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Humphrey</LastName>
<ForeName>Linda L</ForeName>
<Initials>LL</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Mir</LastName>
<ForeName>Tanveer P</ForeName>
<Initials>TP</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Schünemann</LastName>
<ForeName>Holger J</ForeName>
<Initials>HJ</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Schwartz</LastName>
<ForeName>J Sanford</ForeName>
<Initials>JS</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Sweet</LastName>
<ForeName>Donna E</ForeName>
<Initials>DE</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Wilt</LastName>
<ForeName>Timothy</ForeName>
<Initials>T</Initials>
</Investigator>
</InvestigatorList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25222408</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>16</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>12</Day>
</DateCompleted>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">1539-3704</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>161</Volume>
<Issue>6</Issue>
<PubDate>
<Year>2014</Year>
<Month>Sep</Month>
<Day>16</Day>
</PubDate>
</JournalIssue>
<Title>Annals of internal medicine</Title>
<ISOAbbreviation>Ann. Intern. Med.</ISOAbbreviation>
</Journal>
<ArticleTitle>Summaries for patients. Nonsurgical management of urinary incontinence in women: a clinical practice guideline from the American College of Physicians.</ArticleTitle>
<Pagination>
<MedlinePgn>I-34</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.7326/P14-9034</ELocationID>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D029282">Patient Education Handout</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Ann Intern Med</MedlineTA>
<NlmUniqueID>0372351</NlmUniqueID>
<ISSNLinking>0003-4819</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList>
<CommentsCorrections RefType="OriginalReportIn">
<RefSource>Ann Intern Med. 2014 Sep 16;161(6):429-40</RefSource>
<PMID Version="1">25222388</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001521">Behavior Therapy</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001676">Biofeedback, Psychology</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005081">Exercise Therapy</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009765">Obesity</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000150">complications</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000628">therapy</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D017773">Pelvic Floor</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011788">Quality of Life</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001743">Urinary Bladder</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D014549">Urinary Incontinence</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000150">complications</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000188">drug therapy</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000628">therapy</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015431">Weight Loss</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25226636</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>17</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>10</Month>
<Day>09</Day>
</DateCompleted>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">1474-9114</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>24</Volume>
<Issue>5</Issue>
<PubDate>
<MedlineDate>2014 Jul-Aug</MedlineDate>
</PubDate>
</JournalIssue>
<Title>The journal of family health care</Title>
<ISOAbbreviation>J Fam Health Care</ISOAbbreviation>
</Journal>
<ArticleTitle>Innovation in patient care.</ArticleTitle>
<Pagination>
<MedlinePgn>41</MedlinePgn>
</Pagination>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Hosie</LastName>
<ForeName>Penny</ForeName>
<Initials>P</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>England</Country>
<MedlineTA>J Fam Health Care</MedlineTA>
<NlmUniqueID>101142028</NlmUniqueID>
<ISSNLinking>1474-9114</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>N</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000293">Adolescent</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000328">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002648">Child</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002675">Child, Preschool</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008880">Midwifery</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000458">organization &amp; administration</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009765">Obesity</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000628">therapy</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009936">Organizational Innovation</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005791">Patient Care</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D018802">Patient-Centered Care</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000458">organization &amp; administration</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011247">Pregnancy</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25226462</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>17</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>10</Month>
<Day>20</Day>
</DateCompleted>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">1538-3598</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>312</Volume>
<Issue>11</Issue>
<PubDate>
<Year>2014</Year>
<Month>Sep</Month>
<Day>17</Day>
</PubDate>
</JournalIssue>
<Title>JAMA</Title>
<ISOAbbreviation>JAMA</ISOAbbreviation>
</Journal>
<ArticleTitle>USPSTF: Lifestyle counseling advised for overweight, obese adults with other cardiovascular risk factors.</ArticleTitle>
<Pagination>
<MedlinePgn>1085</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1001/jama.2014.12696</ELocationID>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Stephenson</LastName>
<ForeName>Joan</ForeName>
<Initials>J</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016433">News</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>JAMA</MedlineTA>
<NlmUniqueID>7501160</NlmUniqueID>
<ISSNLinking>0098-7484</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002318">Cardiovascular Diseases</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000453">epidemiology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000517">prevention &amp; control</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002986">Clinical Trials as Topic</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D003376">Counseling</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D008019">Life Style</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009765">Obesity</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000628">therapy</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D050177">Overweight</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000628">therapy</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012307">Risk Factors</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25039838</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>17</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>12</Day>
</DateCompleted>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1365-3156</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>19</Volume>
<Issue>10</Issue>
<PubDate>
<Year>2014</Year>
<Month>Oct</Month>
</PubDate>
</JournalIssue>
<Title>Tropical medicine &amp; international health : TM &amp; IH</Title>
<ISOAbbreviation>Trop. Med. Int. Health</ISOAbbreviation>
</Journal>
<ArticleTitle>Hypertension and treatment outcomes in Palestine refugees in United Nations Relief and Works Agency primary health care clinics in Jordan.</ArticleTitle>
<Pagination>
<MedlinePgn>1276-83</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1111/tmi.12356</ELocationID>
<Abstract>
<AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">In six United Nations Relief and Works Agency (UNRWA) primary health care clinics in Jordan serving Palestine refugees diagnosed with hypertension, to determine the number, characteristics, programme outcomes and measures of disease control for those registered up to 30 June, 2013, and in those who attended clinic in the second quarter of 2013, the prevalence of disease-related complications between those with hypertension only and hypertension combined with diabetes mellitus.</AbstractText>
<AbstractText Label="METHOD" NlmCategory="METHODS">Retrospective cohort study with programme and outcome data collected and analysed using E-Health.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">There were 18 881 patients registered with hypertension with females (64%) and persons aged ≥ 40 years (87%) predominating. At baseline, cigarette smoking was recorded in 17%, physical inactivity in 48% and obesity in 71% of patients. 77% of all registered patients attended clinic in the second quarter of 2013; of these, 50% had hypertension and diabetes and 50% had hypertension alone; 9% did not attend the clinics and 10% were lost to follow-up. Amongst those attending clinic, 92% had their blood pressure measured, of whom 83% had blood pressure &lt;140/90 mm Hg. There were significantly more patients with hypertension and diabetes (N = 966, 13%) who had disease-related complications than patients who had hypertension alone (N = 472, 6%) [OR 2.2, 95% CI 2.0-2.5], and these differences were found for both males [18% vs. 10%, OR 1.9, 95% CI 1.6-2.2] and females [11% vs. 5%, OR 2.4, 95% CI 2.1-2.9].</AbstractText>
<AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Large numbers of Palestine refugees are being registered and treated for hypertension in UNRWA primary health care clinics in Jordan. Cohort analysis and E-Health can be used to regularly assess caseload, programme outcomes, clinic performance, blood pressure control and cumulative prevalence of disease-related complications. Current challenges include the need to increase clinic attendance and attain better control of blood pressure.</AbstractText>
<CopyrightInformation>© 2014 John Wiley &amp; Sons Ltd.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Khader</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>United Nations Relief and Works Agency for Palestine Refugees in the Near East, Amman, Jordan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Farajallah</LastName>
<ForeName>L</ForeName>
<Initials>L</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Shahin</LastName>
<ForeName>Y</ForeName>
<Initials>Y</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Hababeh</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Abu-Zayed</LastName>
<ForeName>I</ForeName>
<Initials>I</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Zachariah</LastName>
<ForeName>R</ForeName>
<Initials>R</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Kochi</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Kapur</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Harries</LastName>
<ForeName>A D</ForeName>
<Initials>AD</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Shaikh</LastName>
<ForeName>I</ForeName>
<Initials>I</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Seita</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>07</Month>
<Day>12</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>England</Country>
<MedlineTA>Trop Med Int Health</MedlineTA>
<NlmUniqueID>9610576</NlmUniqueID>
<ISSNLinking>1360-2276</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000328">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000368">Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D000554">Ambulatory Care Facilities</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D018912">Arabs</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001794">Blood Pressure</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D003920">Diabetes Mellitus</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000453">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006973">Hypertension</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000150">complications</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000453">epidemiology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000628">therapy</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" Type="Geographic" UI="D007597">Jordan</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000453">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008875">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009765">Obesity</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000150">complications</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D016017">Odds Ratio</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015995">Prevalence</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D011320">Primary Health Care</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D012036">Refugees</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D012066">Relief Work</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012189">Retrospective Studies</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D016896">Treatment Outcome</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D014480">United Nations</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D055815">Young Adult</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Hipertensión</Keyword>
<Keyword MajorTopicYN="N">Jordan</Keyword>
<Keyword MajorTopicYN="N">Jordania</Keyword>
<Keyword MajorTopicYN="N">Jordanie</Keyword>
<Keyword MajorTopicYN="N">Palestine refugees</Keyword>
<Keyword MajorTopicYN="N">cohort reports</Keyword>
<Keyword MajorTopicYN="N">diabetes mellitus</Keyword>
<Keyword MajorTopicYN="N">diabetes mellitus, refugiados Palestinos</Keyword>
<Keyword MajorTopicYN="N">diabète sucré</Keyword>
<Keyword MajorTopicYN="N">hypertension</Keyword>
<Keyword MajorTopicYN="N">informe de cohortes</Keyword>
<Keyword MajorTopicYN="N">rapports de cohorte</Keyword>
<Keyword MajorTopicYN="N">réfugiés de Palestine</Keyword>
</KeywordList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25229917</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>18</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>09</Month>
<Day>30</Day>
</DateCompleted>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">1533-4406</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>371</Volume>
<Issue>12</Issue>
<PubDate>
<Year>2014</Year>
<Month>Sep</Month>
<Day>18</Day>
</PubDate>
</JournalIssue>
<Title>The New England journal of medicine</Title>
<ISOAbbreviation>N. Engl. J. Med.</ISOAbbreviation>
</Journal>
<ArticleTitle>Ectopic fat in insulin resistance, dyslipidemia, and cardiometabolic disease.</ArticleTitle>
<Pagination>
<MedlinePgn>1131-41</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1056/NEJMra1011035</ELocationID>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Shulman</LastName>
<ForeName>Gerald I</ForeName>
<Initials>GI</Initials>
<AffiliationInfo>
<Affiliation>From the Howard Hughes Medical Institute and the Departments of Internal Medicine and Cellular and Molecular Physiology, Yale University School of Medicine, New Haven, CT.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<Agency>Howard Hughes Medical Institute</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
<PublicationType UI="D016454">Review</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>N Engl J Med</MedlineTA>
<NlmUniqueID>0255562</NlmUniqueID>
<ISSNLinking>0028-4793</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000273">Adipose Tissue</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002828">Choristoma</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D003924">Diabetes Mellitus, Type 2</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000209">etiology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D050171">Dyslipidemias</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006943">Hyperglycemia</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007333">Insulin Resistance</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000502">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008066">Lipolysis</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000502">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009682">Magnetic Resonance Spectroscopy</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008928">Mitochondria</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D018482">Muscle, Skeletal</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009765">Obesity</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25230625</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>18</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>10</Month>
<Day>14</Day>
</DateCompleted>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">1476-4687</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>513</Volume>
<Issue>7518</Issue>
<PubDate>
<Year>2014</Year>
<Month>Sep</Month>
<Day>18</Day>
</PubDate>
</JournalIssue>
<Title>Nature</Title>
<ISOAbbreviation>Nature</ISOAbbreviation>
</Journal>
<ArticleTitle>Sugar substitutes linked to obesity.</ArticleTitle>
<Pagination>
<MedlinePgn>290</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1038/513290a</ELocationID>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Abbott</LastName>
<ForeName>Alison</ForeName>
<Initials>A</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016433">News</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>England</Country>
<MedlineTA>Nature</MedlineTA>
<NlmUniqueID>0410462</NlmUniqueID>
<ISSNLinking>0028-0836</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D013549">Sweetening Agents</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>FST467XS7D</RegistryNumber>
<NameOfSubstance UI="D012439">Saccharin</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000818">Animals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D018149">Glucose Intolerance</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000139">chemically induced</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000382">microbiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D064368">Healthy Volunteers</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007422">Intestines</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000187">drug effects</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000382">microbiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D051379">Mice</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009765">Obesity</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000139">chemically induced</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000382">microbiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D010865">Pilot Projects</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012439">Saccharin</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000009">adverse effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D013549">Sweetening Agents</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000009">adverse effects</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25204697</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>19</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>10</Day>
</DateCompleted>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1471-6771</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>113</Volume>
<Issue>4</Issue>
<PubDate>
<Year>2014</Year>
<Month>Oct</Month>
</PubDate>
</JournalIssue>
<Title>British journal of anaesthesia</Title>
<ISOAbbreviation>Br J Anaesth</ISOAbbreviation>
</Journal>
<ArticleTitle>5th National Audit Project (NAP5) on accidental awareness during general anaesthesia: summary of main findings and risk factors.</ArticleTitle>
<Pagination>
<MedlinePgn>549-59</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1093/bja/aeu313</ELocationID>
<Abstract>
<AbstractText>We present the main findings of the 5th National Audit Project (NAP5) on accidental awareness during general anaesthesia (AAGA). Incidences were estimated using reports of accidental awareness as the numerator, and a parallel national anaesthetic activity survey to provide denominator data. The incidence of certain/probable and possible accidental awareness cases was ~1:19,600 anaesthetics (95% confidence interval 1:16,700-23,450). However, there was considerable variation across subtypes of techniques or subspecialities. The incidence with neuromuscular block (NMB) was ~1:8200 (1:7030-9700), and without, it was ~1:135,900 (1:78,600-299,000). The cases of AAGA reported to NAP5 were overwhelmingly cases of unintended awareness during NMB. The incidence of accidental awareness during Caesarean section was ~1:670 (1:380-1300). Two-thirds (82, 66%) of cases of accidental awareness experiences arose in the dynamic phases of anaesthesia, namely induction of and emergence from anaesthesia. During induction of anaesthesia, contributory factors included: use of thiopental, rapid sequence induction, obesity, difficult airway management, NMB, and interruptions of anaesthetic delivery during movement from anaesthetic room to theatre. During emergence from anaesthesia, residual paralysis was perceived by patients as accidental awareness, and commonly related to a failure to ensure full return of motor capacity. One-third (43, 33%) of accidental awareness events arose during the maintenance phase of anaesthesia, mostly due to problems at induction or towards the end of anaesthesia. Factors increasing the risk of accidental awareness included: female sex, age (younger adults, but not children), obesity, anaesthetist seniority (junior trainees), previous awareness, out-of-hours operating, emergencies, type of surgery (obstetric, cardiac, thoracic), and use of NMB. The following factors were not risk factors for accidental awareness: ASA physical status, race, and use or omission of nitrous oxide. We recommend that an anaesthetic checklist, to be an integral part of the World Health Organization Safer Surgery checklist, is introduced as an aid to preventing accidental awareness. This paper is a shortened version describing the main findings from NAP5--the full report can be found at http://www.nationalauditprojects.org.uk/NAP5_home.</AbstractText>
<CopyrightInformation>© The Author 2014. Published by Oxford University Press on behalf of the British Journal of Anaesthesia. All rights reserved. For Permissions, please email: journals.permissions@oup.com.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Pandit</LastName>
<ForeName>J J</ForeName>
<Initials>JJ</Initials>
<AffiliationInfo>
<Affiliation>Nuffield Department of Anaesthetics, Oxford University Hospitals NHS Trust, Oxford, UK jaideep.pandit@dpag.ox.ac.uk.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Andrade</LastName>
<ForeName>J</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>Department of Psychology, School of Psychology and Cognition Institute, Plymouth University, Plymouth, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Bogod</LastName>
<ForeName>D G</ForeName>
<Initials>DG</Initials>
<AffiliationInfo>
<Affiliation>Department of Anaesthesia, Nottingham University Hospitals NHS Trust, Nottingham, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Hitchman</LastName>
<ForeName>J M</ForeName>
<Initials>JM</Initials>
<AffiliationInfo>
<Affiliation>Member Royal College of Anaesthetists' Lay Committee, London, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Jonker</LastName>
<ForeName>W R</ForeName>
<Initials>WR</Initials>
<AffiliationInfo>
<Affiliation>Department of Anaesthesia, Intensive Care and Pain Medicine, Sligo Regional Hospital, Sligo, Ireland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Lucas</LastName>
<ForeName>N</ForeName>
<Initials>N</Initials>
<AffiliationInfo>
<Affiliation>Department of Anaesthesia, Northwick Park Hospital, Harrow, Middlesex, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Mackay</LastName>
<ForeName>J H</ForeName>
<Initials>JH</Initials>
<AffiliationInfo>
<Affiliation>Department of Anaesthesia, Papworth Hospital, Cambridge, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Nimmo</LastName>
<ForeName>A F</ForeName>
<Initials>AF</Initials>
<AffiliationInfo>
<Affiliation>Department of Anaesthesia, Royal Infirmary of Edinburgh, Edinburgh, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>O'Connor</LastName>
<ForeName>K</ForeName>
<Initials>K</Initials>
<AffiliationInfo>
<Affiliation>Bristol School of Anaesthesia, Bristol, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>O'Sullivan</LastName>
<ForeName>E P</ForeName>
<Initials>EP</Initials>
<AffiliationInfo>
<Affiliation>Department of Anaesthesia, St James Hospital, James Street, Dublin, Ireland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Paul</LastName>
<ForeName>R G</ForeName>
<Initials>RG</Initials>
<AffiliationInfo>
<Affiliation>Adult Intensive Care Unit, Royal Brompton Hospital, London, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Palmer</LastName>
<ForeName>J H M G</ForeName>
<Initials>JH</Initials>
<AffiliationInfo>
<Affiliation>Department of Anaesthesia, Salford Royal Hospital, Salford, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Plaat</LastName>
<ForeName>F</ForeName>
<Initials>F</Initials>
<AffiliationInfo>
<Affiliation>Department of Anaesthesia, Imperial College NHS Trust, London, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Radcliffe</LastName>
<ForeName>J J</ForeName>
<Initials>JJ</Initials>
<AffiliationInfo>
<Affiliation>Department of Neuroanaesthesia, National Hospital for Neurology and Neurosurgery, Queen Square, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Sury</LastName>
<ForeName>M R J</ForeName>
<Initials>MR</Initials>
<AffiliationInfo>
<Affiliation>Department of Anaesthesia, Great Ormond Street Hospital NHS Foundation Trust, London, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Torevell</LastName>
<ForeName>H E</ForeName>
<Initials>HE</Initials>
<AffiliationInfo>
<Affiliation>Bradford Teaching Hospitals NHS Foundation Trust, Bradford, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Wang</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>University of Leicester, Leicester, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Hainsworth</LastName>
<ForeName>J</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>Leicestershire Partnership NHS Trust, Leicester, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Cook</LastName>
<ForeName>T M</ForeName>
<Initials>TM</Initials>
<AffiliationInfo>
<Affiliation>Department of Anaesthesia and Intensive Care Medicine, Royal United Hospital, Bath, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<CollectiveName>Royal College of Anaesthetists</CollectiveName>
</Author>
<Author ValidYN="Y">
<CollectiveName>Association of Anaesthetists of Great Britain and Ireland</CollectiveName>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<Agency>Wellcome Trust</Agency>
<Country>United Kingdom</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>09</Month>
<Day>09</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>England</Country>
<MedlineTA>Br J Anaesth</MedlineTA>
<NlmUniqueID>0372541</NlmUniqueID>
<ISSNLinking>0007-0912</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList>
<CommentsCorrections RefType="CommentIn">
<RefSource>Br J Anaesth. 2014 Oct;113(4):530-3</RefSource>
<PMID Version="1">25236894</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000293">Adolescent</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000328">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D017677">Age Distribution</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000368">Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000369">Aged, 80 and over</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000762">Anesthesia Recovery Period</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000768">Anesthesia, General</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000009">adverse effects</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000771">Anesthesia, Intravenous</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000706">statistics &amp; numerical data</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000773">Anesthesia, Obstetrical</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000009">adverse effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001835">Body Weight</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002648">Child</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002675">Child, Preschool</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D016292">Conscious Sedation</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000009">adverse effects</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000523">psychology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D056805">Consciousness Monitors</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D004351">Drug Resistance</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" Type="Geographic" UI="D006113">Great Britain</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000453">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D019538">Health Care Surveys</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015994">Incidence</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007223">Infant</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D017055">Intensive Care</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000706">statistics &amp; numerical data</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D058926">Intraoperative Awareness</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000453">epidemiology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000628">therapy</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" Type="Geographic" UI="D007494">Ireland</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000453">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D019300">Medical Errors</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000706">statistics &amp; numerical data</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008875">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D019148">Neuromuscular Blockade</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009765">Obesity</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000150">complications</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000453">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D010360">Patient Transfer</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011247">Pregnancy</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012307">Risk Factors</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D013594">Syringes</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D055815">Young Adult</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">National Audit Project</Keyword>
<Keyword MajorTopicYN="N">accidental awareness</Keyword>
<Keyword MajorTopicYN="N">awareness</Keyword>
</KeywordList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25099543</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>20</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>10</Day>
</DateCompleted>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1938-3207</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>100</Volume>
<Issue>4</Issue>
<PubDate>
<Year>2014</Year>
<Month>Oct</Month>
</PubDate>
</JournalIssue>
<Title>The American journal of clinical nutrition</Title>
<ISOAbbreviation>Am. J. Clin. Nutr.</ISOAbbreviation>
</Journal>
<ArticleTitle>Association between Mediterranean and Nordic diet scores and changes in weight and waist circumference: influence of FTO and TCF7L2 loci.</ArticleTitle>
<Pagination>
<MedlinePgn>1188-97</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.3945/ajcn.114.089706</ELocationID>
<Abstract>
<AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Several studies have shown that adherence to the Mediterranean Diet measured by using the Mediterranean diet score (MDS) is associated with lower obesity risk. The newly proposed Nordic Diet could hold similar beneficial effects. Because of the increasing focus on the interaction between diet and genetic predisposition to adiposity, studies should consider both diet and genetics.</AbstractText>
<AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">We investigated whether FTO rs9939609 and TCF7L2 rs7903146 modified the association between the MDS and Nordic diet score (NDS) and changes in weight (Δweight), waist circumference (ΔWC), and waist circumference adjusted for body mass index (BMI) (ΔWCBMI).</AbstractText>
<AbstractText Label="DESIGN" NlmCategory="METHODS">We conducted a case-cohort study with a median follow-up of 6.8 y that included 11,048 participants from 5 European countries; 5552 of these subjects were cases defined as individuals with the greatest degree of unexplained weight gain during follow-up. A randomly selected subcohort included 6548 participants, including 5496 noncases. Cases and noncases were compared in analyses by using logistic regression. Continuous traits (ie, Δweight, ΔWC, and ΔWCBMI) were analyzed by using linear regression models in the random subcohort. Interactions were tested by including interaction terms in models.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">A higher MDS was significantly inversely associated with case status (OR: 0.98; 95% CI: 0.96, 1.00), ΔWC (β = -0.010 cm/y; 95% CI: -0.020, -0.001 cm/y), and ΔWCBMI (β = -0.008; 95% CI:-0.015, -0.001) per 1-point increment but not Δweight (P = 0.53). The NDS was not significantly associated with any outcome. There was a borderline significant interaction between the MDS and TCF7L2 rs7903146 on weight gain (P = 0.05), which suggested a beneficial effect of the MDS only in subjects who carried 1 or 2 risk alleles. FTO did not modify observed associations.</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">A high MDS is associated with a lower ΔWC and ΔWCBMI, regardless of FTO and TCF7L2 risk alleles. For Δweight, findings were less clear, but the effect may depend on the TCF7L2 rs7903146 variant. The NDS was not associated with anthropometric changes during follow-up.</AbstractText>
<CopyrightInformation>© 2014 American Society for Nutrition.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Roswall</LastName>
<ForeName>Nina</ForeName>
<Initials>N</Initials>
<AffiliationInfo>
<Affiliation>From the Danish Cancer Society Research Center, Copenhagen, Denmark (NR, JH, and AT); the Institute of Preventive Medicine, Bispebjerg and Frederiksberg Hospitals-The Capital Region, Copenhagen, Denmark (LÄ, SCL, and TIAS); the Novo Nordisk Foundation Center for Basic Metabolic Research, Section of Metabolic Genetics, University of Copenhagen, Copenhagen, Denmark (TSA and TIAS); the Copenhagen Prospective Studies on Asthma in Childhood, Health Sciences, University of Copenhagen and Danish Pediatric Asthma Center, Copenhagen University Hospital, Gentofte, Denmark (TSA); the Department of Epidemiology and Biostatistics, School of Public Health, Imperial College, London, United Kingdom (DR); the Instituto de Investigación Sanitaria de Palma, Palma de Mallorca, Spain (DR); the Centro de Investigacíon Biomédica en Red Fisiopatologia de la Obesidad y Nutrición, Mallorca, Spain (DR); the Medical Research Council Epidemiology Unit, University of Cambridge, Cambridge, United Kingdom (KSV, NJW, and RJFL); the Hugh Sinclair Unit of Human Nutrition, Department of Food and Nutritional Sciences, School of Chemistry, Food and Pharmacy, University of Reading, Reading, United Kingdom (KSV); the Section for Epidemiology, Department of Public Health, Aarhus University, Aarhus, Denmark (JNØ); the Cancer Research and Prevention Institute-Istituto per lo Studio e la Prevenzione Oncologica, Florence, Italy (BB and DP); the Center for Nutrition, Prevention and Health Services, National Institute for Public Health and the Environment Bilthoven, Netherlands (JMAB and DLvdA); the Department of Epidemiology, German Institute of Human Nutrition Potsdam-Rehbruecke Arthur-Scheunert-Allee 114-116, Nuthetal, Germany (HB); and the Icahn School of Medicine at Mount Sinai, The Charles Bronfman Institute for Personalized Medicine, The Mindich Child Health and Development Institute, The Genetics of Obesity and Related Metabolic Traits Program, New York, NY (RJFL).</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Ängquist</LastName>
<ForeName>Lars</ForeName>
<Initials>L</Initials>
<AffiliationInfo>
<Affiliation>From the Danish Cancer Society Research Center, Copenhagen, Denmark (NR, JH, and AT); the Institute of Preventive Medicine, Bispebjerg and Frederiksberg Hospitals-The Capital Region, Copenhagen, Denmark (LÄ, SCL, and TIAS); the Novo Nordisk Foundation Center for Basic Metabolic Research, Section of Metabolic Genetics, University of Copenhagen, Copenhagen, Denmark (TSA and TIAS); the Copenhagen Prospective Studies on Asthma in Childhood, Health Sciences, University of Copenhagen and Danish Pediatric Asthma Center, Copenhagen University Hospital, Gentofte, Denmark (TSA); the Department of Epidemiology and Biostatistics, School of Public Health, Imperial College, London, United Kingdom (DR); the Instituto de Investigación Sanitaria de Palma, Palma de Mallorca, Spain (DR); the Centro de Investigacíon Biomédica en Red Fisiopatologia de la Obesidad y Nutrición, Mallorca, Spain (DR); the Medical Research Council Epidemiology Unit, University of Cambridge, Cambridge, United Kingdom (KSV, NJW, and RJFL); the Hugh Sinclair Unit of Human Nutrition, Department of Food and Nutritional Sciences, School of Chemistry, Food and Pharmacy, University of Reading, Reading, United Kingdom (KSV); the Section for Epidemiology, Department of Public Health, Aarhus University, Aarhus, Denmark (JNØ); the Cancer Research and Prevention Institute-Istituto per lo Studio e la Prevenzione Oncologica, Florence, Italy (BB and DP); the Center for Nutrition, Prevention and Health Services, National Institute for Public Health and the Environment Bilthoven, Netherlands (JMAB and DLvdA); the Department of Epidemiology, German Institute of Human Nutrition Potsdam-Rehbruecke Arthur-Scheunert-Allee 114-116, Nuthetal, Germany (HB); and the Icahn School of Medicine at Mount Sinai, The Charles Bronfman Institute for Personalized Medicine, The Mindich Child Health and Development Institute, The Genetics of Obesity and Related Metabolic Traits Program, New York, NY (RJFL).</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Ahluwalia</LastName>
<ForeName>Tarunveer S</ForeName>
<Initials>TS</Initials>
<AffiliationInfo>
<Affiliation>From the Danish Cancer Society Research Center, Copenhagen, Denmark (NR, JH, and AT); the Institute of Preventive Medicine, Bispebjerg and Frederiksberg Hospitals-The Capital Region, Copenhagen, Denmark (LÄ, SCL, and TIAS); the Novo Nordisk Foundation Center for Basic Metabolic Research, Section of Metabolic Genetics, University of Copenhagen, Copenhagen, Denmark (TSA and TIAS); the Copenhagen Prospective Studies on Asthma in Childhood, Health Sciences, University of Copenhagen and Danish Pediatric Asthma Center, Copenhagen University Hospital, Gentofte, Denmark (TSA); the Department of Epidemiology and Biostatistics, School of Public Health, Imperial College, London, United Kingdom (DR); the Instituto de Investigación Sanitaria de Palma, Palma de Mallorca, Spain (DR); the Centro de Investigacíon Biomédica en Red Fisiopatologia de la Obesidad y Nutrición, Mallorca, Spain (DR); the Medical Research Council Epidemiology Unit, University of Cambridge, Cambridge, United Kingdom (KSV, NJW, and RJFL); the Hugh Sinclair Unit of Human Nutrition, Department of Food and Nutritional Sciences, School of Chemistry, Food and Pharmacy, University of Reading, Reading, United Kingdom (KSV); the Section for Epidemiology, Department of Public Health, Aarhus University, Aarhus, Denmark (JNØ); the Cancer Research and Prevention Institute-Istituto per lo Studio e la Prevenzione Oncologica, Florence, Italy (BB and DP); the Center for Nutrition, Prevention and Health Services, National Institute for Public Health and the Environment Bilthoven, Netherlands (JMAB and DLvdA); the Department of Epidemiology, German Institute of Human Nutrition Potsdam-Rehbruecke Arthur-Scheunert-Allee 114-116, Nuthetal, Germany (HB); and the Icahn School of Medicine at Mount Sinai, The Charles Bronfman Institute for Personalized Medicine, The Mindich Child Health and Development Institute, The Genetics of Obesity and Related Metabolic Traits Program, New York, NY (RJFL).</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Romaguera</LastName>
<ForeName>Dora</ForeName>
<Initials>D</Initials>
<AffiliationInfo>
<Affiliation>From the Danish Cancer Society Research Center, Copenhagen, Denmark (NR, JH, and AT); the Institute of Preventive Medicine, Bispebjerg and Frederiksberg Hospitals-The Capital Region, Copenhagen, Denmark (LÄ, SCL, and TIAS); the Novo Nordisk Foundation Center for Basic Metabolic Research, Section of Metabolic Genetics, University of Copenhagen, Copenhagen, Denmark (TSA and TIAS); the Copenhagen Prospective Studies on Asthma in Childhood, Health Sciences, University of Copenhagen and Danish Pediatric Asthma Center, Copenhagen University Hospital, Gentofte, Denmark (TSA); the Department of Epidemiology and Biostatistics, School of Public Health, Imperial College, London, United Kingdom (DR); the Instituto de Investigación Sanitaria de Palma, Palma de Mallorca, Spain (DR); the Centro de Investigacíon Biomédica en Red Fisiopatologia de la Obesidad y Nutrición, Mallorca, Spain (DR); the Medical Research Council Epidemiology Unit, University of Cambridge, Cambridge, United Kingdom (KSV, NJW, and RJFL); the Hugh Sinclair Unit of Human Nutrition, Department of Food and Nutritional Sciences, School of Chemistry, Food and Pharmacy, University of Reading, Reading, United Kingdom (KSV); the Section for Epidemiology, Department of Public Health, Aarhus University, Aarhus, Denmark (JNØ); the Cancer Research and Prevention Institute-Istituto per lo Studio e la Prevenzione Oncologica, Florence, Italy (BB and DP); the Center for Nutrition, Prevention and Health Services, National Institute for Public Health and the Environment Bilthoven, Netherlands (JMAB and DLvdA); the Department of Epidemiology, German Institute of Human Nutrition Potsdam-Rehbruecke Arthur-Scheunert-Allee 114-116, Nuthetal, Germany (HB); and the Icahn School of Medicine at Mount Sinai, The Charles Bronfman Institute for Personalized Medicine, The Mindich Child Health and Development Institute, The Genetics of Obesity and Related Metabolic Traits Program, New York, NY (RJFL).</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Larsen</LastName>
<ForeName>Sofus C</ForeName>
<Initials>SC</Initials>
<AffiliationInfo>
<Affiliation>From the Danish Cancer Society Research Center, Copenhagen, Denmark (NR, JH, and AT); the Institute of Preventive Medicine, Bispebjerg and Frederiksberg Hospitals-The Capital Region, Copenhagen, Denmark (LÄ, SCL, and TIAS); the Novo Nordisk Foundation Center for Basic Metabolic Research, Section of Metabolic Genetics, University of Copenhagen, Copenhagen, Denmark (TSA and TIAS); the Copenhagen Prospective Studies on Asthma in Childhood, Health Sciences, University of Copenhagen and Danish Pediatric Asthma Center, Copenhagen University Hospital, Gentofte, Denmark (TSA); the Department of Epidemiology and Biostatistics, School of Public Health, Imperial College, London, United Kingdom (DR); the Instituto de Investigación Sanitaria de Palma, Palma de Mallorca, Spain (DR); the Centro de Investigacíon Biomédica en Red Fisiopatologia de la Obesidad y Nutrición, Mallorca, Spain (DR); the Medical Research Council Epidemiology Unit, University of Cambridge, Cambridge, United Kingdom (KSV, NJW, and RJFL); the Hugh Sinclair Unit of Human Nutrition, Department of Food and Nutritional Sciences, School of Chemistry, Food and Pharmacy, University of Reading, Reading, United Kingdom (KSV); the Section for Epidemiology, Department of Public Health, Aarhus University, Aarhus, Denmark (JNØ); the Cancer Research and Prevention Institute-Istituto per lo Studio e la Prevenzione Oncologica, Florence, Italy (BB and DP); the Center for Nutrition, Prevention and Health Services, National Institute for Public Health and the Environment Bilthoven, Netherlands (JMAB and DLvdA); the Department of Epidemiology, German Institute of Human Nutrition Potsdam-Rehbruecke Arthur-Scheunert-Allee 114-116, Nuthetal, Germany (HB); and the Icahn School of Medicine at Mount Sinai, The Charles Bronfman Institute for Personalized Medicine, The Mindich Child Health and Development Institute, The Genetics of Obesity and Related Metabolic Traits Program, New York, NY (RJFL).</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Østergaard</LastName>
<ForeName>Jane N</ForeName>
<Initials>JN</Initials>
<AffiliationInfo>
<Affiliation>From the Danish Cancer Society Research Center, Copenhagen, Denmark (NR, JH, and AT); the Institute of Preventive Medicine, Bispebjerg and Frederiksberg Hospitals-The Capital Region, Copenhagen, Denmark (LÄ, SCL, and TIAS); the Novo Nordisk Foundation Center for Basic Metabolic Research, Section of Metabolic Genetics, University of Copenhagen, Copenhagen, Denmark (TSA and TIAS); the Copenhagen Prospective Studies on Asthma in Childhood, Health Sciences, University of Copenhagen and Danish Pediatric Asthma Center, Copenhagen University Hospital, Gentofte, Denmark (TSA); the Department of Epidemiology and Biostatistics, School of Public Health, Imperial College, London, United Kingdom (DR); the Instituto de Investigación Sanitaria de Palma, Palma de Mallorca, Spain (DR); the Centro de Investigacíon Biomédica en Red Fisiopatologia de la Obesidad y Nutrición, Mallorca, Spain (DR); the Medical Research Council Epidemiology Unit, University of Cambridge, Cambridge, United Kingdom (KSV, NJW, and RJFL); the Hugh Sinclair Unit of Human Nutrition, Department of Food and Nutritional Sciences, School of Chemistry, Food and Pharmacy, University of Reading, Reading, United Kingdom (KSV); the Section for Epidemiology, Department of Public Health, Aarhus University, Aarhus, Denmark (JNØ); the Cancer Research and Prevention Institute-Istituto per lo Studio e la Prevenzione Oncologica, Florence, Italy (BB and DP); the Center for Nutrition, Prevention and Health Services, National Institute for Public Health and the Environment Bilthoven, Netherlands (JMAB and DLvdA); the Department of Epidemiology, German Institute of Human Nutrition Potsdam-Rehbruecke Arthur-Scheunert-Allee 114-116, Nuthetal, Germany (HB); and the Icahn School of Medicine at Mount Sinai, The Charles Bronfman Institute for Personalized Medicine, The Mindich Child Health and Development Institute, The Genetics of Obesity and Related Metabolic Traits Program, New York, NY (RJFL).</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Halkjaer</LastName>
<ForeName>Jytte</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>From the Danish Cancer Society Research Center, Copenhagen, Denmark (NR, JH, and AT); the Institute of Preventive Medicine, Bispebjerg and Frederiksberg Hospitals-The Capital Region, Copenhagen, Denmark (LÄ, SCL, and TIAS); the Novo Nordisk Foundation Center for Basic Metabolic Research, Section of Metabolic Genetics, University of Copenhagen, Copenhagen, Denmark (TSA and TIAS); the Copenhagen Prospective Studies on Asthma in Childhood, Health Sciences, University of Copenhagen and Danish Pediatric Asthma Center, Copenhagen University Hospital, Gentofte, Denmark (TSA); the Department of Epidemiology and Biostatistics, School of Public Health, Imperial College, London, United Kingdom (DR); the Instituto de Investigación Sanitaria de Palma, Palma de Mallorca, Spain (DR); the Centro de Investigacíon Biomédica en Red Fisiopatologia de la Obesidad y Nutrición, Mallorca, Spain (DR); the Medical Research Council Epidemiology Unit, University of Cambridge, Cambridge, United Kingdom (KSV, NJW, and RJFL); the Hugh Sinclair Unit of Human Nutrition, Department of Food and Nutritional Sciences, School of Chemistry, Food and Pharmacy, University of Reading, Reading, United Kingdom (KSV); the Section for Epidemiology, Department of Public Health, Aarhus University, Aarhus, Denmark (JNØ); the Cancer Research and Prevention Institute-Istituto per lo Studio e la Prevenzione Oncologica, Florence, Italy (BB and DP); the Center for Nutrition, Prevention and Health Services, National Institute for Public Health and the Environment Bilthoven, Netherlands (JMAB and DLvdA); the Department of Epidemiology, German Institute of Human Nutrition Potsdam-Rehbruecke Arthur-Scheunert-Allee 114-116, Nuthetal, Germany (HB); and the Icahn School of Medicine at Mount Sinai, The Charles Bronfman Institute for Personalized Medicine, The Mindich Child Health and Development Institute, The Genetics of Obesity and Related Metabolic Traits Program, New York, NY (RJFL).</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Vimaleswaran</LastName>
<ForeName>Karani S</ForeName>
<Initials>KS</Initials>
<AffiliationInfo>
<Affiliation>From the Danish Cancer Society Research Center, Copenhagen, Denmark (NR, JH, and AT); the Institute of Preventive Medicine, Bispebjerg and Frederiksberg Hospitals-The Capital Region, Copenhagen, Denmark (LÄ, SCL, and TIAS); the Novo Nordisk Foundation Center for Basic Metabolic Research, Section of Metabolic Genetics, University of Copenhagen, Copenhagen, Denmark (TSA and TIAS); the Copenhagen Prospective Studies on Asthma in Childhood, Health Sciences, University of Copenhagen and Danish Pediatric Asthma Center, Copenhagen University Hospital, Gentofte, Denmark (TSA); the Department of Epidemiology and Biostatistics, School of Public Health, Imperial College, London, United Kingdom (DR); the Instituto de Investigación Sanitaria de Palma, Palma de Mallorca, Spain (DR); the Centro de Investigacíon Biomédica en Red Fisiopatologia de la Obesidad y Nutrición, Mallorca, Spain (DR); the Medical Research Council Epidemiology Unit, University of Cambridge, Cambridge, United Kingdom (KSV, NJW, and RJFL); the Hugh Sinclair Unit of Human Nutrition, Department of Food and Nutritional Sciences, School of Chemistry, Food and Pharmacy, University of Reading, Reading, United Kingdom (KSV); the Section for Epidemiology, Department of Public Health, Aarhus University, Aarhus, Denmark (JNØ); the Cancer Research and Prevention Institute-Istituto per lo Studio e la Prevenzione Oncologica, Florence, Italy (BB and DP); the Center for Nutrition, Prevention and Health Services, National Institute for Public Health and the Environment Bilthoven, Netherlands (JMAB and DLvdA); the Department of Epidemiology, German Institute of Human Nutrition Potsdam-Rehbruecke Arthur-Scheunert-Allee 114-116, Nuthetal, Germany (HB); and the Icahn School of Medicine at Mount Sinai, The Charles Bronfman Institute for Personalized Medicine, The Mindich Child Health and Development Institute, The Genetics of Obesity and Related Metabolic Traits Program, New York, NY (RJFL).</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Wareham</LastName>
<ForeName>Nicolas J</ForeName>
<Initials>NJ</Initials>
<AffiliationInfo>
<Affiliation>From the Danish Cancer Society Research Center, Copenhagen, Denmark (NR, JH, and AT); the Institute of Preventive Medicine, Bispebjerg and Frederiksberg Hospitals-The Capital Region, Copenhagen, Denmark (LÄ, SCL, and TIAS); the Novo Nordisk Foundation Center for Basic Metabolic Research, Section of Metabolic Genetics, University of Copenhagen, Copenhagen, Denmark (TSA and TIAS); the Copenhagen Prospective Studies on Asthma in Childhood, Health Sciences, University of Copenhagen and Danish Pediatric Asthma Center, Copenhagen University Hospital, Gentofte, Denmark (TSA); the Department of Epidemiology and Biostatistics, School of Public Health, Imperial College, London, United Kingdom (DR); the Instituto de Investigación Sanitaria de Palma, Palma de Mallorca, Spain (DR); the Centro de Investigacíon Biomédica en Red Fisiopatologia de la Obesidad y Nutrición, Mallorca, Spain (DR); the Medical Research Council Epidemiology Unit, University of Cambridge, Cambridge, United Kingdom (KSV, NJW, and RJFL); the Hugh Sinclair Unit of Human Nutrition, Department of Food and Nutritional Sciences, School of Chemistry, Food and Pharmacy, University of Reading, Reading, United Kingdom (KSV); the Section for Epidemiology, Department of Public Health, Aarhus University, Aarhus, Denmark (JNØ); the Cancer Research and Prevention Institute-Istituto per lo Studio e la Prevenzione Oncologica, Florence, Italy (BB and DP); the Center for Nutrition, Prevention and Health Services, National Institute for Public Health and the Environment Bilthoven, Netherlands (JMAB and DLvdA); the Department of Epidemiology, German Institute of Human Nutrition Potsdam-Rehbruecke Arthur-Scheunert-Allee 114-116, Nuthetal, Germany (HB); and the Icahn School of Medicine at Mount Sinai, The Charles Bronfman Institute for Personalized Medicine, The Mindich Child Health and Development Institute, The Genetics of Obesity and Related Metabolic Traits Program, New York, NY (RJFL).</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Bendinelli</LastName>
<ForeName>Benedetta</ForeName>
<Initials>B</Initials>
<AffiliationInfo>
<Affiliation>From the Danish Cancer Society Research Center, Copenhagen, Denmark (NR, JH, and AT); the Institute of Preventive Medicine, Bispebjerg and Frederiksberg Hospitals-The Capital Region, Copenhagen, Denmark (LÄ, SCL, and TIAS); the Novo Nordisk Foundation Center for Basic Metabolic Research, Section of Metabolic Genetics, University of Copenhagen, Copenhagen, Denmark (TSA and TIAS); the Copenhagen Prospective Studies on Asthma in Childhood, Health Sciences, University of Copenhagen and Danish Pediatric Asthma Center, Copenhagen University Hospital, Gentofte, Denmark (TSA); the Department of Epidemiology and Biostatistics, School of Public Health, Imperial College, London, United Kingdom (DR); the Instituto de Investigación Sanitaria de Palma, Palma de Mallorca, Spain (DR); the Centro de Investigacíon Biomédica en Red Fisiopatologia de la Obesidad y Nutrición, Mallorca, Spain (DR); the Medical Research Council Epidemiology Unit, University of Cambridge, Cambridge, United Kingdom (KSV, NJW, and RJFL); the Hugh Sinclair Unit of Human Nutrition, Department of Food and Nutritional Sciences, School of Chemistry, Food and Pharmacy, University of Reading, Reading, United Kingdom (KSV); the Section for Epidemiology, Department of Public Health, Aarhus University, Aarhus, Denmark (JNØ); the Cancer Research and Prevention Institute-Istituto per lo Studio e la Prevenzione Oncologica, Florence, Italy (BB and DP); the Center for Nutrition, Prevention and Health Services, National Institute for Public Health and the Environment Bilthoven, Netherlands (JMAB and DLvdA); the Department of Epidemiology, German Institute of Human Nutrition Potsdam-Rehbruecke Arthur-Scheunert-Allee 114-116, Nuthetal, Germany (HB); and the Icahn School of Medicine at Mount Sinai, The Charles Bronfman Institute for Personalized Medicine, The Mindich Child Health and Development Institute, The Genetics of Obesity and Related Metabolic Traits Program, New York, NY (RJFL).</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Palli</LastName>
<ForeName>Domenico</ForeName>
<Initials>D</Initials>
<AffiliationInfo>
<Affiliation>From the Danish Cancer Society Research Center, Copenhagen, Denmark (NR, JH, and AT); the Institute of Preventive Medicine, Bispebjerg and Frederiksberg Hospitals-The Capital Region, Copenhagen, Denmark (LÄ, SCL, and TIAS); the Novo Nordisk Foundation Center for Basic Metabolic Research, Section of Metabolic Genetics, University of Copenhagen, Copenhagen, Denmark (TSA and TIAS); the Copenhagen Prospective Studies on Asthma in Childhood, Health Sciences, University of Copenhagen and Danish Pediatric Asthma Center, Copenhagen University Hospital, Gentofte, Denmark (TSA); the Department of Epidemiology and Biostatistics, School of Public Health, Imperial College, London, United Kingdom (DR); the Instituto de Investigación Sanitaria de Palma, Palma de Mallorca, Spain (DR); the Centro de Investigacíon Biomédica en Red Fisiopatologia de la Obesidad y Nutrición, Mallorca, Spain (DR); the Medical Research Council Epidemiology Unit, University of Cambridge, Cambridge, United Kingdom (KSV, NJW, and RJFL); the Hugh Sinclair Unit of Human Nutrition, Department of Food and Nutritional Sciences, School of Chemistry, Food and Pharmacy, University of Reading, Reading, United Kingdom (KSV); the Section for Epidemiology, Department of Public Health, Aarhus University, Aarhus, Denmark (JNØ); the Cancer Research and Prevention Institute-Istituto per lo Studio e la Prevenzione Oncologica, Florence, Italy (BB and DP); the Center for Nutrition, Prevention and Health Services, National Institute for Public Health and the Environment Bilthoven, Netherlands (JMAB and DLvdA); the Department of Epidemiology, German Institute of Human Nutrition Potsdam-Rehbruecke Arthur-Scheunert-Allee 114-116, Nuthetal, Germany (HB); and the Icahn School of Medicine at Mount Sinai, The Charles Bronfman Institute for Personalized Medicine, The Mindich Child Health and Development Institute, The Genetics of Obesity and Related Metabolic Traits Program, New York, NY (RJFL).</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Boer</LastName>
<ForeName>Jolanda M A</ForeName>
<Initials>JM</Initials>
<AffiliationInfo>
<Affiliation>From the Danish Cancer Society Research Center, Copenhagen, Denmark (NR, JH, and AT); the Institute of Preventive Medicine, Bispebjerg and Frederiksberg Hospitals-The Capital Region, Copenhagen, Denmark (LÄ, SCL, and TIAS); the Novo Nordisk Foundation Center for Basic Metabolic Research, Section of Metabolic Genetics, University of Copenhagen, Copenhagen, Denmark (TSA and TIAS); the Copenhagen Prospective Studies on Asthma in Childhood, Health Sciences, University of Copenhagen and Danish Pediatric Asthma Center, Copenhagen University Hospital, Gentofte, Denmark (TSA); the Department of Epidemiology and Biostatistics, School of Public Health, Imperial College, London, United Kingdom (DR); the Instituto de Investigación Sanitaria de Palma, Palma de Mallorca, Spain (DR); the Centro de Investigacíon Biomédica en Red Fisiopatologia de la Obesidad y Nutrición, Mallorca, Spain (DR); the Medical Research Council Epidemiology Unit, University of Cambridge, Cambridge, United Kingdom (KSV, NJW, and RJFL); the Hugh Sinclair Unit of Human Nutrition, Department of Food and Nutritional Sciences, School of Chemistry, Food and Pharmacy, University of Reading, Reading, United Kingdom (KSV); the Section for Epidemiology, Department of Public Health, Aarhus University, Aarhus, Denmark (JNØ); the Cancer Research and Prevention Institute-Istituto per lo Studio e la Prevenzione Oncologica, Florence, Italy (BB and DP); the Center for Nutrition, Prevention and Health Services, National Institute for Public Health and the Environment Bilthoven, Netherlands (JMAB and DLvdA); the Department of Epidemiology, German Institute of Human Nutrition Potsdam-Rehbruecke Arthur-Scheunert-Allee 114-116, Nuthetal, Germany (HB); and the Icahn School of Medicine at Mount Sinai, The Charles Bronfman Institute for Personalized Medicine, The Mindich Child Health and Development Institute, The Genetics of Obesity and Related Metabolic Traits Program, New York, NY (RJFL).</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>van der A</LastName>
<ForeName>Daphne L</ForeName>
<Initials>DL</Initials>
<AffiliationInfo>
<Affiliation>From the Danish Cancer Society Research Center, Copenhagen, Denmark (NR, JH, and AT); the Institute of Preventive Medicine, Bispebjerg and Frederiksberg Hospitals-The Capital Region, Copenhagen, Denmark (LÄ, SCL, and TIAS); the Novo Nordisk Foundation Center for Basic Metabolic Research, Section of Metabolic Genetics, University of Copenhagen, Copenhagen, Denmark (TSA and TIAS); the Copenhagen Prospective Studies on Asthma in Childhood, Health Sciences, University of Copenhagen and Danish Pediatric Asthma Center, Copenhagen University Hospital, Gentofte, Denmark (TSA); the Department of Epidemiology and Biostatistics, School of Public Health, Imperial College, London, United Kingdom (DR); the Instituto de Investigación Sanitaria de Palma, Palma de Mallorca, Spain (DR); the Centro de Investigacíon Biomédica en Red Fisiopatologia de la Obesidad y Nutrición, Mallorca, Spain (DR); the Medical Research Council Epidemiology Unit, University of Cambridge, Cambridge, United Kingdom (KSV, NJW, and RJFL); the Hugh Sinclair Unit of Human Nutrition, Department of Food and Nutritional Sciences, School of Chemistry, Food and Pharmacy, University of Reading, Reading, United Kingdom (KSV); the Section for Epidemiology, Department of Public Health, Aarhus University, Aarhus, Denmark (JNØ); the Cancer Research and Prevention Institute-Istituto per lo Studio e la Prevenzione Oncologica, Florence, Italy (BB and DP); the Center for Nutrition, Prevention and Health Services, National Institute for Public Health and the Environment Bilthoven, Netherlands (JMAB and DLvdA); the Department of Epidemiology, German Institute of Human Nutrition Potsdam-Rehbruecke Arthur-Scheunert-Allee 114-116, Nuthetal, Germany (HB); and the Icahn School of Medicine at Mount Sinai, The Charles Bronfman Institute for Personalized Medicine, The Mindich Child Health and Development Institute, The Genetics of Obesity and Related Metabolic Traits Program, New York, NY (RJFL).</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Boeing</LastName>
<ForeName>Heiner</ForeName>
<Initials>H</Initials>
<AffiliationInfo>
<Affiliation>From the Danish Cancer Society Research Center, Copenhagen, Denmark (NR, JH, and AT); the Institute of Preventive Medicine, Bispebjerg and Frederiksberg Hospitals-The Capital Region, Copenhagen, Denmark (LÄ, SCL, and TIAS); the Novo Nordisk Foundation Center for Basic Metabolic Research, Section of Metabolic Genetics, University of Copenhagen, Copenhagen, Denmark (TSA and TIAS); the Copenhagen Prospective Studies on Asthma in Childhood, Health Sciences, University of Copenhagen and Danish Pediatric Asthma Center, Copenhagen University Hospital, Gentofte, Denmark (TSA); the Department of Epidemiology and Biostatistics, School of Public Health, Imperial College, London, United Kingdom (DR); the Instituto de Investigación Sanitaria de Palma, Palma de Mallorca, Spain (DR); the Centro de Investigacíon Biomédica en Red Fisiopatologia de la Obesidad y Nutrición, Mallorca, Spain (DR); the Medical Research Council Epidemiology Unit, University of Cambridge, Cambridge, United Kingdom (KSV, NJW, and RJFL); the Hugh Sinclair Unit of Human Nutrition, Department of Food and Nutritional Sciences, School of Chemistry, Food and Pharmacy, University of Reading, Reading, United Kingdom (KSV); the Section for Epidemiology, Department of Public Health, Aarhus University, Aarhus, Denmark (JNØ); the Cancer Research and Prevention Institute-Istituto per lo Studio e la Prevenzione Oncologica, Florence, Italy (BB and DP); the Center for Nutrition, Prevention and Health Services, National Institute for Public Health and the Environment Bilthoven, Netherlands (JMAB and DLvdA); the Department of Epidemiology, German Institute of Human Nutrition Potsdam-Rehbruecke Arthur-Scheunert-Allee 114-116, Nuthetal, Germany (HB); and the Icahn School of Medicine at Mount Sinai, The Charles Bronfman Institute for Personalized Medicine, The Mindich Child Health and Development Institute, The Genetics of Obesity and Related Metabolic Traits Program, New York, NY (RJFL).</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Loos</LastName>
<ForeName>Ruth J F</ForeName>
<Initials>RJ</Initials>
<AffiliationInfo>
<Affiliation>From the Danish Cancer Society Research Center, Copenhagen, Denmark (NR, JH, and AT); the Institute of Preventive Medicine, Bispebjerg and Frederiksberg Hospitals-The Capital Region, Copenhagen, Denmark (LÄ, SCL, and TIAS); the Novo Nordisk Foundation Center for Basic Metabolic Research, Section of Metabolic Genetics, University of Copenhagen, Copenhagen, Denmark (TSA and TIAS); the Copenhagen Prospective Studies on Asthma in Childhood, Health Sciences, University of Copenhagen and Danish Pediatric Asthma Center, Copenhagen University Hospital, Gentofte, Denmark (TSA); the Department of Epidemiology and Biostatistics, School of Public Health, Imperial College, London, United Kingdom (DR); the Instituto de Investigación Sanitaria de Palma, Palma de Mallorca, Spain (DR); the Centro de Investigacíon Biomédica en Red Fisiopatologia de la Obesidad y Nutrición, Mallorca, Spain (DR); the Medical Research Council Epidemiology Unit, University of Cambridge, Cambridge, United Kingdom (KSV, NJW, and RJFL); the Hugh Sinclair Unit of Human Nutrition, Department of Food and Nutritional Sciences, School of Chemistry, Food and Pharmacy, University of Reading, Reading, United Kingdom (KSV); the Section for Epidemiology, Department of Public Health, Aarhus University, Aarhus, Denmark (JNØ); the Cancer Research and Prevention Institute-Istituto per lo Studio e la Prevenzione Oncologica, Florence, Italy (BB and DP); the Center for Nutrition, Prevention and Health Services, National Institute for Public Health and the Environment Bilthoven, Netherlands (JMAB and DLvdA); the Department of Epidemiology, German Institute of Human Nutrition Potsdam-Rehbruecke Arthur-Scheunert-Allee 114-116, Nuthetal, Germany (HB); and the Icahn School of Medicine at Mount Sinai, The Charles Bronfman Institute for Personalized Medicine, The Mindich Child Health and Development Institute, The Genetics of Obesity and Related Metabolic Traits Program, New York, NY (RJFL).</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Sørensen</LastName>
<ForeName>Thorkild I A</ForeName>
<Initials>TI</Initials>
<AffiliationInfo>
<Affiliation>From the Danish Cancer Society Research Center, Copenhagen, Denmark (NR, JH, and AT); the Institute of Preventive Medicine, Bispebjerg and Frederiksberg Hospitals-The Capital Region, Copenhagen, Denmark (LÄ, SCL, and TIAS); the Novo Nordisk Foundation Center for Basic Metabolic Research, Section of Metabolic Genetics, University of Copenhagen, Copenhagen, Denmark (TSA and TIAS); the Copenhagen Prospective Studies on Asthma in Childhood, Health Sciences, University of Copenhagen and Danish Pediatric Asthma Center, Copenhagen University Hospital, Gentofte, Denmark (TSA); the Department of Epidemiology and Biostatistics, School of Public Health, Imperial College, London, United Kingdom (DR); the Instituto de Investigación Sanitaria de Palma, Palma de Mallorca, Spain (DR); the Centro de Investigacíon Biomédica en Red Fisiopatologia de la Obesidad y Nutrición, Mallorca, Spain (DR); the Medical Research Council Epidemiology Unit, University of Cambridge, Cambridge, United Kingdom (KSV, NJW, and RJFL); the Hugh Sinclair Unit of Human Nutrition, Department of Food and Nutritional Sciences, School of Chemistry, Food and Pharmacy, University of Reading, Reading, United Kingdom (KSV); the Section for Epidemiology, Department of Public Health, Aarhus University, Aarhus, Denmark (JNØ); the Cancer Research and Prevention Institute-Istituto per lo Studio e la Prevenzione Oncologica, Florence, Italy (BB and DP); the Center for Nutrition, Prevention and Health Services, National Institute for Public Health and the Environment Bilthoven, Netherlands (JMAB and DLvdA); the Department of Epidemiology, German Institute of Human Nutrition Potsdam-Rehbruecke Arthur-Scheunert-Allee 114-116, Nuthetal, Germany (HB); and the Icahn School of Medicine at Mount Sinai, The Charles Bronfman Institute for Personalized Medicine, The Mindich Child Health and Development Institute, The Genetics of Obesity and Related Metabolic Traits Program, New York, NY (RJFL).</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Tjønneland</LastName>
<ForeName>Anne</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>From the Danish Cancer Society Research Center, Copenhagen, Denmark (NR, JH, and AT); the Institute of Preventive Medicine, Bispebjerg and Frederiksberg Hospitals-The Capital Region, Copenhagen, Denmark (LÄ, SCL, and TIAS); the Novo Nordisk Foundation Center for Basic Metabolic Research, Section of Metabolic Genetics, University of Copenhagen, Copenhagen, Denmark (TSA and TIAS); the Copenhagen Prospective Studies on Asthma in Childhood, Health Sciences, University of Copenhagen and Danish Pediatric Asthma Center, Copenhagen University Hospital, Gentofte, Denmark (TSA); the Department of Epidemiology and Biostatistics, School of Public Health, Imperial College, London, United Kingdom (DR); the Instituto de Investigación Sanitaria de Palma, Palma de Mallorca, Spain (DR); the Centro de Investigacíon Biomédica en Red Fisiopatologia de la Obesidad y Nutrición, Mallorca, Spain (DR); the Medical Research Council Epidemiology Unit, University of Cambridge, Cambridge, United Kingdom (KSV, NJW, and RJFL); the Hugh Sinclair Unit of Human Nutrition, Department of Food and Nutritional Sciences, School of Chemistry, Food and Pharmacy, University of Reading, Reading, United Kingdom (KSV); the Section for Epidemiology, Department of Public Health, Aarhus University, Aarhus, Denmark (JNØ); the Cancer Research and Prevention Institute-Istituto per lo Studio e la Prevenzione Oncologica, Florence, Italy (BB and DP); the Center for Nutrition, Prevention and Health Services, National Institute for Public Health and the Environment Bilthoven, Netherlands (JMAB and DLvdA); the Department of Epidemiology, German Institute of Human Nutrition Potsdam-Rehbruecke Arthur-Scheunert-Allee 114-116, Nuthetal, Germany (HB); and the Icahn School of Medicine at Mount Sinai, The Charles Bronfman Institute for Personalized Medicine, The Mindich Child Health and Development Institute, The Genetics of Obesity and Related Metabolic Traits Program, New York, NY (RJFL).</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>08</Month>
<Day>06</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Am J Clin Nutr</MedlineTA>
<NlmUniqueID>0376027</NlmUniqueID>
<ISSNLinking>0002-9165</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C526492">FTO protein, human</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D011506">Proteins</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C544894">TCF7L2 protein, human</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D058118">Transcription Factor 7-Like 2 Protein</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D050154">Adiposity</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000328">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000483">Alleles</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015992">Body Mass Index</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D004032">Diet</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D038441">Diet, Mediterranean</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" Type="Geographic" UI="D005060">Europe</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005500">Follow-Up Studies</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D056426">Genetic Loci</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D020022">Genetic Predisposition to Disease</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D016014">Linear Models</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015810">Linkage Disequilibrium</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008875">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009765">Obesity</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000178">diet therapy</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000235">genetics</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D020641">Polymorphism, Single Nucleotide</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011446">Prospective Studies</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011506">Proteins</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000235">genetics</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D058118">Transcription Factor 7-Like 2 Protein</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000235">genetics</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D055105">Waist Circumference</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000235">genetics</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015430">Weight Gain</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000235">genetics</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25099551</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>20</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>10</Day>
</DateCompleted>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1938-3207</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>100</Volume>
<Issue>4</Issue>
<PubDate>
<Year>2014</Year>
<Month>Oct</Month>
</PubDate>
</JournalIssue>
<Title>The American journal of clinical nutrition</Title>
<ISOAbbreviation>Am. J. Clin. Nutr.</ISOAbbreviation>
</Journal>
<ArticleTitle>The threshold shift paradigm of obesity: evidence from surgically induced weight loss.</ArticleTitle>
<Pagination>
<MedlinePgn>996-1002</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.3945/ajcn.114.090167</ELocationID>
<Abstract>
<AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The high prevalence of obesity has called attention to the near-intractable problem of sustained weight reduction and its underlying mechanisms. With diet-induced weight loss, achieved body weight is closely related to initial body weight.</AbstractText>
<AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">The objective was to compare the relation between initial and achieved body mass index (BMI) in patients treated with diet-induced weight loss or bariatric surgery.</AbstractText>
<AbstractText Label="DESIGN" NlmCategory="METHODS">We analyzed data from a cohort of 223 healthy individuals who lost a mean (±SD) of 5 ± 3 kg body weight over 3 y by diet (diet group) and data from 182 obese individuals [BMI (in kg/m(2)) ≥35] who had lost an average of 47 ± 17 kg 1 y after Roux-en-Y gastric bypass (a restrictive procedure; n = 71) or biliopancreatic diversion (a malabsorptive procedure; n = 111) (surgery group).</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">In the diet group, final BMI was strongly related to initial BMI (r = 0.96, P &lt; 0.0001). By multivariate analysis, the decrease in BMI at 3 y was age independent and was predicted only by initial BMI and sex (both P &lt; 0.0001). Strikingly, final BMI was also strongly related to initial BMI (r = 0.67, P &lt; 0.0001) in the surgery group, irrespective of the type of operation. The surgically induced decrease in BMI was predicted by age (P = 0.0002) and initial BMI (P &lt; 0.0001). In 110 surgery patients, serum leptin concentrations decreased from 39 ± 16 to 10 ± 5 ng/mL after surgery (P &lt; 0.0001) and were correlated with BMI both before and after surgery, but the slope of the relation was significantly (P &lt; 0.01) flatter after surgery.</AbstractText>
<AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">The strong predictivity of initial BMI for achieved BMI observed even when voluntary control of energy intake is interfered with through diverse anatomical rearrangements of the gastrointestinal tract supports the concept of a weight "threshold" paradigm: in the obese, anabolic responses are triggered by adiposity-related signals at a higher threshold, which leads to defense of a higher body weight.</AbstractText>
<CopyrightInformation>© 2014 American Society for Nutrition.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Ferrannini</LastName>
<ForeName>Ele</ForeName>
<Initials>E</Initials>
<AffiliationInfo>
<Affiliation>From the Department of Clinical &amp; Experimental Medicine, University of Pisa School of Medicine, Pisa, Italy (EF), and the Department of Pediatrics, Division of Molecular Genetics, Columbia University College of Physicians and Surgeons, New York, NY (MR and RLL).</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Rosenbaum</LastName>
<ForeName>Michael</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>From the Department of Clinical &amp; Experimental Medicine, University of Pisa School of Medicine, Pisa, Italy (EF), and the Department of Pediatrics, Division of Molecular Genetics, Columbia University College of Physicians and Surgeons, New York, NY (MR and RLL).</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Leibel</LastName>
<ForeName>Rudolph L</ForeName>
<Initials>RL</Initials>
<AffiliationInfo>
<Affiliation>From the Department of Clinical &amp; Experimental Medicine, University of Pisa School of Medicine, Pisa, Italy (EF), and the Department of Pediatrics, Division of Molecular Genetics, Columbia University College of Physicians and Surgeons, New York, NY (MR and RLL).</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D003160">Comparative Study</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>08</Month>
<Day>06</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Am J Clin Nutr</MedlineTA>
<NlmUniqueID>0376027</NlmUniqueID>
<ISSNLinking>0002-9165</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D020738">Leptin</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList>
<CommentsCorrections RefType="CommentIn">
<RefSource>Am J Clin Nutr. 2014 Oct;100(4):991-2</RefSource>
<PMID Version="1">25240068</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000328">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000713">Anastomosis, Roux-en-Y</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D015992">Body Mass Index</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015331">Cohort Studies</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D004038">Diet, Reducing</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002149">Energy Intake</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015390">Gastric Bypass</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000009">adverse effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D020738">Leptin</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000097">blood</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D016014">Linear Models</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008875">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015999">Multivariate Analysis</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009765">Obesity</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000178">diet therapy</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000601">surgery</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015995">Prevalence</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D015431">Weight Loss</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25240068</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>20</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>10</Day>
</DateCompleted>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1938-3207</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>100</Volume>
<Issue>4</Issue>
<PubDate>
<Year>2014</Year>
<Month>Oct</Month>
</PubDate>
</JournalIssue>
<Title>The American journal of clinical nutrition</Title>
<ISOAbbreviation>Am. J. Clin. Nutr.</ISOAbbreviation>
</Journal>
<ArticleTitle>The battle of the bulge: defense versus offense.</ArticleTitle>
<Pagination>
<MedlinePgn>991-2</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.3945/ajcn.114.096529</ELocationID>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Magkos</LastName>
<ForeName>Faidon</ForeName>
<Initials>F</Initials>
<AffiliationInfo>
<Affiliation>From the Center for Human Nutrition and Atkins Center of Excellence in Obesity Medicine, Washington University School of Medicine, St Louis, MO (FM and SK), and the Department of Surgery, Vanderbilt University School of Medicine, Nashville, TN (RAT and NNA). fmagkos@dom.wustl.edu.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Tamboli</LastName>
<ForeName>Robyn A</ForeName>
<Initials>RA</Initials>
<AffiliationInfo>
<Affiliation>From the Center for Human Nutrition and Atkins Center of Excellence in Obesity Medicine, Washington University School of Medicine, St Louis, MO (FM and SK), and the Department of Surgery, Vanderbilt University School of Medicine, Nashville, TN (RAT and NNA).</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Abumrad</LastName>
<ForeName>Naji N</ForeName>
<Initials>NN</Initials>
<AffiliationInfo>
<Affiliation>From the Center for Human Nutrition and Atkins Center of Excellence in Obesity Medicine, Washington University School of Medicine, St Louis, MO (FM and SK), and the Department of Surgery, Vanderbilt University School of Medicine, Nashville, TN (RAT and NNA).</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Klein</LastName>
<ForeName>Samuel</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>From the Center for Human Nutrition and Atkins Center of Excellence in Obesity Medicine, Washington University School of Medicine, St Louis, MO (FM and SK), and the Department of Surgery, Vanderbilt University School of Medicine, Nashville, TN (RAT and NNA).</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016420">Comment</PublicationType>
<PublicationType UI="D016421">Editorial</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>08</Month>
<Day>27</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Am J Clin Nutr</MedlineTA>
<NlmUniqueID>0376027</NlmUniqueID>
<ISSNLinking>0002-9165</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList>
<CommentsCorrections RefType="CommentOn">
<RefSource>Am J Clin Nutr. 2014 Oct;100(4):996-1002</RefSource>
<PMID Version="1">25099551</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D015992">Body Mass Index</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009765">Obesity</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000178">diet therapy</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000601">surgery</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D015431">Weight Loss</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25240070</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>20</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>10</Day>
</DateCompleted>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1938-3207</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>100</Volume>
<Issue>4</Issue>
<PubDate>
<Year>2014</Year>
<Month>Oct</Month>
</PubDate>
</JournalIssue>
<Title>The American journal of clinical nutrition</Title>
<ISOAbbreviation>Am. J. Clin. Nutr.</ISOAbbreviation>
</Journal>
<ArticleTitle>Targeted prevention of excess weight gain and eating disorders in high-risk adolescent girls: a randomized controlled trial.</ArticleTitle>
<Pagination>
<MedlinePgn>1010-8</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.3945/ajcn.114.092536</ELocationID>
<Abstract>
<AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The high prevalence and incidence of obesity and eating disorders in US adolescent girls are serious health problems. Because of the shared risk factors for obesity and eating disorders, a targeted prevention of both conditions is a priority.</AbstractText>
<AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">We determined whether an adapted interpersonal psychotherapy prevention program is more efficacious for reducing excess weight gain and worsening disordered eating than health education in adolescent girls at high risk of obesity and eating disorders.</AbstractText>
<AbstractText Label="DESIGN" NlmCategory="METHODS">A parallel-group, randomized controlled trial was conducted between September 2008 and January 2013 in a university-based laboratory and a federal research hospital. The study included 113 adolescent (12-17-y-old) girls deemed at high risk of adult obesity and eating disorders because of a body mass index (BMI) between the 75th and 97th percentiles and reports of episodes of a loss of control over their eating. Girls were randomly assigned to participate in an adapted interpersonal psychotherapy or a health-education group program for 12 weekly 90-min group sessions. Follow-up assessments occurred immediately after group programs and at 6 and 12 mo.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">Participation in both conditions was associated with decreases in expected BMI gain, age-adjusted BMI metrics, the percentage of fat by using dual-energy X-ray absorptiometry, symptoms of depression and anxiety, and the frequency of loss-of-control eating over 12 mo of follow-up (Ps &lt; 0.001) with no group difference. In follow-up analyses, interpersonal psychotherapy was more efficacious than health education at reducing objective binge eating at the 12-mo follow-up (P &lt; 0.05).</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The intervention with adolescent girls with loss-of-control eating is associated with lower age-adjusted BMI and percentage of adiposity as well as improved mood symptoms over 1 y. Interpersonal psychotherapy further reduced objective binge eating. Additional research is needed to elucidate the mechanisms by which physical and psychological improvements were observed. This trial was registered at clinicaltrials.gov as NCT00680979.</AbstractText>
<CopyrightInformation>© 2014 American Society for Nutrition.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Tanofsky-Kraff</LastName>
<ForeName>Marian</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>From Medical and Clinical Psychology, Uniformed Services University of the Health Sciences, Bethesda, MD (MT-K, LBS, TS, MS, LMR, CE, RMR, AV, EJB, RO, SSB, and CO); the Nutrition Department (MK) and Nuclear Medicine Department (JCR), Hatfield Clinical Research Center, and the Section on Growth and Obesity, Eunice Kennedy Shriver National Institute of Child Health and Human Development (MT-K, LBS, LMR, CE, SB, RMR, AV, SSB, and JAY), NIH, Bethesda, MD; the Department of Psychiatry, Washington University School of Medicine, St Louis, MO (DEW); and Applied and Professional Psychology, Rutgers University, Piscataway Township, NJ (JFY).</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Shomaker</LastName>
<ForeName>Lauren B</ForeName>
<Initials>LB</Initials>
<AffiliationInfo>
<Affiliation>From Medical and Clinical Psychology, Uniformed Services University of the Health Sciences, Bethesda, MD (MT-K, LBS, TS, MS, LMR, CE, RMR, AV, EJB, RO, SSB, and CO); the Nutrition Department (MK) and Nuclear Medicine Department (JCR), Hatfield Clinical Research Center, and the Section on Growth and Obesity, Eunice Kennedy Shriver National Institute of Child Health and Human Development (MT-K, LBS, LMR, CE, SB, RMR, AV, SSB, and JAY), NIH, Bethesda, MD; the Department of Psychiatry, Washington University School of Medicine, St Louis, MO (DEW); and Applied and Professional Psychology, Rutgers University, Piscataway Township, NJ (JFY).</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Wilfley</LastName>
<ForeName>Denise E</ForeName>
<Initials>DE</Initials>
<AffiliationInfo>
<Affiliation>From Medical and Clinical Psychology, Uniformed Services University of the Health Sciences, Bethesda, MD (MT-K, LBS, TS, MS, LMR, CE, RMR, AV, EJB, RO, SSB, and CO); the Nutrition Department (MK) and Nuclear Medicine Department (JCR), Hatfield Clinical Research Center, and the Section on Growth and Obesity, Eunice Kennedy Shriver National Institute of Child Health and Human Development (MT-K, LBS, LMR, CE, SB, RMR, AV, SSB, and JAY), NIH, Bethesda, MD; the Department of Psychiatry, Washington University School of Medicine, St Louis, MO (DEW); and Applied and Professional Psychology, Rutgers University, Piscataway Township, NJ (JFY).</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Young</LastName>
<ForeName>Jami F</ForeName>
<Initials>JF</Initials>
<AffiliationInfo>
<Affiliation>From Medical and Clinical Psychology, Uniformed Services University of the Health Sciences, Bethesda, MD (MT-K, LBS, TS, MS, LMR, CE, RMR, AV, EJB, RO, SSB, and CO); the Nutrition Department (MK) and Nuclear Medicine Department (JCR), Hatfield Clinical Research Center, and the Section on Growth and Obesity, Eunice Kennedy Shriver National Institute of Child Health and Human Development (MT-K, LBS, LMR, CE, SB, RMR, AV, SSB, and JAY), NIH, Bethesda, MD; the Department of Psychiatry, Washington University School of Medicine, St Louis, MO (DEW); and Applied and Professional Psychology, Rutgers University, Piscataway Township, NJ (JFY).</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Sbrocco</LastName>
<ForeName>Tracy</ForeName>
<Initials>T</Initials>
<AffiliationInfo>
<Affiliation>From Medical and Clinical Psychology, Uniformed Services University of the Health Sciences, Bethesda, MD (MT-K, LBS, TS, MS, LMR, CE, RMR, AV, EJB, RO, SSB, and CO); the Nutrition Department (MK) and Nuclear Medicine Department (JCR), Hatfield Clinical Research Center, and the Section on Growth and Obesity, Eunice Kennedy Shriver National Institute of Child Health and Human Development (MT-K, LBS, LMR, CE, SB, RMR, AV, SSB, and JAY), NIH, Bethesda, MD; the Department of Psychiatry, Washington University School of Medicine, St Louis, MO (DEW); and Applied and Professional Psychology, Rutgers University, Piscataway Township, NJ (JFY).</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Stephens</LastName>
<ForeName>Mark</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>From Medical and Clinical Psychology, Uniformed Services University of the Health Sciences, Bethesda, MD (MT-K, LBS, TS, MS, LMR, CE, RMR, AV, EJB, RO, SSB, and CO); the Nutrition Department (MK) and Nuclear Medicine Department (JCR), Hatfield Clinical Research Center, and the Section on Growth and Obesity, Eunice Kennedy Shriver National Institute of Child Health and Human Development (MT-K, LBS, LMR, CE, SB, RMR, AV, SSB, and JAY), NIH, Bethesda, MD; the Department of Psychiatry, Washington University School of Medicine, St Louis, MO (DEW); and Applied and Professional Psychology, Rutgers University, Piscataway Township, NJ (JFY).</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Ranzenhofer</LastName>
<ForeName>Lisa M</ForeName>
<Initials>LM</Initials>
<AffiliationInfo>
<Affiliation>From Medical and Clinical Psychology, Uniformed Services University of the Health Sciences, Bethesda, MD (MT-K, LBS, TS, MS, LMR, CE, RMR, AV, EJB, RO, SSB, and CO); the Nutrition Department (MK) and Nuclear Medicine Department (JCR), Hatfield Clinical Research Center, and the Section on Growth and Obesity, Eunice Kennedy Shriver National Institute of Child Health and Human Development (MT-K, LBS, LMR, CE, SB, RMR, AV, SSB, and JAY), NIH, Bethesda, MD; the Department of Psychiatry, Washington University School of Medicine, St Louis, MO (DEW); and Applied and Professional Psychology, Rutgers University, Piscataway Township, NJ (JFY).</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Elliott</LastName>
<ForeName>Camden</ForeName>
<Initials>C</Initials>
<AffiliationInfo>
<Affiliation>From Medical and Clinical Psychology, Uniformed Services University of the Health Sciences, Bethesda, MD (MT-K, LBS, TS, MS, LMR, CE, RMR, AV, EJB, RO, SSB, and CO); the Nutrition Department (MK) and Nuclear Medicine Department (JCR), Hatfield Clinical Research Center, and the Section on Growth and Obesity, Eunice Kennedy Shriver National Institute of Child Health and Human Development (MT-K, LBS, LMR, CE, SB, RMR, AV, SSB, and JAY), NIH, Bethesda, MD; the Department of Psychiatry, Washington University School of Medicine, St Louis, MO (DEW); and Applied and Professional Psychology, Rutgers University, Piscataway Township, NJ (JFY).</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Brady</LastName>
<ForeName>Sheila</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>From Medical and Clinical Psychology, Uniformed Services University of the Health Sciences, Bethesda, MD (MT-K, LBS, TS, MS, LMR, CE, RMR, AV, EJB, RO, SSB, and CO); the Nutrition Department (MK) and Nuclear Medicine Department (JCR), Hatfield Clinical Research Center, and the Section on Growth and Obesity, Eunice Kennedy Shriver National Institute of Child Health and Human Development (MT-K, LBS, LMR, CE, SB, RMR, AV, SSB, and JAY), NIH, Bethesda, MD; the Department of Psychiatry, Washington University School of Medicine, St Louis, MO (DEW); and Applied and Professional Psychology, Rutgers University, Piscataway Township, NJ (JFY).</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Radin</LastName>
<ForeName>Rachel M</ForeName>
<Initials>RM</Initials>
<AffiliationInfo>
<Affiliation>From Medical and Clinical Psychology, Uniformed Services University of the Health Sciences, Bethesda, MD (MT-K, LBS, TS, MS, LMR, CE, RMR, AV, EJB, RO, SSB, and CO); the Nutrition Department (MK) and Nuclear Medicine Department (JCR), Hatfield Clinical Research Center, and the Section on Growth and Obesity, Eunice Kennedy Shriver National Institute of Child Health and Human Development (MT-K, LBS, LMR, CE, SB, RMR, AV, SSB, and JAY), NIH, Bethesda, MD; the Department of Psychiatry, Washington University School of Medicine, St Louis, MO (DEW); and Applied and Professional Psychology, Rutgers University, Piscataway Township, NJ (JFY).</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Vannucci</LastName>
<ForeName>Anna</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>From Medical and Clinical Psychology, Uniformed Services University of the Health Sciences, Bethesda, MD (MT-K, LBS, TS, MS, LMR, CE, RMR, AV, EJB, RO, SSB, and CO); the Nutrition Department (MK) and Nuclear Medicine Department (JCR), Hatfield Clinical Research Center, and the Section on Growth and Obesity, Eunice Kennedy Shriver National Institute of Child Health and Human Development (MT-K, LBS, LMR, CE, SB, RMR, AV, SSB, and JAY), NIH, Bethesda, MD; the Department of Psychiatry, Washington University School of Medicine, St Louis, MO (DEW); and Applied and Professional Psychology, Rutgers University, Piscataway Township, NJ (JFY).</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Bryant</LastName>
<ForeName>Edny J</ForeName>
<Initials>EJ</Initials>
<AffiliationInfo>
<Affiliation>From Medical and Clinical Psychology, Uniformed Services University of the Health Sciences, Bethesda, MD (MT-K, LBS, TS, MS, LMR, CE, RMR, AV, EJB, RO, SSB, and CO); the Nutrition Department (MK) and Nuclear Medicine Department (JCR), Hatfield Clinical Research Center, and the Section on Growth and Obesity, Eunice Kennedy Shriver National Institute of Child Health and Human Development (MT-K, LBS, LMR, CE, SB, RMR, AV, SSB, and JAY), NIH, Bethesda, MD; the Department of Psychiatry, Washington University School of Medicine, St Louis, MO (DEW); and Applied and Professional Psychology, Rutgers University, Piscataway Township, NJ (JFY).</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Osborn</LastName>
<ForeName>Robyn</ForeName>
<Initials>R</Initials>
<AffiliationInfo>
<Affiliation>From Medical and Clinical Psychology, Uniformed Services University of the Health Sciences, Bethesda, MD (MT-K, LBS, TS, MS, LMR, CE, RMR, AV, EJB, RO, SSB, and CO); the Nutrition Department (MK) and Nuclear Medicine Department (JCR), Hatfield Clinical Research Center, and the Section on Growth and Obesity, Eunice Kennedy Shriver National Institute of Child Health and Human Development (MT-K, LBS, LMR, CE, SB, RMR, AV, SSB, and JAY), NIH, Bethesda, MD; the Department of Psychiatry, Washington University School of Medicine, St Louis, MO (DEW); and Applied and Professional Psychology, Rutgers University, Piscataway Township, NJ (JFY).</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Berger</LastName>
<ForeName>Sarah S</ForeName>
<Initials>SS</Initials>
<AffiliationInfo>
<Affiliation>From Medical and Clinical Psychology, Uniformed Services University of the Health Sciences, Bethesda, MD (MT-K, LBS, TS, MS, LMR, CE, RMR, AV, EJB, RO, SSB, and CO); the Nutrition Department (MK) and Nuclear Medicine Department (JCR), Hatfield Clinical Research Center, and the Section on Growth and Obesity, Eunice Kennedy Shriver National Institute of Child Health and Human Development (MT-K, LBS, LMR, CE, SB, RMR, AV, SSB, and JAY), NIH, Bethesda, MD; the Department of Psychiatry, Washington University School of Medicine, St Louis, MO (DEW); and Applied and Professional Psychology, Rutgers University, Piscataway Township, NJ (JFY).</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Olsen</LastName>
<ForeName>Cara</ForeName>
<Initials>C</Initials>
<AffiliationInfo>
<Affiliation>From Medical and Clinical Psychology, Uniformed Services University of the Health Sciences, Bethesda, MD (MT-K, LBS, TS, MS, LMR, CE, RMR, AV, EJB, RO, SSB, and CO); the Nutrition Department (MK) and Nuclear Medicine Department (JCR), Hatfield Clinical Research Center, and the Section on Growth and Obesity, Eunice Kennedy Shriver National Institute of Child Health and Human Development (MT-K, LBS, LMR, CE, SB, RMR, AV, SSB, and JAY), NIH, Bethesda, MD; the Department of Psychiatry, Washington University School of Medicine, St Louis, MO (DEW); and Applied and Professional Psychology, Rutgers University, Piscataway Township, NJ (JFY).</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Kozlosky</LastName>
<ForeName>Merel</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>From Medical and Clinical Psychology, Uniformed Services University of the Health Sciences, Bethesda, MD (MT-K, LBS, TS, MS, LMR, CE, RMR, AV, EJB, RO, SSB, and CO); the Nutrition Department (MK) and Nuclear Medicine Department (JCR), Hatfield Clinical Research Center, and the Section on Growth and Obesity, Eunice Kennedy Shriver National Institute of Child Health and Human Development (MT-K, LBS, LMR, CE, SB, RMR, AV, SSB, and JAY), NIH, Bethesda, MD; the Department of Psychiatry, Washington University School of Medicine, St Louis, MO (DEW); and Applied and Professional Psychology, Rutgers University, Piscataway Township, NJ (JFY).</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Reynolds</LastName>
<ForeName>James C</ForeName>
<Initials>JC</Initials>
<AffiliationInfo>
<Affiliation>From Medical and Clinical Psychology, Uniformed Services University of the Health Sciences, Bethesda, MD (MT-K, LBS, TS, MS, LMR, CE, RMR, AV, EJB, RO, SSB, and CO); the Nutrition Department (MK) and Nuclear Medicine Department (JCR), Hatfield Clinical Research Center, and the Section on Growth and Obesity, Eunice Kennedy Shriver National Institute of Child Health and Human Development (MT-K, LBS, LMR, CE, SB, RMR, AV, SSB, and JAY), NIH, Bethesda, MD; the Department of Psychiatry, Washington University School of Medicine, St Louis, MO (DEW); and Applied and Professional Psychology, Rutgers University, Piscataway Township, NJ (JFY).</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Yanovski</LastName>
<ForeName>Jack A</ForeName>
<Initials>JA</Initials>
<AffiliationInfo>
<Affiliation>From Medical and Clinical Psychology, Uniformed Services University of the Health Sciences, Bethesda, MD (MT-K, LBS, TS, MS, LMR, CE, RMR, AV, EJB, RO, SSB, and CO); the Nutrition Department (MK) and Nuclear Medicine Department (JCR), Hatfield Clinical Research Center, and the Section on Growth and Obesity, Eunice Kennedy Shriver National Institute of Child Health and Human Development (MT-K, LBS, LMR, CE, SB, RMR, AV, SSB, and JAY), NIH, Bethesda, MD; the Department of Psychiatry, Washington University School of Medicine, St Louis, MO (DEW); and Applied and Professional Psychology, Rutgers University, Piscataway Township, NJ (JFY).</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<DataBankList CompleteYN="Y">
<DataBank>
<DataBankName>ClinicalTrials.gov</DataBankName>
<AccessionNumberList>
<AccessionNumber>NCT00680979</AccessionNumber>
</AccessionNumberList>
</DataBank>
</DataBankList>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>1K24 MH070446</GrantID>
<Acronym>MH</Acronym>
<Agency>NIMH NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>1R01DK080906</GrantID>
<Acronym>DK</Acronym>
<Agency>NIDDK NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>ZIA-HO-00641</GrantID>
<Acronym>HO</Acronym>
<Agency>NHLBI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016449">Randomized Controlled Trial</PublicationType>
<PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
<PublicationType UI="D052060">Research Support, N.I.H., Intramural</PublicationType>
<PublicationType UI="D013486">Research Support, U.S. Gov't, Non-P.H.S.</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>08</Month>
<Day>13</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Am J Clin Nutr</MedlineTA>
<NlmUniqueID>0376027</NlmUniqueID>
<ISSNLinking>0002-9165</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015502">Absorptiometry, Photon</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D050154">Adiposity</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000502">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000293">Adolescent</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D056912">Binge-Eating Disorder</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000517">prevention &amp; control</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000523">psychology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015992">Body Mass Index</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002648">Child</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005500">Follow-Up Studies</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015438">Health Behavior</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006266">Health Education</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D016033">Intervention Studies</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009765">Obesity</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000517">prevention &amp; control</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000523">psychology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011446">Prospective Studies</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011613">Psychotherapy</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012307">Risk Factors</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D015430">Weight Gain</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015431">Weight Loss</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<OtherID Source="NLM">PMC4163791 [Available on 10/01/15]</OtherID>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25240080</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>20</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>10</Day>
</DateCompleted>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1938-3207</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>100</Volume>
<Issue>4</Issue>
<PubDate>
<Year>2014</Year>
<Month>Oct</Month>
</PubDate>
</JournalIssue>
<Title>The American journal of clinical nutrition</Title>
<ISOAbbreviation>Am. J. Clin. Nutr.</ISOAbbreviation>
</Journal>
<ArticleTitle>Longitudinal relations of television, electronic games, and digital versatile discs with changes in diet in adolescents.</ArticleTitle>
<Pagination>
<MedlinePgn>1173-81</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.3945/ajcn.114.088500</ELocationID>
<Abstract>
<AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Youth spend more time with screens than any activity except sleeping. Screen time is a risk factor for obesity, possibly because of the influence of food and beverage advertising on diet.</AbstractText>
<AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">We sought to assess longitudinal relations of screen time [ie, television, electronic games, digital versatile discs (DVDs)/videos, and total screen time] with the 2-y changes in consumption of foods of low nutritional quality (FLNQ) that are commonly advertised on screens [ie, sugar-sweetened beverages, fast food, sweets, salty snacks, and the sum of these foods (total FLNQ)] and fruit and vegetables.</AbstractText>
<AbstractText Label="DESIGN" NlmCategory="METHODS">With the use of 2004, 2006, and 2008 waves of the Growing Up Today Study II, which consisted of a cohort of 6002 female and 4917 male adolescents aged 9-16 y in 2004, we assessed screen time (change and baseline) in relation to the 2-y dietary changes. Regression models included 4604 girls and 3668 boys with complete screen time and diet data on ≥2 consecutive questionnaires.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">Each hour-per-day increase in television, electronic games, and DVDs/videos was associated with increased intake of total FLNQ (range: 0.10-0.28 servings/d; P &lt; 0.05). Each hour-per-day increase in total screen time predicted increased intakes of sugar-sweetened beverages, fast food, sweets, and salty snacks (range: 0.02-0.06 servings/d; P &lt; 0.001) and decreased intakes of fruit and vegetables (range: -0.05 to -0.02 servings/d; P &lt; 0.05). Greater screen time at baseline (except electronic games in boys) was associated with subsequent increased intake of total FLNQ, and greater screen time at baseline (except DVDs/videos) was associated with decreased intake of fruit and vegetables (P &lt; 0.05). Across sex and food groups and in sensitivity analyses, television was most consistently associated with dietary changes.</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Increases in screen time were associated with increased consumption of foods and beverages of low nutritional quality and decreased consumption of fruit and vegetables. Our results caution against excessive use of screen media, especially television, in youth.</AbstractText>
<CopyrightInformation>© 2014 American Society for Nutrition.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Falbe</LastName>
<ForeName>Jennifer</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>From the Departments of Nutrition (JF and WCW), Epidemiology (JF, WCW, and AEF), and Social and Behavioral Sciences and Prevention Research Center (SLG), Harvard School of Public Health, Boston, MA; the Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA (BR, WCW, and AEF); and the Division of Adolescent Medicine, Boston Children's Hospital, Boston, MA (AEF and KRS).</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Willett</LastName>
<ForeName>Walter C</ForeName>
<Initials>WC</Initials>
<AffiliationInfo>
<Affiliation>From the Departments of Nutrition (JF and WCW), Epidemiology (JF, WCW, and AEF), and Social and Behavioral Sciences and Prevention Research Center (SLG), Harvard School of Public Health, Boston, MA; the Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA (BR, WCW, and AEF); and the Division of Adolescent Medicine, Boston Children's Hospital, Boston, MA (AEF and KRS).</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Rosner</LastName>
<ForeName>Bernard</ForeName>
<Initials>B</Initials>
<AffiliationInfo>
<Affiliation>From the Departments of Nutrition (JF and WCW), Epidemiology (JF, WCW, and AEF), and Social and Behavioral Sciences and Prevention Research Center (SLG), Harvard School of Public Health, Boston, MA; the Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA (BR, WCW, and AEF); and the Division of Adolescent Medicine, Boston Children's Hospital, Boston, MA (AEF and KRS).</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Gortmaker</LastName>
<ForeName>Steve L</ForeName>
<Initials>SL</Initials>
<AffiliationInfo>
<Affiliation>From the Departments of Nutrition (JF and WCW), Epidemiology (JF, WCW, and AEF), and Social and Behavioral Sciences and Prevention Research Center (SLG), Harvard School of Public Health, Boston, MA; the Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA (BR, WCW, and AEF); and the Division of Adolescent Medicine, Boston Children's Hospital, Boston, MA (AEF and KRS).</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Sonneville</LastName>
<ForeName>Kendrin R</ForeName>
<Initials>KR</Initials>
<AffiliationInfo>
<Affiliation>From the Departments of Nutrition (JF and WCW), Epidemiology (JF, WCW, and AEF), and Social and Behavioral Sciences and Prevention Research Center (SLG), Harvard School of Public Health, Boston, MA; the Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA (BR, WCW, and AEF); and the Division of Adolescent Medicine, Boston Children's Hospital, Boston, MA (AEF and KRS).</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Field</LastName>
<ForeName>Alison E</ForeName>
<Initials>AE</Initials>
<AffiliationInfo>
<Affiliation>From the Departments of Nutrition (JF and WCW), Epidemiology (JF, WCW, and AEF), and Social and Behavioral Sciences and Prevention Research Center (SLG), Harvard School of Public Health, Boston, MA; the Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA (BR, WCW, and AEF); and the Division of Adolescent Medicine, Boston Children's Hospital, Boston, MA (AEF and KRS).</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>DK007703</GrantID>
<Acronym>DK</Acronym>
<Agency>NIDDK NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>DK084001</GrantID>
<Acronym>DK</Acronym>
<Agency>NIDDK NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>08</Month>
<Day>13</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Am J Clin Nutr</MedlineTA>
<NlmUniqueID>0376027</NlmUniqueID>
<ISSNLinking>0002-9165</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000293">Adolescent</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001628">Beverages</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015992">Body Mass Index</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002648">Child</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D004032">Diet</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002149">Energy Intake</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D005510">Food Habits</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005638">Fruit</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008137">Longitudinal Studies</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009753">Nutritive Value</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009765">Obesity</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011795">Questionnaires</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D062410">Snacks</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D013690">Television</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D014675">Vegetables</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D018910">Video Games</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<OtherID Source="NLM">PMC4163796 [Available on 10/01/15]</OtherID>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25240083</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>20</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>10</Day>
</DateCompleted>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">1938-3207</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>100</Volume>
<Issue>4</Issue>
<PubDate>
<Year>2014</Year>
<Month>Oct</Month>
</PubDate>
</JournalIssue>
<Title>The American journal of clinical nutrition</Title>
<ISOAbbreviation>Am. J. Clin. Nutr.</ISOAbbreviation>
</Journal>
<ArticleTitle>Additional analyses in a study on the obesity paradox.</ArticleTitle>
<Pagination>
<MedlinePgn>1208</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.3945/ajcn.114.092742</ELocationID>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Winkels</LastName>
<ForeName>Renate M</ForeName>
<Initials>RM</Initials>
<AffiliationInfo>
<Affiliation>Division of Human Nutrition, Wageningen University, PO Box 8129, 6700 EV Wageningen, Netherlands, E-mail: renate.winkels@wur.nl.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Gomora</LastName>
<ForeName>Zephenia</ForeName>
<Initials>Z</Initials>
<AffiliationInfo>
<Affiliation>Division of Human Nutrition, Wageningen University, PO Box 8129, 6700 EV Wageningen, Netherlands, E-mail: renate.winkels@wur.nl.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>van Zutphen</LastName>
<ForeName>Moniek</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Division of Human Nutrition, Wageningen University, PO Box 8129, 6700 EV Wageningen, Netherlands, E-mail: renate.winkels@wur.nl.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Kampman</LastName>
<ForeName>Ellen</ForeName>
<Initials>E</Initials>
<AffiliationInfo>
<Affiliation>Division of Human Nutrition, Wageningen University, PO Box 8129, 6700 EV Wageningen, Netherlands, E-mail: renate.winkels@wur.nl.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016420">Comment</PublicationType>
<PublicationType UI="D016422">Letter</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Am J Clin Nutr</MedlineTA>
<NlmUniqueID>0376027</NlmUniqueID>
<ISSNLinking>0002-9165</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList>
<CommentsCorrections RefType="CommentIn">
<RefSource>Am J Clin Nutr. 2014 Oct;100(4):1208-9</RefSource>
<PMID Version="1">25240084</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="CommentOn">
<RefSource>Am J Clin Nutr. 2014 May;99(5):999-1005</RefSource>
<PMID Version="1">24572565</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001823">Body Composition</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000502">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009369">Neoplasms</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000175">diagnosis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009765">Obesity</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000503">physiopathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D055948">Sarcopenia</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000503">physiopathology</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25240084</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>20</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>10</Day>
</DateCompleted>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">1938-3207</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>100</Volume>
<Issue>4</Issue>
<PubDate>
<Year>2014</Year>
<Month>Oct</Month>
</PubDate>
</JournalIssue>
<Title>The American journal of clinical nutrition</Title>
<ISOAbbreviation>Am. J. Clin. Nutr.</ISOAbbreviation>
</Journal>
<ArticleTitle>Reply to RM Winkels et al.</ArticleTitle>
<Pagination>
<MedlinePgn>1208-9</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.3945/ajcn.114.093054</ELocationID>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Gonzalez</LastName>
<ForeName>Maria Cristina</ForeName>
<Initials>MC</Initials>
<AffiliationInfo>
<Affiliation>Postgraduate Program of Health and Behavior, Catholic University of Pelotas, Rua Vereador Ariano Requião de Carvalho, 301, Pelotas - Rio Grande do Sul CEP 96055-800, Brazil, E-mail: cristinagbs@hotmal.com.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Pastore</LastName>
<ForeName>Carla A</ForeName>
<Initials>CA</Initials>
<AffiliationInfo>
<Affiliation>Nutrition College of Nutrition, Federal University of Pelotas Rio Grande do Sul, Brazil.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Orlandi</LastName>
<ForeName>Silvana P</ForeName>
<Initials>SP</Initials>
<AffiliationInfo>
<Affiliation>Nutrition College of Nutrition, Federal University of Pelotas Rio Grande do Sul, Brazil.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Heymsfield</LastName>
<ForeName>Steven B</ForeName>
<Initials>SB</Initials>
<AffiliationInfo>
<Affiliation>Pennington Biomedical Research Center, Baton Rouge, LA.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016420">Comment</PublicationType>
<PublicationType UI="D016422">Letter</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Am J Clin Nutr</MedlineTA>
<NlmUniqueID>0376027</NlmUniqueID>
<ISSNLinking>0002-9165</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList>
<CommentsCorrections RefType="CommentOn">
<RefSource>Am J Clin Nutr. 2014 Oct;100(4):1208</RefSource>
<PMID Version="1">25240083</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="CommentOn">
<RefSource>Am J Clin Nutr. 2014 May;99(5):999-1005</RefSource>
<PMID Version="1">24572565</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001823">Body Composition</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000502">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009369">Neoplasms</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000175">diagnosis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009765">Obesity</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000503">physiopathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D055948">Sarcopenia</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000503">physiopathology</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25239343</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>20</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>13</Day>
</DateCompleted>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">1532-7361</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>156</Volume>
<Issue>4</Issue>
<PubDate>
<Year>2014</Year>
<Month>Oct</Month>
</PubDate>
</JournalIssue>
<Title>Surgery</Title>
<ISOAbbreviation>Surgery</ISOAbbreviation>
</Journal>
<ArticleTitle>A prospective, randomized, multicenter trial of Surgisis Gold, a biologic prosthetic, as a sublay reinforcement of the fascial closure after open bariatric surgery.</ArticleTitle>
<Pagination>
<MedlinePgn>902-8</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.surg.2014.06.022</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0039-6060(14)00361-4</ELocationID>
<Abstract>
<AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">This prospective, multicenter, randomized clinical trial was performed to compare the effectiveness of the bioprosthesis Surgisis Gold (Cook Biotech, Inc, West Lafayette, IN) to suture closure alone in reinforcing the abdominal wall after open Roux-en-Y gastric bypass (RYGB).</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">A total of 402 adult patients (body mass index ≥35 kg/m(2)) scheduled to undergo open RYGB procedures were randomized to receive either Surgisis Gold placed as a sublay directly under and opposed to the posterior rectus fascia without intervening preperitoneal fat or suture closure alone. Peri- and postoperative complications were tracked. Incisional hernia formation in each group was examined at 6 weeks, 3, 6, and 9 months, and 1 and 2 years after RYGB.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 380 (78 male; 302 female) patients with a mean age of 45 years (range 18-69) and a mean BMI of 48 (range 35-79) underwent RYGB. There were no differences in patient demographics or comorbidities between groups. Placement of the Surgisis Gold increased operating time by an average of 14 minutes. Complications were more common in the Surgisis Gold group with significantly more wound events and seroma formation compared with the suture closure alone group. At final follow-up, 32 of 185 (17%) of patients in the reinforced arm and 38 of 195 (20%) in the suture alone arm developed an incisional hernia (P = .6).</AbstractText>
<AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">In this challenging patient population, the use of Surgisis Gold for reinforcing the abdominal wall after open RYGB was not shown to be greatly different from a primary suture repair.</AbstractText>
<CopyrightInformation>Copyright © 2014 Elsevier Inc. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Sarr</LastName>
<ForeName>Michael G</ForeName>
<Initials>MG</Initials>
<AffiliationInfo>
<Affiliation>Department of Surgery, Mayo Clinic, Rochester, MN. Electronic address: sarr.michael@mayo.edu.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Hutcher</LastName>
<ForeName>Neil E</ForeName>
<Initials>NE</Initials>
<AffiliationInfo>
<Affiliation>Virginia Commonwealth Surgeons, Richmond, VA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Snyder</LastName>
<ForeName>Scott</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Cook Biotech, Incorporated, West Lafayette, IN.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Hodde</LastName>
<ForeName>Jason</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>Cook Biotech, Incorporated, West Lafayette, IN.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Carmody</LastName>
<ForeName>Brennan</ForeName>
<Initials>B</Initials>
<AffiliationInfo>
<Affiliation>Virginia Commonwealth Surgeons, Richmond, VA.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<DataBankList CompleteYN="Y">
<DataBank>
<DataBankName>ClinicalTrials.gov</DataBankName>
<AccessionNumberList>
<AccessionNumber>NCT00274625</AccessionNumber>
</AccessionNumberList>
</DataBank>
</DataBankList>
<PublicationTypeList>
<PublicationType UI="D003160">Comparative Study</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016448">Multicenter Study</PublicationType>
<PublicationType UI="D016449">Randomized Controlled Trial</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Surgery</MedlineTA>
<NlmUniqueID>0417347</NlmUniqueID>
<ISSNLinking>0039-6060</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C588278">surgisis</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>9007-34-5</RegistryNumber>
<NameOfSubstance UI="D003094">Collagen</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList>
<CommentsCorrections RefType="CommentIn">
<RefSource>Surgery. 2014 Oct;156(4):908-9</RefSource>
<PMID Version="1">25239344</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D058107">Abdominal Wound Closure Techniques</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000295">instrumentation</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000293">Adolescent</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000328">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000368">Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D003094">Collagen</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005500">Follow-Up Studies</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D015390">Gastric Bypass</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006555">Hernia, Ventral</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000209">etiology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000517">prevention &amp; control</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008875">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009765">Obesity</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000601">surgery</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011183">Postoperative Complications</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000209">etiology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000517">prevention &amp; control</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011446">Prospective Studies</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D013526">Surgical Mesh</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D013536">Suture Techniques</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D016896">Treatment Outcome</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D055815">Young Adult</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25239344</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>20</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>13</Day>
</DateCompleted>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">1532-7361</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>156</Volume>
<Issue>4</Issue>
<PubDate>
<Year>2014</Year>
<Month>Oct</Month>
</PubDate>
</JournalIssue>
<Title>Surgery</Title>
<ISOAbbreviation>Surgery</ISOAbbreviation>
</Journal>
<ArticleTitle>Discussion.</ArticleTitle>
<Pagination>
<MedlinePgn>908-9</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.surg.2014.06.038</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0039-6060(14)00377-8</ELocationID>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016420">Comment</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Surgery</MedlineTA>
<NlmUniqueID>0417347</NlmUniqueID>
<ISSNLinking>0039-6060</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C588278">surgisis</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>9007-34-5</RegistryNumber>
<NameOfSubstance UI="D003094">Collagen</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList>
<CommentsCorrections RefType="CommentOn">
<RefSource>Surgery. 2014 Oct;156(4):902-8</RefSource>
<PMID Version="1">25239343</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D058107">Abdominal Wound Closure Techniques</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000295">instrumentation</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D003094">Collagen</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D015390">Gastric Bypass</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009765">Obesity</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000601">surgery</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D013526">Surgical Mesh</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D013536">Suture Techniques</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25241557</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>22</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>04</Day>
</DateCompleted>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">2067-2993</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>63</Volume>
<Issue>2</Issue>
<PubDate>
<MedlineDate>2014 Apr-Jun</MedlineDate>
</PubDate>
</JournalIssue>
<Title>Pneumologia (Bucharest, Romania)</Title>
<ISOAbbreviation>Pneumologia</ISOAbbreviation>
</Journal>
<ArticleTitle>[Metabolic profile in obese patients with obstructive sleep apnea. A comparison between patients with insulin resistance and with insulin sensitivity].</ArticleTitle>
<Pagination>
<MedlinePgn>100-2, 104-6</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Obstructive sleep apnea syndrome (OSAS) may induce metabolic abnormalities through intermittent hypoxemia and simpathetic activation. It is difficult to demonstrate an independent role of OSAS in the occurrence of metabolic abnormalities, as obesity represents an important risk factor for both OSAS and metabolic abnormalities.</AbstractText>
<AbstractText Label="AIM" NlmCategory="OBJECTIVE">to assess the relations between insulin resistance (IR), insulin sensitivity (IS), OSAS severity and nocturnal oxyhaemoglobin levels in obese, nondiabetic patients with daytime sleepiness.</AbstractText>
<AbstractText Label="MATERIAL AND METHODS" NlmCategory="METHODS">We evaluated 99 consecutive, obese, nondiabetic patients (fasting glycemia &lt; 126 mg/dL, no hypoglycemic or hypolipemiant medication) diagnosed with OSAS (AHI &gt; 5/hour and daytime sleepiness) by an ambulatory six channel cardio-respiratory polygraphy. Hight, weight serum triglycerides (TG), high density lipoprotein-cholesterol (HDL-C) levels were evaluated. Correlations between Apneea Hypopnea Index (AHI), Oxygen Desaturation Index (ODI), average and lowest oxyhaemoglobin saturation (SaO), body mass index (BMI) and insulin resistance or sensitivity were assesed. IR was defined as a TG/ HDL-Cratio &gt; 3, and insulin sensitivity (IS) as a TG/HDL-C ratio &lt; 2.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">64 patients (out of 99) had lR and 18 IS. In the IR group (44 men and 20 women), the mean age was 52 +/- 10.6 years, mean BMI: 38.54 +/- 6.67 Kg/m2 (30-60), TG/HDL-C:5, 27 +/- 2.03 (3.02-11.1), mean AHI: 49.65 +/- 25.55/hour (7-110), mean ODI: 4769 +/- 24.95/hour (4-98), mean average SaO2 89.42 +/- 4.6 and mean lowest SaO2 68.4% +/- 13.8% (32-88%). 48 patients had severe, 7 moderate and 9 mild OSAS. In the IS group (10 men and 8 women), the mean age was 58.4 +/- 8.2years, mean BMI: 35.4 +/- 4.29 Kg/m2 (30-46), TG/ HDL-C: 1.64 +/- 0.29 (1.13-1.95), mean AHI: 45.8 +/- 30.3/hour (9-131), mean ODI: 39.9 +/- 32.2/hour (2-133), mean average SaO2 90.8 +/- 8.2 (81-95) and mean lowest SaO2: 74% +/- 10.8% (52-87%). 12 patients had severe, 3 moderate and 3 mild OSAS. Insulin sensitivity positively correlated with mean average SaO2 (r: 0.49; p: 0.037) and negatively with ODI (r: - 0,56; p: 0.014). Insulin resistance negatively correlated with mean lowest SaO2 (r: -0,25; p: 0.045). Mean lowest SaO2 values were significant lower in patients with IR than in those with IS (p: 0.042). No statistically significant difference was found for BMI, AHI or ODI between IR and IS patients.</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">nocturnal oxyhaemoglobin levels rather than OSAS severity (expressed as AHI or ODI) may be involved in the occurrence of metabolic abnormalities in obese nondiabetic patients. Preserving insulin sensitivity is more likely when oxyhaemoglobin levels are higher and ODI is lower. Mean lowest nocturnal SaO2 levels seems to be independently involved in the development of insulin resistance as no statistically significant differences were found for BMI between the two groups.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Dumitrache-Rujinski</LastName>
<ForeName>Stefan</ForeName>
<Initials>S</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Dinu</LastName>
<ForeName>Ioana</ForeName>
<Initials>I</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Călcăianu</LastName>
<ForeName>George</ForeName>
<Initials>G</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Erhan</LastName>
<ForeName>Ionela</ForeName>
<Initials>I</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Cocieru</LastName>
<ForeName>Alexandru</ForeName>
<Initials>A</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Zaharia</LastName>
<ForeName>Dragoş</ForeName>
<Initials>D</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Toma</LastName>
<ForeName>Claudia Lucia</ForeName>
<Initials>CL</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Bogdan</LastName>
<ForeName>Miron Alexandru</ForeName>
<Initials>MA</Initials>
</Author>
</AuthorList>
<Language>rum</Language>
<PublicationTypeList>
<PublicationType UI="D003160">Comparative Study</PublicationType>
<PublicationType UI="D004740">English Abstract</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<VernacularTitle>Profilul metabolic al pacienţilor cu sindrom de apnee obstructivă în somn şi obezitate. Comparaţie între pacienţi cu insulinorezistenţă şi pacienţi cu insulinosensibilitate.</VernacularTitle>
</Article>
<MedlineJournalInfo>
<Country>Romania</Country>
<MedlineTA>Pneumologia</MedlineTA>
<NlmUniqueID>100941067</NlmUniqueID>
<ISSNLinking>2067-2993</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D015415">Biological Markers</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D008076">Cholesterol, HDL</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D014280">Triglycerides</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>S88TT14065</RegistryNumber>
<NameOfSubstance UI="D010100">Oxygen</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000328">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000368">Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015415">Biological Markers</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000097">blood</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001827">Body Height</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015992">Body Mass Index</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001835">Body Weight</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008076">Cholesterol, HDL</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000097">blood</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D007333">Insulin Resistance</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008875">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009765">Obesity</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000097">blood</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000175">diagnosis</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D010100">Oxygen</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D017286">Polysomnography</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011237">Predictive Value of Tests</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012680">Sensitivity and Specificity</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D020181">Sleep Apnea, Obstructive</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000097">blood</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000175">diagnosis</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D014280">Triglycerides</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000097">blood</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">24998970</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>22</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>17</Day>
</DateCompleted>
<DateRevised>
<Year>2014</Year>
<Month>11</Month>
<Day>20</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1096-0333</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>279</Volume>
<Issue>3</Issue>
<PubDate>
<Year>2014</Year>
<Month>Sep</Month>
<Day>15</Day>
</PubDate>
</JournalIssue>
<Title>Toxicology and applied pharmacology</Title>
<ISOAbbreviation>Toxicol. Appl. Pharmacol.</ISOAbbreviation>
</Journal>
<ArticleTitle>Evaluation of Aroclor 1260 exposure in a mouse model of diet-induced obesity and non-alcoholic fatty liver disease.</ArticleTitle>
<Pagination>
<MedlinePgn>380-90</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.taap.2014.06.019</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0041-008X(14)00248-8</ELocationID>
<Abstract>
<AbstractText>Polychlorinated biphenyls (PCBs) are persistent organic pollutants associated with non-alcoholic fatty liver disease (NAFLD) in epidemiologic studies. The purpose of this study was to evaluate the hepatic effects of a PCB mixture, Aroclor 1260, whose composition mimics human bioaccumulation patterns, in a mouse model of diet-induced obesity (DIO). Male C57Bl/6J mice were fed control diet or 42% high fat diet (HFD) and exposed to Aroclor 1260 (20mg/kg or 200mg/kg in corn oil) for 12weeks. A glucose tolerance test was performed; plasma/tissues were obtained at necropsy for measurements of adipocytokine levels, histology, and gene expression. Aroclor 1260 exposure was associated with decreased body fat in HFD-fed mice but had no effect on blood glucose/lipid levels. Paradoxically, Aroclor 1260+HFD co-exposed mice demonstrated increased hepatic inflammatory foci at both doses while the degree of steatosis did not change. Serum cytokines, ALT levels and hepatic expression of IL-6 and TNFα were increased only at 20mg/kg, suggesting an inhibition of pro-inflammatory cytokine production at the 200mg/kg exposure. Aroclor 1260 induced hepatic expression of cytochrome P450s including Cyp3a11 (Pregnane-Xenobiotic Receptor target) and Cyp2b10 (constitutive androstane receptor target) but Cyp2b10 inducibility was diminished with HFD-feeding. Cyp1a2 (aryl hydrocarbon Receptor target) was induced only at 200mg/kg. In summary, Aroclor 1260 worsened hepatic and systemic inflammation in DIO. The results indicated a bimodal response of PCB-diet interactions in the context of inflammation which could potentially be explained by xenobiotic receptor activation. Thus, PCB exposure may be a relevant "second hit" in the transformation of steatosis to steatohepatitis. </AbstractText>
<CopyrightInformation>Copyright © 2014. Published by Elsevier Inc.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Wahlang</LastName>
<ForeName>Banrida</ForeName>
<Initials>B</Initials>
<AffiliationInfo>
<Affiliation>Department of Pharmacology and Toxicology, University of Louisville School of Medicine, Louisville, KY 40202, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Song</LastName>
<ForeName>Ming</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Department of Medicine, Division of Gastroenterology, Hepatology and Nutrition, University of Louisville School of Medicine, Louisville, KY 40202, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Beier</LastName>
<ForeName>Juliane I</ForeName>
<Initials>JI</Initials>
<AffiliationInfo>
<Affiliation>Department of Pharmacology and Toxicology, University of Louisville School of Medicine, Louisville, KY 40202, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Cameron Falkner</LastName>
<ForeName>K</ForeName>
<Initials>K</Initials>
<AffiliationInfo>
<Affiliation>Department of Medicine, Division of Gastroenterology, Hepatology and Nutrition, University of Louisville School of Medicine, Louisville, KY 40202, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Al-Eryani</LastName>
<ForeName>Laila</ForeName>
<Initials>L</Initials>
<AffiliationInfo>
<Affiliation>Department of Pharmacology and Toxicology, University of Louisville School of Medicine, Louisville, KY 40202, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Clair</LastName>
<ForeName>Heather B</ForeName>
<Initials>HB</Initials>
<AffiliationInfo>
<Affiliation>Department of Biochemistry and Molecular Biology, University of Louisville School of Medicine, Louisville, KY 40202, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Prough</LastName>
<ForeName>Russell A</ForeName>
<Initials>RA</Initials>
<AffiliationInfo>
<Affiliation>Department of Biochemistry and Molecular Biology, University of Louisville School of Medicine, Louisville, KY 40202, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Osborne</LastName>
<ForeName>Tanasa S</ForeName>
<Initials>TS</Initials>
<AffiliationInfo>
<Affiliation>Cellular and Molecular Pathology Branch, National Toxicology Program, National Institute of Environmental Health Sciences, Research Triangle Park, NC 27709, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Malarkey</LastName>
<ForeName>David E</ForeName>
<Initials>DE</Initials>
<AffiliationInfo>
<Affiliation>Cellular and Molecular Pathology Branch, National Toxicology Program, National Institute of Environmental Health Sciences, Research Triangle Park, NC 27709, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Christopher States</LastName>
<ForeName>J</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>Department of Pharmacology and Toxicology, University of Louisville School of Medicine, Louisville, KY 40202, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Cave</LastName>
<ForeName>Matthew C</ForeName>
<Initials>MC</Initials>
<AffiliationInfo>
<Affiliation>Department of Pharmacology and Toxicology, University of Louisville School of Medicine, Louisville, KY 40202, USA; Department of Medicine, Division of Gastroenterology, Hepatology and Nutrition, University of Louisville School of Medicine, Louisville, KY 40202, USA; The Robley Rex Veterans Affairs Medical Center, Louisville, KY 40206, USA. Electronic address: matt.cave@louisville.edu.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>1R01ES021375</GrantID>
<Acronym>ES</Acronym>
<Agency>NIEHS NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>K23AA018399]</GrantID>
<Acronym>AA</Acronym>
<Agency>NIAAA NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R01 ES021375</GrantID>
<Acronym>ES</Acronym>
<Agency>NIEHS NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>T35ES14559</GrantID>
<Acronym>ES</Acronym>
<Agency>NIEHS NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>07</Month>
<Day>03</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Toxicol Appl Pharmacol</MedlineTA>
<NlmUniqueID>0416575</NlmUniqueID>
<ISSNLinking>0041-008X</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D054392">Adipokines</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D001140">Aroclors</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D001786">Blood Glucose</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D004785">Environmental Pollutants</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D008565">Membrane Proteins</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D018336">Receptors, Aryl Hydrocarbon</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D051197">Toll-Like Receptor 4</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D014280">Triglycerides</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>11096-82-5</RegistryNumber>
<NameOfSubstance UI="C026987">aroclor 1260</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>97C5T2UQ7J</RegistryNumber>
<NameOfSubstance UI="D002784">Cholesterol</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 1.14.-</RegistryNumber>
<NameOfSubstance UI="D013250">Steroid Hydroxylases</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 1.14.14.1</RegistryNumber>
<NameOfSubstance UI="D001189">Aryl Hydrocarbon Hydroxylases</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 1.14.14.1</RegistryNumber>
<NameOfSubstance UI="C101679">Cyp2b10 protein, mouse</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 1.14.14.1</RegistryNumber>
<NameOfSubstance UI="C496508">Cyp3a11 protein, mouse</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 1.14.14.1</RegistryNumber>
<NameOfSubstance UI="D051544">Cytochrome P-450 CYP3A</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList>
<CommentsCorrections RefType="Cites">
<RefSource>Toxicol Sci. 2013 Aug;134(2):291-303</RefSource>
<PMID Version="1">23640861</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Nutr Biochem. 2013 Sep;24(9):1587-95</RefSource>
<PMID Version="1">23618531</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Obesity (Silver Spring). 2014 Mar;22(3):663-72</RefSource>
<PMID Version="1">24339378</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Toxicol Sci. 2014 Aug 1;140(2):283-97</RefSource>
<PMID Version="1">24812009</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Methods. 2001 Dec;25(4):402-8</RefSource>
<PMID Version="1">11846609</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Sci Total Environ. 2002 May 6;290(1-3):181-98</RefSource>
<PMID Version="1">12083709</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mol Cell Biol. 2004 Sep;24(18):7931-40</RefSource>
<PMID Version="1">15340055</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Br J Ind Med. 1982 Nov;39(4):361-9</RefSource>
<PMID Version="1">6128023</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Environ Health Perspect. 1989 May;81:225-39</RefSource>
<PMID Version="1">2503374</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Pharmacol Rev. 1994 Dec;46(4):483-549</RefSource>
<PMID Version="1">7899475</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Can J Biochem Physiol. 1959 Aug;37(8):911-7</RefSource>
<PMID Version="1">13671378</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Natl Toxicol Program Tech Rep Ser. 2006 Jan;(520):4-246</RefSource>
<PMID Version="1">16628245</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Drug Metab Dispos. 2006 Oct;34(10):1677-87</RefSource>
<PMID Version="1">16815962</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Natl Toxicol Program Tech Rep Ser. 2006 Aug;(530):1-258</RefSource>
<PMID Version="1">17160104</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 2007 Mar 30;282(13):9768-76</RefSource>
<PMID Version="1">17267396</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Gastroenterology. 2008 Feb;134(2):556-67</RefSource>
<PMID Version="1">18242221</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Drug Metab Pharmacokinet. 2008;23(1):8-13</RefSource>
<PMID Version="1">18305370</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mol Pharmacol. 2008 Apr;73(4):1282-9</RefSource>
<PMID Version="1">18187584</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cytokine. 2008 May;42(2):145-51</RefSource>
<PMID Version="1">18304834</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Rev Environ Contam Toxicol. 2009;201:137-58</RefSource>
<PMID Version="1">19484591</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Exp Med. 2009 Aug 31;206(9):2027-35</RefSource>
<PMID Version="1">19703987</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 2009 Sep 18;284(38):25984-92</RefSource>
<PMID Version="1">19617349</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>QJM. 2010 Feb;103(2):71-83</RefSource>
<PMID Version="1">19914930</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Hepatology. 2010 Feb;51(2):474-81</RefSource>
<PMID Version="1">19902480</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Toxicol Appl Pharmacol. 2010 Mar 15;243(3):359-71</RefSource>
<PMID Version="1">20005886</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Chem Biol Interact. 2010 Mar 30;184(3):376-87</RefSource>
<PMID Version="1">20079722</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Environ Health Perspect. 2010 Apr;118(4):465-71</RefSource>
<PMID Version="1">20064776</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Environ Health Perspect. 2010 Jun;118(6):796-802</RefSource>
<PMID Version="1">20146964</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Drug Metab Dispos. 2010 Dec;38(12):2091-5</RefSource>
<PMID Version="1">20736325</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Clin Sci (Lond). 2011 Mar;120(6):239-50</RefSource>
<PMID Version="1">20929443</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Environ Health Perspect. 2010 Dec;118(12):1735-42</RefSource>
<PMID Version="1">21126940</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Gastroenterology. 2011 Jan;140(1):124-31</RefSource>
<PMID Version="1">20858492</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Environ Health Perspect. 2011 Mar;119(3):319-25</RefSource>
<PMID Version="1">21362590</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Life Sci. 2011 Jul 4;89(1-2):57-64</RefSource>
<PMID Version="1">21620874</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Aliment Pharmacol Ther. 2011 Aug;34(3):274-85</RefSource>
<PMID Version="1">21623852</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Drug Metab Rev. 2011 Aug;43(3):317-34</RefSource>
<PMID Version="1">21612324</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Environ Health Perspect. 2012 May;120(5):727-32</RefSource>
<PMID Version="1">22334129</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 2012 Jun 8;287(24):20132-43</RefSource>
<PMID Version="1">22511764</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>PLoS One. 2012;7(6):e38734</RefSource>
<PMID Version="1">22723881</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Toxicol Appl Pharmacol. 2012 Aug 15;263(1):7-13</RefSource>
<PMID Version="1">22664347</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Toxicol Sci. 2012 Aug;128(2):377-86</RefSource>
<PMID Version="1">22539624</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Expert Opin Drug Metab Toxicol. 2013 Mar;9(3):253-66</RefSource>
<PMID Version="1">23327618</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Diabetes. 2013 Jun;62(6):1876-87</RefSource>
<PMID Version="1">23349477</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D054392">Adipokines</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000273">Adipose Tissue</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000818">Animals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001140">Aroclors</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000633">toxicity</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001189">Aryl Hydrocarbon Hydroxylases</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000096">biosynthesis</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000235">genetics</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001786">Blood Glucose</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002784">Cholesterol</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D051544">Cytochrome P-450 CYP3A</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000096">biosynthesis</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000235">genetics</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D004032">Diet</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D004785">Environmental Pollutants</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000633">toxicity</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005234">Fatty Liver</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000139">chemically induced</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015870">Gene Expression</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000187">drug effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005951">Glucose Tolerance Test</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007249">Inflammation</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000139">chemically induced</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008099">Liver</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008565">Membrane Proteins</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000096">biosynthesis</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000235">genetics</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D051379">Mice</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008810">Mice, Inbred C57BL</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D065626">Non-alcoholic Fatty Liver Disease</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009765">Obesity</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000139">chemically induced</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D060888">Real-Time Polymerase Chain Reaction</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D018336">Receptors, Aryl Hydrocarbon</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000096">biosynthesis</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000235">genetics</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D013250">Steroid Hydroxylases</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000096">biosynthesis</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000235">genetics</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D051197">Toll-Like Receptor 4</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000096">biosynthesis</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000235">genetics</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D014280">Triglycerides</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
</MeshHeadingList>
<OtherID Source="NLM">NIHMS638036</OtherID>
<OtherID Source="NLM">PMC4225625</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">AhR</Keyword>
<Keyword MajorTopicYN="N">Aroclor 1260</Keyword>
<Keyword MajorTopicYN="N">CAR</Keyword>
<Keyword MajorTopicYN="N">NAFLD</Keyword>
<Keyword MajorTopicYN="N">PCBs</Keyword>
<Keyword MajorTopicYN="N">PXR</Keyword>
</KeywordList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25107565</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>23</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>14</Day>
</DateCompleted>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1532-8600</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>63</Volume>
<Issue>10</Issue>
<PubDate>
<Year>2014</Year>
<Month>Oct</Month>
</PubDate>
</JournalIssue>
<Title>Metabolism: clinical and experimental</Title>
<ISOAbbreviation>Metab. Clin. Exp.</ISOAbbreviation>
</Journal>
<ArticleTitle>Thermogenic adipocytes: from cells to physiology and medicine.</ArticleTitle>
<Pagination>
<MedlinePgn>1238-49</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.metabol.2014.07.002</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0026-0495(14)00197-8</ELocationID>
<Abstract>
<AbstractText>The identification of active brown fat in humans has evoked widespread interest in the biology of non-shivering thermogenesis among basic and clinical researchers. As a consequence we have experienced a plethora of contributions related to cellular and molecular processes in thermogenic adipocytes as well as their function in the organismal context and their relevance to human physiology. In this review we focus on the cellular basis of non-shivering thermogenesis, particularly in relation to human health and metabolic disease. We provide an overview of the cellular function and distribution of thermogenic adipocytes in mouse and humans, and how this can be affected by environmental factors, such as prolonged cold exposure. We elaborate on recent evidence and open questions on the distinction of classical brown versus beige/brite adipocytes. Further, the origin of thermogenic adipocytes as well as current models for the recruitment of beige/brite adipocytes is discussed with an emphasis on the role of progenitor cells. Focusing on humans, we describe the expanding evidence for the activity, function and physiological relevance of thermogenic adipocytes. Finally, as the potential of thermogenic adipocyte activation as a therapeutic approach for the treatment of obesity and associated metabolic diseases becomes evident, we highlight goals and challenges for current research on the road to clinical translation. </AbstractText>
<CopyrightInformation>Copyright © 2014 Elsevier Inc. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Diaz</LastName>
<ForeName>Mauricio Berriel</ForeName>
<Initials>MB</Initials>
<AffiliationInfo>
<Affiliation>Joint Division Molecular Metabolic Control, DKFZ-ZMBH Alliance and Network Aging Research, German Cancer Research Center (DKFZ) Heidelberg, Center for Molecular Biology (ZMBH) and University Hospital, Heidelberg University, 69120 Heidelberg, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Herzig</LastName>
<ForeName>Stephan</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Joint Division Molecular Metabolic Control, DKFZ-ZMBH Alliance and Network Aging Research, German Cancer Research Center (DKFZ) Heidelberg, Center for Molecular Biology (ZMBH) and University Hospital, Heidelberg University, 69120 Heidelberg, Germany. Electronic address: s.herzig@dkfz.de.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Vegiopoulos</LastName>
<ForeName>Alexandros</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Joint Division Molecular Metabolic Control, DKFZ-ZMBH Alliance and Network Aging Research, German Cancer Research Center (DKFZ) Heidelberg, Center for Molecular Biology (ZMBH) and University Hospital, Heidelberg University, 69120 Heidelberg, Germany; DKFZ Junior Group Metabolism and Stem Cell Plasticity, DKFZ-ZMBH Alliance and Network Aging Research, German Cancer Research Center (DKFZ) Heidelberg, Center for Molecular Biology (ZMBH) and University Hospital, Heidelberg University, 69120 Heidelberg, Germany.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
<PublicationType UI="D016454">Review</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>07</Month>
<Day>07</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Metabolism</MedlineTA>
<NlmUniqueID>0375267</NlmUniqueID>
<ISSNLinking>0026-0495</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D017667">Adipocytes</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000502">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002001">Adipose Tissue, Brown</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000502">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000818">Animals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D004777">Environment</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009765">Obesity</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000503">physiopathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D022722">Thermogenesis</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000502">physiology</QualifierName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Adipogenesis</Keyword>
<Keyword MajorTopicYN="N">Beige/brite adipocytes</Keyword>
<Keyword MajorTopicYN="N">Brown adipose tissue</Keyword>
<Keyword MajorTopicYN="N">Obesity</Keyword>
<Keyword MajorTopicYN="N">Thermogenesis</Keyword>
</KeywordList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">24789918</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>18</Day>
</DateCompleted>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1939-327X</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>63</Volume>
<Issue>10</Issue>
<PubDate>
<Year>2014</Year>
<Month>Oct</Month>
</PubDate>
</JournalIssue>
<Title>Diabetes</Title>
<ISOAbbreviation>Diabetes</ISOAbbreviation>
</Journal>
<ArticleTitle>Lysosomal stress in obese adipose tissue macrophages contributes to MITF-dependent Gpnmb induction.</ArticleTitle>
<Pagination>
<MedlinePgn>3310-23</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.2337/db13-1720</ELocationID>
<Abstract>
<AbstractText>In obesity, adipose tissue (AT) contains crown-like structures where macrophages surround nonviable adipocytes. To understand how AT macrophages (ATMs) contribute to development of insulin resistance, we examined their character in more detail. In silico analysis of F2 mouse populations revealed significant correlation between adipose glycoprotein nonmetastatic melanoma protein B (Gpnmb) expression and body weight. In obese mice and obese individuals, Gpnmb expression was induced in ATMs. Cultured RAW264.7 cells were used to obtain insight into the mechanism of Gpnmb regulation. Gpnmb was potently induced by lysosomal stress inducers, including palmitate and chloroquine, or Torin1, an inhibitor of mammalian target of rapamycin complex 1 (mTORC1). These stimuli also provoked microphthalmia transcription factor (MITF) translocation to the nucleus, and knockdown of MITF by short hairpin RNA indicated its absolute requirement for Gpnmb induction. In agreement with our in vitro data, reduced mTORC1 activity was observed in isolated ATMs from obese mice, which coincided with increased nuclear MITF localization and Gpnmb transcription. Aberrant nutrient sensing provokes lysosomal stress, resulting in attenuated mTORC1 activity and enhanced MITF-dependent Gpnmb induction. Our data identify Gpnmb as a novel marker for obesity-induced ATM infiltration and potentiator of interleukin-4 responses and point toward a crucial role for MITF in driving part of the ATM phenotype. </AbstractText>
<CopyrightInformation>© 2014 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Gabriel</LastName>
<ForeName>Tanit L</ForeName>
<Initials>TL</Initials>
<AffiliationInfo>
<Affiliation>Department of Medical Biochemistry, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Tol</LastName>
<ForeName>Marc J</ForeName>
<Initials>MJ</Initials>
<AffiliationInfo>
<Affiliation>Department of Medical Biochemistry, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Ottenhof</LastName>
<ForeName>Roelof</ForeName>
<Initials>R</Initials>
<AffiliationInfo>
<Affiliation>Department of Medical Biochemistry, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>van Roomen</LastName>
<ForeName>Cindy</ForeName>
<Initials>C</Initials>
<AffiliationInfo>
<Affiliation>Department of Medical Biochemistry, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Aten</LastName>
<ForeName>Jan</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>Department of Pathology, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Claessen</LastName>
<ForeName>Nike</ForeName>
<Initials>N</Initials>
<AffiliationInfo>
<Affiliation>Department of Pathology, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Hooibrink</LastName>
<ForeName>Berend</ForeName>
<Initials>B</Initials>
<AffiliationInfo>
<Affiliation>Department of Cell Biology, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>de Weijer</LastName>
<ForeName>Barbara</ForeName>
<Initials>B</Initials>
<AffiliationInfo>
<Affiliation>Department of Endocrinology and Metabolism, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Serlie</LastName>
<ForeName>Mireille J</ForeName>
<Initials>MJ</Initials>
<AffiliationInfo>
<Affiliation>Department of Endocrinology and Metabolism, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Argmann</LastName>
<ForeName>Carmen</ForeName>
<Initials>C</Initials>
<AffiliationInfo>
<Affiliation>Department of Genetics and Genomic Sciences, Icahn Institute for Genomics and Multiscale Biology, Icahn School of Medicine at Mount Sinai, New York, NY.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>van Elsenburg</LastName>
<ForeName>Leonie</ForeName>
<Initials>L</Initials>
<AffiliationInfo>
<Affiliation>Department of Medical Biochemistry, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Aerts</LastName>
<ForeName>Johannes M F G</ForeName>
<Initials>JM</Initials>
<AffiliationInfo>
<Affiliation>Department of Medical Biochemistry, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>van Eijk</LastName>
<ForeName>Marco</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Department of Medical Biochemistry, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands m.c.vaneijk@amc.uva.nl.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>05</Month>
<Day>01</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Diabetes</MedlineTA>
<NlmUniqueID>0372763</NlmUniqueID>
<ISSNLinking>0012-1797</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C553294">1-(4-(4-propionylpiperazin-1-yl)-3-(trifluoromethyl)phenyl)-9-(quinolin-3-yl)benzo(h)(1,6)naphthyridin-2(1H)-one</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C503042">GPNMB protein, human</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D008562">Membrane Glycoproteins</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D051739">Microphthalmia-Associated Transcription Factor</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D009287">Naphthyridines</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>207137-56-2</RegistryNumber>
<NameOfSubstance UI="D015847">Interleukin-4</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>2V16EO95H1</RegistryNumber>
<NameOfSubstance UI="D019308">Palmitic Acid</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>886U3H6UFF</RegistryNumber>
<NameOfSubstance UI="D002738">Chloroquine</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000273">Adipose Tissue</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000187">drug effects</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000328">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000818">Animals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002467">Cell Nucleus</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002478">Cells, Cultured</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002738">Chloroquine</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000494">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015847">Interleukin-4</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008247">Lysosomes</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000187">drug effects</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008264">Macrophages</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000187">drug effects</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008562">Membrane Glycoproteins</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000235">genetics</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D051379">Mice</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D051739">Microphthalmia-Associated Transcription Factor</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000235">genetics</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008875">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009287">Naphthyridines</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000494">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009765">Obesity</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D019308">Palmitic Acid</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000494">pharmacology</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">24789921</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>18</Day>
</DateCompleted>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1939-327X</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>63</Volume>
<Issue>10</Issue>
<PubDate>
<Year>2014</Year>
<Month>Oct</Month>
</PubDate>
</JournalIssue>
<Title>Diabetes</Title>
<ISOAbbreviation>Diabetes</ISOAbbreviation>
</Journal>
<ArticleTitle>HIF prolyl 4-hydroxylase-2 inhibition improves glucose and lipid metabolism and protects against obesity and metabolic dysfunction.</ArticleTitle>
<Pagination>
<MedlinePgn>3324-33</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.2337/db14-0472</ELocationID>
<Abstract>
<AbstractText>Obesity is a major public health problem, predisposing subjects to metabolic syndrome, type 2 diabetes, and cardiovascular diseases. Specific prolyl 4-hydroxylases (P4Hs) regulate the stability of the hypoxia-inducible factor (HIF), a potent governor of metabolism, with isoenzyme 2 being the main regulator. We investigated whether HIF-P4H-2 inhibition could be used to treat obesity and its consequences. Hif-p4h-2-deficient mice, whether fed normal chow or a high-fat diet, had less adipose tissue, smaller adipocytes, and less adipose tissue inflammation than their littermates. They also had improved glucose tolerance and insulin sensitivity. Furthermore, the mRNA levels of the HIF-1 targets glucose transporters, glycolytic enzymes, and pyruvate dehydrogenase kinase-1 were increased in their tissues, whereas acetyl-CoA concentration was decreased. The hepatic mRNA level of the HIF-2 target insulin receptor substrate-2 was higher, whereas that of two key enzymes of fatty acid synthesis was lower. Serum cholesterol levels and de novo lipid synthesis were decreased, and the mice were protected against hepatic steatosis. Oral administration of an HIF-P4H inhibitor, FG-4497, to wild-type mice with metabolic dysfunction phenocopied these beneficial effects. HIF-P4H-2 inhibition may be a novel therapy that not only protects against the development of obesity and its consequences but also reverses these conditions. </AbstractText>
<CopyrightInformation>© 2014 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Rahtu-Korpela</LastName>
<ForeName>Lea</ForeName>
<Initials>L</Initials>
<AffiliationInfo>
<Affiliation>Biocenter Oulu, Faculty of Biochemistry and Molecular Medicine, Oulu Center for Cell-Matrix Research, University of Oulu, FIN-90014 Oulu, Finland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Karsikas</LastName>
<ForeName>Sara</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Biocenter Oulu, Faculty of Biochemistry and Molecular Medicine, Oulu Center for Cell-Matrix Research, University of Oulu, FIN-90014 Oulu, Finland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Hörkkö</LastName>
<ForeName>Sohvi</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Nordlab Oulu, Oulu University Hospital, FIN-90220 Oulu, Finland Department of Medical Microbiology and Immunology, Medical Research Center, University of Oulu, FIN-90014 Oulu, Finland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Blanco Sequeiros</LastName>
<ForeName>Roberto</ForeName>
<Initials>R</Initials>
<AffiliationInfo>
<Affiliation>Department of Radiology, Oulu University Hospital and University of Oulu, FIN-90029 Oulu, Finland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Lammentausta</LastName>
<ForeName>Eveliina</ForeName>
<Initials>E</Initials>
<AffiliationInfo>
<Affiliation>Department of Radiology, Oulu University Hospital and University of Oulu, FIN-90029 Oulu, Finland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Mäkelä</LastName>
<ForeName>Kari A</ForeName>
<Initials>KA</Initials>
<AffiliationInfo>
<Affiliation>Biocenter Oulu, Department of Physiology, University of Oulu, FIN-90014 Oulu, Finland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Herzig</LastName>
<ForeName>Karl-Heinz</ForeName>
<Initials>KH</Initials>
<AffiliationInfo>
<Affiliation>Biocenter Oulu, Department of Physiology, University of Oulu, FIN-90014 Oulu, Finland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Walkinshaw</LastName>
<ForeName>Gail</ForeName>
<Initials>G</Initials>
<AffiliationInfo>
<Affiliation>FibroGen, Inc., San Francisco, CA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Kivirikko</LastName>
<ForeName>Kari I</ForeName>
<Initials>KI</Initials>
<AffiliationInfo>
<Affiliation>Biocenter Oulu, Faculty of Biochemistry and Molecular Medicine, Oulu Center for Cell-Matrix Research, University of Oulu, FIN-90014 Oulu, Finland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Myllyharju</LastName>
<ForeName>Johanna</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>Biocenter Oulu, Faculty of Biochemistry and Molecular Medicine, Oulu Center for Cell-Matrix Research, University of Oulu, FIN-90014 Oulu, Finland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Serpi</LastName>
<ForeName>Raisa</ForeName>
<Initials>R</Initials>
<AffiliationInfo>
<Affiliation>Biocenter Oulu, Faculty of Biochemistry and Molecular Medicine, Oulu Center for Cell-Matrix Research, University of Oulu, FIN-90014 Oulu, Finland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Koivunen</LastName>
<ForeName>Peppi</ForeName>
<Initials>P</Initials>
<AffiliationInfo>
<Affiliation>Biocenter Oulu, Faculty of Biochemistry and Molecular Medicine, Oulu Center for Cell-Matrix Research, University of Oulu, FIN-90014 Oulu, Finland peppi.koivunen@oulu.fi.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>05</Month>
<Day>01</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Diabetes</MedlineTA>
<NlmUniqueID>0372763</NlmUniqueID>
<ISSNLinking>0012-1797</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>EC 1.14.11.29</RegistryNumber>
<NameOfSubstance UI="D064799">Hypoxia-Inducible Factor-Proline Dioxygenases</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>IY9XDZ35W2</RegistryNumber>
<NameOfSubstance UI="D005947">Glucose</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D017667">Adipocytes</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000818">Animals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D050260">Carbohydrate Metabolism</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000502">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D004032">Diet</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005947">Glucose</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D064799">Hypoxia-Inducible Factor-Proline Dioxygenases</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000235">genetics</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007249">Inflammation</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000235">genetics</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D050356">Lipid Metabolism</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000502">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008099">Liver</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D024821">Metabolic Syndrome X</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D051379">Mice</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D018345">Mice, Knockout</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009765">Obesity</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000235">genetics</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">24812431</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>18</Day>
</DateCompleted>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1939-327X</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>63</Volume>
<Issue>10</Issue>
<PubDate>
<Year>2014</Year>
<Month>Oct</Month>
</PubDate>
</JournalIssue>
<Title>Diabetes</Title>
<ISOAbbreviation>Diabetes</ISOAbbreviation>
</Journal>
<ArticleTitle>IKKε is key to induction of insulin resistance in the hypothalamus, and its inhibition reverses obesity.</ArticleTitle>
<Pagination>
<MedlinePgn>3334-45</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.2337/db13-1817</ELocationID>
<Abstract>
<AbstractText>IKK epsilon (IKKε) is induced by the activation of nuclear factor-κB (NF-κB). Whole-body IKKε knockout mice on a high-fat diet (HFD) were protected from insulin resistance and showed altered energy balance. We demonstrate that IKKε is expressed in neurons and is upregulated in the hypothalamus of obese mice, contributing to insulin and leptin resistance. Blocking IKKε in the hypothalamus of obese mice with CAYMAN10576 or small interfering RNA decreased NF-κB activation in this tissue, relieving the inflammatory environment. Inhibition of IKKε activity, but not TBK1, reduced IRS-1(Ser307) phosphorylation and insulin and leptin resistance by an improvement of the IR/IRS-1/Akt and JAK2/STAT3 pathways in the hypothalamus. These improvements were independent of body weight and food intake. Increased insulin and leptin action/signaling in the hypothalamus may contribute to a decrease in adiposity and hypophagia and an enhancement of energy expenditure accompanied by lower NPY and increased POMC mRNA levels. Improvement of hypothalamic insulin action decreases fasting glycemia, glycemia after pyruvate injection, and PEPCK protein expression in the liver of HFD-fed and db/db mice, suggesting a reduction in hepatic glucose production. We suggest that IKKε may be a key inflammatory mediator in the hypothalamus of obese mice, and its hypothalamic inhibition improves energy and glucose metabolism. </AbstractText>
<CopyrightInformation>© 2014 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Weissmann</LastName>
<ForeName>Laís</ForeName>
<Initials>L</Initials>
<AffiliationInfo>
<Affiliation>Department of Internal Medicine, State University of Campinas (UNICAMP), Campinas, São Paulo, Brazil.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Quaresma</LastName>
<ForeName>Paula G F</ForeName>
<Initials>PG</Initials>
<AffiliationInfo>
<Affiliation>Department of Internal Medicine, State University of Campinas (UNICAMP), Campinas, São Paulo, Brazil.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Santos</LastName>
<ForeName>Andressa C</ForeName>
<Initials>AC</Initials>
<AffiliationInfo>
<Affiliation>Department of Internal Medicine, State University of Campinas (UNICAMP), Campinas, São Paulo, Brazil.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>de Matos</LastName>
<ForeName>Alexandre H B</ForeName>
<Initials>AH</Initials>
<AffiliationInfo>
<Affiliation>Department of Internal Medicine, State University of Campinas (UNICAMP), Campinas, São Paulo, Brazil.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Pascoal</LastName>
<ForeName>Vínicius D'Ávila Bittencourt</ForeName>
<Initials>VD</Initials>
<AffiliationInfo>
<Affiliation>Department of Internal Medicine, State University of Campinas (UNICAMP), Campinas, São Paulo, Brazil.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Zanotto</LastName>
<ForeName>Tamires M</ForeName>
<Initials>TM</Initials>
<AffiliationInfo>
<Affiliation>Department of Internal Medicine, State University of Campinas (UNICAMP), Campinas, São Paulo, Brazil.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Castro</LastName>
<ForeName>Gisele</ForeName>
<Initials>G</Initials>
<AffiliationInfo>
<Affiliation>Department of Internal Medicine, State University of Campinas (UNICAMP), Campinas, São Paulo, Brazil.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Guadagnini</LastName>
<ForeName>Dioze</ForeName>
<Initials>D</Initials>
<AffiliationInfo>
<Affiliation>Department of Internal Medicine, State University of Campinas (UNICAMP), Campinas, São Paulo, Brazil.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>da Silva</LastName>
<ForeName>Joelcimar Martins</ForeName>
<Initials>JM</Initials>
<AffiliationInfo>
<Affiliation>Department of Anatomy, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Velloso</LastName>
<ForeName>Licio A</ForeName>
<Initials>LA</Initials>
<AffiliationInfo>
<Affiliation>Department of Internal Medicine, State University of Campinas (UNICAMP), Campinas, São Paulo, Brazil.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Bittencourt</LastName>
<ForeName>Jackson C</ForeName>
<Initials>JC</Initials>
<AffiliationInfo>
<Affiliation>Department of Anatomy, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Lopes-Cendes</LastName>
<ForeName>Iscia</ForeName>
<Initials>I</Initials>
<AffiliationInfo>
<Affiliation>Department of Internal Medicine, State University of Campinas (UNICAMP), Campinas, São Paulo, Brazil.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Saad</LastName>
<ForeName>Mario J A</ForeName>
<Initials>MJ</Initials>
<AffiliationInfo>
<Affiliation>Department of Internal Medicine, State University of Campinas (UNICAMP), Campinas, São Paulo, Brazil.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Prada</LastName>
<ForeName>Patricia O</ForeName>
<Initials>PO</Initials>
<AffiliationInfo>
<Affiliation>Department of Internal Medicine, State University of Campinas (UNICAMP), Campinas, São Paulo, Brazil School of Applied Sciences, State University of Campinas (UNICAMP), Campinas, São Paulo, Brazil pprada@fcm.unicamp.br.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>05</Month>
<Day>08</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Diabetes</MedlineTA>
<NlmUniqueID>0372763</NlmUniqueID>
<ISSNLinking>0012-1797</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D007328">Insulin</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D020738">Leptin</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 2.7.11.10</RegistryNumber>
<NameOfSubstance UI="D051550">I-kappa B Kinase</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000818">Animals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001835">Body Weight</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000502">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D059305">Diet, High-Fat</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007031">Hypothalamus</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D051550">I-kappa B Kinase</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000037">antagonists &amp; inhibitors</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007328">Insulin</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007333">Insulin Resistance</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000502">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D020738">Leptin</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008099">Liver</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D051379">Mice</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008820">Mice, Obese</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009474">Neurons</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009765">Obesity</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D010766">Phosphorylation</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015398">Signal Transduction</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000502">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015854">Up-Regulation</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">24848063</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>18</Day>
</DateCompleted>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1939-327X</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>63</Volume>
<Issue>10</Issue>
<PubDate>
<Year>2014</Year>
<Month>Oct</Month>
</PubDate>
</JournalIssue>
<Title>Diabetes</Title>
<ISOAbbreviation>Diabetes</ISOAbbreviation>
</Journal>
<ArticleTitle>Orally active osteoanabolic agent GTDF binds to adiponectin receptors, with a preference for AdipoR1, induces adiponectin-associated signaling, and improves metabolic health in a rodent model of diabetes.</ArticleTitle>
<Pagination>
<MedlinePgn>3530-44</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.2337/db13-1619</ELocationID>
<Abstract>
<AbstractText>Adiponectin is an adipocytokine that signals through plasma membrane-bound adiponectin receptors 1 and 2 (AdipoR1 and -2). Plasma adiponectin depletion is associated with type 2 diabetes, obesity, and cardiovascular diseases. Adiponectin therapy, however, is yet unavailable owing to its large size, complex multimerization, and functional differences of the multimers. We report discovery and characterization of 6-C-β-D-glucopyranosyl-(2S,3S)-(+)-5,7,3',4'-tetrahydroxydihydroflavonol (GTDF) as an orally active adiponectin mimetic. GTDF interacted with both AdipoRs, with a preference for AdipoR1. It induced adiponectin-associated signaling and enhanced glucose uptake and fatty acid oxidation in vitro, which were augmented or abolished by AdipoR1 overexpression or silencing, respectively. GTDF improved metabolic health, characterized by elevated glucose clearance, β-cell survival, reduced steatohepatitis, browning of white adipose tissue, and improved lipid profile in an AdipoR1-expressing but not an AdipoR1-depleted strain of diabetic mice. The discovery of GTDF as an adiponectin mimetic provides a promising therapeutic tool for the treatment of metabolic diseases.</AbstractText>
<CopyrightInformation>© 2014 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Singh</LastName>
<ForeName>Abhishek Kumar</ForeName>
<Initials>AK</Initials>
<AffiliationInfo>
<Affiliation>Biochemistry Division, Council of Scientific and Industrial Research-Central Drug Research Institute (CSIR-CDRI), Lucknow, Uttar Pradesh, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Joharapurkar</LastName>
<ForeName>Amit Arvind</ForeName>
<Initials>AA</Initials>
<AffiliationInfo>
<Affiliation>Zydus Research Center, Moraiya, Ahmedabad, Gujarat, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Khan</LastName>
<ForeName>Mohd Parvez</ForeName>
<Initials>MP</Initials>
<AffiliationInfo>
<Affiliation>Division of Endocrinology, CSIR-CDRI, Lucknow, Uttar Pradesh, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Mishra</LastName>
<ForeName>Jay Sharan</ForeName>
<Initials>JS</Initials>
<AffiliationInfo>
<Affiliation>Biochemistry Division, Council of Scientific and Industrial Research-Central Drug Research Institute (CSIR-CDRI), Lucknow, Uttar Pradesh, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Singh</LastName>
<ForeName>Nidhi</ForeName>
<Initials>N</Initials>
<AffiliationInfo>
<Affiliation>Biochemistry Division, Council of Scientific and Industrial Research-Central Drug Research Institute (CSIR-CDRI), Lucknow, Uttar Pradesh, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Yadav</LastName>
<ForeName>Manisha</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Biochemistry Division, Council of Scientific and Industrial Research-Central Drug Research Institute (CSIR-CDRI), Lucknow, Uttar Pradesh, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Hossain</LastName>
<ForeName>Zakir</ForeName>
<Initials>Z</Initials>
<AffiliationInfo>
<Affiliation>Division of Phramacokinetics, CSIR-CDRI, Lucknow, Uttar Pradesh, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Khan</LastName>
<ForeName>Kainat</ForeName>
<Initials>K</Initials>
<AffiliationInfo>
<Affiliation>Division of Endocrinology, CSIR-CDRI, Lucknow, Uttar Pradesh, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Kumar</LastName>
<ForeName>Sudhir</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Division of Medicinal and Process Chemistry, CSIR-CDRI, Lucknow, Uttar Pradesh, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Dhanesha</LastName>
<ForeName>Nirav Anilkumar</ForeName>
<Initials>NA</Initials>
<AffiliationInfo>
<Affiliation>Zydus Research Center, Moraiya, Ahmedabad, Gujarat, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Mishra</LastName>
<ForeName>Devendra Pratap</ForeName>
<Initials>DP</Initials>
<AffiliationInfo>
<Affiliation>Division of Medicinal and Process Chemistry, CSIR-CDRI, Lucknow, Uttar Pradesh, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Maurya</LastName>
<ForeName>Rakesh</ForeName>
<Initials>R</Initials>
<AffiliationInfo>
<Affiliation>Division of Medicinal and Process Chemistry, CSIR-CDRI, Lucknow, Uttar Pradesh, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Sharma</LastName>
<ForeName>Sharad</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Division of Toxicology, CSIR-CDRI, Lucknow, Uttar Pradesh, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Jain</LastName>
<ForeName>Mukul Rameshchandra</ForeName>
<Initials>MR</Initials>
<AffiliationInfo>
<Affiliation>Zydus Research Center, Moraiya, Ahmedabad, Gujarat, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Trivedi</LastName>
<ForeName>Arun Kumar</ForeName>
<Initials>AK</Initials>
<AffiliationInfo>
<Affiliation>Biochemistry Division, Council of Scientific and Industrial Research-Central Drug Research Institute (CSIR-CDRI), Lucknow, Uttar Pradesh, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Godbole</LastName>
<ForeName>Madan Madhav</ForeName>
<Initials>MM</Initials>
<AffiliationInfo>
<Affiliation>Department of Molecular Medicine, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, Uttar Pradesh, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Gayen</LastName>
<ForeName>Jiaur Rahaman</ForeName>
<Initials>JR</Initials>
<AffiliationInfo>
<Affiliation>Division of Phramacokinetics, CSIR-CDRI, Lucknow, Uttar Pradesh, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Chattopadhyay</LastName>
<ForeName>Naibedya</ForeName>
<Initials>N</Initials>
<AffiliationInfo>
<Affiliation>Division of Endocrinology, CSIR-CDRI, Lucknow, Uttar Pradesh, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Sanyal</LastName>
<ForeName>Sabyasachi</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Biochemistry Division, Council of Scientific and Industrial Research-Central Drug Research Institute (CSIR-CDRI), Lucknow, Uttar Pradesh, India sanyal@cdri.res.in.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>05</Month>
<Day>21</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Diabetes</MedlineTA>
<NlmUniqueID>0372763</NlmUniqueID>
<ISSNLinking>0012-1797</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D052242">Adiponectin</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D005227">Fatty Acids</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D007328">Insulin</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D054419">Receptors, Adiponectin</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>9IKM0I5T1E</RegistryNumber>
<NameOfSubstance UI="D011794">Quercetin</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>IY9XDZ35W2</RegistryNumber>
<NameOfSubstance UI="D005947">Glucose</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D052242">Adiponectin</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000097">blood</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000818">Animals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D003924">Diabetes Mellitus, Type 2</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000188">drug therapy</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D004195">Disease Models, Animal</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005227">Fatty Acids</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005947">Glucose</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007328">Insulin</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007333">Insulin Resistance</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D050356">Lipid Metabolism</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000187">drug effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D051379">Mice</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D018482">Muscle, Skeletal</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000187">drug effects</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009765">Obesity</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011794">Quercetin</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000031">analogs &amp; derivatives</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000494">pharmacology</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000627">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D054419">Receptors, Adiponectin</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015398">Signal Transduction</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000187">drug effects</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">24917578</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>18</Day>
</DateCompleted>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1939-327X</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>63</Volume>
<Issue>10</Issue>
<PubDate>
<Year>2014</Year>
<Month>Oct</Month>
</PubDate>
</JournalIssue>
<Title>Diabetes</Title>
<ISOAbbreviation>Diabetes</ISOAbbreviation>
</Journal>
<ArticleTitle>GLP-1 agonism stimulates brown adipose tissue thermogenesis and browning through hypothalamic AMPK.</ArticleTitle>
<Pagination>
<MedlinePgn>3346-58</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.2337/db14-0302</ELocationID>
<Abstract>
<AbstractText>GLP-1 receptor (GLP-1R) is widely located throughout the brain, but the precise molecular mechanisms mediating the actions of GLP-1 and its long-acting analogs on adipose tissue as well as the brain areas responsible for these interactions remain largely unknown. We found that central injection of a clinically used GLP-1R agonist, liraglutide, in mice stimulates brown adipose tissue (BAT) thermogenesis and adipocyte browning independent of nutrient intake. The mechanism controlling these actions is located in the hypothalamic ventromedial nucleus (VMH), and the activation of AMPK in this area is sufficient to blunt both central liraglutide-induced thermogenesis and adipocyte browning. The decreased body weight caused by the central injection of liraglutide in other hypothalamic sites was sufficiently explained by the suppression of food intake. In a longitudinal study involving obese type 2 diabetic patients treated for 1 year with GLP-1R agonists, both exenatide and liraglutide increased energy expenditure. Although the results do not exclude the possibility that extrahypothalamic areas are also modulating the effects of GLP-1R agonists, the data indicate that long-acting GLP-1R agonists influence body weight by regulating either food intake or energy expenditure through various hypothalamic sites and that these mechanisms might be clinically relevant. </AbstractText>
<CopyrightInformation>© 2014 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Beiroa</LastName>
<ForeName>Daniel</ForeName>
<Initials>D</Initials>
<AffiliationInfo>
<Affiliation>Department of Physiology, CIMUS, University of Santiago de Compostela-Instituto de Investigación Sanitaria, Santiago de Compostela, Spain CIBER Fisiopatología de la Obesidad y Nutrición (CIBERobn), Santiago de Compostela, Spain.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Imbernon</LastName>
<ForeName>Monica</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Department of Physiology, CIMUS, University of Santiago de Compostela-Instituto de Investigación Sanitaria, Santiago de Compostela, Spain CIBER Fisiopatología de la Obesidad y Nutrición (CIBERobn), Santiago de Compostela, Spain.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Gallego</LastName>
<ForeName>Rosalía</ForeName>
<Initials>R</Initials>
<AffiliationInfo>
<Affiliation>Department of Morphological Sciences, School of Medicine, University of Santiago de Compostela-Instituto de Investigación Sanitaria, Santiago de Compostela, Spain.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Senra</LastName>
<ForeName>Ana</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Department of Physiology, CIMUS, University of Santiago de Compostela-Instituto de Investigación Sanitaria, Santiago de Compostela, Spain.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Herranz</LastName>
<ForeName>Daniel</ForeName>
<Initials>D</Initials>
<AffiliationInfo>
<Affiliation>Tumor Suppression Group, Spanish National Cancer Research Center (CNIO), Madrid, Spain.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Villarroya</LastName>
<ForeName>Francesc</ForeName>
<Initials>F</Initials>
<AffiliationInfo>
<Affiliation>CIBER Fisiopatología de la Obesidad y Nutrición (CIBERobn), Santiago de Compostela, Spain Department of Biochemistry and Molecular Biology and Institute of Biomedicine (IBUB), University of Barcelona, Barcelona, Spain.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Serrano</LastName>
<ForeName>Manuel</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Tumor Suppression Group, Spanish National Cancer Research Center (CNIO), Madrid, Spain.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Fernø</LastName>
<ForeName>Johan</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>Department of Clinical Science, K.G. Jebsen Center for Diabetes Research, University of Bergen, Bergen, Norway.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Salvador</LastName>
<ForeName>Javier</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>CIBER Fisiopatología de la Obesidad y Nutrición (CIBERobn), Santiago de Compostela, Spain Department of Endocrinology and Nutrition, Clínica Universidad de Navarra, Pamplona, Spain.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Escalada</LastName>
<ForeName>Javier</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>CIBER Fisiopatología de la Obesidad y Nutrición (CIBERobn), Santiago de Compostela, Spain Department of Endocrinology and Nutrition, Clínica Universidad de Navarra, Pamplona, Spain.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Dieguez</LastName>
<ForeName>Carlos</ForeName>
<Initials>C</Initials>
<AffiliationInfo>
<Affiliation>Department of Physiology, CIMUS, University of Santiago de Compostela-Instituto de Investigación Sanitaria, Santiago de Compostela, Spain CIBER Fisiopatología de la Obesidad y Nutrición (CIBERobn), Santiago de Compostela, Spain.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Lopez</LastName>
<ForeName>Miguel</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Department of Physiology, CIMUS, University of Santiago de Compostela-Instituto de Investigación Sanitaria, Santiago de Compostela, Spain CIBER Fisiopatología de la Obesidad y Nutrición (CIBERobn), Santiago de Compostela, Spain.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Frühbeck</LastName>
<ForeName>Gema</ForeName>
<Initials>G</Initials>
<AffiliationInfo>
<Affiliation>CIBER Fisiopatología de la Obesidad y Nutrición (CIBERobn), Santiago de Compostela, Spain Department of Endocrinology and Nutrition, Clínica Universidad de Navarra, Pamplona, Spain.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Nogueiras</LastName>
<ForeName>Ruben</ForeName>
<Initials>R</Initials>
<AffiliationInfo>
<Affiliation>Department of Physiology, CIMUS, University of Santiago de Compostela-Instituto de Investigación Sanitaria, Santiago de Compostela, Spain CIBER Fisiopatología de la Obesidad y Nutrición (CIBERobn), Santiago de Compostela, Spain ruben.nogueiras@usc.es.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>06</Month>
<Day>10</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Diabetes</MedlineTA>
<NlmUniqueID>0372763</NlmUniqueID>
<ISSNLinking>0012-1797</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D007004">Hypoglycemic Agents</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D010455">Peptides</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D014688">Venoms</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>839I73S42A</RegistryNumber>
<NameOfSubstance UI="C439759">liraglutide</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>89750-14-1</RegistryNumber>
<NameOfSubstance UI="D052216">Glucagon-Like Peptide 1</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>9100L32L2N</RegistryNumber>
<NameOfSubstance UI="D008687">Metformin</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>9P1872D4OL</RegistryNumber>
<NameOfSubstance UI="C074031">exenatide</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 2.7.-</RegistryNumber>
<NameOfSubstance UI="D011494">Protein Kinases</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 2.7.1.-</RegistryNumber>
<NameOfSubstance UI="C086028">AMP-activated protein kinase kinase</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002001">Adipose Tissue, Brown</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000187">drug effects</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000328">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000368">Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000369">Aged, 80 and over</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000818">Animals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D003924">Diabetes Mellitus, Type 2</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000188">drug therapy</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D004359">Drug Therapy, Combination</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D004435">Eating</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000187">drug effects</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000502">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D004734">Energy Metabolism</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000187">drug effects</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000502">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D052216">Glucagon-Like Peptide 1</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000819">agonists</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000031">analogs &amp; derivatives</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000494">pharmacology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000627">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007004">Hypoglycemic Agents</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000494">pharmacology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000627">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007031">Hypothalamus</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000187">drug effects</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008687">Metformin</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000494">pharmacology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000627">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D051379">Mice</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008875">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009765">Obesity</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000188">drug therapy</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D010455">Peptides</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000494">pharmacology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000627">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011494">Protein Kinases</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D051381">Rats</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D022722">Thermogenesis</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000187">drug effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D014688">Venoms</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000494">pharmacology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000627">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D055815">Young Adult</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">24947359</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>18</Day>
</DateCompleted>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1939-327X</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>63</Volume>
<Issue>10</Issue>
<PubDate>
<Year>2014</Year>
<Month>Oct</Month>
</PubDate>
</JournalIssue>
<Title>Diabetes</Title>
<ISOAbbreviation>Diabetes</ISOAbbreviation>
</Journal>
<ArticleTitle>Macrophage HIF-2α ameliorates adipose tissue inflammation and insulin resistance in obesity.</ArticleTitle>
<Pagination>
<MedlinePgn>3359-71</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.2337/db13-1965</ELocationID>
<Abstract>
<AbstractText>In obesity, adipose tissue macrophages (ATMs) play a key role in mediating proinflammatory responses in the adipose tissue, which are associated with obesity-related metabolic complications. Recently, adipose tissue hypoxia has been implicated in the regulation of ATMs in obesity. However, the role of hypoxia-inducible factor (HIF)-2α, one of the major transcription factors induced by hypoxia, has not been fully elucidated in ATMs. In this study, we demonstrate that elevation of macrophage HIF-2α would attenuate adipose tissue inflammation and improve insulin resistance in obesity. In macrophages, overexpression of HIF-2α decreased nitric oxide production and suppressed expression of proinflammatory cytokines through induction of arginase 1. HIF-2α-overexpressing macrophages alleviated proinflammatory responses and improved insulin resistance in adipocytes. In contrast, knockdown of macrophage HIF-2α augmented palmitate-induced proinflammatory gene expression in adipocytes. Furthermore, compared with wild-type mice, Hif-2α heterozygous-null mice aggravated insulin resistance and adipose tissue inflammation with more M1-like ATMs upon high-fat diet (HFD). Moreover, glucose intolerance in HFD-fed Hif-2α heterozygous-null mice was relieved by macrophage depletion with clodronate treatment, implying that increase of proinflammatory ATMs is responsible for insulin resistance by haplodeficiency of Hif-2α upon HFD. Taken together, these data suggest that macrophage HIF-2α would counteract the proinflammatory responses to relieve obesity-induced insulin resistance in adipose tissue. </AbstractText>
<CopyrightInformation>© 2014 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Choe</LastName>
<ForeName>Sung Sik</ForeName>
<Initials>SS</Initials>
<AffiliationInfo>
<Affiliation>Department of Biological Sciences, Institute of Molecular Biology and Genetics, National Creative Research Initiatives Center for Adipose Tissue Remodeling, Seoul National University, Seoul, Korea.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Shin</LastName>
<ForeName>Kyung Cheul</ForeName>
<Initials>KC</Initials>
<AffiliationInfo>
<Affiliation>Department of Biological Sciences, Institute of Molecular Biology and Genetics, National Creative Research Initiatives Center for Adipose Tissue Remodeling, Seoul National University, Seoul, Korea.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Ka</LastName>
<ForeName>Sojeong</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Department of Biological Sciences, Institute of Molecular Biology and Genetics, National Creative Research Initiatives Center for Adipose Tissue Remodeling, Seoul National University, Seoul, Korea.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Lee</LastName>
<ForeName>Yun Kyung</ForeName>
<Initials>YK</Initials>
<AffiliationInfo>
<Affiliation>Department of Biological Sciences, Institute of Molecular Biology and Genetics, National Creative Research Initiatives Center for Adipose Tissue Remodeling, Seoul National University, Seoul, Korea.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Chun</LastName>
<ForeName>Jang-Soo</ForeName>
<Initials>JS</Initials>
<AffiliationInfo>
<Affiliation>Cell Dynamics Research Center, School of Life Sciences, Gwangju Institute of Science and Technology, Gwangju, Korea.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Kim</LastName>
<ForeName>Jae Bum</ForeName>
<Initials>JB</Initials>
<AffiliationInfo>
<Affiliation>Department of Biological Sciences, Institute of Molecular Biology and Genetics, National Creative Research Initiatives Center for Adipose Tissue Remodeling, Seoul National University, Seoul, Korea jaebkim@snu.ac.kr.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>06</Month>
<Day>19</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Diabetes</MedlineTA>
<NlmUniqueID>0372763</NlmUniqueID>
<ISSNLinking>0012-1797</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D051792">Basic Helix-Loop-Helix Transcription Factors</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D034741">RNA, Small Interfering</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C105713">endothelial PAS domain-containing protein 1</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList>
<CommentsCorrections RefType="CommentIn">
<RefSource>Diabetes. 2014 Oct;63(10):3169-71</RefSource>
<PMID Version="1">25249641</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D017667">Adipocytes</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000273">Adipose Tissue</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000818">Animals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D051792">Basic Helix-Loop-Helix Transcription Factors</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000235">genetics</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007249">Inflammation</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007333">Insulin Resistance</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000502">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008264">Macrophages</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D051379">Mice</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009765">Obesity</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D034741">RNA, Small Interfering</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25249641</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>18</Day>
</DateCompleted>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">1939-327X</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>63</Volume>
<Issue>10</Issue>
<PubDate>
<Year>2014</Year>
<Month>Oct</Month>
</PubDate>
</JournalIssue>
<Title>Diabetes</Title>
<ISOAbbreviation>Diabetes</ISOAbbreviation>
</Journal>
<ArticleTitle>HIF-2α blows out the flames of adipose tissue macrophages to keep obesity in a safe zone.</ArticleTitle>
<Pagination>
<MedlinePgn>3169-71</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.2337/db14-0878</ELocationID>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Aouadi</LastName>
<ForeName>Myriam</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Program in Molecular Medicine, University of Massachusetts Medical School, Worcester, MA myriam.aouadi@umassmed.edu.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016420">Comment</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Diabetes</MedlineTA>
<NlmUniqueID>0372763</NlmUniqueID>
<ISSNLinking>0012-1797</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D051792">Basic Helix-Loop-Helix Transcription Factors</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C105713">endothelial PAS domain-containing protein 1</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList>
<CommentsCorrections RefType="CommentOn">
<RefSource>Diabetes. 2014 Oct;63(10):3359-71</RefSource>
<PMID Version="1">24947359</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000273">Adipose Tissue</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000818">Animals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D051792">Basic Helix-Loop-Helix Transcription Factors</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007249">Inflammation</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007333">Insulin Resistance</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000502">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008264">Macrophages</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009765">Obesity</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25249645</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>18</Day>
</DateCompleted>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">1939-327X</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>63</Volume>
<Issue>10</Issue>
<PubDate>
<Year>2014</Year>
<Month>Oct</Month>
</PubDate>
</JournalIssue>
<Title>Diabetes</Title>
<ISOAbbreviation>Diabetes</ISOAbbreviation>
</Journal>
<ArticleTitle>Androgen receptor roles in insulin resistance and obesity in males: the linkage of androgen-deprivation therapy to metabolic syndrome.</ArticleTitle>
<Pagination>
<MedlinePgn>3180-8</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.2337/db13-1505</ELocationID>
<Abstract>
<AbstractText>Prostate cancer (PCa) is one of the most frequently diagnosed malignancies in men. Androgen-deprivation therapy (ADT) is the first-line treatment and fundamental management for men with advanced PCa to suppress functions of androgen/androgen receptor (AR) signaling. ADT is effective at improving cancer symptoms and prolonging survival. However, epidemiological and clinical studies support the notion that testosterone deficiency in men leads to the development of metabolic syndrome that increases cardiovascular disease risk. The underlying mechanisms by which androgen/AR signaling regulates metabolic homeostasis in men are complex, and in this review, we discuss molecular mechanisms mediated by AR signaling that link ADT to metabolic syndrome. Results derived from various AR knockout mouse models reveal tissue-specific AR signaling that is involved in regulation of metabolism. These data suggest that steps be taken early to manage metabolic complications associated with PCa patients receiving ADT, which could be accomplished using tissue-selective modulation of AR signaling and by treatment with insulin-sensitizing agents. </AbstractText>
<CopyrightInformation>© 2014 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Yu</LastName>
<ForeName>I-Chen</ForeName>
<Initials>IC</Initials>
<AffiliationInfo>
<Affiliation>Department of Pathology, George Whipple Laboratory for Cancer Research, University of Rochester Medical Center, Rochester, NY Department of Urology, George Whipple Laboratory for Cancer Research, University of Rochester Medical Center, Rochester, NY Wilmot Cancer Center, University of Rochester Medical Center, Rochester, NY.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Lin</LastName>
<ForeName>Hung-Yun</ForeName>
<Initials>HY</Initials>
<AffiliationInfo>
<Affiliation>Department of Pathology, George Whipple Laboratory for Cancer Research, University of Rochester Medical Center, Rochester, NY Department of Urology, George Whipple Laboratory for Cancer Research, University of Rochester Medical Center, Rochester, NY Wilmot Cancer Center, University of Rochester Medical Center, Rochester, NY.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Sparks</LastName>
<ForeName>Janet D</ForeName>
<Initials>JD</Initials>
<AffiliationInfo>
<Affiliation>Department of Pathology, George Whipple Laboratory for Cancer Research, University of Rochester Medical Center, Rochester, NY Department of Urology, George Whipple Laboratory for Cancer Research, University of Rochester Medical Center, Rochester, NY Wilmot Cancer Center, University of Rochester Medical Center, Rochester, NY.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Yeh</LastName>
<ForeName>Shuyuan</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Department of Pathology, George Whipple Laboratory for Cancer Research, University of Rochester Medical Center, Rochester, NY Department of Urology, George Whipple Laboratory for Cancer Research, University of Rochester Medical Center, Rochester, NY Wilmot Cancer Center, University of Rochester Medical Center, Rochester, NY.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Chang</LastName>
<ForeName>Chawnshang</ForeName>
<Initials>C</Initials>
<AffiliationInfo>
<Affiliation>Department of Pathology, George Whipple Laboratory for Cancer Research, University of Rochester Medical Center, Rochester, NY Department of Urology, George Whipple Laboratory for Cancer Research, University of Rochester Medical Center, Rochester, NY Wilmot Cancer Center, University of Rochester Medical Center, Rochester, NY Sex Hormone Research Center, China Medical University/Hospital, Taichung, Taiwan chang@urmc.rochester.edu.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>DK-73414</GrantID>
<Acronym>DK</Acronym>
<Agency>NIDDK NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
<PublicationType UI="D016454">Review</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Diabetes</MedlineTA>
<NlmUniqueID>0372763</NlmUniqueID>
<ISSNLinking>0012-1797</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C410798">AR protein, human</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000728">Androgens</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D011944">Receptors, Androgen</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000728">Androgens</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000818">Animals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007333">Insulin Resistance</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000502">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D024821">Metabolic Syndrome X</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000209">etiology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D051379">Mice</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009765">Obesity</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000209">etiology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011944">Receptors, Androgen</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
</MeshHeadingList>
<OtherID Source="NLM">PMC4171661 [Available on 10/01/15]</OtherID>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25252442</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>25</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>10</Month>
<Day>23</Day>
</DateCompleted>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">1426-9686</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>37</Volume>
<Issue>218</Issue>
<PubDate>
<Year>2014</Year>
<Month>Aug</Month>
</PubDate>
</JournalIssue>
<Title>Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego</Title>
<ISOAbbreviation>Pol. Merkur. Lekarski</ISOAbbreviation>
</Journal>
<ArticleTitle>[Comparison of increase in depressive disorders in dependence of BMI value].</ArticleTitle>
<Pagination>
<MedlinePgn>91-5</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText Label="UNLABELLED">In recent years, the research for the relation between depression and obesity is the basis of many studies. Interest in this subject results from the continuous increase in the incidence of both diseases and complications thereof, which constitute a serious social and economic problem. The aim of the study is to establish the dependence between depressive disorders and BMI.</AbstractText>
<AbstractText Label="MATERIAL AND METHODS" NlmCategory="METHODS">One hundred twenty three patients aged 18-67 years with a diagnosis of depressive episode (F32) and recurrent depressive disorder (F33.0-F33.8) were used in the study. 21 items Hamilton Depression Rating Scale (HDRS21) was used to evaluate intensification of depressive disorders. Appraisal of psychiatric conditions with HDRS21 was performed twice: at the beginning of the study and after receiving the response on pharmacotherapy (averagely after 8 weeks).</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">No relation between depressive disorders and BMI has been observed.</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Study did not demonstrated explicit link between BMI value and increase in depressive disorders. Considering the complexity of this problem, another studies should be carried out.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Kuśmierek</LastName>
<ForeName>Maciej</ForeName>
<Initials>M</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Błaszczyk</LastName>
<ForeName>Justyna</ForeName>
<Initials>J</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Talarowska</LastName>
<ForeName>Monika</ForeName>
<Initials>M</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Orzechowska</LastName>
<ForeName>Agata</ForeName>
<Initials>A</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Bobińska</LastName>
<ForeName>Kinga</ForeName>
<Initials>K</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Gałecki</LastName>
<ForeName>Piotr</ForeName>
<Initials>P</Initials>
</Author>
</AuthorList>
<Language>pol</Language>
<PublicationTypeList>
<PublicationType UI="D003160">Comparative Study</PublicationType>
<PublicationType UI="D004740">English Abstract</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<VernacularTitle>Porównanie nasilenia zaburzeń depresyjnych w zalezności od wartości wskaźnika BMI.</VernacularTitle>
</Article>
<MedlineJournalInfo>
<Country>Poland</Country>
<MedlineTA>Pol Merkur Lekarski</MedlineTA>
<NlmUniqueID>9705469</NlmUniqueID>
<ISSNLinking>1426-9686</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000293">Adolescent</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000328">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000368">Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015992">Body Mass Index</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015897">Comorbidity</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D003866">Depressive Disorder</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000145">classification</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000453">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015994">Incidence</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008875">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009765">Obesity</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000175">diagnosis</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000453">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" Type="Geographic" UI="D011044">Poland</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D055815">Young Adult</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25255608</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>26</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>10</Month>
<Day>21</Day>
</DateCompleted>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0030-9982</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>64</Volume>
<Issue>7</Issue>
<PubDate>
<Year>2014</Year>
<Month>Jul</Month>
</PubDate>
</JournalIssue>
<Title>JPMA. The Journal of the Pakistan Medical Association</Title>
<ISOAbbreviation>J Pak Med Assoc</ISOAbbreviation>
</Journal>
<ArticleTitle>Weight misperception and rising adolescent obesity.</ArticleTitle>
<Pagination>
<MedlinePgn>860</MedlinePgn>
</Pagination>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Shah</LastName>
<ForeName>Dania Aijaz</ForeName>
<Initials>DA</Initials>
</Author>
<Author ValidYN="Y">
<LastName>ud Deen</LastName>
<ForeName>Zia</ForeName>
<Initials>Z</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Anwer</LastName>
<ForeName>Mohammad Osama</ForeName>
<Initials>MO</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Qasim</LastName>
<ForeName>Muhammad</ForeName>
<Initials>M</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016422">Letter</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>Pakistan</Country>
<MedlineTA>J Pak Med Assoc</MedlineTA>
<NlmUniqueID>7501162</NlmUniqueID>
<ISSNLinking>0030-9982</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000293">Adolescent</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001828">Body Image</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000523">psychology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D003717">Denial (Psychology)</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008019">Life Style</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009765">Obesity</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000453">epidemiology</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000517">prevention &amp; control</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000523">psychology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D010290">Parents</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000523">psychology</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25179745</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>26</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>18</Day>
</DateCompleted>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">1294-9361</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>16</Volume>
<Issue>3</Issue>
<PubDate>
<Year>2014</Year>
<Month>Sep</Month>
</PubDate>
</JournalIssue>
<Title>Epileptic disorders : international epilepsy journal with videotape</Title>
<ISOAbbreviation>Epileptic Disord</ISOAbbreviation>
</Journal>
<ArticleTitle>Obesity and its association with generalised epilepsy, idiopathic syndrome, and family history of epilepsy.</ArticleTitle>
<Pagination>
<MedlinePgn>343-53</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1684/epd.2014.0677</ELocationID>
<Abstract>
<AbstractText>Aim. Previous studies support the concept that obesity is a common comorbid condition in patients with epilepsy (PWE). In this study, we present the body mass index (BMI) and data from a survey to assess physical activity in a sample of PWE from an epilepsy clinic. Methods. Between June of 2011 and January of 2013, 100 PWE from an adult epilepsy clinic were included. We obtained BMI, waist circumference, and information regarding physical activity using a standardised questionnaire. Clinical, demographic, electrographic, and imaging parameters were collected from charts. Results. Mean age of patients was 40 ± 14 (18-77) years. The BMI distribution was as follows: 2 patients (2%) underweight, 26 (26%) normal weight, 34 (34%) overweight, 25 (25%) obese, and 13 (13%) with morbid obesity. In our study, obesity was defined as having a BMI ≥ 30. We found 38 (38%) patients in this range. There was no difference in the rate of drug-resistant epilepsy between obese and non-obese patients (55 vs. 55%; p=0.05). Leisure time habit was reported in 82% of obese patients and 79% of patients without obesity. Overall, the most frequent activity was walking (70%). Factors associated with obesity were generalised epilepsy (OR: 2.7, 1.1-6.6; p=0.012), idiopathic syndrome (OR: 2.7, 1.04-7; p=0.018), and family history of epilepsy (OR: 6.1, 1.5-24.2; p=0.002). Conclusion. Our study suggests an association between obesity, idiopathic generalised epilepsy, and family history of epilepsy. Our study shows that PWE are physically active and there is no clear relation between exercise and obesity. We could not identify any association between drug-resistant epilepsy and obesity. Absence of direct comparison with a control non-epileptic population; a cross-sectional design not allowing evaluation of a causal association among variables; and reliance on self-reported physical activity are to be considered as limitations of the present study.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Ladino</LastName>
<ForeName>Lady D</ForeName>
<Initials>LD</Initials>
<AffiliationInfo>
<Affiliation>Department of Medicine, Division of Neurology, University of Saskatchewan, Saskatoon, Canada, Department of Neurology, Hospital Pablo Tobón Uribe, Medellín, Colombia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Hernández-Ronquillo</LastName>
<ForeName>Lizbeth</ForeName>
<Initials>L</Initials>
<AffiliationInfo>
<Affiliation>Department of Medicine, Division of Neurology, University of Saskatchewan, Saskatoon, Canada.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Téllez-Zenteno</LastName>
<ForeName>José F</ForeName>
<Initials>JF</Initials>
<AffiliationInfo>
<Affiliation>Department of Medicine, Division of Neurology, University of Saskatchewan, Saskatoon, Canada.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>France</Country>
<MedlineTA>Epileptic Disord</MedlineTA>
<NlmUniqueID>100891853</NlmUniqueID>
<ISSNLinking>1294-9361</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000293">Adolescent</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000328">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000368">Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015992">Body Mass Index</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D003430">Cross-Sectional Studies</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D004827">Epilepsy</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000150">complications</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000235">genetics</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000503">physiopathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D008019">Life Style</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008875">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D009043">Motor Activity</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009765">Obesity</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000150">complications</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000235">genetics</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000503">physiopathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011795">Questionnaires</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D055815">Young Adult</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">body mass index</Keyword>
<Keyword MajorTopicYN="N">genetic syndrome</Keyword>
<Keyword MajorTopicYN="N">leisure activity</Keyword>
<Keyword MajorTopicYN="N">overweight</Keyword>
<Keyword MajorTopicYN="N">physical activity and waist circumference</Keyword>
</KeywordList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25272579</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>29</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>10</Month>
<Day>09</Day>
</DateCompleted>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0035-7715</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>65</Volume>
<Issue>2</Issue>
<PubDate>
<Year>2014</Year>
</PubDate>
</JournalIssue>
<Title>Roczniki Państwowego Zakładu Higieny</Title>
<ISOAbbreviation>Rocz Panstw Zakl Hig</ISOAbbreviation>
</Journal>
<ArticleTitle>Energy and nutritional value of the meals in kindergartens in Nis (Serbia).</ArticleTitle>
<Pagination>
<MedlinePgn>127-31</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">It is well known that high-energy diet, rich in fat and carbohydrates, increases the risk of obesity. Preschool age is an important period to acquire the eating habits continued later in adulthood. Therefore, evaluation of child nutrition in kindergartens is especially important in the prevention of future obesity.</AbstractText>
<AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">To determine the energy value and energy density of meals consumed by children in kindergartens in Nis (Serbia), including the different types of food, in respect to a probable risk of obesity.</AbstractText>
<AbstractText Label="MATERIAL AND METHODS" NlmCategory="METHODS">The study had been conducted in the years 1998-2012. Three-hundred samples of the meals were gathered and analysed, and the amount of selected food groups used to prepare the meals in kindergartens was calculated (weight, protein, fat and carbohydrate content) in the accredited laboratory of the Public Health Institute in Nis according to the ISO 17025 recommendation.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">The mean energy value of meals was 978.9 kcal (range: 810 - 1144 kcal). The energy density was low (mean: 1.02 kcal/g, range: 0.92 - 1.42 kcal/g) and decreased over the years, what would imply a reduction in the risk of obesity. The intake of same high-energy food products, such as fats and oils as well as sweets (13.9% and 7.3%, respectively) was higher compared to low-energy foods (fruits - 5.2% and vegetables - 10.8%).</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The results of our study indicate that children in kindergarten in Nis, in general, were properly nourished in total energy content. The energy value and energy density of the meals consumed did not pose a risk of developing obesity. However, the distribution of food groups differentiated by the energy density level was unfavourable; the deficit of low-energy foods was observed. Planning the child nutrition in kindergartens, with laboratory control of meals, may be an effective strategy in adequate energy intake and prevention of obesity. Providing the higher amount of low-energy foods (fruits and vegetables) in meals in kindergartens is recommended.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Lazarevic</LastName>
<ForeName>Konstansa</ForeName>
<Initials>K</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Stojanovic</LastName>
<ForeName>Dusica</ForeName>
<Initials>D</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Bogdanović</LastName>
<ForeName>Dragan</ForeName>
<Initials>D</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>Poland</Country>
<MedlineTA>Rocz Panstw Zakl Hig</MedlineTA>
<NlmUniqueID>0414756</NlmUniqueID>
<ISSNLinking>0035-7715</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D002664">Child Nutritional Physiological Phenomena</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002675">Child, Preschool</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D002149">Energy Intake</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D005504">Food Analysis</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D062407">Meals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D009753">Nutritive Value</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009765">Obesity</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000517">prevention &amp; control</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D012574">Schools</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" Type="Geographic" UI="D055771">Serbia</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25272580</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>29</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>10</Month>
<Day>09</Day>
</DateCompleted>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0035-7715</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>65</Volume>
<Issue>2</Issue>
<PubDate>
<Year>2014</Year>
</PubDate>
</JournalIssue>
<Title>Roczniki Państwowego Zakładu Higieny</Title>
<ISOAbbreviation>Rocz Panstw Zakl Hig</ISOAbbreviation>
</Journal>
<ArticleTitle>Comparing diabetic with non-diabetic overweight subjects through assessing dietary intakes and key parameters of blood biochemistry and haematology.</ArticleTitle>
<Pagination>
<MedlinePgn>133-8</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">An important way of preventing type 2 diabetes is by adopting a proper diet by which means appropriate control over blood glycaemia and lipids can be achieved.</AbstractText>
<AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">To assess selected biochemical and haematological markers in overweight subjects or those suffering from type 2 diabetes in relation to their estimated dietary intake.</AbstractText>
<AbstractText Label="MATERIAL AND METHODS" NlmCategory="METHODS">The study was conducted in 2012 on n = 86 overweight or obese subjects living in Warsaw or its environs, of whom n = 43 had type 2 diabetes. Dietary intakes were compared between non-diabetics (control group) and diabetics (test group) by 3 day records, whilst the relevant blood biochemistry and haematology results were obtained from medical records; with patient consent.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">Diabetic subjects had significantly higher serum glucose and CRP levels than controls, respectively; 190 vs 98 mg/ dl and 1.4 vs 1.1 mg/dl. Lipid profiles were however more significantly abnormal in controls, compared to diabetics with respectively; total cholesterol 220 vs 194 mg/dl, LDL-cholesterol 131 vs 107 mg/dl and triglycerides 206 vs 157 mg/dl. There were no significant differences in HDL-cholesterol; respectively 55 vs 51 mg/dl. In the diabetics, calorific intakes from carbohydrates, especially sugars, were significantly lower than controls i.e. 9% vs 13%. The proportional share of calories derived from dietary fats did not differ between groups, nevertheless a positive correlation was observed between dietary fat content with blood cholesterol concentrations in diabetics.</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Disorders of carbohydrate metabolism were confirmed in both overweight and diabetic (type 2) subjects. In addition, both groups demonstrated untoward lipid profiles that correlated with their improper nutrition.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Gajda</LastName>
<ForeName>Karolina</ForeName>
<Initials>K</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Sulich</LastName>
<ForeName>Agnieszka</ForeName>
<Initials>A</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Hamułka</LastName>
<ForeName>Jadwiga</ForeName>
<Initials>J</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Białkowska</LastName>
<ForeName>Agnieszka</ForeName>
<Initials>A</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D003160">Comparative Study</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>Poland</Country>
<MedlineTA>Rocz Panstw Zakl Hig</MedlineTA>
<NlmUniqueID>0414756</NlmUniqueID>
<ISSNLinking>0035-7715</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D001786">Blood Glucose</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D008076">Cholesterol, HDL</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D008078">Cholesterol, LDL</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D004041">Dietary Fats</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D014280">Triglycerides</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000328">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000368">Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001786">Blood Glucose</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008076">Cholesterol, HDL</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000097">blood</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008078">Cholesterol, LDL</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000097">blood</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D003924">Diabetes Mellitus, Type 2</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000097">blood</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000150">complications</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000517">prevention &amp; control</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D004041">Dietary Fats</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D002149">Energy Intake</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005510">Food Habits</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000145">classification</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008875">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D015596">Nutrition Assessment</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009765">Obesity</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000097">blood</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000150">complications</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" Type="Geographic" UI="D011044">Poland</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D014280">Triglycerides</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000097">blood</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">24726461</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>29</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>17</Day>
</DateCompleted>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1878-1810</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>164</Volume>
<Issue>4</Issue>
<PubDate>
<Year>2014</Year>
<Month>Oct</Month>
</PubDate>
</JournalIssue>
<Title>Translational research : the journal of laboratory and clinical medicine</Title>
<ISOAbbreviation>Transl Res</ISOAbbreviation>
</Journal>
<ArticleTitle>The relationship between obesity and coronary artery disease.</ArticleTitle>
<Pagination>
<MedlinePgn>336-44</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.trsl.2014.03.010</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S1931-5244(14)00112-1</ELocationID>
<Abstract>
<AbstractText>Obesity continues to be a growing issue in the United States, with an estimated prevalence of 72 million people. There are major health implications associated with obesity, including its relationship with hypertension, diabetes mellitus type 2, metabolic syndrome, and dyslipidemia, all independent risk factors for coronary artery disease (CAD). Despite the increased risk of developing CAD, in recent years an "obesity paradox" has been described in which moderately obese individuals with established cardiovascular disease, including CAD, appear to have mortality similar to their normal-weight counterparts. This review examines the relationship between obesity and CAD, including the increased risk of hypertension, diabetes mellitus, metabolic syndrome, and dyslipidemia, along with a discussion of the obesity paradox and the benefits of weight reduction.</AbstractText>
<CopyrightInformation>Copyright © 2014 Elsevier Inc. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Jahangir</LastName>
<ForeName>Eiman</ForeName>
<Initials>E</Initials>
<AffiliationInfo>
<Affiliation>John Ochsner Heart and Vascular Institute, Department of Cardiovascular Diseases, Ochsner Clinical School-The University of Queensland School of Medicine, New Orleans, La. Electronic address: eimanjahangir@gmail.com.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>De Schutter</LastName>
<ForeName>Alban</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>John Ochsner Heart and Vascular Institute, Department of Cardiovascular Diseases, Ochsner Clinical School-The University of Queensland School of Medicine, New Orleans, La.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Lavie</LastName>
<ForeName>Carl J</ForeName>
<Initials>CJ</Initials>
<AffiliationInfo>
<Affiliation>John Ochsner Heart and Vascular Institute, Department of Cardiovascular Diseases, Ochsner Clinical School-The University of Queensland School of Medicine, New Orleans, La; Department of Preventive Medicine, Pennington Biomedical Research Center, Louisiana State University System, Baton Rouge, La.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016454">Review</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>03</Month>
<Day>22</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Transl Res</MedlineTA>
<NlmUniqueID>101280339</NlmUniqueID>
<ISSNLinking>1878-1810</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D003324">Coronary Artery Disease</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000209">etiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007333">Insulin Resistance</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009765">Obesity</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000150">complications</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012307">Risk Factors</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">24814682</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>29</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>17</Day>
</DateCompleted>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1878-1810</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>164</Volume>
<Issue>4</Issue>
<PubDate>
<Year>2014</Year>
<Month>Oct</Month>
</PubDate>
</JournalIssue>
<Title>Translational research : the journal of laboratory and clinical medicine</Title>
<ISOAbbreviation>Transl Res</ISOAbbreviation>
</Journal>
<ArticleTitle>Obesity and heart failure: epidemiology, pathophysiology, clinical manifestations, and management.</ArticleTitle>
<Pagination>
<MedlinePgn>345-56</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.trsl.2014.04.010</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S1931-5244(14)00134-0</ELocationID>
<Abstract>
<AbstractText>Obesity is a risk factor for heart failure (HF) in both men and women. The mortality risk of overweight and class I and II obese adults with HF is lower than that of normal weight or underweight adults with HF of comparable severity, a phenomenon referred to as the obesity paradox. Severe obesity produces hemodynamic alterations that predispose to changes in cardiac morphology and ventricular function, which may lead to the development of HF. The presence of systemic hypertension, sleep apnea, and hypoventilation, comorbidities that occur commonly with severe obesity, may contribute to HF in such patients. The resultant syndrome is known as obesity cardiomyopathy. Substantial weight loss in severely obese persons is capable of reversing most obesity-related abnormalities of cardiac performance and morphology and improving the clinical manifestations of obesity cardiomyopathy.</AbstractText>
<CopyrightInformation>Copyright © 2014 Elsevier Inc. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Alpert</LastName>
<ForeName>Martin A</ForeName>
<Initials>MA</Initials>
<AffiliationInfo>
<Affiliation>Division of Cardiovascular Medicine, University of Missouri, Columbia, Missouri. Electronic address: malpert815@yahoo.com.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Lavie</LastName>
<ForeName>Carl J</ForeName>
<Initials>CJ</Initials>
<AffiliationInfo>
<Affiliation>Department of Cardiology, John Ochsner Heart and Vascular Institute, New Orleans, Louisiana.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Agrawal</LastName>
<ForeName>Harsh</ForeName>
<Initials>H</Initials>
<AffiliationInfo>
<Affiliation>Division of Cardiovascular Medicine, University of Missouri, Columbia, Missouri.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Aggarwal</LastName>
<ForeName>Kul B</ForeName>
<Initials>KB</Initials>
<AffiliationInfo>
<Affiliation>Division of Cardiovascular Medicine, University of Missouri, Columbia, Missouri.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Kumar</LastName>
<ForeName>Senthil A</ForeName>
<Initials>SA</Initials>
<AffiliationInfo>
<Affiliation>Division of Cardiovascular Medicine, University of Missouri, Columbia, Missouri.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016454">Review</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>04</Month>
<Day>18</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Transl Res</MedlineTA>
<NlmUniqueID>101280339</NlmUniqueID>
<ISSNLinking>1878-1810</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000465">Algorithms</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009202">Cardiomyopathies</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000145">classification</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000209">etiology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000401">mortality</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000503">physiopathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006333">Heart Failure</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000209">etiology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000401">mortality</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000503">physiopathology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000628">therapy</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009765">Obesity</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000150">complications</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">24880146</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>29</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>17</Day>
</DateCompleted>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1878-1810</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>164</Volume>
<Issue>4</Issue>
<PubDate>
<Year>2014</Year>
<Month>Oct</Month>
</PubDate>
</JournalIssue>
<Title>Translational research : the journal of laboratory and clinical medicine</Title>
<ISOAbbreviation>Transl Res</ISOAbbreviation>
</Journal>
<ArticleTitle>Obesity, metabolic dysfunction, and cardiac fibrosis: pathophysiological pathways, molecular mechanisms, and therapeutic opportunities.</ArticleTitle>
<Pagination>
<MedlinePgn>323-35</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.trsl.2014.05.001</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S1931-5244(14)00164-9</ELocationID>
<Abstract>
<AbstractText>Cardiac fibrosis is strongly associated with obesity and metabolic dysfunction and may contribute to the increased incidence of heart failure, atrial arrhythmias, and sudden cardiac death in obese subjects. This review discusses the evidence linking obesity and myocardial fibrosis in animal models and human patients, focusing on the fundamental pathophysiological alterations that may trigger fibrogenic signaling, the cellular effectors of fibrosis, and the molecular signals that may regulate the fibrotic response. Obesity is associated with a wide range of pathophysiological alterations (such as pressure and volume overload, metabolic dysregulation, neurohumoral activation, and systemic inflammation); their relative role in mediating cardiac fibrosis is poorly defined. Activation of fibroblasts likely plays a major role in obesity-associated fibrosis; however, inflammatory cells, cardiomyocytes, and vascular cells may also contribute to fibrogenic signaling. Several molecular processes have been implicated in regulation of the fibrotic response in obesity. Activation of the renin-angiotensin-aldosterone system, induction of transforming growth factor β, oxidative stress, advanced glycation end-products, endothelin 1, Rho-kinase signaling, leptin-mediated actions, and upregulation of matricellular proteins (such as thrombospondin 1) may play a role in the development of fibrosis in models of obesity and metabolic dysfunction. Moreover, experimental evidence suggests that obesity and insulin resistance profoundly affect the fibrotic and remodeling response after cardiac injury. Understanding the pathways implicated in obesity-associated fibrosis may lead to the development of novel therapies to prevent heart failure and attenuate postinfarction cardiac remodeling in patients with obesity.</AbstractText>
<CopyrightInformation>Copyright © 2014 Elsevier Inc. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Cavalera</LastName>
<ForeName>Michele</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Division of Cardiology, Department of Medicine, The Wilf Cardiovascular Research Institute, Albert Einstein College of Medicine, Bronx, New York.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Wang</LastName>
<ForeName>Junhong</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>Division of Cardiology, Department of Medicine, The Wilf Cardiovascular Research Institute, Albert Einstein College of Medicine, Bronx, New York.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Frangogiannis</LastName>
<ForeName>Nikolaos G</ForeName>
<Initials>NG</Initials>
<AffiliationInfo>
<Affiliation>Division of Cardiology, Department of Medicine, The Wilf Cardiovascular Research Institute, Albert Einstein College of Medicine, Bronx, New York. Electronic address: ngf@bcm.edu.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>R01 HL076246</GrantID>
<Acronym>HL</Acronym>
<Agency>NHLBI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R01 HL085440</GrantID>
<Acronym>HL</Acronym>
<Agency>NHLBI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R01 HL76246</GrantID>
<Acronym>HL</Acronym>
<Agency>NHLBI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R01 HL85440</GrantID>
<Acronym>HL</Acronym>
<Agency>NHLBI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
<PublicationType UI="D016454">Review</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>05</Month>
<Day>10</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Transl Res</MedlineTA>
<NlmUniqueID>101280339</NlmUniqueID>
<ISSNLinking>1878-1810</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000818">Animals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005355">Fibrosis</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000209">etiology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006331">Heart Diseases</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000209">etiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009765">Obesity</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000150">complications</QualifierName>
</MeshHeading>
</MeshHeadingList>
<OtherID Source="NLM">NIHMS595027 [Available on 10/01/15]</OtherID>
<OtherID Source="NLM">PMC4180761 [Available on 10/01/15]</OtherID>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">24929206</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>29</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>17</Day>
</DateCompleted>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1878-1810</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>164</Volume>
<Issue>4</Issue>
<PubDate>
<Year>2014</Year>
<Month>Oct</Month>
</PubDate>
</JournalIssue>
<Title>Translational research : the journal of laboratory and clinical medicine</Title>
<ISOAbbreviation>Transl Res</ISOAbbreviation>
</Journal>
<ArticleTitle>Adipose tissue changes in obesity and the impact on metabolic function.</ArticleTitle>
<Pagination>
<MedlinePgn>284-92</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.trsl.2014.05.008</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S1931-5244(14)00176-5</ELocationID>
<Abstract>
<AbstractText>Obesity is associated with adverse alterations in adipose tissue that predispose to metabolic dysregulation. These adverse alterations include accumulation of inflammatory macrophages leading to the activation of inflammation pathways, reduction in lipid turnover, and deposition of fat in ectopic locations. These alterations are precursors to the development of insulin resistance and metabolic dysfunction. </AbstractText>
<CopyrightInformation>Copyright © 2014 Elsevier Inc. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Sam</LastName>
<ForeName>Susan</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Department of Medicine, Section of Endocrinology, Pritzker School of Medicine, University of Chicago, Chicago, Ill. Electronic address: ssam@medicine.bsd.uchicago.edu.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Mazzone</LastName>
<ForeName>Theodore</ForeName>
<Initials>T</Initials>
<AffiliationInfo>
<Affiliation>Department of Medicine, NorthShore University Health System, Pritzker School of Medicine, University of Chicago, Chicago, Ill.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016454">Review</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>05</Month>
<Day>24</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Transl Res</MedlineTA>
<NlmUniqueID>101280339</NlmUniqueID>
<ISSNLinking>1878-1810</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000273">Adipose Tissue</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000502">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D004734">Energy Metabolism</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000502">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009765">Obesity</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">24929207</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>29</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>17</Day>
</DateCompleted>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1878-1810</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>164</Volume>
<Issue>4</Issue>
<PubDate>
<Year>2014</Year>
<Month>Oct</Month>
</PubDate>
</JournalIssue>
<Title>Translational research : the journal of laboratory and clinical medicine</Title>
<ISOAbbreviation>Transl Res</ISOAbbreviation>
</Journal>
<ArticleTitle>The genetics of human obesity.</ArticleTitle>
<Pagination>
<MedlinePgn>293-301</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.trsl.2014.05.010</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S1931-5244(14)00197-2</ELocationID>
<Abstract>
<AbstractText>The heritability of obesity has long been appreciated and the genetics of obesity has been the focus of intensive study for decades. Early studies elucidating genetic factors involved in rare monogenic and syndromic forms of extreme obesity focused attention on dysfunction of hypothalamic leptin-related pathways in the control of food intake as a major contributor. Subsequent genome-wide association studies of common genetic variants identified novel loci that are involved in more common forms of obesity across populations of diverse ethnicities and ages. The subsequent search for factors contributing to the heritability of obesity not explained by these 2 approaches ("missing heritability") has revealed additional rare variants, copy number variants, and epigenetic changes that contribute. Although clinical applications of these findings have been limited to date, the increasing understanding of the interplay of these genetic factors with environmental conditions, such as the increased availability of high calorie foods and decreased energy expenditure of sedentary lifestyles, promises to accelerate the translation of genetic findings into more successful preventive and therapeutic interventions.</AbstractText>
<CopyrightInformation>Copyright © 2014 Elsevier Inc. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Waalen</LastName>
<ForeName>Jill</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>The Scripps Research Institute and the Scripps Translational Science Institute, La Jolla, California. Electronic address: jwaalen@scripps.edu.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016454">Review</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>05</Month>
<Day>23</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Transl Res</MedlineTA>
<NlmUniqueID>101280339</NlmUniqueID>
<ISSNLinking>1878-1810</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005786">Gene Expression Regulation</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008957">Models, Genetic</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009765">Obesity</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000235">genetics</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">24993615</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>29</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>17</Day>
</DateCompleted>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1878-1810</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>164</Volume>
<Issue>4</Issue>
<PubDate>
<Year>2014</Year>
<Month>Oct</Month>
</PubDate>
</JournalIssue>
<Title>Translational research : the journal of laboratory and clinical medicine</Title>
<ISOAbbreviation>Transl Res</ISOAbbreviation>
</Journal>
<ArticleTitle>Intermittent fasting vs daily calorie restriction for type 2 diabetes prevention: a review of human findings.</ArticleTitle>
<Pagination>
<MedlinePgn>302-11</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.trsl.2014.05.013</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S1931-5244(14)00200-X</ELocationID>
<Abstract>
<AbstractText>Intermittent fasting (IF) regimens have gained considerable popularity in recent years, as some people find these diets easier to follow than traditional calorie restriction (CR) approaches. IF involves restricting energy intake on 1-3 d/wk, and eating freely on the nonrestriction days. Alternate day fasting (ADF) is a subclass of IF, which consists of a "fast day" (75% energy restriction) alternating with a "feed day" (ad libitum food consumption). Recent findings suggest that IF and ADF are equally as effective as CR for weight loss and cardioprotection. What remains unclear, however, is whether IF/ADF elicits comparable improvements in diabetes risk indicators, when compared with CR. Accordingly, the goal of this review was to compare the effects of IF and ADF with daily CR on body weight, fasting glucose, fasting insulin, and insulin sensitivity in overweight and obese adults. Results reveal superior decreases in body weight by CR vs IF/ADF regimens, yet comparable reductions in visceral fat mass, fasting insulin, and insulin resistance. None of the interventions produced clinically meaningful reductions in glucose concentrations. Taken together, these preliminary findings show promise for the use of IF and ADF as alternatives to CR for weight loss and type 2 diabetes risk reduction in overweight and obese populations, but more research is required before solid conclusions can be reached.</AbstractText>
<CopyrightInformation>Copyright © 2014 Elsevier Inc. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Barnosky</LastName>
<ForeName>Adrienne R</ForeName>
<Initials>AR</Initials>
<AffiliationInfo>
<Affiliation>Division of Endocrinology, Department of Medicine, University of Illinois at Chicago, Chicago, Ill.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Hoddy</LastName>
<ForeName>Kristin K</ForeName>
<Initials>KK</Initials>
<AffiliationInfo>
<Affiliation>Department of Kinesiology and Nutrition, University of Illinois at Chicago, Chicago, Ill.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Unterman</LastName>
<ForeName>Terry G</ForeName>
<Initials>TG</Initials>
<AffiliationInfo>
<Affiliation>Division of Endocrinology, Department of Medicine, University of Illinois at Chicago, Chicago, Ill.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Varady</LastName>
<ForeName>Krista A</ForeName>
<Initials>KA</Initials>
<AffiliationInfo>
<Affiliation>Department of Kinesiology and Nutrition, University of Illinois at Chicago, Chicago, Ill. Electronic address: varady@uic.edu.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>1R01HL106228-01</GrantID>
<Acronym>HL</Acronym>
<Agency>NHLBI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>T32DK080674</GrantID>
<Acronym>DK</Acronym>
<Agency>NIDDK NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
<PublicationType UI="D016454">Review</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>06</Month>
<Day>12</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Transl Res</MedlineTA>
<NlmUniqueID>101280339</NlmUniqueID>
<ISSNLinking>1878-1810</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D031204">Caloric Restriction</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D003924">Diabetes Mellitus, Type 2</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000517">prevention &amp; control</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D004038">Diet, Reducing</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D005215">Fasting</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009765">Obesity</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000178">diet therapy</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25028077</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>29</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>17</Day>
</DateCompleted>
<DateRevised>
<Year>2014</Year>
<Month>11</Month>
<Day>20</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1878-1810</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>164</Volume>
<Issue>4</Issue>
<PubDate>
<Year>2014</Year>
<Month>Oct</Month>
</PubDate>
</JournalIssue>
<Title>Translational research : the journal of laboratory and clinical medicine</Title>
<ISOAbbreviation>Transl Res</ISOAbbreviation>
</Journal>
<ArticleTitle>Obesity and the liver: nonalcoholic fatty liver disease.</ArticleTitle>
<Pagination>
<MedlinePgn>312-22</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.trsl.2014.06.008</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S1931-5244(14)00215-1</ELocationID>
<Abstract>
<AbstractText>The increasing prevalence of nonalcoholic fatty liver disease (NAFLD) parallels the rise of obesity and its complications. NAFLD is a common cause of cirrhosis and a leading indication for liver transplant. Genetic susceptibility, dietary composition, and exercise habits influence the development of NAFLD, and insulin resistance results in widespread metabolic perturbations with a net effect of triglyceride accumulation in the liver. Some patients will develop hepatocyte cellular injury and fibrosis of the liver, which can progress to cirrhosis and require liver transplant. Treatments targeting the pathophysiological mechanisms of NAFLD exist, but carry some potential risk and are not universally effective. Weight loss and lifestyle changes remain the most effective and safest approach, but sustainable change is difficult for most patients to achieve. Future work will continue to focus on developing effective and safe interventions to prevent the development of advanced liver disease, whereas efforts in the public health domain continue to combat obesity.</AbstractText>
<CopyrightInformation>Copyright © 2014 Elsevier Inc. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Koppe</LastName>
<ForeName>Sean W P</ForeName>
<Initials>SW</Initials>
<AffiliationInfo>
<Affiliation>Division of Gastroenterology and Hepatology, Northwestern University, Chicago, Ill. Electronic address: sean.koppe@nmff.org.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016454">Review</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>06</Month>
<Day>25</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Transl Res</MedlineTA>
<NlmUniqueID>101280339</NlmUniqueID>
<ISSNLinking>1878-1810</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005234">Fatty Liver</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000209">etiology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000235">genetics</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000628">therapy</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D020022">Genetic Predisposition to Disease</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008099">Liver</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D065626">Non-alcoholic Fatty Liver Disease</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009765">Obesity</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000150">complications</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25046478</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>29</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>17</Day>
</DateCompleted>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1878-1810</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>164</Volume>
<Issue>4</Issue>
<PubDate>
<Year>2014</Year>
<Month>Oct</Month>
</PubDate>
</JournalIssue>
<Title>Translational research : the journal of laboratory and clinical medicine</Title>
<ISOAbbreviation>Transl Res</ISOAbbreviation>
</Journal>
<ArticleTitle>Exploring the spectrum of diseases influenced by excess adiposity.</ArticleTitle>
<Pagination>
<MedlinePgn>278-83</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.trsl.2014.06.009</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S1931-5244(14)00236-9</ELocationID>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Poirier</LastName>
<ForeName>Paul</ForeName>
<Initials>P</Initials>
<AffiliationInfo>
<Affiliation>Institut Universitaire de Cardiologie et de Pneumologie de Québec, Université Laval, Québec, Canada and Faculté de Pharmacie, Université Laval, Québec, Canada. Electronic address: paul.poirier@criucpq.ulaval.ca.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016454">Review</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>06</Month>
<Day>30</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Transl Res</MedlineTA>
<NlmUniqueID>101280339</NlmUniqueID>
<ISSNLinking>1878-1810</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D050154">Adiposity</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000502">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002318">Cardiovascular Diseases</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009765">Obesity</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000150">complications</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012307">Risk Factors</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25265842</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>30</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>10</Month>
<Day>14</Day>
</DateCompleted>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">1068-8838</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>88</Volume>
<Issue>8</Issue>
<PubDate>
<Year>2014</Year>
<Month>Aug</Month>
</PubDate>
</JournalIssue>
<Title>Hospitals &amp; health networks / AHA</Title>
<ISOAbbreviation>Hosp Health Netw</ISOAbbreviation>
</Journal>
<ArticleTitle>The AHA NOVA award.</ArticleTitle>
<Pagination>
<MedlinePgn>34-8</MedlinePgn>
</Pagination>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Larson</LastName>
<ForeName>Laurie</ForeName>
<Initials>L</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Hosp Health Netw</MedlineTA>
<NlmUniqueID>9312077</NlmUniqueID>
<ISSNLinking>1068-8838</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D000573">American Hospital Association</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001363">Awards and Prizes</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002318">Cardiovascular Diseases</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000175">diagnosis</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000517">prevention &amp; control</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D003153">Community Health Services</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000458">organization &amp; administration</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D003299">Cooperative Behavior</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D003920">Diabetes Mellitus</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000175">diagnosis</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000628">therapy</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015438">Health Behavior</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D007722">Health Knowledge, Attitudes, Practice</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D006739">Hospital Administration</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008403">Mass Screening</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009765">Obesity</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000517">prevention &amp; control</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011787">Quality of Health Care</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000458">organization &amp; administration</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" Type="Geographic" UI="D014481">United States</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25269230</PMID>
<DateCreated>
<Year>2014</Year>
<Month>10</Month>
<Day>01</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>10</Month>
<Day>23</Day>
</DateCompleted>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">1708-1890</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>11</Volume>
<Issue>4</Issue>
<PubDate>
<MedlineDate>2014 Sep-Oct</MedlineDate>
</PubDate>
</JournalIssue>
<Title>Perspective infirmière : revue officielle de l'Ordre des infirmières et infirmiers du Québec</Title>
<ISOAbbreviation>Perspect Infirm</ISOAbbreviation>
</Journal>
<ArticleTitle>[According to the World Health Organization, the less sugar, the better].</ArticleTitle>
<Pagination>
<MedlinePgn>13</MedlinePgn>
</Pagination>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Sabourin</LastName>
<ForeName>Guy</ForeName>
<Initials>G</Initials>
</Author>
</AuthorList>
<Language>fre</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<VernacularTitle>Selon l'OMS, moins de sucre, c'est mieux.</VernacularTitle>
</Article>
<MedlineJournalInfo>
<Country>Canada</Country>
<MedlineTA>Perspect Infirm</MedlineTA>
<NlmUniqueID>101196674</NlmUniqueID>
<ISSNLinking>1708-1890</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D019422">Dietary Sucrose</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>N</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D003731">Dental Caries</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000517">prevention &amp; control</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D019422">Dietary Sucrose</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000008">administration &amp; dosage</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000009">adverse effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009765">Obesity</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000517">prevention &amp; control</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D014944">World Health Organization</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">24898844</PMID>
<DateCreated>
<Year>2014</Year>
<Month>10</Month>
<Day>01</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>10</Month>
<Day>20</Day>
</DateCompleted>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">1522-1490</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>307</Volume>
<Issue>2</Issue>
<PubDate>
<Year>2014</Year>
<Month>Jul</Month>
<Day>15</Day>
</PubDate>
</JournalIssue>
<Title>American journal of physiology. Regulatory, integrative and comparative physiology</Title>
<ISOAbbreviation>Am. J. Physiol. Regul. Integr. Comp. Physiol.</ISOAbbreviation>
</Journal>
<ArticleTitle>Roux-en-Y gastric bypass does not affect daily water intake or the drinking response to dipsogenic stimuli in rats.</ArticleTitle>
<Pagination>
<MedlinePgn>R114-20</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>Bariatric surgery is currently the most effective treatment for severe obesity, and Roux-en-Y gastric bypass (RYGB) is the most common approach in the United States and worldwide. Many studies have documented the changes in body weight, food intake, and glycemic control associated with the procedure. Although dehydration is commonly listed as a postoperative complication, little focus has been directed to testing the response to dipsogenic treatments after RYGB. Accordingly, we used a rat model of RYGB to test for procedure-induced changes in daily water intake and in the response to three dipsogenic treatments: central administration of ANG II, peripheral injection of hypertonic saline, and overnight water deprivation. We did not find any systematic differences in daily water intake of sham-operated and RYGB rats, nor did we find any differences in the response to the dipsogenic treatments. The results of these experiments suggest that RYGB does not impair thirst responses and does not enhance any satiating effect of water intake. Furthermore, these data support the current view that feedback from the stomach is unnecessary for the termination of drinking behavior and are consistent with a role of orosensory or postgastric feedback.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Marshall</LastName>
<ForeName>Anikó</ForeName>
<Initials>A</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Santollo</LastName>
<ForeName>Jessica</ForeName>
<Initials>J</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Corteville</LastName>
<ForeName>Caroline</ForeName>
<Initials>C</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Lutz</LastName>
<ForeName>Thomas A</ForeName>
<Initials>TA</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Daniels</LastName>
<ForeName>Derek</ForeName>
<Initials>D</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>HL-091911</GrantID>
<Acronym>HL</Acronym>
<Agency>NHLBI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Am J Physiol Regul Integr Comp Physiol</MedlineTA>
<NlmUniqueID>100901230</NlmUniqueID>
<ISSNLinking>0363-6119</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000818">Animals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001835">Body Weight</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000502">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D004195">Disease Models, Animal</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D004326">Drinking</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000502">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D004435">Eating</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000502">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D004734">Energy Metabolism</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000502">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D015390">Gastric Bypass</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009765">Obesity</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000601">surgery</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D051381">Rats</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D017207">Rats, Sprague-Dawley</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015431">Weight Loss</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000502">physiology</QualifierName>
</MeshHeading>
</MeshHeadingList>
<OtherID Source="NLM">PMC4101614 [Available on 07/15/15]</OtherID>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">24821943</PMID>
<DateCreated>
<Year>2014</Year>
<Month>10</Month>
<Day>01</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>10</Month>
<Day>17</Day>
</DateCompleted>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">1524-4563</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>64</Volume>
<Issue>2</Issue>
<PubDate>
<Year>2014</Year>
<Month>Aug</Month>
</PubDate>
</JournalIssue>
<Title>Hypertension</Title>
<ISOAbbreviation>Hypertension</ISOAbbreviation>
</Journal>
<ArticleTitle>Obesity-associated hypertension: recent progress in deciphering the pathogenesis.</ArticleTitle>
<Pagination>
<MedlinePgn>215-21</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1161/HYPERTENSIONAHA.114.00920</ELocationID>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Rahmouni</LastName>
<ForeName>Kamal</ForeName>
<Initials>K</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>HL084207</GrantID>
<Acronym>HL</Acronym>
<Agency>NHLBI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>P01 HL084207</GrantID>
<Acronym>HL</Acronym>
<Agency>NHLBI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
<PublicationType UI="D016454">Review</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Hypertension</MedlineTA>
<NlmUniqueID>7906255</NlmUniqueID>
<ISSNLinking>0194-911X</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006973">Hypertension</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000209">etiology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000503">physiopathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009765">Obesity</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000150">complications</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000503">physiopathology</QualifierName>
</MeshHeading>
</MeshHeadingList>
<OtherID Source="NLM">NIHMS587187 [Available on 08/01/15]</OtherID>
<OtherID Source="NLM">PMC4184930 [Available on 08/01/15]</OtherID>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">24866141</PMID>
<DateCreated>
<Year>2014</Year>
<Month>10</Month>
<Day>01</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>10</Month>
<Day>17</Day>
</DateCompleted>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">1524-4563</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>64</Volume>
<Issue>2</Issue>
<PubDate>
<Year>2014</Year>
<Month>Aug</Month>
</PubDate>
</JournalIssue>
<Title>Hypertension</Title>
<ISOAbbreviation>Hypertension</ISOAbbreviation>
</Journal>
<ArticleTitle>Sympathetic inhibition after bariatric surgery.</ArticleTitle>
<Pagination>
<MedlinePgn>235-6</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1161/HYPERTENSIONAHA.114.03183</ELocationID>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Mark</LastName>
<ForeName>Allyn L</ForeName>
<Initials>AL</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Norris</LastName>
<ForeName>Andrew W</ForeName>
<Initials>AW</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Rahmouni</LastName>
<ForeName>Kamal</ForeName>
<Initials>K</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>DK-09782</GrantID>
<Acronym>DK</Acronym>
<Agency>NIDDK NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>DK-96518</GrantID>
<Acronym>DK</Acronym>
<Agency>NIDDK NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>HL-84207</GrantID>
<Acronym>HL</Acronym>
<Agency>NHLBI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>P01 HL084207</GrantID>
<Acronym>HL</Acronym>
<Agency>NHLBI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016420">Comment</PublicationType>
<PublicationType UI="D016421">Editorial</PublicationType>
<PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Hypertension</MedlineTA>
<NlmUniqueID>7906255</NlmUniqueID>
<ISSNLinking>0194-911X</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList>
<CommentsCorrections RefType="CommentOn">
<RefSource>Hypertension. 2014 Aug;64(2):431-7</RefSource>
<PMID Version="1">24866140</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001794">Blood Pressure</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000502">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006973">Hypertension</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000601">surgery</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007333">Insulin Resistance</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000502">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009765">Obesity</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000601">surgery</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D013564">Sympathetic Nervous System</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000503">physiopathology</QualifierName>
</MeshHeading>
</MeshHeadingList>
<OtherID Source="NLM">NIHMS592215 [Available on 08/01/15]</OtherID>
<OtherID Source="NLM">PMC4184982 [Available on 08/01/15]</OtherID>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">24842920</PMID>
<DateCreated>
<Year>2014</Year>
<Month>10</Month>
<Day>01</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>10</Month>
<Day>17</Day>
</DateCompleted>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">1524-4563</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>64</Volume>
<Issue>2</Issue>
<PubDate>
<Year>2014</Year>
<Month>Aug</Month>
</PubDate>
</JournalIssue>
<Title>Hypertension</Title>
<ISOAbbreviation>Hypertension</ISOAbbreviation>
</Journal>
<ArticleTitle>Role of body mass index history in predicting risk of the development of hypertension in Japanese individuals: Toranomon Hospital Health Management Center Study 18 (TOPICS 18).</ArticleTitle>
<Pagination>
<MedlinePgn>247-52</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1161/HYPERTENSIONAHA.113.02918</ELocationID>
<Abstract>
<AbstractText>It has not been clarified whether overall adiposity in early adulthood or at the lifetime maximum weight would confer a residual risk of hypertension after considering the risk associated with current adiposity. Studied were 6121 Japanese without hypertension. The risk of developing hypertension 4 years after a baseline examination was investigated using the body mass index in the early 20s, at the lifetime maximum, or at the baseline examination. An elevated body mass index at baseline or at the maximum rather than in the early 20s was strongly associated with future hypertension. Compared with individuals with low body mass index both at baseline and in the early 20s, those with an elevated body mass index at the baseline alone had an odds ratio of 1.89 (95% confidence interval, 1.58–2.27) and those with an elevated body mass index both at baseline and in the early 20s had the highest odds ratio of 2.26 (1.76–2.89). Individuals with an elevated body mass index both at baseline and at the maximum had a 2.26-fold (1.87–2.72) increased risk of hypertension compared with those without the 2 factors. An elevated body mass index at the baseline examination weakened the favorable influence of a low body mass index in early adulthood on developing hypertension. Adding information on body mass index in early adulthood or at the maximum in addition to that at the baseline examination contributed to differentiating the risk of hypertension among Japanese, particularly among those with an elevated overall adiposity at present.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Heianza</LastName>
<ForeName>Yoriko</ForeName>
<Initials>Y</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Kodama</LastName>
<ForeName>Satoru</ForeName>
<Initials>S</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Arase</LastName>
<ForeName>Yasuji</ForeName>
<Initials>Y</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Hsieh</LastName>
<ForeName>Shiun Dong</ForeName>
<Initials>SD</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Yoshizawa</LastName>
<ForeName>Sakiko</ForeName>
<Initials>S</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Tsuji</LastName>
<ForeName>Hiroshi</ForeName>
<Initials>H</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Saito</LastName>
<ForeName>Kazumi</ForeName>
<Initials>K</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Tanaka</LastName>
<ForeName>Shiro</ForeName>
<Initials>S</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Hara</LastName>
<ForeName>Shigeko</ForeName>
<Initials>S</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Sone</LastName>
<ForeName>Hirohito</ForeName>
<Initials>H</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Hypertension</MedlineTA>
<NlmUniqueID>7906255</NlmUniqueID>
<ISSNLinking>0194-911X</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000328">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D044466">Asian Continental Ancestry Group</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001794">Blood Pressure</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000502">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015992">Body Mass Index</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006973">Hypertension</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000209">etiology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000503">physiopathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" Type="Geographic" UI="D007564">Japan</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008875">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009765">Obesity</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000150">complications</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000503">physiopathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012307">Risk Factors</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">24866145</PMID>
<DateCreated>
<Year>2014</Year>
<Month>10</Month>
<Day>01</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>10</Month>
<Day>17</Day>
</DateCompleted>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">1524-4563</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>64</Volume>
<Issue>2</Issue>
<PubDate>
<Year>2014</Year>
<Month>Aug</Month>
</PubDate>
</JournalIssue>
<Title>Hypertension</Title>
<ISOAbbreviation>Hypertension</ISOAbbreviation>
</Journal>
<ArticleTitle>Maternal parity, fetal and childhood growth, and cardiometabolic risk factors.</ArticleTitle>
<Pagination>
<MedlinePgn>266-74</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1161/HYPERTENSIONAHA.114.03492</ELocationID>
<Abstract>
<AbstractText>We examined the associations of maternal parity with fetal and childhood growth characteristics and childhood cardiometabolic risk factors in a population-based prospective cohort study among 9031 mothers and their children. Fetal and childhood growth were repeatedly measured. We measured childhood anthropometrics, body fat distribution, left ventricular mass, blood pressure, blood lipids, and insulin levels at the age of 6 years. Compared with nulliparous mothers, multiparous mothers had children with higher third trimester fetal head circumference, length and weight growth, and lower risks of preterm birth and small-size-for-gestational-age at birth but a higher risk of large-size-for-gestational-age at birth (P&lt;0.05). Children from multiparous mothers had lower rates of accelerated infant growth and lower levels of childhood body mass index, total fat mass percentage, and total and low-density lipoprotein cholesterol than children of nulliparous mothers (P&lt;0.05). They also had a lower risk of childhood overweight (odds ratio, 0.75 [95% confidence interval, 0.63–0.88]). The risk of childhood clustering of cardiometabolic risk factors was not statistically significantly different (odds ratio, 0.82; 95% confidence interval, 0.64–1.05). Among children from multiparous mothers only, we observed consistent trends toward a lower risk of childhood overweight and lower cholesterol levels with increasing parity (P&lt;0.05). In conclusion, offspring from nulliparous mothers have lower fetal but higher infant growth rates and higher risks of childhood overweight and adverse metabolic profile. Maternal nulliparity may have persistent cardiometabolic consequences for the offspring.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Gaillard</LastName>
<ForeName>Romy</ForeName>
<Initials>R</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Rurangirwa</LastName>
<ForeName>Akashi A</ForeName>
<Initials>AA</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Williams</LastName>
<ForeName>Michelle A</ForeName>
<Initials>MA</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Hofman</LastName>
<ForeName>Albert</ForeName>
<Initials>A</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Mackenbach</LastName>
<ForeName>Johan P</ForeName>
<Initials>JP</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Franco</LastName>
<ForeName>Oscar H</ForeName>
<Initials>OH</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Steegers</LastName>
<ForeName>Eric A P</ForeName>
<Initials>EA</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Jaddoe</LastName>
<ForeName>Vincent W V</ForeName>
<Initials>VW</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Hypertension</MedlineTA>
<NlmUniqueID>7906255</NlmUniqueID>
<ISSNLinking>0194-911X</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D007328">Insulin</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D008055">Lipids</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000328">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001794">Blood Pressure</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000502">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D015992">Body Mass Index</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001835">Body Weight</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000502">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002648">Child</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002675">Child, Preschool</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007328">Insulin</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000097">blood</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008055">Lipids</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000097">blood</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008137">Longitudinal Studies</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009765">Obesity</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000209">etiology</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000503">physiopathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D010298">Parity</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000502">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011247">Pregnancy</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011446">Prospective Studies</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012307">Risk Factors</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25277011</PMID>
<DateCreated>
<Year>2014</Year>
<Month>10</Month>
<Day>03</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>10</Month>
<Day>23</Day>
</DateCompleted>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">1660-9379</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>10</Volume>
<Issue>440</Issue>
<PubDate>
<Year>2014</Year>
<Month>Sep</Month>
<Day>3</Day>
</PubDate>
</JournalIssue>
<Title>Revue médicale suisse</Title>
<ISOAbbreviation>Rev Med Suisse</ISOAbbreviation>
</Journal>
<ArticleTitle>[In children, obesity and lack of sleep are linked].</ArticleTitle>
<Pagination>
<MedlinePgn>1637</MedlinePgn>
</Pagination>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Perrier</LastName>
<ForeName>Benoît</ForeName>
<Initials>B</Initials>
</Author>
</AuthorList>
<Language>fre</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<VernacularTitle>Chez l'enfant, surpoids et manque de sommeil seraient liés.</VernacularTitle>
</Article>
<MedlineJournalInfo>
<Country>Switzerland</Country>
<MedlineTA>Rev Med Suisse</MedlineTA>
<NlmUniqueID>101219148</NlmUniqueID>
<ISSNLinking>1660-9379</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002648">Child</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D005192">Family Health</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D015438">Health Behavior</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009765">Obesity</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000150">complications</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D016487">Parenting</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012892">Sleep Deprivation</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000150">complications</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D013690">Television</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25231870</PMID>
<DateCreated>
<Year>2014</Year>
<Month>10</Month>
<Day>04</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>10</Month>
<Day>23</Day>
</DateCompleted>
<DateRevised>
<Year>2014</Year>
<Month>10</Month>
<Day>28</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1476-4687</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>514</Volume>
<Issue>7520</Issue>
<PubDate>
<Year>2014</Year>
<Month>Oct</Month>
<Day>2</Day>
</PubDate>
</JournalIssue>
<Title>Nature</Title>
<ISOAbbreviation>Nature</ISOAbbreviation>
</Journal>
<ArticleTitle>Parent-of-origin-specific allelic associations among 106 genomic loci for age at menarche.</ArticleTitle>
<Pagination>
<MedlinePgn>92-7</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1038/nature13545</ELocationID>
<Abstract>
<AbstractText>Age at menarche is a marker of timing of puberty in females. It varies widely between individuals, is a heritable trait and is associated with risks for obesity, type 2 diabetes, cardiovascular disease, breast cancer and all-cause mortality. Studies of rare human disorders of puberty and animal models point to a complex hypothalamic-pituitary-hormonal regulation, but the mechanisms that determine pubertal timing and underlie its links to disease risk remain unclear. Here, using genome-wide and custom-genotyping arrays in up to 182,416 women of European descent from 57 studies, we found robust evidence (P &lt; 5 × 10(-8)) for 123 signals at 106 genomic loci associated with age at menarche. Many loci were associated with other pubertal traits in both sexes, and there was substantial overlap with genes implicated in body mass index and various diseases, including rare disorders of puberty. Menarche signals were enriched in imprinted regions, with three loci (DLK1-WDR25, MKRN3-MAGEL2 and KCNK9) demonstrating parent-of-origin-specific associations concordant with known parental expression patterns. Pathway analyses implicated nuclear hormone receptors, particularly retinoic acid and γ-aminobutyric acid-B2 receptor signalling, among novel mechanisms that regulate pubertal timing in humans. Our findings suggest a genetic architecture involving at least hundreds of common variants in the coordinated timing of the pubertal transition. </AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Perry</LastName>
<ForeName>John R B</ForeName>
<Initials>JR</Initials>
<AffiliationInfo>
<Affiliation>1] MRC Epidemiology Unit, University of Cambridge School of Clinical Medicine, Box 285 Institute of Metabolic Science, Cambridge Biomedical Campus, Cambridge CB2 0QQ, UK. [2] University of Exeter Medical School, University of Exeter, Exeter EX1 2LU, UK. [3] Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford OX3 7BN, UK. [4] Department of Twin Research and Genetic Epidemiology, King's College London, London SE1 7EH, UK. [5].</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Day</LastName>
<ForeName>Felix</ForeName>
<Initials>F</Initials>
<AffiliationInfo>
<Affiliation>1] MRC Epidemiology Unit, University of Cambridge School of Clinical Medicine, Box 285 Institute of Metabolic Science, Cambridge Biomedical Campus, Cambridge CB2 0QQ, UK. [2].</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Elks</LastName>
<ForeName>Cathy E</ForeName>
<Initials>CE</Initials>
<AffiliationInfo>
<Affiliation>1] MRC Epidemiology Unit, University of Cambridge School of Clinical Medicine, Box 285 Institute of Metabolic Science, Cambridge Biomedical Campus, Cambridge CB2 0QQ, UK. [2].</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Sulem</LastName>
<ForeName>Patrick</ForeName>
<Initials>P</Initials>
<AffiliationInfo>
<Affiliation>1] deCODE Genetics, Reykjavik IS-101, Iceland. [2].</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Thompson</LastName>
<ForeName>Deborah J</ForeName>
<Initials>DJ</Initials>
<AffiliationInfo>
<Affiliation>Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge CB1 8RN, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Ferreira</LastName>
<ForeName>Teresa</ForeName>
<Initials>T</Initials>
<AffiliationInfo>
<Affiliation>Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford OX3 7BN, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>He</LastName>
<ForeName>Chunyan</ForeName>
<Initials>C</Initials>
<AffiliationInfo>
<Affiliation>1] Department of Epidemiology, Indiana University Richard M Fairbanks School of Public Health, Indianapolis, Indiana 46202, USA. [2] Indiana University Melvin and Bren Simon Cancer Center, Indianapolis, Indiana 46202, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Chasman</LastName>
<ForeName>Daniel I</ForeName>
<Initials>DI</Initials>
<AffiliationInfo>
<Affiliation>1] Division of Preventive Medicine, Brigham and Women's Hospital, Boston, Massachusetts 02215, USA. [2] Harvard Medical School, Boston, Massachusetts 02115, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Esko</LastName>
<ForeName>Tõnu</ForeName>
<Initials>T</Initials>
<AffiliationInfo>
<Affiliation>1] Estonian Genome Center, University of Tartu, Tartu, 51010, Estonia. [2] Divisions of Endocrinology and Genetics and Center for Basic and Translational Obesity Research, Boston Children's Hospital, Boston, Massachusetts 02115, USA. [3] Broad Institute of the Massachusetts Institute of Technology and Harvard University, 140 Cambridge, Massachusetts 02142, USA. [4] Department of Genetics, Harvard Medical School, Boston, Massachusetts 02115, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Thorleifsson</LastName>
<ForeName>Gudmar</ForeName>
<Initials>G</Initials>
<AffiliationInfo>
<Affiliation>deCODE Genetics, Reykjavik IS-101, Iceland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Albrecht</LastName>
<ForeName>Eva</ForeName>
<Initials>E</Initials>
<AffiliationInfo>
<Affiliation>Institute of Genetic Epidemiology, Helmholtz Zentrum München - German Research Center for Environmental Health, D-85764 Neuherberg, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Ang</LastName>
<ForeName>Wei Q</ForeName>
<Initials>WQ</Initials>
<AffiliationInfo>
<Affiliation>School of Women's and Infants' Health, The University of Western Australia, WA-6009, Australia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Corre</LastName>
<ForeName>Tanguy</ForeName>
<Initials>T</Initials>
<AffiliationInfo>
<Affiliation>1] Department of Medical Genetics, University of Lausanne, CH-1005 Lausanne, Switzerland. [2] Swiss Institute of Bioinformatics, CH-1015 Lausanne, Switzerland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Cousminer</LastName>
<ForeName>Diana L</ForeName>
<Initials>DL</Initials>
<AffiliationInfo>
<Affiliation>Institute for Molecular Medicine Finland (FIMM), University of Helsinki, FI-00014, Finland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Feenstra</LastName>
<ForeName>Bjarke</ForeName>
<Initials>B</Initials>
<AffiliationInfo>
<Affiliation>Department of Epidemiology Research, Statens Serum Institut, DK-2300 Copenhagen, Denmark.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Franceschini</LastName>
<ForeName>Nora</ForeName>
<Initials>N</Initials>
<AffiliationInfo>
<Affiliation>Department of Epidemiology, University of North Carolina, Chapel Hill, North Carolina 27599-7400, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Ganna</LastName>
<ForeName>Andrea</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, 17177 Stockholm, Sweden.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Johnson</LastName>
<ForeName>Andrew D</ForeName>
<Initials>AD</Initials>
<AffiliationInfo>
<Affiliation>NHLBI's and Boston University's Framingham Heart Study, Framingham, Massachusetts 01702-5827, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Kjellqvist</LastName>
<ForeName>Sanela</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Science for Life Laboratory, Karolinska Institutet, Stockholm, Box 1031, 17121 Solna, Sweden.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Lunetta</LastName>
<ForeName>Kathryn L</ForeName>
<Initials>KL</Initials>
<AffiliationInfo>
<Affiliation>1] NHLBI's and Boston University's Framingham Heart Study, Framingham, Massachusetts 01702-5827, USA. [2] Boston University School of Public Health, Department of Biostatistics, Boston, Massachusetts 02118, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>McMahon</LastName>
<ForeName>George</ForeName>
<Initials>G</Initials>
<AffiliationInfo>
<Affiliation>1] MRC Integrative Epidemiology Unit, University of Bristol, Bristol BS8 2BN, UK. [2] School of Social and Community Medicine, University of Bristol, Oakfield House, Oakfield Grove, Bristol BS8 2BN, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Nolte</LastName>
<ForeName>Ilja M</ForeName>
<Initials>IM</Initials>
<AffiliationInfo>
<Affiliation>Department of Epidemiology, University of Groningen, University Medical Center Groningen, 9700 RB Groningen, The Netherlands.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Paternoster</LastName>
<ForeName>Lavinia</ForeName>
<Initials>L</Initials>
<AffiliationInfo>
<Affiliation>MRC Integrative Epidemiology Unit, University of Bristol, Bristol BS8 2BN, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Porcu</LastName>
<ForeName>Eleonora</ForeName>
<Initials>E</Initials>
<AffiliationInfo>
<Affiliation>1] Institute of Genetics and Biomedical Research, National Research Council, Cagliari, 09042 Sardinia, Italy. [2] University of Sassari, Department of Biomedical Sciences, 07100 Sassari, Italy.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Smith</LastName>
<ForeName>Albert V</ForeName>
<Initials>AV</Initials>
<AffiliationInfo>
<Affiliation>1] Icelandic Heart Association, IS-201 Kopavogur, Iceland. [2] University of Iceland, IS-101 Reykjavik, Iceland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Stolk</LastName>
<ForeName>Lisette</ForeName>
<Initials>L</Initials>
<AffiliationInfo>
<Affiliation>1] Department of Internal Medicine, Erasmus MC, 3015 GE Rotterdam, the Netherlands. [2] Netherlands Consortium on Health Aging and National Genomics Initiative, 2300 RC Leiden, the Netherlands.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Teumer</LastName>
<ForeName>Alexander</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Interfaculty Institute for Genetics and Functional Genomics, University Medicine Greifswald, D-17475 Greifswald, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Tšernikova</LastName>
<ForeName>Natalia</ForeName>
<Initials>N</Initials>
<AffiliationInfo>
<Affiliation>1] Estonian Genome Center, University of Tartu, Tartu, 51010, Estonia. [2] Department of Biotechnology, University of Tartu, 51010 Tartu, Estonia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Tikkanen</LastName>
<ForeName>Emmi</ForeName>
<Initials>E</Initials>
<AffiliationInfo>
<Affiliation>1] Institute for Molecular Medicine Finland (FIMM), University of Helsinki, FI-00014, Finland. [2] Hjelt Institute, University of Helsinki, FI-00014, Finland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Ulivi</LastName>
<ForeName>Sheila</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Institute for Maternal and Child Health - IRCCS "Burlo Garofolo", 34137 Trieste, Italy.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Wagner</LastName>
<ForeName>Erin K</ForeName>
<Initials>EK</Initials>
<AffiliationInfo>
<Affiliation>1] Department of Epidemiology, Indiana University Richard M Fairbanks School of Public Health, Indianapolis, Indiana 46202, USA. [2] Indiana University Melvin and Bren Simon Cancer Center, Indianapolis, Indiana 46202, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Amin</LastName>
<ForeName>Najaf</ForeName>
<Initials>N</Initials>
<AffiliationInfo>
<Affiliation>Genetic Epidemiology Unit Department of Epidemiology, Erasmus MC, 3015 GE, Rotterdam, the Netherlands.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Bierut</LastName>
<ForeName>Laura J</ForeName>
<Initials>LJ</Initials>
<AffiliationInfo>
<Affiliation>Department of Psychiatry, Washington University, St Louis, Missouri 63110, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Byrne</LastName>
<ForeName>Enda M</ForeName>
<Initials>EM</Initials>
<AffiliationInfo>
<Affiliation>1] The University of Queensland, Queensland Brain Institute, St Lucia, Queensland 4072, Australia. [2] QIMR Berghofer Medical Research Institute, Brisbane, Queensland 4006, Australia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Hottenga</LastName>
<ForeName>Jouke-Jan</ForeName>
<Initials>JJ</Initials>
<AffiliationInfo>
<Affiliation>Department of Biological Psychology, VU University Amsterdam, van der Boechorststraat 1, 1081 BT, Amsterdam, The Netherlands.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Koller</LastName>
<ForeName>Daniel L</ForeName>
<Initials>DL</Initials>
<AffiliationInfo>
<Affiliation>Department of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, Indiana 46202-3082, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Mangino</LastName>
<ForeName>Massimo</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Department of Twin Research and Genetic Epidemiology, King's College London, London SE1 7EH, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Pers</LastName>
<ForeName>Tune H</ForeName>
<Initials>TH</Initials>
<AffiliationInfo>
<Affiliation>1] Divisions of Endocrinology and Genetics and Center for Basic and Translational Obesity Research, Boston Children's Hospital, Boston, Massachusetts 02115, USA. [2] Broad Institute of the Massachusetts Institute of Technology and Harvard University, 140 Cambridge, Massachusetts 02142, USA. [3] Medical and Population Genetics, Broad Institute, Cambridge, Massachusetts 02142, USA. [4] Center for Biological Sequence Analysis, Department of Systems Biology, Technical 142 University of Denmark, DK-2800 Lyngby, Denmark.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Yerges-Armstrong</LastName>
<ForeName>Laura M</ForeName>
<Initials>LM</Initials>
<AffiliationInfo>
<Affiliation>Program in Personalized and Genomic Medicine, and Department of Medicine, Division of Endocrinology, Diabetes and Nutrition, University of Maryland School of Medicine, Baltimore, Maryland 21201, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Hua Zhao</LastName>
<ForeName>Jing</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>MRC Epidemiology Unit, University of Cambridge School of Clinical Medicine, Box 285 Institute of Metabolic Science, Cambridge Biomedical Campus, Cambridge CB2 0QQ, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Andrulis</LastName>
<ForeName>Irene L</ForeName>
<Initials>IL</Initials>
<AffiliationInfo>
<Affiliation>1] Ontario Cancer Genetics Network, Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Toronto, Ontario M5G 1X5, Canada. [2] Department of Molecular Genetics, University of Toronto, Toronto, Ontario M5S 1A8, Canada.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Anton-Culver</LastName>
<ForeName>Hoda</ForeName>
<Initials>H</Initials>
<AffiliationInfo>
<Affiliation>Department of Epidemiology, University of California Irvine, Irvine, California 92697-7550, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Atsma</LastName>
<ForeName>Femke</ForeName>
<Initials>F</Initials>
<AffiliationInfo>
<Affiliation>Sanquin Research, 6525 GA Nijmegen, The Netherlands.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Bandinelli</LastName>
<ForeName>Stefania</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>1] Tuscany Regional Health Agency, Florence, Italy, I.O.T. and Department of Medical and Surgical Critical Care, University of Florence, 50134 Florence, Italy. [2] Geriatric Unit, Azienda Sanitaria di Firenze, 50122 Florence, Italy.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Beckmann</LastName>
<ForeName>Matthias W</ForeName>
<Initials>MW</Initials>
<AffiliationInfo>
<Affiliation>University Breast Center Franconia, Department of Gynecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-EMN, D-91054 Erlangen, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Benitez</LastName>
<ForeName>Javier</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>1] Human Genetics Group, Human Cancer Genetics Program, Spanish National Cancer Research Centre (CNIO), E-28029 Madrid, Spain. [2] Centro de Investigación en Red de Enfermedades Raras (CIBERER), E-46010 Valencia, Spain.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Blomqvist</LastName>
<ForeName>Carl</ForeName>
<Initials>C</Initials>
<AffiliationInfo>
<Affiliation>Department of Oncology, University of Helsinki and Helsinki University Central Hospital, FI-00100 Helsinki, Finland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Bojesen</LastName>
<ForeName>Stig E</ForeName>
<Initials>SE</Initials>
<AffiliationInfo>
<Affiliation>1] Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, University of Copenhagen, DK-2100 Copenhagen, Denmark. [2] Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, University of Copenhagen, DK-2100 Copenhagen, Denmark.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Bolla</LastName>
<ForeName>Manjeet K</ForeName>
<Initials>MK</Initials>
<AffiliationInfo>
<Affiliation>Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge CB1 8RN, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Bonanni</LastName>
<ForeName>Bernardo</ForeName>
<Initials>B</Initials>
<AffiliationInfo>
<Affiliation>Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia (IEO), 20139 Milan, Italy.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Brauch</LastName>
<ForeName>Hiltrud</ForeName>
<Initials>H</Initials>
<AffiliationInfo>
<Affiliation>1] DrMargarete Fischer-Bosch-Institute of Clinical Pharmacology, D-70376 Stuttgart, Germany. [2] University of Tübingen, D-72074 Tübingen, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Brenner</LastName>
<ForeName>Hermann</ForeName>
<Initials>H</Initials>
<AffiliationInfo>
<Affiliation>1] Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), D-69120 Heidelberg, Germany. [2] German Cancer Consortium (DKTK), D-69120 Heidelberg, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Buring</LastName>
<ForeName>Julie E</ForeName>
<Initials>JE</Initials>
<AffiliationInfo>
<Affiliation>1] Division of Preventive Medicine, Brigham and Women's Hospital, Boston, Massachusetts 02215, USA. [2] Harvard Medical School, Boston, Massachusetts 02115, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Chang-Claude</LastName>
<ForeName>Jenny</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), D-69120 Heidelberg, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Chanock</LastName>
<ForeName>Stephen</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland 20892, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Chen</LastName>
<ForeName>Jinhui</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>1] Departments of Anatomy and Neurological Surgery, Indiana University school of Medicine, Indianapolis, Indiana 46202, USA. [2] Stark Neuroscience Research Center, Indiana University school of Medicine, Indianapolis, Indiana 46202, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Chenevix-Trench</LastName>
<ForeName>Georgia</ForeName>
<Initials>G</Initials>
<AffiliationInfo>
<Affiliation>Department of Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Queensland 4006 Australia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Collée</LastName>
<ForeName>J Margriet</ForeName>
<Initials>JM</Initials>
<AffiliationInfo>
<Affiliation>Department of Clinical Genetics, Erasmus University Medical Center, 3000 CA Rotterdam, The Netherlands.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Couch</LastName>
<ForeName>Fergus J</ForeName>
<Initials>FJ</Initials>
<AffiliationInfo>
<Affiliation>Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota 55905, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Couper</LastName>
<ForeName>David</ForeName>
<Initials>D</Initials>
<AffiliationInfo>
<Affiliation>Department of Biostatistics, University of North Carolina, Chapel Hill, North Carolina 27599-7420, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Coviello</LastName>
<ForeName>Andrea D</ForeName>
<Initials>AD</Initials>
<AffiliationInfo>
<Affiliation>Boston University School of Medicine, Department of Medicine, Sections of Preventive Medicine and Endocrinology, Boston, Massachusetts 02118, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Cox</LastName>
<ForeName>Angela</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Sheffield Cancer Research Centre, Department of Oncology, University of Sheffield, Sheffield S10 2RX, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Czene</LastName>
<ForeName>Kamila</ForeName>
<Initials>K</Initials>
<AffiliationInfo>
<Affiliation>Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, 17177 Stockholm, Sweden.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>D'adamo</LastName>
<ForeName>Adamo Pio</ForeName>
<Initials>AP</Initials>
<AffiliationInfo>
<Affiliation>1] Institute for Maternal and Child Health - IRCCS "Burlo Garofolo", 34137 Trieste, Italy. [2] Department of Clinical Medical Sciences, Surgical and Health, University of Trieste, 34149 Trieste, Italy.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Davey Smith</LastName>
<ForeName>George</ForeName>
<Initials>G</Initials>
<AffiliationInfo>
<Affiliation>1] MRC Integrative Epidemiology Unit, University of Bristol, Bristol BS8 2BN, UK. [2] School of Social and Community Medicine, University of Bristol, Oakfield House, Oakfield Grove, Bristol BS8 2BN, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>De Vivo</LastName>
<ForeName>Immaculata</ForeName>
<Initials>I</Initials>
<AffiliationInfo>
<Affiliation>1] Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts 02115, USA. [2] Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts 02115, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Demerath</LastName>
<ForeName>Ellen W</ForeName>
<Initials>EW</Initials>
<AffiliationInfo>
<Affiliation>Division of Epidemiology and Community Health, School of Public Health, University of Minnesota, Minneapolis, Minnesota 55455, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Dennis</LastName>
<ForeName>Joe</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge CB1 8RN, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Devilee</LastName>
<ForeName>Peter</ForeName>
<Initials>P</Initials>
<AffiliationInfo>
<Affiliation>Department of Human Genetics &amp;Department of Pathology, Leiden University Medical Center, 2300 RC Leiden, The Netherlands.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Dieffenbach</LastName>
<ForeName>Aida K</ForeName>
<Initials>AK</Initials>
<AffiliationInfo>
<Affiliation>1] Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), D-69120 Heidelberg, Germany. [2] German Cancer Consortium (DKTK), D-69120 Heidelberg, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Dunning</LastName>
<ForeName>Alison M</ForeName>
<Initials>AM</Initials>
<AffiliationInfo>
<Affiliation>Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge CB1 8RN, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Eiriksdottir</LastName>
<ForeName>Gudny</ForeName>
<Initials>G</Initials>
<AffiliationInfo>
<Affiliation>Icelandic Heart Association, IS-201 Kopavogur, Iceland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Eriksson</LastName>
<ForeName>Johan G</ForeName>
<Initials>JG</Initials>
<AffiliationInfo>
<Affiliation>1] National Institute for Health and Welfare, P.O. Box 30, FI-00271 Helsinki, Finland. [2] Department of General Practice and Primary health Care, University of Helsinki, FI-00014 Helsinki, Finland. [3] Helsinki University Central Hospital, Unit of General Practice, FI-00029 HUS Helsinki, Finland. [4] Folkhalsan Research Centre, FI-00290 Helsinki, Finland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Fasching</LastName>
<ForeName>Peter A</ForeName>
<Initials>PA</Initials>
<AffiliationInfo>
<Affiliation>University Breast Center Franconia, Department of Gynecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-EMN, D-91054 Erlangen, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Ferrucci</LastName>
<ForeName>Luigi</ForeName>
<Initials>L</Initials>
<AffiliationInfo>
<Affiliation>Longitudinal Studies Section, Clinical Research Branch, Gerontology Research Center, National Institute on Aging, Baltimore, Maryland 20892, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Flesch-Janys</LastName>
<ForeName>Dieter</ForeName>
<Initials>D</Initials>
<AffiliationInfo>
<Affiliation>Department of Cancer Epidemiology/Clinical Cancer Registry and Institute for Medical Biometrics and Epidemiology, University Clinic Hamburg-Eppendorf, D-20246 Hamburg, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Flyger</LastName>
<ForeName>Henrik</ForeName>
<Initials>H</Initials>
<AffiliationInfo>
<Affiliation>Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, DK-2100 Copenhagen, Denmark.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Foroud</LastName>
<ForeName>Tatiana</ForeName>
<Initials>T</Initials>
<AffiliationInfo>
<Affiliation>Department of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, Indiana 46202-3082, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Franke</LastName>
<ForeName>Lude</ForeName>
<Initials>L</Initials>
<AffiliationInfo>
<Affiliation>Department of Genetics, University of Groningen, University Medical Centre Groningen, P.O. Box 72, 9700 AB Groningen, The Netherlands.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Garcia</LastName>
<ForeName>Melissa E</ForeName>
<Initials>ME</Initials>
<AffiliationInfo>
<Affiliation>National Insitute on Aging, National Institutes of Health, Baltimore, Maryland 20892, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>García-Closas</LastName>
<ForeName>Montserrat</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>1] Division of Genetics and Epidemiology, Institute of Cancer Research, Sutton, Surrey SM2 5NG, UK. [2] Breakthrough Breast Cancer Research Centre, Division of Breast Cancer Research, The Institute of Cancer Research, London SW3 6JB, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Geller</LastName>
<ForeName>Frank</ForeName>
<Initials>F</Initials>
<AffiliationInfo>
<Affiliation>Department of Epidemiology Research, Statens Serum Institut, DK-2300 Copenhagen, Denmark.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>de Geus</LastName>
<ForeName>Eco E J</ForeName>
<Initials>EE</Initials>
<AffiliationInfo>
<Affiliation>1] Department of Biological Psychology, VU University Amsterdam, van der Boechorststraat 1, 1081 BT, Amsterdam, The Netherlands. [2] EMGO + Institute for Health and Care Research, VU University Medical Centre, Van der Boechorststraat 7, 1081 Bt, Amsterdam, The Netherlands.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Giles</LastName>
<ForeName>Graham G</ForeName>
<Initials>GG</Initials>
<AffiliationInfo>
<Affiliation>1] Cancer Epidemiology Centre, Cancer Council Victoria, Melbourne, Victoria 3004, Australia. [2] Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Victoria 3010, Australia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Gudbjartsson</LastName>
<ForeName>Daniel F</ForeName>
<Initials>DF</Initials>
<AffiliationInfo>
<Affiliation>1] deCODE Genetics, Reykjavik IS-101, Iceland. [2] Faculty of Medicine, University of Iceland, IS-101 Reykjavik, Iceland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Gudnason</LastName>
<ForeName>Vilmundur</ForeName>
<Initials>V</Initials>
<AffiliationInfo>
<Affiliation>1] Icelandic Heart Association, IS-201 Kopavogur, Iceland. [2] University of Iceland, IS-101 Reykjavik, Iceland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Guénel</LastName>
<ForeName>Pascal</ForeName>
<Initials>P</Initials>
<AffiliationInfo>
<Affiliation>1] Inserm (National Institute of Health and Medical Research), CESP (Center for Research in Epidemiology and Population Health), U1018, Environmental Epidemiology of Cancer, F-94807 Villejuif, France. [2] University Paris-Sud, UMRS 1018, F-94807 Villejuif, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Guo</LastName>
<ForeName>Suiqun</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Department of Obstetrics and Gynecology, Southern Medical University, 510515 Guangzhou, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Hall</LastName>
<ForeName>Per</ForeName>
<Initials>P</Initials>
<AffiliationInfo>
<Affiliation>Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, 17177 Stockholm, Sweden.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Hamann</LastName>
<ForeName>Ute</ForeName>
<Initials>U</Initials>
<AffiliationInfo>
<Affiliation>Molecular Genetics of Breast Cancer, Deutsches Krebsforschungszentrum (DKFZ), D-69120 Heidelberg, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Haring</LastName>
<ForeName>Robin</ForeName>
<Initials>R</Initials>
<AffiliationInfo>
<Affiliation>Institute of Clinical Chemistry and Laboratory Medicine, University Medicine Greifswald, D-17475 Greifswald, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Hartman</LastName>
<ForeName>Catharina A</ForeName>
<Initials>CA</Initials>
<AffiliationInfo>
<Affiliation>Department of Psychiatry, University of Groningen, University Medical Center Groningen, P.O. Box 72, 9700 AB Groningen, The Netherlands.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Heath</LastName>
<ForeName>Andrew C</ForeName>
<Initials>AC</Initials>
<AffiliationInfo>
<Affiliation>Washington University, Department of Psychiatry, St Louis, Missouri 63110, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Hofman</LastName>
<ForeName>Albert</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Department of Epidemiology, Erasmus MC, PO Box 2040, 3000 CA Rotterdam, the Netherlands.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Hooning</LastName>
<ForeName>Maartje J</ForeName>
<Initials>MJ</Initials>
<AffiliationInfo>
<Affiliation>Department of Medical Oncology, Erasmus University Medical Center, P.O. Box 2040, 3000 CA Rotterdam, The Netherlands.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Hopper</LastName>
<ForeName>John L</ForeName>
<Initials>JL</Initials>
<AffiliationInfo>
<Affiliation>Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Victoria 3010, Australia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Hu</LastName>
<ForeName>Frank B</ForeName>
<Initials>FB</Initials>
<AffiliationInfo>
<Affiliation>1] Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts 02115, USA. [2] Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts 02115, USA. [3] Department of Nutrition, Harvard School of Public Health, Boston, Massachusetts 02115, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Hunter</LastName>
<ForeName>David J</ForeName>
<Initials>DJ</Initials>
<AffiliationInfo>
<Affiliation>1] Broad Institute of the Massachusetts Institute of Technology and Harvard University, 140 Cambridge, Massachusetts 02142, USA. [2] Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts 02115, USA. [3] Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts 02115, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Karasik</LastName>
<ForeName>David</ForeName>
<Initials>D</Initials>
<AffiliationInfo>
<Affiliation>1] Harvard Medical School, Boston, Massachusetts 02115, USA. [2] Hebrew SeniorLife Institute for Aging Research, Boston, Massachusetts 02131, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Kiel</LastName>
<ForeName>Douglas P</ForeName>
<Initials>DP</Initials>
<AffiliationInfo>
<Affiliation>1] Hebrew SeniorLife Institute for Aging Research, Boston, Massachusetts 02131, USA. [2] Department of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts 02115, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Knight</LastName>
<ForeName>Julia A</ForeName>
<Initials>JA</Initials>
<AffiliationInfo>
<Affiliation>1] Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Toronto, Ontario M5G 1X5, Canada. [2] Division of Epidemiology, Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario M5T 3M7, Canada.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Kosma</LastName>
<ForeName>Veli-Matti</ForeName>
<Initials>VM</Initials>
<AffiliationInfo>
<Affiliation>1] School of Medicine, Institute of Clinical Medicine, Pathology and Forensic Medicine, University of Eastern Finland, P.O. Box 1627, FI-70211 Kuopio, Finland. [2] Imaging Center, Department of Clinical Pathology, Kuopio University Hospital, P.O. Box 100, FI-70029 Kuopio, Finland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Kutalik</LastName>
<ForeName>Zoltan</ForeName>
<Initials>Z</Initials>
<AffiliationInfo>
<Affiliation>1] Department of Medical Genetics, University of Lausanne, CH-1005 Lausanne, Switzerland. [2] Swiss Institute of Bioinformatics, CH-1015 Lausanne, Switzerland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Lai</LastName>
<ForeName>Sandra</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Institute of Genetics and Biomedical Research, National Research Council, Cagliari, 09042 Sardinia, Italy.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Lambrechts</LastName>
<ForeName>Diether</ForeName>
<Initials>D</Initials>
<AffiliationInfo>
<Affiliation>1] Vesalius Research Center (VRC), VIB, 3000 Leuven, Belgium. [2] Laboratory for Translational Genetics, Department of Oncology, University of Leuven, 3000 Leuven, Belgium.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Lindblom</LastName>
<ForeName>Annika</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Department of Molecular Medicine and Surgery, Karolinska Institutet, SE-171 77 Stockholm, Sweden.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Mägi</LastName>
<ForeName>Reedik</ForeName>
<Initials>R</Initials>
<AffiliationInfo>
<Affiliation>Estonian Genome Center, University of Tartu, Tartu, 51010, Estonia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Magnusson</LastName>
<ForeName>Patrik K</ForeName>
<Initials>PK</Initials>
<AffiliationInfo>
<Affiliation>Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, 17177 Stockholm, Sweden.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Mannermaa</LastName>
<ForeName>Arto</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>1] School of Medicine, Institute of Clinical Medicine, Pathology and Forensic Medicine, University of Eastern Finland, P.O. Box 1627, FI-70211 Kuopio, Finland. [2] Imaging Center, Department of Clinical Pathology, Kuopio University Hospital, P.O. Box 100, FI-70029 Kuopio, Finland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Martin</LastName>
<ForeName>Nicholas G</ForeName>
<Initials>NG</Initials>
<AffiliationInfo>
<Affiliation>Department of Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Queensland 4006 Australia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Masson</LastName>
<ForeName>Gisli</ForeName>
<Initials>G</Initials>
<AffiliationInfo>
<Affiliation>deCODE Genetics, Reykjavik IS-101, Iceland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>McArdle</LastName>
<ForeName>Patrick F</ForeName>
<Initials>PF</Initials>
<AffiliationInfo>
<Affiliation>Program in Personalized and Genomic Medicine, and Department of Medicine, Division of Endocrinology, Diabetes and Nutrition, University of Maryland School of Medicine, Baltimore, Maryland 21201, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>McArdle</LastName>
<ForeName>Wendy L</ForeName>
<Initials>WL</Initials>
<AffiliationInfo>
<Affiliation>School of Social and Community Medicine, University of Bristol, Oakfield House, Oakfield Grove, Bristol BS8 2BN, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Melbye</LastName>
<ForeName>Mads</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>1] Department of Epidemiology Research, Statens Serum Institut, DK-2300 Copenhagen, Denmark. [2] Department of Medicine, Stanford School of Medicine, Stanford, California 94305-5101, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Michailidou</LastName>
<ForeName>Kyriaki</ForeName>
<Initials>K</Initials>
<AffiliationInfo>
<Affiliation>Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge CB1 8RN, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Mihailov</LastName>
<ForeName>Evelin</ForeName>
<Initials>E</Initials>
<AffiliationInfo>
<Affiliation>1] Estonian Genome Center, University of Tartu, Tartu, 51010, Estonia. [2] Department of Biotechnology, University of Tartu, 51010 Tartu, Estonia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Milani</LastName>
<ForeName>Lili</ForeName>
<Initials>L</Initials>
<AffiliationInfo>
<Affiliation>Estonian Genome Center, University of Tartu, Tartu, 51010, Estonia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Milne</LastName>
<ForeName>Roger L</ForeName>
<Initials>RL</Initials>
<AffiliationInfo>
<Affiliation>1] Cancer Epidemiology Centre, Cancer Council Victoria, Melbourne, Victoria 3004, Australia. [2] Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Victoria 3010, Australia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Nevanlinna</LastName>
<ForeName>Heli</ForeName>
<Initials>H</Initials>
<AffiliationInfo>
<Affiliation>Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Central Hospital, P.O. Box 100, FI-00029 HUS Helsinki, Finland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Neven</LastName>
<ForeName>Patrick</ForeName>
<Initials>P</Initials>
<AffiliationInfo>
<Affiliation>KULeuven (University of Leuven), Department of Oncology, Multidisciplinary Breast Center, University Hospitals Leuven, 3000 Leuven, Belgium.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Nohr</LastName>
<ForeName>Ellen A</ForeName>
<Initials>EA</Initials>
<AffiliationInfo>
<Affiliation>Research Unit of Obstetrics &amp;Gynecology, Institute of Clinical Research, University of Southern Denmark, DK-5000 Odense C, Denmark.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Oldehinkel</LastName>
<ForeName>Albertine J</ForeName>
<Initials>AJ</Initials>
<AffiliationInfo>
<Affiliation>Interdisciplinary Center Psychopathology and Emotion Regulation, University of Groningen, University Medical Center Groningen, P.O. Box 30.001, 9700 RB Groningen, The Netherlands.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Oostra</LastName>
<ForeName>Ben A</ForeName>
<Initials>BA</Initials>
<AffiliationInfo>
<Affiliation>Genetic Epidemiology Unit Department of Epidemiology, Erasmus MC, 3015 GE, Rotterdam, the Netherlands.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Palotie</LastName>
<ForeName>Aarno</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>1] Institute for Molecular Medicine Finland (FIMM), University of Helsinki, FI-00014, Finland. [2] Analytic and Translational Genetics Unit, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts 02114, USA. [3] Program in Medical and Population Genetics, Broad Institute, Cambridge, Massachusetts 02142, USA. [4] Psychiatric &amp;Neurodevelopmental Genetics Unit, Department of Psychiatry, Massachusetts General Hospital, Boston, Massachusetts 02114, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Peacock</LastName>
<ForeName>Munro</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Department of Medicine, Indiana University School of Medicine, Indianapolis, Indiana 46202, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Pedersen</LastName>
<ForeName>Nancy L</ForeName>
<Initials>NL</Initials>
<AffiliationInfo>
<Affiliation>Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, 17177 Stockholm, Sweden.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Peterlongo</LastName>
<ForeName>Paolo</ForeName>
<Initials>P</Initials>
<AffiliationInfo>
<Affiliation>IFOM, Fondazione Istituto FIRC di Oncologia Molecolare, 20139 Milan, Italy.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Peto</LastName>
<ForeName>Julian</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>Non-communicable Disease Epidemiology Department, London School of Hygiene and Tropical Medicine, London WC1E 7HT, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Pharoah</LastName>
<ForeName>Paul D P</ForeName>
<Initials>PD</Initials>
<AffiliationInfo>
<Affiliation>Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge CB1 8RN, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Postma</LastName>
<ForeName>Dirkje S</ForeName>
<Initials>DS</Initials>
<AffiliationInfo>
<Affiliation>University Groningen, University Medical Center Groningen, Department Pulmonary Medicine and Tuberculosis, GRIAC Research Institute, P.O. Box 30.001, NL-9700 RB Groningen, The Netherlands.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Pouta</LastName>
<ForeName>Anneli</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>1] National Institute for Health and Welfare, P.O. Box 30, FI-00271 Helsinki, Finland. [2] Department of Obstetrics and Gynecology, Oulu University Hospital, P.O. Box 10, FI-90029 OYS Oulu, Finland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Pylkäs</LastName>
<ForeName>Katri</ForeName>
<Initials>K</Initials>
<AffiliationInfo>
<Affiliation>Laboratory of Cancer Genetics and Tumor Biology, Department of Clinical Chemistry and Biocenter Oulu, University of Oulu, Oulu University Hospital/NordLab Oulu, P.O. Box 3000, FI-90014 Oulu, Finland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Radice</LastName>
<ForeName>Paolo</ForeName>
<Initials>P</Initials>
<AffiliationInfo>
<Affiliation>Unit of Molecular Bases of Genetic Risk and Genetic Testing, Department of Preventive and Predictive Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori (INT), 20133 Milan, Italy.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Ring</LastName>
<ForeName>Susan</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>1] MRC Integrative Epidemiology Unit, University of Bristol, Bristol BS8 2BN, UK. [2] School of Social and Community Medicine, University of Bristol, Oakfield House, Oakfield Grove, Bristol BS8 2BN, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Rivadeneira</LastName>
<ForeName>Fernando</ForeName>
<Initials>F</Initials>
<AffiliationInfo>
<Affiliation>1] Department of Internal Medicine, Erasmus MC, 3015 GE Rotterdam, the Netherlands. [2] Netherlands Consortium on Health Aging and National Genomics Initiative, 2300 RC Leiden, the Netherlands. [3] Department of Epidemiology, Erasmus MC, PO Box 2040, 3000 CA Rotterdam, the Netherlands.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Robino</LastName>
<ForeName>Antonietta</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>1] Institute for Maternal and Child Health - IRCCS "Burlo Garofolo", 34137 Trieste, Italy. [2] Department of Clinical Medical Sciences, Surgical and Health, University of Trieste, 34149 Trieste, Italy.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Rose</LastName>
<ForeName>Lynda M</ForeName>
<Initials>LM</Initials>
<AffiliationInfo>
<Affiliation>Division of Preventive Medicine, Brigham and Women's Hospital, Boston, Massachusetts 02215, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Rudolph</LastName>
<ForeName>Anja</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), D-69120 Heidelberg, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Salomaa</LastName>
<ForeName>Veikko</ForeName>
<Initials>V</Initials>
<AffiliationInfo>
<Affiliation>National Institute for Health and Welfare, P.O. Box 30, FI-00271 Helsinki, Finland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Sanna</LastName>
<ForeName>Serena</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Institute of Genetics and Biomedical Research, National Research Council, Cagliari, 09042 Sardinia, Italy.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Schlessinger</LastName>
<ForeName>David</ForeName>
<Initials>D</Initials>
<AffiliationInfo>
<Affiliation>National Institute on Aging, Intramural Research Program, Baltimore, Maryland 21224-6825, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Schmidt</LastName>
<ForeName>Marjanka K</ForeName>
<Initials>MK</Initials>
<AffiliationInfo>
<Affiliation>Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Postbus 90203, 1006 BE Amsterdam, The Netherlands.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Southey</LastName>
<ForeName>Mellissa C</ForeName>
<Initials>MC</Initials>
<AffiliationInfo>
<Affiliation>Department of Pathology, The University of Melbourne, Melbourne, Victoria 3010, Australia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Sovio</LastName>
<ForeName>Ulla</ForeName>
<Initials>U</Initials>
<AffiliationInfo>
<Affiliation>1] Department of Epidemiology and Biostatistics, MRC Health Protection Agency (HPA) Centre for Environment and Health, School of Public Health, Imperial College London, London W2 1PG, UK. [2] Department of Obstetrics and Gynaecology, University of Cambridge, Cambridge CB2 0SW, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Stampfer</LastName>
<ForeName>Meir J</ForeName>
<Initials>MJ</Initials>
<AffiliationInfo>
<Affiliation>1] Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts 02115, USA. [2] Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts 02115, USA. [3] Department of Nutrition, Harvard School of Public Health, Boston, Massachusetts 02115, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Stöckl</LastName>
<ForeName>Doris</ForeName>
<Initials>D</Initials>
<AffiliationInfo>
<Affiliation>1] Institute of Epidemiology II, Helmholtz Zentrum München - German Research Center for Environmental Health, D-8576 Neuherberg, Germany. [2] Department of Obstetrics and Gynaecology, Campus Grosshadern, Ludwig-Maximilians-University, D-81377 Munich, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Storniolo</LastName>
<ForeName>Anna M</ForeName>
<Initials>AM</Initials>
<AffiliationInfo>
<Affiliation>Department of Medicine, Indiana University School of Medicine, Indianapolis, Indiana 46202, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Timpson</LastName>
<ForeName>Nicholas J</ForeName>
<Initials>NJ</Initials>
<AffiliationInfo>
<Affiliation>1] MRC Integrative Epidemiology Unit, University of Bristol, Bristol BS8 2BN, UK. [2] School of Social and Community Medicine, University of Bristol, Oakfield House, Oakfield Grove, Bristol BS8 2BN, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Tyrer</LastName>
<ForeName>Jonathan</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge CB1 8RN, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Visser</LastName>
<ForeName>Jenny A</ForeName>
<Initials>JA</Initials>
<AffiliationInfo>
<Affiliation>Department of Internal Medicine, Erasmus MC, 3015 GE Rotterdam, the Netherlands.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Vollenweider</LastName>
<ForeName>Peter</ForeName>
<Initials>P</Initials>
<AffiliationInfo>
<Affiliation>Department of Internal Medicine, Lausanne University Hospital, CH-1015 Lausanne, Switzerland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Völzke</LastName>
<ForeName>Henry</ForeName>
<Initials>H</Initials>
<AffiliationInfo>
<Affiliation>1] Institute for Community Medicine, University Medicine Greifswald, D-17475 Greifswald, Germany. [2] DZHK (German Centre for Cardiovascular Research), partner site Greifswald, D-17475 Greifswald, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Waeber</LastName>
<ForeName>Gerard</ForeName>
<Initials>G</Initials>
<AffiliationInfo>
<Affiliation>Department of Internal Medicine, Lausanne University Hospital, CH-1015 Lausanne, Switzerland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Waldenberger</LastName>
<ForeName>Melanie</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Research Unit of Molecular Epidemiology, Helmholtz Zentrum München - German Research Center for Environmental Health, D-8576 Neuherberg, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Wallaschofski</LastName>
<ForeName>Henri</ForeName>
<Initials>H</Initials>
<AffiliationInfo>
<Affiliation>1] Institute of Clinical Chemistry and Laboratory Medicine, University Medicine Greifswald, D-17475 Greifswald, Germany. [2] DZHK (German Centre for Cardiovascular Research), partner site Greifswald, D-17475 Greifswald, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Wang</LastName>
<ForeName>Qin</ForeName>
<Initials>Q</Initials>
<AffiliationInfo>
<Affiliation>Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge CB1 8RN, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Willemsen</LastName>
<ForeName>Gonneke</ForeName>
<Initials>G</Initials>
<AffiliationInfo>
<Affiliation>Department of Biological Psychology, VU University Amsterdam, van der Boechorststraat 1, 1081 BT, Amsterdam, The Netherlands.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Winqvist</LastName>
<ForeName>Robert</ForeName>
<Initials>R</Initials>
<AffiliationInfo>
<Affiliation>Laboratory of Cancer Genetics and Tumor Biology, Department of Clinical Chemistry and Biocenter Oulu, University of Oulu, Oulu University Hospital/NordLab Oulu, P.O. Box 3000, FI-90014 Oulu, Finland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Wolffenbuttel</LastName>
<ForeName>Bruce H R</ForeName>
<Initials>BH</Initials>
<AffiliationInfo>
<Affiliation>Department of Endocrinology, University of Groningen, University Medical Centre Groningen, P.O. Box 72, 9700 AB Groningen, The Netherlands.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Wright</LastName>
<ForeName>Margaret J</ForeName>
<Initials>MJ</Initials>
<AffiliationInfo>
<Affiliation>Queensland Insitute of Medical Research, Brisbane, Queensland 4029, Australia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<CollectiveName>Australian Ovarian Cancer Study</CollectiveName>
</Author>
<Author ValidYN="Y">
<CollectiveName>GENICA Network</CollectiveName>
</Author>
<Author ValidYN="Y">
<CollectiveName>kConFab</CollectiveName>
</Author>
<Author ValidYN="Y">
<CollectiveName>LifeLines Cohort Study</CollectiveName>
</Author>
<Author ValidYN="Y">
<CollectiveName>InterAct Consortium</CollectiveName>
</Author>
<Author ValidYN="Y">
<CollectiveName>Early Growth Genetics (EGG) Consortium</CollectiveName>
</Author>
<Author ValidYN="Y">
<LastName>Boomsma</LastName>
<ForeName>Dorret I</ForeName>
<Initials>DI</Initials>
<AffiliationInfo>
<Affiliation>Department of Biological Psychology, VU University Amsterdam, van der Boechorststraat 1, 1081 BT, Amsterdam, The Netherlands.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Econs</LastName>
<ForeName>Michael J</ForeName>
<Initials>MJ</Initials>
<AffiliationInfo>
<Affiliation>1] Department of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, Indiana 46202-3082, USA. [2] Department of Medicine, Indiana University School of Medicine, Indianapolis, Indiana 46202, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Khaw</LastName>
<ForeName>Kay-Tee</ForeName>
<Initials>KT</Initials>
<AffiliationInfo>
<Affiliation>Department of Public Health and Primary Care, Institute of Public Health, University of Cambridge, Cambridge CB2 0QQ, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Loos</LastName>
<ForeName>Ruth J F</ForeName>
<Initials>RJ</Initials>
<AffiliationInfo>
<Affiliation>1] MRC Epidemiology Unit, University of Cambridge School of Clinical Medicine, Box 285 Institute of Metabolic Science, Cambridge Biomedical Campus, Cambridge CB2 0QQ, UK. [2] Genetics of Obesity and Related Metabolic Traits Program, The Charles Bronfman Institute for Personalized Medicine, The Mindich Child Health and Development Institute, Department of Preventive Medicine, Icahn School of Medicine at Mount Sinai, 1 Gustave L Levy Place, Box 1003, New York, New York 10029, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>McCarthy</LastName>
<ForeName>Mark I</ForeName>
<Initials>MI</Initials>
<AffiliationInfo>
<Affiliation>1] Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford OX3 7BN, UK. [2] NIHR Oxford Biomedical Research Centre, Churchill Hospital, Oxford OX3 7LE, UK. [3] Oxford Centre for Diabetes, Endocrinology, &amp;Metabolism, University of Oxford, Churchill Hospital, Oxford OX3 7LJ, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Montgomery</LastName>
<ForeName>Grant W</ForeName>
<Initials>GW</Initials>
<AffiliationInfo>
<Affiliation>Queensland Insitute of Medical Research, Brisbane, Queensland 4029, Australia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Rice</LastName>
<ForeName>John P</ForeName>
<Initials>JP</Initials>
<AffiliationInfo>
<Affiliation>Department of Psychiatry, Washington University, St Louis, Missouri 63110, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Streeten</LastName>
<ForeName>Elizabeth A</ForeName>
<Initials>EA</Initials>
<AffiliationInfo>
<Affiliation>1] Program in Personalized and Genomic Medicine, and Department of Medicine, Division of Endocrinology, Diabetes and Nutrition, University of Maryland School of Medicine, Baltimore, Maryland 21201, USA. [2] Geriatric Research and Education Clinical Center (GRECC) - Veterans Administration Medical Center, Baltimore, Maryland 21201, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Thorsteinsdottir</LastName>
<ForeName>Unnur</ForeName>
<Initials>U</Initials>
<AffiliationInfo>
<Affiliation>1] deCODE Genetics, Reykjavik IS-101, Iceland. [2] Faculty of Medicine, University of Iceland, IS-101 Reykjavik, Iceland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>van Duijn</LastName>
<ForeName>Cornelia M</ForeName>
<Initials>CM</Initials>
<AffiliationInfo>
<Affiliation>1] Netherlands Consortium on Health Aging and National Genomics Initiative, 2300 RC Leiden, the Netherlands. [2] Genetic Epidemiology Unit Department of Epidemiology, Erasmus MC, 3015 GE, Rotterdam, the Netherlands. [3] Centre of Medical Systems Biology, PO Box 9600, 2300 RC Leiden, the Netherlands.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Alizadeh</LastName>
<ForeName>Behrooz Z</ForeName>
<Initials>BZ</Initials>
<AffiliationInfo>
<Affiliation>Department of Epidemiology, University of Groningen, University Medical Center Groningen, 9700 RB Groningen, The Netherlands.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Bergmann</LastName>
<ForeName>Sven</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>1] Department of Medical Genetics, University of Lausanne, CH-1005 Lausanne, Switzerland. [2] Swiss Institute of Bioinformatics, CH-1015 Lausanne, Switzerland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Boerwinkle</LastName>
<ForeName>Eric</ForeName>
<Initials>E</Initials>
<AffiliationInfo>
<Affiliation>Human Genetics Center and Divof Epidemiology, University of Houston, P.O. Box 20186, Texas 77025 USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Boyd</LastName>
<ForeName>Heather A</ForeName>
<Initials>HA</Initials>
<AffiliationInfo>
<Affiliation>Department of Epidemiology Research, Statens Serum Institut, DK-2300 Copenhagen, Denmark.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Crisponi</LastName>
<ForeName>Laura</ForeName>
<Initials>L</Initials>
<AffiliationInfo>
<Affiliation>Institute of Genetics and Biomedical Research, National Research Council, Cagliari, 09042 Sardinia, Italy.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Gasparini</LastName>
<ForeName>Paolo</ForeName>
<Initials>P</Initials>
<AffiliationInfo>
<Affiliation>1] Institute for Maternal and Child Health - IRCCS "Burlo Garofolo", 34137 Trieste, Italy. [2] Department of Clinical Medical Sciences, Surgical and Health, University of Trieste, 34149 Trieste, Italy.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Gieger</LastName>
<ForeName>Christian</ForeName>
<Initials>C</Initials>
<AffiliationInfo>
<Affiliation>Institute of Genetic Epidemiology, Helmholtz Zentrum München - German Research Center for Environmental Health, D-85764 Neuherberg, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Harris</LastName>
<ForeName>Tamara B</ForeName>
<Initials>TB</Initials>
<AffiliationInfo>
<Affiliation>National Insitute on Aging, National Institutes of Health, Baltimore, Maryland 20892, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Ingelsson</LastName>
<ForeName>Erik</ForeName>
<Initials>E</Initials>
<AffiliationInfo>
<Affiliation>Department of Medical Sciences, Molecular Epidemiology and Science for Life Laboratory, Uppsala University, Box 256, 751 05 Uppsala, Sweden.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Järvelin</LastName>
<ForeName>Marjo-Riitta</ForeName>
<Initials>MR</Initials>
<AffiliationInfo>
<Affiliation>1] Department of Epidemiology and Biostatistics, MRC Health Protection Agency (HPA) Centre for Environment and Health, School of Public Health, Imperial College London, London W2 1PG, UK. [2] Institute of Health Sciences, University of Oulu, P.O. Box 5000, FI-90014 Oulu, Finland. [3] Biocenter Oulu, University of Oulu, P.O. Box 5000, Aapistie 5A, FI-90014 Oulu, Finland. [4] Department of Children and Young People and Families, National Institute for Health and Welfare, Aapistie 1, Box 310, FI-90101 Oulu, Finland. [5] Unit of Primary Care, Oulu University Hospital, Kajaanintie 50, P.O. Box 20, FI-90220 Oulu, 90029 OYS, Finland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Kraft</LastName>
<ForeName>Peter</ForeName>
<Initials>P</Initials>
<AffiliationInfo>
<Affiliation>1] Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts 02115, USA. [2] Department of Biostatistics, Harvard School of Public Health, Boston, Massachusetts 02115, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Lawlor</LastName>
<ForeName>Debbie</ForeName>
<Initials>D</Initials>
<AffiliationInfo>
<Affiliation>1] MRC Integrative Epidemiology Unit, University of Bristol, Bristol BS8 2BN, UK. [2] School of Social and Community Medicine, University of Bristol, Oakfield House, Oakfield Grove, Bristol BS8 2BN, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Metspalu</LastName>
<ForeName>Andres</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>1] Estonian Genome Center, University of Tartu, Tartu, 51010, Estonia. [2] Department of Biotechnology, University of Tartu, 51010 Tartu, Estonia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Pennell</LastName>
<ForeName>Craig E</ForeName>
<Initials>CE</Initials>
<AffiliationInfo>
<Affiliation>School of Women's and Infants' Health, The University of Western Australia, WA-6009, Australia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Ridker</LastName>
<ForeName>Paul M</ForeName>
<Initials>PM</Initials>
<AffiliationInfo>
<Affiliation>1] Division of Preventive Medicine, Brigham and Women's Hospital, Boston, Massachusetts 02215, USA. [2] Harvard Medical School, Boston, Massachusetts 02115, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Snieder</LastName>
<ForeName>Harold</ForeName>
<Initials>H</Initials>
<AffiliationInfo>
<Affiliation>Department of Epidemiology, University of Groningen, University Medical Center Groningen, 9700 RB Groningen, The Netherlands.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Sørensen</LastName>
<ForeName>Thorkild I A</ForeName>
<Initials>TI</Initials>
<AffiliationInfo>
<Affiliation>1] Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, DK-2200, Denmark. [2] Institute of Preventive Medicine, Bispebjerg and Frederiksberg Hospitals, The Capital Region, Copenhagen, DK-2000 Frederiksberg, Denmark.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Spector</LastName>
<ForeName>Tim D</ForeName>
<Initials>TD</Initials>
<AffiliationInfo>
<Affiliation>Department of Twin Research and Genetic Epidemiology, King's College London, London SE1 7EH, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Strachan</LastName>
<ForeName>David P</ForeName>
<Initials>DP</Initials>
<AffiliationInfo>
<Affiliation>Division of Population Health Sciences and Education, St George's, University of London, Cranmer Terrace, London SW17 0RE, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Uitterlinden</LastName>
<ForeName>André G</ForeName>
<Initials>AG</Initials>
<AffiliationInfo>
<Affiliation>1] Department of Internal Medicine, Erasmus MC, 3015 GE Rotterdam, the Netherlands. [2] Netherlands Consortium on Health Aging and National Genomics Initiative, 2300 RC Leiden, the Netherlands. [3] Department of Epidemiology, Erasmus MC, PO Box 2040, 3000 CA Rotterdam, the Netherlands.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Wareham</LastName>
<ForeName>Nicholas J</ForeName>
<Initials>NJ</Initials>
<AffiliationInfo>
<Affiliation>MRC Epidemiology Unit, University of Cambridge School of Clinical Medicine, Box 285 Institute of Metabolic Science, Cambridge Biomedical Campus, Cambridge CB2 0QQ, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Widen</LastName>
<ForeName>Elisabeth</ForeName>
<Initials>E</Initials>
<AffiliationInfo>
<Affiliation>Institute for Molecular Medicine Finland (FIMM), University of Helsinki, FI-00014, Finland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Zygmunt</LastName>
<ForeName>Marek</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Department of Obstetrics and Gynecology, University Medicine Greifswald, D-17475 Greifswald, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Murray</LastName>
<ForeName>Anna</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>University of Exeter Medical School, University of Exeter, Exeter EX1 2LU, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Easton</LastName>
<ForeName>Douglas F</ForeName>
<Initials>DF</Initials>
<AffiliationInfo>
<Affiliation>Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge CB1 8RN, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Stefansson</LastName>
<ForeName>Kari</ForeName>
<Initials>K</Initials>
<AffiliationInfo>
<Affiliation>1] deCODE Genetics, Reykjavik IS-101, Iceland. [2] Faculty of Medicine, University of Iceland, IS-101 Reykjavik, Iceland. [3].</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Murabito</LastName>
<ForeName>Joanne M</ForeName>
<Initials>JM</Initials>
<AffiliationInfo>
<Affiliation>1] NHLBI's and Boston University's Framingham Heart Study, Framingham, Massachusetts 01702-5827, USA. [2] Boston University School of Medicine, Department of Medicine, Section of General Internal Medicine, Boston, Massachusetts 02118, USA. [3].</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Ong</LastName>
<ForeName>Ken K</ForeName>
<Initials>KK</Initials>
<AffiliationInfo>
<Affiliation>1] MRC Epidemiology Unit, University of Cambridge School of Clinical Medicine, Box 285 Institute of Metabolic Science, Cambridge Biomedical Campus, Cambridge CB2 0QQ, UK. [2] Department of Paediatrics, University of Cambridge, Cambridge CB2 0QQ, UK. [3].</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>14136</GrantID>
<Agency>Cancer Research UK</Agency>
<Country>United Kingdom</Country>
</Grant>
<Grant>
<GrantID>16561</GrantID>
<Agency>Cancer Research UK</Agency>
<Country>United Kingdom</Country>
</Grant>
<Grant>
<GrantID>G1000143</GrantID>
<Agency>Medical Research Council</Agency>
<Country>United Kingdom</Country>
</Grant>
<Grant>
<GrantID>MC_UU_12013/3</GrantID>
<Agency>Medical Research Council</Agency>
<Country>United Kingdom</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>07</Month>
<Day>23</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>England</Country>
<MedlineTA>Nature</MedlineTA>
<NlmUniqueID>0410462</NlmUniqueID>
<ISSNLinking>0028-0836</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C512941">DLK1 protein, human</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D036341">Intercellular Signaling Peptides and Proteins</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C498655">KCNK9 protein, human</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C510822">MAGEL2 protein, human</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C119425">MKRN3 protein, human</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D008565">Membrane Proteins</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D024683">Potassium Channels, Tandem Pore Domain</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D011506">Proteins</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D018080">Receptors, GABA-B</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D018168">Receptors, Retinoic Acid</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D012261">Ribonucleoproteins</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C496192">WDR25 protein, human</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000293">Adolescent</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000367">Age Factors</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D000483">Alleles</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015992">Body Mass Index</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001943">Breast Neoplasms</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000235">genetics</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002318">Cardiovascular Diseases</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000235">genetics</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002648">Child</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D003924">Diabetes Mellitus, Type 2</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000235">genetics</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" Type="Geographic" UI="D005060">Europe</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000208">ethnology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D056426">Genetic Loci</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000235">genetics</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D055106">Genome-Wide Association Study</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D018392">Genomic Imprinting</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000235">genetics</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007030">Hypothalamo-Hypophyseal System</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000502">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D036341">Intercellular Signaling Peptides and Proteins</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000235">genetics</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008565">Membrane Proteins</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000235">genetics</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008572">Menarche</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000235">genetics</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009765">Obesity</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000235">genetics</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D010053">Ovary</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000502">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D010290">Parents</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D020641">Polymorphism, Single Nucleotide</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000235">genetics</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D024683">Potassium Channels, Tandem Pore Domain</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000235">genetics</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011506">Proteins</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000235">genetics</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D040641">Quantitative Trait Loci</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000235">genetics</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D018080">Receptors, GABA-B</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D018168">Receptors, Retinoic Acid</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012261">Ribonucleoproteins</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000235">genetics</QualifierName>
</MeshHeading>
</MeshHeadingList>
<OtherID Source="NLM">EMS58897 [Available on 04/02/15]</OtherID>
<OtherID Source="NLM">PMC4185210 [Available on 04/02/15]</OtherID>
<InvestigatorList>
<Investigator ValidYN="Y">
<LastName>Cousminer</LastName>
<ForeName>Diana L</ForeName>
<Initials>DL</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Stergiakouli</LastName>
<ForeName>Evangelia</ForeName>
<Initials>E</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Berry</LastName>
<ForeName>Diane J</ForeName>
<Initials>DJ</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Ang</LastName>
<ForeName>Wei</ForeName>
<Initials>W</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Groen-Blokhuis</LastName>
<ForeName>Maria M</ForeName>
<Initials>MM</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Körner</LastName>
<ForeName>Antje</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Siitonen</LastName>
<ForeName>Niina</ForeName>
<Initials>N</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Ntalla</LastName>
<ForeName>Ioanna</ForeName>
<Initials>I</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Marinelli</LastName>
<ForeName>Marcella</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Perry</LastName>
<ForeName>John R  B</ForeName>
<Initials>JR</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Kettunen</LastName>
<ForeName>Johannes</ForeName>
<Initials>J</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Jansen</LastName>
<ForeName>Rick</ForeName>
<Initials>R</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Surakka</LastName>
<ForeName>Ida</ForeName>
<Initials>I</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Timpson</LastName>
<ForeName>Nicholas J</ForeName>
<Initials>NJ</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Ring</LastName>
<ForeName>Susan</ForeName>
<Initials>S</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>McMahon</LastName>
<ForeName>George</ForeName>
<Initials>G</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Power</LastName>
<ForeName>Chris</ForeName>
<Initials>C</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Wang</LastName>
<ForeName>Carol</ForeName>
<Initials>C</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Kähönen</LastName>
<ForeName>Mika</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Viikari</LastName>
<ForeName>Jorma</ForeName>
<Initials>J</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Lehtimäki</LastName>
<ForeName>Terho</ForeName>
<Initials>T</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Middeldorp</LastName>
<ForeName>Christel M</ForeName>
<Initials>CM</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Hulshoff</LastName>
<ForeName>Hilleke E</ForeName>
<Initials>HE</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Neef</LastName>
<ForeName>Madlen</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Weise</LastName>
<ForeName>Sebastian</ForeName>
<Initials>S</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Pahkala</LastName>
<ForeName>Katja</ForeName>
<Initials>K</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Niinikoski</LastName>
<ForeName>Harri</ForeName>
<Initials>H</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Zeggini</LastName>
<ForeName>Eleftheria</ForeName>
<Initials>E</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Panoutsopoulou</LastName>
<ForeName>Kalliope</ForeName>
<Initials>K</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Bustamante</LastName>
<ForeName>Mariona</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Penninx</LastName>
<ForeName>Brenda W  J  H</ForeName>
<Initials>BW</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Murabito</LastName>
<ForeName>Joanne</ForeName>
<Initials>J</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Torrent</LastName>
<ForeName>Maties</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Dedoussis</LastName>
<ForeName>George V</ForeName>
<Initials>GV</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Kiess</LastName>
<ForeName>Wieland</ForeName>
<Initials>W</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Boomsma</LastName>
<ForeName>Dorret I</ForeName>
<Initials>DI</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Pennell</LastName>
<ForeName>Craig E</ForeName>
<Initials>CE</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Raitakari</LastName>
<ForeName>Olli T</ForeName>
<Initials>OT</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Hyppönen</LastName>
<ForeName>Elina</ForeName>
<Initials>E</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Davey  Smith</LastName>
<ForeName>George</ForeName>
<Initials>G</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Ripatti</LastName>
<ForeName>Samuli</ForeName>
<Initials>S</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>McCarthy</LastName>
<ForeName>Mark I</ForeName>
<Initials>MI</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Widén</LastName>
<ForeName>Elisabeth</ForeName>
<Initials>E</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Alizadeh</LastName>
<ForeName>Behrooz Z</ForeName>
<Initials>BZ</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>de Boer</LastName>
<ForeName>Rudolf A</ForeName>
<Initials>RA</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Boezen</LastName>
<ForeName>H Marike</ForeName>
<Initials>HM</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Bruinenberg</LastName>
<ForeName>Marcel</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Franke</LastName>
<ForeName>Lude</ForeName>
<Initials>L</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>van der Harst</LastName>
<ForeName>Pim</ForeName>
<Initials>P</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Hillege</LastName>
<ForeName>Hans L</ForeName>
<Initials>HL</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>van der Klauw</LastName>
<ForeName>Melanie M</ForeName>
<Initials>MM</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Navis</LastName>
<ForeName>Gerjan</ForeName>
<Initials>G</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Ormel</LastName>
<ForeName>Johan</ForeName>
<Initials>J</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Postma</LastName>
<ForeName>Dirkje  S</ForeName>
<Initials>D</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Rosmalen</LastName>
<ForeName>Judith G M</ForeName>
<Initials>JG</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Slaets</LastName>
<ForeName>Joris P</ForeName>
<Initials>JP</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Snieder</LastName>
<ForeName>Harold</ForeName>
<Initials>H</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Stolk</LastName>
<ForeName>Ronald P</ForeName>
<Initials>RP</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Wolffenbuttel</LastName>
<ForeName>Bruce H R</ForeName>
<Initials>BH</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Wijmenga</LastName>
<ForeName>Cisca</ForeName>
<Initials>C</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Forouhi</LastName>
<ForeName>Nita  G</ForeName>
<Initials>N</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Kerrison</LastName>
<ForeName>Nicola D</ForeName>
<Initials>ND</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Langenberg</LastName>
<ForeName>Claudia</ForeName>
<Initials>C</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Scott</LastName>
<ForeName>Robert A</ForeName>
<Initials>RA</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Sharp</LastName>
<ForeName>Stephen J</ForeName>
<Initials>SJ</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Sims</LastName>
<ForeName>Matt</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Barroso</LastName>
<ForeName>Inês</ForeName>
<Initials>I</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Deloukas</LastName>
<ForeName>Panos</ForeName>
<Initials>P</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>McCarthy</LastName>
<ForeName>Mark I</ForeName>
<Initials>MI</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Arriola</LastName>
<ForeName>Larraitz</ForeName>
<Initials>L</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Balkau</LastName>
<ForeName>Beverley</ForeName>
<Initials>B</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Barricarte</LastName>
<ForeName>Aurelio</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Boeing</LastName>
<ForeName>Heiner</ForeName>
<Initials>H</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Franks</LastName>
<ForeName>Paul W</ForeName>
<Initials>PW</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Gonzalez</LastName>
<ForeName>Carlos</ForeName>
<Initials>C</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Grioni</LastName>
<ForeName>Sara</ForeName>
<Initials>S</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Kaaks</LastName>
<ForeName>Rudolf</ForeName>
<Initials>R</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Key</LastName>
<ForeName>Timothy J</ForeName>
<Initials>TJ</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Navarro</LastName>
<ForeName>Carmen</ForeName>
<Initials>C</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Nilsson</LastName>
<ForeName>Peter M</ForeName>
<Initials>PM</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Overvad</LastName>
<ForeName>Kim</ForeName>
<Initials>K</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Palli</LastName>
<ForeName>Domenico</ForeName>
<Initials>D</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Panico</LastName>
<ForeName>Salvatore</ForeName>
<Initials>S</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Quirós</LastName>
<ForeName>J  Ramón</ForeName>
<Initials>J</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Rolandsson</LastName>
<ForeName>Olov</ForeName>
<Initials>O</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Sacerdote</LastName>
<ForeName>Carlotta</ForeName>
<Initials>C</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Sánchez</LastName>
<ForeName>María-José</ForeName>
<Initials>MJ</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Slimani</LastName>
<ForeName>Nadia</ForeName>
<Initials>N</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Tjonneland</LastName>
<ForeName>Anne</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Tumino</LastName>
<ForeName>Rosario</ForeName>
<Initials>R</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>van der A</LastName>
<ForeName>Daphne L</ForeName>
<Initials>DL</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>van der Schouw</LastName>
<ForeName>Yvonne T</ForeName>
<Initials>YT</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Riboli</LastName>
<ForeName>Elio</ForeName>
<Initials>E</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Wareham</LastName>
<ForeName>Nicholas J</ForeName>
<Initials>NJ</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Bowtell</LastName>
<ForeName>David D</ForeName>
<Initials>DD</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Green</LastName>
<ForeName>Adele  C</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Chenevix-Trench</LastName>
<ForeName>Georgia</ForeName>
<Initials>G</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>deFazio</LastName>
<ForeName>Anna</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Gertig</LastName>
<ForeName>Dorota</ForeName>
<Initials>D</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Webb</LastName>
<ForeName>Penelope M</ForeName>
<Initials>PM</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Brauch</LastName>
<ForeName>Hiltrud</ForeName>
<Initials>H</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Justenhoven</LastName>
<ForeName>Christina</ForeName>
<Initials>C</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Hamann</LastName>
<ForeName>Ute</ForeName>
<Initials>U</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Ko</LastName>
<ForeName>Yon-Dschun</ForeName>
<Initials>YD</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Baisch</LastName>
<ForeName>Christian</ForeName>
<Initials>C</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Fischer</LastName>
<ForeName>Hans-Peter</ForeName>
<Initials>HP</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Pesch</LastName>
<ForeName>Beate</ForeName>
<Initials>B</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Rabstein</LastName>
<ForeName>Sylvia</ForeName>
<Initials>S</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Spickenheuer</LastName>
<ForeName>Anne</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Harth</LastName>
<ForeName>Volker</ForeName>
<Initials>V</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Aghmesheh</LastName>
<ForeName>Morteza</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Amor</LastName>
<ForeName>David</ForeName>
<Initials>D</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Andrews</LastName>
<ForeName>Lesley</ForeName>
<Initials>L</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Antill</LastName>
<ForeName>Yoland</ForeName>
<Initials>Y</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Armitage</LastName>
<ForeName>Shane</ForeName>
<Initials>S</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Arnold</LastName>
<ForeName>Leanne</ForeName>
<Initials>L</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Balleine</LastName>
<ForeName>Rosemary</ForeName>
<Initials>R</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Bankier</LastName>
<ForeName>Agnes</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Bastick</LastName>
<ForeName>Patti</ForeName>
<Initials>P</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Beesley</LastName>
<ForeName>Jonathan</ForeName>
<Initials>J</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Beilby</LastName>
<ForeName>John</ForeName>
<Initials>J</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Bennett</LastName>
<ForeName>Ian</ForeName>
<Initials>I</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Bennett</LastName>
<ForeName>Barbara</ForeName>
<Initials>B</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Berry</LastName>
<ForeName>Geoffrey</ForeName>
<Initials>G</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Blackburn</LastName>
<ForeName>Anneke</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Bogwitz</LastName>
<ForeName>Michael</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Brennan</LastName>
<ForeName>Meagan</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Brown</LastName>
<ForeName>Melissa</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Buckley</LastName>
<ForeName>Michael</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Burgess</LastName>
<ForeName>Matthew</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Burke</LastName>
<ForeName>Jo</ForeName>
<Initials>J</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Butow</LastName>
<ForeName>Phyllis</ForeName>
<Initials>P</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Byron</LastName>
<ForeName>Keith</ForeName>
<Initials>K</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Callen</LastName>
<ForeName>David</ForeName>
<Initials>D</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Campbell</LastName>
<ForeName>Ian</ForeName>
<Initials>I</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Chauhan</LastName>
<ForeName>Deepa</ForeName>
<Initials>D</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Chenevix-Trench</LastName>
<ForeName>Georgia</ForeName>
<Initials>G</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Christian</LastName>
<ForeName>Alice</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Clarke</LastName>
<ForeName>Christine</ForeName>
<Initials>C</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Colley</LastName>
<ForeName>Alison</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Cotton</LastName>
<ForeName>Dick</ForeName>
<Initials>D</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Crook</LastName>
<ForeName>Ashley</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Cui</LastName>
<ForeName>James</ForeName>
<Initials>J</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Culling</LastName>
<ForeName>Bronwyn</ForeName>
<Initials>B</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Cummings</LastName>
<ForeName>Margaret</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Dawson</LastName>
<ForeName>Sarah-Jane</ForeName>
<Initials>SJ</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>deFazio</LastName>
<ForeName>Anna</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Delatycki</LastName>
<ForeName>Martin</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Dickson</LastName>
<ForeName>Rebecca</ForeName>
<Initials>R</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Dixon</LastName>
<ForeName>Joanne</ForeName>
<Initials>J</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Dobrovic</LastName>
<ForeName>Alexander</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Dudding</LastName>
<ForeName>Tracy</ForeName>
<Initials>T</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Edkins</LastName>
<ForeName>Ted</ForeName>
<Initials>T</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Edwards</LastName>
<ForeName>Stacey</ForeName>
<Initials>S</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Eisenbruch</LastName>
<ForeName>Maurice</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Farshid</LastName>
<ForeName>Gelareh</ForeName>
<Initials>G</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Fawcett</LastName>
<ForeName>Susan</ForeName>
<Initials>S</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Fellows</LastName>
<ForeName>Andrew</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Fenton</LastName>
<ForeName>Georgina</ForeName>
<Initials>G</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Field</LastName>
<ForeName>Michael</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Firgaira</LastName>
<ForeName>Frank</ForeName>
<Initials>F</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Flanagan</LastName>
<ForeName>James</ForeName>
<Initials>J</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Fleming</LastName>
<ForeName>Jean</ForeName>
<Initials>J</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Fong</LastName>
<ForeName>Peter</ForeName>
<Initials>P</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Forbes</LastName>
<ForeName>John</ForeName>
<Initials>J</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Fox</LastName>
<ForeName>Stephen</ForeName>
<Initials>S</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>French</LastName>
<ForeName>Juliet</ForeName>
<Initials>J</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Friedlander</LastName>
<ForeName>Michael</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Gaff</LastName>
<ForeName>Clara</ForeName>
<Initials>C</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Gardner</LastName>
<ForeName>Mac</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Gattas</LastName>
<ForeName>Mike</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>George</LastName>
<ForeName>Peter</ForeName>
<Initials>P</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Giles</LastName>
<ForeName>Graham</ForeName>
<Initials>G</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Gill</LastName>
<ForeName>Grantley</ForeName>
<Initials>G</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Goldblatt</LastName>
<ForeName>Jack</ForeName>
<Initials>J</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Greening</LastName>
<ForeName>Sian</ForeName>
<Initials>S</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Grist</LastName>
<ForeName>Scott</ForeName>
<Initials>S</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Eric</LastName>
<ForeName>Haan</ForeName>
<Initials>H</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Hardie</LastName>
<ForeName>Kate</ForeName>
<Initials>K</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Harris</LastName>
<ForeName>Marion</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Hart</LastName>
<ForeName>Stewart</ForeName>
<Initials>S</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Hayward</LastName>
<ForeName>Nick</ForeName>
<Initials>N</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Healey</LastName>
<ForeName>Sue</ForeName>
<Initials>S</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Heiniger</LastName>
<ForeName>Louise</ForeName>
<Initials>L</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Hopper</LastName>
<ForeName>John</ForeName>
<Initials>J</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Humphrey</LastName>
<ForeName>Evelyn</ForeName>
<Initials>E</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Hunt</LastName>
<ForeName>Clare</ForeName>
<Initials>C</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>James</LastName>
<ForeName>Paul</ForeName>
<Initials>P</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Jenkins</LastName>
<ForeName>Mark</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Jones</LastName>
<ForeName>Alison</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Kefford</LastName>
<ForeName>Rick</ForeName>
<Initials>R</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Kidd</LastName>
<ForeName>Alexa</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Kiely</LastName>
<ForeName>Belinda</ForeName>
<Initials>B</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Kirk</LastName>
<ForeName>Judy</ForeName>
<Initials>J</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Koehler</LastName>
<ForeName>Jessica</ForeName>
<Initials>J</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Kollias</LastName>
<ForeName>James</ForeName>
<Initials>J</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Kovalenko</LastName>
<ForeName>Serguei</ForeName>
<Initials>S</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Lakhani</LastName>
<ForeName>Sunil</ForeName>
<Initials>S</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Leaming</LastName>
<ForeName>Amanda</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Leary</LastName>
<ForeName>Jennifer</ForeName>
<Initials>J</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Lim</LastName>
<ForeName>Jacqueline</ForeName>
<Initials>J</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Lindeman</LastName>
<ForeName>Geoff</ForeName>
<Initials>G</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Lipton</LastName>
<ForeName>Lara</ForeName>
<Initials>L</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Lobb</LastName>
<ForeName>Liz</ForeName>
<Initials>L</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Mann</LastName>
<ForeName>Graham</ForeName>
<Initials>G</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Marsh</LastName>
<ForeName>Deborah</ForeName>
<Initials>D</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>McLachlan</LastName>
<ForeName>Sue Anne</ForeName>
<Initials>SA</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Meiser</LastName>
<ForeName>Bettina</ForeName>
<Initials>B</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Meldrum</LastName>
<ForeName>Cliff</ForeName>
<Initials>C</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Milne</LastName>
<ForeName>Roger</ForeName>
<Initials>R</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Mitchell</LastName>
<ForeName>Gillian</ForeName>
<Initials>G</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Newman</LastName>
<ForeName>Beth</ForeName>
<Initials>B</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>O'Connell</LastName>
<ForeName>Shona</ForeName>
<Initials>S</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>O'Loughlin</LastName>
<ForeName>Imelda</ForeName>
<Initials>I</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Osborne</LastName>
<ForeName>Richard</ForeName>
<Initials>R</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Pachter</LastName>
<ForeName>Nick</ForeName>
<Initials>N</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Patterson</LastName>
<ForeName>Briony</ForeName>
<Initials>B</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Peters</LastName>
<ForeName>Lester</ForeName>
<Initials>L</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Phillips</LastName>
<ForeName>Kelly</ForeName>
<Initials>K</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Price</LastName>
<ForeName>Melanie</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Purser</LastName>
<ForeName>Lynne</ForeName>
<Initials>L</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Reeve</LastName>
<ForeName>Jeanne</ForeName>
<Initials>J</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Reeve</LastName>
<ForeName>Tony</ForeName>
<Initials>T</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Richards</LastName>
<ForeName>Robert</ForeName>
<Initials>R</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Rickard</LastName>
<ForeName>Edwina</ForeName>
<Initials>E</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Robinson</LastName>
<ForeName>Bridget</ForeName>
<Initials>B</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Rudzki</LastName>
<ForeName>Barney</ForeName>
<Initials>B</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Saleh</LastName>
<ForeName>Mona</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Salisbury</LastName>
<ForeName>Elizabeth</ForeName>
<Initials>E</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Sambrook</LastName>
<ForeName>Joe</ForeName>
<Initials>J</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Saunders</LastName>
<ForeName>Christobel</ForeName>
<Initials>C</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Saunus</LastName>
<ForeName>Jodi</ForeName>
<Initials>J</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Sayer</LastName>
<ForeName>Robyn</ForeName>
<Initials>R</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Scott</LastName>
<ForeName>Elizabeth</ForeName>
<Initials>E</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Scott</LastName>
<ForeName>Rodney</ForeName>
<Initials>R</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Scott</LastName>
<ForeName>Clare</ForeName>
<Initials>C</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Seshadri</LastName>
<ForeName>Ram</ForeName>
<Initials>R</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Sexton</LastName>
<ForeName>Adrienne</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Sharma</LastName>
<ForeName>Raghwa</ForeName>
<Initials>R</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Shelling</LastName>
<ForeName>Andrew</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Simpson</LastName>
<ForeName>Peter</ForeName>
<Initials>P</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Southey</LastName>
<ForeName>Melissa</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Spurdle</LastName>
<ForeName>Amanda</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Suthers</LastName>
<ForeName>Graeme</ForeName>
<Initials>G</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Sykes</LastName>
<ForeName>Pamela</ForeName>
<Initials>P</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Taylor</LastName>
<ForeName>Donna</ForeName>
<Initials>D</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Taylor</LastName>
<ForeName>Jessica</ForeName>
<Initials>J</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Thierry</LastName>
<ForeName>Benjamin</ForeName>
<Initials>B</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Thompson</LastName>
<ForeName>Ella</ForeName>
<Initials>E</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Thorne</LastName>
<ForeName>Heather</ForeName>
<Initials>H</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Townshend</LastName>
<ForeName>Sharron</ForeName>
<Initials>S</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Trainer</LastName>
<ForeName>Alison</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Tran</LastName>
<ForeName>Lan</ForeName>
<Initials>L</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Tucker</LastName>
<ForeName>Kathy</ForeName>
<Initials>K</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Tyler</LastName>
<ForeName>Janet</ForeName>
<Initials>J</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Visvader</LastName>
<ForeName>Jane</ForeName>
<Initials>J</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Walker</LastName>
<ForeName>Logan</ForeName>
<Initials>L</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Walpole</LastName>
<ForeName>Ian</ForeName>
<Initials>I</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Waring</LastName>
<ForeName>Paul</ForeName>
<Initials>P</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Warner</LastName>
<ForeName>Bev</ForeName>
<Initials>B</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Warren</LastName>
<ForeName>Graham</ForeName>
<Initials>G</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Williams</LastName>
<ForeName>Rachael</ForeName>
<Initials>R</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Wilson</LastName>
<ForeName>Judy</ForeName>
<Initials>J</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Winship</LastName>
<ForeName>Ingrid</ForeName>
<Initials>I</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Wu</LastName>
<ForeName>Kathy</ForeName>
<Initials>K</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Young</LastName>
<ForeName>Mary Ann</ForeName>
<Initials>MA</Initials>
</Investigator>
</InvestigatorList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25282915</PMID>
<DateCreated>
<Year>2014</Year>
<Month>10</Month>
<Day>06</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>10</Month>
<Day>30</Day>
</DateCompleted>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">1438-3276</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>156</Volume>
<Issue>15</Issue>
<PubDate>
<Year>2014</Year>
<Month>Sep</Month>
<Day>11</Day>
</PubDate>
</JournalIssue>
<Title>MMW Fortschritte der Medizin</Title>
<ISOAbbreviation>MMW Fortschr Med</ISOAbbreviation>
</Journal>
<ArticleTitle>[Life style change. The family practitioner as fitness coach].</ArticleTitle>
<Pagination>
<MedlinePgn>8-9</MedlinePgn>
</Pagination>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Büssow</LastName>
<ForeName>Robert</ForeName>
<Initials>R</Initials>
</Author>
</AuthorList>
<Language>ger</Language>
<PublicationTypeList>
<PublicationType UI="D016433">News</PublicationType>
</PublicationTypeList>
<VernacularTitle>Lebensstiländerung. Der Hausarzt als Fitness-Coach.</VernacularTitle>
</Article>
<MedlineJournalInfo>
<Country>Germany</Country>
<MedlineTA>MMW Fortschr Med</MedlineTA>
<NlmUniqueID>100893959</NlmUniqueID>
<ISSNLinking>1438-3276</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015444">Exercise</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D005194">Family Practice</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005510">Food Habits</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" Type="Geographic" UI="D005858">Germany</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006973">Hypertension</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000628">therapy</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D008019">Life Style</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009765">Obesity</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000628">therapy</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D010809">Physical Fitness</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D010819">Physician's Role</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25283032</PMID>
<DateCreated>
<Year>2014</Year>
<Month>10</Month>
<Day>06</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>10</Month>
<Day>23</Day>
</DateCompleted>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">8750-2186</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>33</Volume>
<Issue>9</Issue>
<PubDate>
<Year>2014</Year>
<Month>Sep</Month>
</PubDate>
</JournalIssue>
<Title>Dentistry today</Title>
<ISOAbbreviation>Dent Today</ISOAbbreviation>
</Journal>
<ArticleTitle>Treating obstructive sleep apnea. A manifest destiny for 21st century dentists.</ArticleTitle>
<Pagination>
<MedlinePgn>138, 140-2</MedlinePgn>
</Pagination>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Keropian</LastName>
<ForeName>Bryan</ForeName>
<Initials>B</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Murphy</LastName>
<ForeName>Neal C</ForeName>
<Initials>NC</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Yong</LastName>
<ForeName>Marjorie</ForeName>
<Initials>M</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Dent Today</MedlineTA>
<NlmUniqueID>9005357</NlmUniqueID>
<ISSNLinking>8750-2186</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>D</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000328">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000402">Airway Obstruction</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000503">physiopathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000860">Anoxia</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000503">physiopathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002648">Child</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D045422">Continuous Positive Airway Pressure</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D019186">Mandibular Advancement</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000295">instrumentation</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009765">Obesity</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000150">complications</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D017090">Occlusal Splints</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D016382">Orthodontic Appliance Design</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012307">Risk Factors</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D020181">Sleep Apnea, Obstructive</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000150">complications</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000503">physiopathology</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000628">therapy</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012913">Snoring</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000503">physiopathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D016312">Treatment Refusal</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25286598</PMID>
<DateCreated>
<Year>2014</Year>
<Month>10</Month>
<Day>07</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>10</Month>
<Day>17</Day>
</DateCompleted>
<DateRevised>
<Year>2014</Year>
<Month>10</Month>
<Day>20</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">1019-5297</ISSN>
<JournalIssue CitedMedium="Print">
<Issue>3-4</Issue>
<PubDate>
<MedlineDate>2014 Mar-Apr</MedlineDate>
</PubDate>
</JournalIssue>
<Title>Likars'ka sprava / Ministerstvo okhorony zdorov'ia Ukraïny</Title>
<ISOAbbreviation>Lik. Sprava</ISOAbbreviation>
</Journal>
<ArticleTitle>[Methods for early detection of predisposition to abnormal increases in body weight of children and adolescents].</ArticleTitle>
<Pagination>
<MedlinePgn>52-5</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>This article presents the results of a special method designed for the early identification of children's and adolescents' propensity for abnormal weight gain. The basis of this technique is the principle of monitoring the actual values of body mass index for each child or young person at the age of dynamic changes in the index of the normal range. The weekly body weight of each child or adolescent who participates in the study is measured and the results are included in a special registry. Measurement of the body weight of the children and adolescents occurs in the morning at the same hour on an empty stomach after use of the toilet and performance of necessary hygiene. Afterwards, the obtained values of their body mass indices are compared with those considered normal for age, according to official data. In cases when the resulting body mass index of a child or young person exceeds the range of normal-for-age values, an in-depth medical examination of the child or adolescent is conducted together with the nature of their food intake and mode of physical activity, which may then be corrected.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Ivashchenko</LastName>
<ForeName>S N</ForeName>
<Initials>SN</Initials>
</Author>
</AuthorList>
<Language>rus</Language>
<PublicationTypeList>
<PublicationType UI="D004740">English Abstract</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>Ukraine</Country>
<MedlineTA>Lik Sprava</MedlineTA>
<NlmUniqueID>9601540</NlmUniqueID>
<ISSNLinking>1019-5297</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000293">Adolescent</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015992">Body Mass Index</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002648">Child</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D004032">Diet</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D042241">Early Diagnosis</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005510">Food Habits</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000523">psychology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D015233">Models, Statistical</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009043">Motor Activity</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009765">Obesity</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000175">diagnosis</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000503">physiopathology</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000517">prevention &amp; control</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000523">psychology</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25204338</PMID>
<DateCreated>
<Year>2014</Year>
<Month>10</Month>
<Day>08</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>17</Day>
</DateCompleted>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1521-0103</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>351</Volume>
<Issue>2</Issue>
<PubDate>
<Year>2014</Year>
<Month>Nov</Month>
</PubDate>
</JournalIssue>
<Title>The Journal of pharmacology and experimental therapeutics</Title>
<ISOAbbreviation>J. Pharmacol. Exp. Ther.</ISOAbbreviation>
</Journal>
<ArticleTitle>Andrographolide prevents high-fat diet-induced obesity in C57BL/6 mice by suppressing the sterol regulatory element-binding protein pathway.</ArticleTitle>
<Pagination>
<MedlinePgn>474-83</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1124/jpet.114.217968</ELocationID>
<Abstract>
<AbstractText>Sterol regulatory element-binding proteins (SREBPs) are major transcription factors regulating the expression of genes involved in biosynthesis of cholesterol, fatty acids, and triglycerides. We investigated the effect of the specific SREBP suppressor andrographolide, a natural compound isolated from Andrographis paniculata, on the regulation of SREBP signaling by use of Western blot, reporter gene assay, and quantitative real-time polymerase chain reaction analysis. In addition, the antiobesity effects of andrographolide were evaluated in C57BL/6 mice with high-fat diet (HFD)-induced obesity. Our results showed that andrographolide downregulated the expressions of SREBPs target genes and decreased cellular lipid accumulation in vitro. Further, andrographolide (100 mg/kg per day) attenuated HFD-induced body weight gain and fat accumulation in liver or adipose tissues, and improved serum lipid levels and insulin or glucose sensitivity in HFD-induced obese mice. Andrographolide effectively suppressed the respiratory quotient, energy expenditure, and oxygen consumption, which may have contributed to the decreased body-weight gain of the obese mice fed with a HFD. Consistently, andrographolide regulated SREBP target genes and metabolism-associated genes in liver or brown adipose tissue, which may have directly contributed to the lower lipid levels and enhanced insulin sensitivity. Taken together, our results indicated that andrographolide ameliorated lipid metabolism and improved glucose use in mice with HFD-induced obesity. Andrographolide has potential as a leading compound in the prevention or treatment of obesity and insulin resistance. </AbstractText>
<CopyrightInformation>Copyright © 2014 by The American Society for Pharmacology and Experimental Therapeutics.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Ding</LastName>
<ForeName>Lili</ForeName>
<Initials>L</Initials>
<AffiliationInfo>
<Affiliation>Shanghai Key Laboratory of Complex Prescriptions and MOE Key Laboratory for Standardization of Chinese Medicines, Institute of Chinese Materia Medica, Shanghai University of Traditional Chinese Medicine, Shanghai, People's Republic of China (L.D., J.L., B.Z., X.T., M.Q., Qim.Y., Qia.Y., L.Y., Z.W.); Shanghai R&amp;D Center for Standardization of Traditional Chinese Medicines, Shanghai, People's Republic of China (L.D., J.L., B.Z., X.T., M.Q., Qim.Y., Qia.Y., L.Y., Z.W.); State Key Laboratory of Molecular Biology, Institute of Biochemistry and Cell Biology, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai, People's Republic of China (B.S., X.X.); Department of Diabetes and Metabolic Diseases Research, Beckman Research Institute, City of Hope National Medical Center, Duarte, California (W.H.); and Department of Pharmacognosy, China Pharmaceutical University, Nanjing, People's Republic of China (J.L.).</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Li</LastName>
<ForeName>Jinmei</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>Shanghai Key Laboratory of Complex Prescriptions and MOE Key Laboratory for Standardization of Chinese Medicines, Institute of Chinese Materia Medica, Shanghai University of Traditional Chinese Medicine, Shanghai, People's Republic of China (L.D., J.L., B.Z., X.T., M.Q., Qim.Y., Qia.Y., L.Y., Z.W.); Shanghai R&amp;D Center for Standardization of Traditional Chinese Medicines, Shanghai, People's Republic of China (L.D., J.L., B.Z., X.T., M.Q., Qim.Y., Qia.Y., L.Y., Z.W.); State Key Laboratory of Molecular Biology, Institute of Biochemistry and Cell Biology, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai, People's Republic of China (B.S., X.X.); Department of Diabetes and Metabolic Diseases Research, Beckman Research Institute, City of Hope National Medical Center, Duarte, California (W.H.); and Department of Pharmacognosy, China Pharmaceutical University, Nanjing, People's Republic of China (J.L.).</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Song</LastName>
<ForeName>Baoliang</ForeName>
<Initials>B</Initials>
<AffiliationInfo>
<Affiliation>Shanghai Key Laboratory of Complex Prescriptions and MOE Key Laboratory for Standardization of Chinese Medicines, Institute of Chinese Materia Medica, Shanghai University of Traditional Chinese Medicine, Shanghai, People's Republic of China (L.D., J.L., B.Z., X.T., M.Q., Qim.Y., Qia.Y., L.Y., Z.W.); Shanghai R&amp;D Center for Standardization of Traditional Chinese Medicines, Shanghai, People's Republic of China (L.D., J.L., B.Z., X.T., M.Q., Qim.Y., Qia.Y., L.Y., Z.W.); State Key Laboratory of Molecular Biology, Institute of Biochemistry and Cell Biology, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai, People's Republic of China (B.S., X.X.); Department of Diabetes and Metabolic Diseases Research, Beckman Research Institute, City of Hope National Medical Center, Duarte, California (W.H.); and Department of Pharmacognosy, China Pharmaceutical University, Nanjing, People's Republic of China (J.L.).</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Xiao</LastName>
<ForeName>Xu</ForeName>
<Initials>X</Initials>
<AffiliationInfo>
<Affiliation>Shanghai Key Laboratory of Complex Prescriptions and MOE Key Laboratory for Standardization of Chinese Medicines, Institute of Chinese Materia Medica, Shanghai University of Traditional Chinese Medicine, Shanghai, People's Republic of China (L.D., J.L., B.Z., X.T., M.Q., Qim.Y., Qia.Y., L.Y., Z.W.); Shanghai R&amp;D Center for Standardization of Traditional Chinese Medicines, Shanghai, People's Republic of China (L.D., J.L., B.Z., X.T., M.Q., Qim.Y., Qia.Y., L.Y., Z.W.); State Key Laboratory of Molecular Biology, Institute of Biochemistry and Cell Biology, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai, People's Republic of China (B.S., X.X.); Department of Diabetes and Metabolic Diseases Research, Beckman Research Institute, City of Hope National Medical Center, Duarte, California (W.H.); and Department of Pharmacognosy, China Pharmaceutical University, Nanjing, People's Republic of China (J.L.).</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Huang</LastName>
<ForeName>Wendong</ForeName>
<Initials>W</Initials>
<AffiliationInfo>
<Affiliation>Shanghai Key Laboratory of Complex Prescriptions and MOE Key Laboratory for Standardization of Chinese Medicines, Institute of Chinese Materia Medica, Shanghai University of Traditional Chinese Medicine, Shanghai, People's Republic of China (L.D., J.L., B.Z., X.T., M.Q., Qim.Y., Qia.Y., L.Y., Z.W.); Shanghai R&amp;D Center for Standardization of Traditional Chinese Medicines, Shanghai, People's Republic of China (L.D., J.L., B.Z., X.T., M.Q., Qim.Y., Qia.Y., L.Y., Z.W.); State Key Laboratory of Molecular Biology, Institute of Biochemistry and Cell Biology, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai, People's Republic of China (B.S., X.X.); Department of Diabetes and Metabolic Diseases Research, Beckman Research Institute, City of Hope National Medical Center, Duarte, California (W.H.); and Department of Pharmacognosy, China Pharmaceutical University, Nanjing, People's Republic of China (J.L.).</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Zhang</LastName>
<ForeName>Binfeng</ForeName>
<Initials>B</Initials>
<AffiliationInfo>
<Affiliation>Shanghai Key Laboratory of Complex Prescriptions and MOE Key Laboratory for Standardization of Chinese Medicines, Institute of Chinese Materia Medica, Shanghai University of Traditional Chinese Medicine, Shanghai, People's Republic of China (L.D., J.L., B.Z., X.T., M.Q., Qim.Y., Qia.Y., L.Y., Z.W.); Shanghai R&amp;D Center for Standardization of Traditional Chinese Medicines, Shanghai, People's Republic of China (L.D., J.L., B.Z., X.T., M.Q., Qim.Y., Qia.Y., L.Y., Z.W.); State Key Laboratory of Molecular Biology, Institute of Biochemistry and Cell Biology, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai, People's Republic of China (B.S., X.X.); Department of Diabetes and Metabolic Diseases Research, Beckman Research Institute, City of Hope National Medical Center, Duarte, California (W.H.); and Department of Pharmacognosy, China Pharmaceutical University, Nanjing, People's Republic of China (J.L.).</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Tang</LastName>
<ForeName>Xiaowen</ForeName>
<Initials>X</Initials>
<AffiliationInfo>
<Affiliation>Shanghai Key Laboratory of Complex Prescriptions and MOE Key Laboratory for Standardization of Chinese Medicines, Institute of Chinese Materia Medica, Shanghai University of Traditional Chinese Medicine, Shanghai, People's Republic of China (L.D., J.L., B.Z., X.T., M.Q., Qim.Y., Qia.Y., L.Y., Z.W.); Shanghai R&amp;D Center for Standardization of Traditional Chinese Medicines, Shanghai, People's Republic of China (L.D., J.L., B.Z., X.T., M.Q., Qim.Y., Qia.Y., L.Y., Z.W.); State Key Laboratory of Molecular Biology, Institute of Biochemistry and Cell Biology, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai, People's Republic of China (B.S., X.X.); Department of Diabetes and Metabolic Diseases Research, Beckman Research Institute, City of Hope National Medical Center, Duarte, California (W.H.); and Department of Pharmacognosy, China Pharmaceutical University, Nanjing, People's Republic of China (J.L.).</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Qi</LastName>
<ForeName>Meng</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Shanghai Key Laboratory of Complex Prescriptions and MOE Key Laboratory for Standardization of Chinese Medicines, Institute of Chinese Materia Medica, Shanghai University of Traditional Chinese Medicine, Shanghai, People's Republic of China (L.D., J.L., B.Z., X.T., M.Q., Qim.Y., Qia.Y., L.Y., Z.W.); Shanghai R&amp;D Center for Standardization of Traditional Chinese Medicines, Shanghai, People's Republic of China (L.D., J.L., B.Z., X.T., M.Q., Qim.Y., Qia.Y., L.Y., Z.W.); State Key Laboratory of Molecular Biology, Institute of Biochemistry and Cell Biology, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai, People's Republic of China (B.S., X.X.); Department of Diabetes and Metabolic Diseases Research, Beckman Research Institute, City of Hope National Medical Center, Duarte, California (W.H.); and Department of Pharmacognosy, China Pharmaceutical University, Nanjing, People's Republic of China (J.L.).</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Yang</LastName>
<ForeName>Qiming</ForeName>
<Initials>Q</Initials>
<AffiliationInfo>
<Affiliation>Shanghai Key Laboratory of Complex Prescriptions and MOE Key Laboratory for Standardization of Chinese Medicines, Institute of Chinese Materia Medica, Shanghai University of Traditional Chinese Medicine, Shanghai, People's Republic of China (L.D., J.L., B.Z., X.T., M.Q., Qim.Y., Qia.Y., L.Y., Z.W.); Shanghai R&amp;D Center for Standardization of Traditional Chinese Medicines, Shanghai, People's Republic of China (L.D., J.L., B.Z., X.T., M.Q., Qim.Y., Qia.Y., L.Y., Z.W.); State Key Laboratory of Molecular Biology, Institute of Biochemistry and Cell Biology, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai, People's Republic of China (B.S., X.X.); Department of Diabetes and Metabolic Diseases Research, Beckman Research Institute, City of Hope National Medical Center, Duarte, California (W.H.); and Department of Pharmacognosy, China Pharmaceutical University, Nanjing, People's Republic of China (J.L.).</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Yang</LastName>
<ForeName>Qiaoling</ForeName>
<Initials>Q</Initials>
<AffiliationInfo>
<Affiliation>Shanghai Key Laboratory of Complex Prescriptions and MOE Key Laboratory for Standardization of Chinese Medicines, Institute of Chinese Materia Medica, Shanghai University of Traditional Chinese Medicine, Shanghai, People's Republic of China (L.D., J.L., B.Z., X.T., M.Q., Qim.Y., Qia.Y., L.Y., Z.W.); Shanghai R&amp;D Center for Standardization of Traditional Chinese Medicines, Shanghai, People's Republic of China (L.D., J.L., B.Z., X.T., M.Q., Qim.Y., Qia.Y., L.Y., Z.W.); State Key Laboratory of Molecular Biology, Institute of Biochemistry and Cell Biology, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai, People's Republic of China (B.S., X.X.); Department of Diabetes and Metabolic Diseases Research, Beckman Research Institute, City of Hope National Medical Center, Duarte, California (W.H.); and Department of Pharmacognosy, China Pharmaceutical University, Nanjing, People's Republic of China (J.L.).</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Yang</LastName>
<ForeName>Li</ForeName>
<Initials>L</Initials>
<AffiliationInfo>
<Affiliation>Shanghai Key Laboratory of Complex Prescriptions and MOE Key Laboratory for Standardization of Chinese Medicines, Institute of Chinese Materia Medica, Shanghai University of Traditional Chinese Medicine, Shanghai, People's Republic of China (L.D., J.L., B.Z., X.T., M.Q., Qim.Y., Qia.Y., L.Y., Z.W.); Shanghai R&amp;D Center for Standardization of Traditional Chinese Medicines, Shanghai, People's Republic of China (L.D., J.L., B.Z., X.T., M.Q., Qim.Y., Qia.Y., L.Y., Z.W.); State Key Laboratory of Molecular Biology, Institute of Biochemistry and Cell Biology, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai, People's Republic of China (B.S., X.X.); Department of Diabetes and Metabolic Diseases Research, Beckman Research Institute, City of Hope National Medical Center, Duarte, California (W.H.); and Department of Pharmacognosy, China Pharmaceutical University, Nanjing, People's Republic of China (J.L.) yangli7951@hotmail.com wangzht@hotmail.com.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Wang</LastName>
<ForeName>Zhengtao</ForeName>
<Initials>Z</Initials>
<AffiliationInfo>
<Affiliation>Shanghai Key Laboratory of Complex Prescriptions and MOE Key Laboratory for Standardization of Chinese Medicines, Institute of Chinese Materia Medica, Shanghai University of Traditional Chinese Medicine, Shanghai, People's Republic of China (L.D., J.L., B.Z., X.T., M.Q., Qim.Y., Qia.Y., L.Y., Z.W.); Shanghai R&amp;D Center for Standardization of Traditional Chinese Medicines, Shanghai, People's Republic of China (L.D., J.L., B.Z., X.T., M.Q., Qim.Y., Qia.Y., L.Y., Z.W.); State Key Laboratory of Molecular Biology, Institute of Biochemistry and Cell Biology, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai, People's Republic of China (B.S., X.X.); Department of Diabetes and Metabolic Diseases Research, Beckman Research Institute, City of Hope National Medical Center, Duarte, California (W.H.); and Department of Pharmacognosy, China Pharmaceutical University, Nanjing, People's Republic of China (J.L.) yangli7951@hotmail.com wangzht@hotmail.com.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>09</Month>
<Day>09</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>J Pharmacol Exp Ther</MedlineTA>
<NlmUniqueID>0376362</NlmUniqueID>
<ISSNLinking>0022-3565</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D004224">Diterpenes</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D007328">Insulin</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D008055">Lipids</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D051779">Sterol Regulatory Element Binding Proteins</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>410105JHGR</RegistryNumber>
<NameOfSubstance UI="C030419">andrographolide</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>IY9XDZ35W2</RegistryNumber>
<NameOfSubstance UI="D005947">Glucose</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002001">Adipose Tissue, Brown</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000187">drug effects</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000818">Animals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D045744">Cell Line, Tumor</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D059305">Diet, High-Fat</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000009">adverse effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D004224">Diterpenes</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000494">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015536">Down-Regulation</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000187">drug effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D004734">Energy Metabolism</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000187">drug effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005947">Glucose</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D056945">Hep G2 Cells</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007328">Insulin</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007333">Insulin Resistance</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000502">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D050356">Lipid Metabolism</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000187">drug effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008055">Lipids</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000097">blood</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008099">Liver</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000187">drug effects</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D051379">Mice</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008810">Mice, Inbred C57BL</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008820">Mice, Obese</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009765">Obesity</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000188">drug therapy</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D010101">Oxygen Consumption</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000187">drug effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D051779">Sterol Regulatory Element Binding Proteins</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015430">Weight Gain</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000187">drug effects</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25296490</PMID>
<DateCreated>
<Year>2014</Year>
<Month>10</Month>
<Day>09</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>10</Month>
<Day>30</Day>
</DateCompleted>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0743-2550</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>31</Volume>
<Issue>4</Issue>
<PubDate>
<MedlineDate>2014 Oct-Dec</MedlineDate>
</PubDate>
</JournalIssue>
<Title>Journal of Christian nursing : a quarterly publication of Nurses Christian Fellowship</Title>
<ISOAbbreviation>J Christ Nurs</ISOAbbreviation>
</Journal>
<ArticleTitle>I choose health (Elijo Salud: impacting youth through parish nursing.</ArticleTitle>
<Pagination>
<MedlinePgn>252-7</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>The 2009-2010 National Health and Nutritional Examination Survey (NHANES) found that 34% of adolescents are overweight and 18% obese. The chance of an overweight/obese adolescent becoming an overweight/obese adult by age 35 is 60%. Hispanic youth are at risk for becoming obese related to eating habits. This paper describes an intervention, I Choose Health (Elijo Salud), with Hispanic church youth.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Oakley</LastName>
<ForeName>Janet</ForeName>
<Initials>J</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Hoebeke</LastName>
<ForeName>Roberta</ForeName>
<Initials>R</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>J Christ Nurs</MedlineTA>
<NlmUniqueID>8411743</NlmUniqueID>
<ISSNLinking>0743-2550</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>N</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000293">Adolescent</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000328">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D003466">Cultural Characteristics</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D003920">Diabetes Mellitus</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000517">prevention &amp; control</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005247">Feeding Behavior</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000208">ethnology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006293">Health Promotion</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000458">organization &amp; administration</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006630">Hispanic Americans</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000208">ethnology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009765">Obesity</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000208">ethnology</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000451">nursing</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000517">prevention &amp; control</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D064698">Parish Nursing</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000458">organization &amp; administration</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015397">Program Evaluation</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" Type="Geographic" UI="D014481">United States</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000208">ethnology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D055815">Young Adult</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25296496</PMID>
<DateCreated>
<Year>2014</Year>
<Month>10</Month>
<Day>09</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>10</Month>
<Day>23</Day>
</DateCompleted>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0301-1208</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>51</Volume>
<Issue>4</Issue>
<PubDate>
<Year>2014</Year>
<Month>Aug</Month>
</PubDate>
</JournalIssue>
<Title>Indian journal of biochemistry &amp; biophysics</Title>
<ISOAbbreviation>Indian J. Biochem. Biophys.</ISOAbbreviation>
</Journal>
<ArticleTitle>Amyloid beta lowering and cognition enhancing effects of ghrelin receptor analog [D-Lys (3)] GHRP-6 in rat model of obesity.</ArticleTitle>
<Pagination>
<MedlinePgn>257-62</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>Obesity arising due to the dietary and life style changes is fast reaching epidemic proportions all over the world. There is increasing evidence that the incidence of Alzheimer disease (AD) is significantly influenced by a cluster of metabolic diseases, including diabetes and obesity. This study was aimed to test the suitability of experimentally-induced obesity in rats as an experimental animal model of AD. We used the procedure of neonatal administration of rats with monosodium L-glutamate (MSG), which generates adult obese animals as our study design and assessed the AD-like changes by measuring amyloid beta (1-42) and acetylcholinesterase (AChE) levels in the hippocampal extracts and cognitive impairments by Barnes maze task. Further, we investigated the influence of anti-obesity substance [D-Lys (3)] GHRP-6 on blood glucose, hippocampal Abeta, AChE levels and restoration of cognitive deficits. Results revealed that administration of MSG to neonatal rats exhibited increased body mass index and serum glucose levels over the controls. Measurement of markers for AD-like molecular changes i.e. amyloid beta (Abeta) and AChE levels showed marked elevation in these two parameters in the hippocampus of MSG-treated rats. Assessment of cognitive abilities by Barnes maze revealed spatial disorientation characteristic of AD. Administration of ghrelin receptor analog [D-Lys (3)] GHRP-6 to obese rats resulted in significant restoration of serum cholesterol, glucose, leptin and ghrelin levels to that of control with concomitant reduction in hippocampal Abeta and AChE levels. In addition, the treated animals exhibited marked improvement in Barne's maze task. These findings suggest that MSG-induced obese rats may serve as non-transgenic animal model for AD research. Further, the results indicate the potential of [D-Lys (3)] GHRP-6 as a promising anti-Alzheimer candidate.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Madhavadas</LastName>
<ForeName>Sowmya</ForeName>
<Initials>S</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Kutty</LastName>
<ForeName>Bindu M</ForeName>
<Initials>BM</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Subramanian</LastName>
<ForeName>Sarada</ForeName>
<Initials>S</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>India</Country>
<MedlineTA>Indian J Biochem Biophys</MedlineTA>
<NlmUniqueID>0310774</NlmUniqueID>
<ISSNLinking>0301-1208</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D016229">Amyloid beta-Peptides</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D009842">Oligopeptides</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>87616-84-0</RegistryNumber>
<NameOfSubstance UI="C041048">growth hormone releasing hexapeptide</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D016229">Amyloid beta-Peptides</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000818">Animals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D003071">Cognition</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D004195">Disease Models, Animal</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D004797">Enzyme-Linked Immunosorbent Assay</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009765">Obesity</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009842">Oligopeptides</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000502">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D051381">Rats</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D017207">Rats, Sprague-Dawley</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">24668052</PMID>
<DateCreated>
<Year>2014</Year>
<Month>10</Month>
<Day>09</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>10</Month>
<Day>23</Day>
</DateCompleted>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0003-4894</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>123</Volume>
<Issue>7</Issue>
<PubDate>
<Year>2014</Year>
<Month>Jul</Month>
</PubDate>
</JournalIssue>
<Title>The Annals of otology, rhinology, and laryngology</Title>
<ISOAbbreviation>Ann. Otol. Rhinol. Laryngol.</ISOAbbreviation>
</Journal>
<ArticleTitle>Sex-specific characteristics of anthropometry in patients with obstructive sleep apnea: neck circumference and waist-hip ratio.</ArticleTitle>
<Pagination>
<MedlinePgn>517-23</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">This study aimed to investigate the sex-specific effects of anthropometric profiles on the occurrence and severity of obstructive sleep apnea (OSA).</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">We evaluated 151 patients with suspected OSA undergoing polysomnography and anthropometric measurements such as body mass index (BMI), neck and waist circumference (NC and WC), and waist-hip ratio (WHR).</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">In men, NC (P = .006), WC (P = .035), and WHR (P = .003) were significantly increased in OSA and all were significantly correlated with apnea hypopnea index (AHI). However, in female OSA patients, BMI (P = .05), WC (P = .008), and WHR (P = .001) were elevated, but only WHR was significantly correlated with AHI. Correlation analyses showed significant correlations between NC and other anthropometric indexes in men but not in women. The receiver operating characteristic curves revealed that NC and WHR in men, and WHR in women, were significant in both model I (AHI &gt; or = 5) and model 2 (AHI &gt; or = 15).</AbstractText>
<AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Waist-hip ratio is the most reliable correlate of OSA in both sexes. Neck circumference is an independent risk factor for male, but not for female, OSA patients. These different aspects of obesity may contribute to the pathogenesis of OSA and provide helpful guidance in the screening of OSA.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Lim</LastName>
<ForeName>Young-Hyo</ForeName>
<Initials>YH</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Choi</LastName>
<ForeName>Jihye</ForeName>
<Initials>J</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Kim</LastName>
<ForeName>Kyung Rae</ForeName>
<Initials>KR</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Shin</LastName>
<ForeName>Jinho</ForeName>
<Initials>J</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Hwang</LastName>
<ForeName>Kyung Gyun</ForeName>
<Initials>KG</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Ryu</LastName>
<ForeName>Seungho</ForeName>
<Initials>S</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Cho</LastName>
<ForeName>Seok Hyun</ForeName>
<Initials>SH</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Ann Otol Rhinol Laryngol</MedlineTA>
<NlmUniqueID>0407300</NlmUniqueID>
<ISSNLinking>0003-4894</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000328">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000368">Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D015992">Body Mass Index</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008875">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009333">Neck</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000033">anatomy &amp; histology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009765">Obesity</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000150">complications</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011237">Predictive Value of Tests</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012372">ROC Curve</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012307">Risk Factors</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012720">Severity of Illness Index</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D012737">Sex Factors</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D020181">Sleep Apnea, Obstructive</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000175">diagnosis</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000209">etiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D049629">Waist-Hip Ratio</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D055815">Young Adult</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25119041</PMID>
<DateCreated>
<Year>2014</Year>
<Month>10</Month>
<Day>09</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>03</Day>
</DateCompleted>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1476-4687</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>514</Volume>
<Issue>7521</Issue>
<PubDate>
<Year>2014</Year>
<Month>Oct</Month>
<Day>9</Day>
</PubDate>
</JournalIssue>
<Title>Nature</Title>
<ISOAbbreviation>Nature</ISOAbbreviation>
</Journal>
<ArticleTitle>Interleukin-22 alleviates metabolic disorders and restores mucosal immunity in diabetes.</ArticleTitle>
<Pagination>
<MedlinePgn>237-41</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1038/nature13564</ELocationID>
<Abstract>
<AbstractText>The connection between an altered gut microbiota and metabolic disorders such as obesity, diabetes, and cardiovascular disease is well established. Defects in preserving the integrity of the mucosal barriers can result in systemic endotoxaemia that contributes to chronic low-grade inflammation, which further promotes the development of metabolic syndrome. Interleukin (IL)-22 exerts essential roles in eliciting antimicrobial immunity and maintaining mucosal barrier integrity within the intestine. Here we investigate the connection between IL-22 and metabolic disorders. We find that the induction of IL-22 from innate lymphoid cells and CD4(+) T cells is impaired in obese mice under various immune challenges, especially in the colon during infection with Citrobacter rodentium. While innate lymphoid cell populations are largely intact in obese mice, the upregulation of IL-23, a cytokine upstream of IL-22, is compromised during the infection. Consequently, these mice are susceptible to C. rodentium infection, and both exogenous IL-22 and IL-23 are able to restore the mucosal host defence. Importantly, we further unveil unexpected functions of IL-22 in regulating metabolism. Mice deficient in IL-22 receptor and fed with high-fat diet are prone to developing metabolic disorders. Strikingly, administration of exogenous IL-22 in genetically obese leptin-receptor-deficient (db/db) mice and mice fed with high-fat diet reverses many of the metabolic symptoms, including hyperglycaemia and insulin resistance. IL-22 shows diverse metabolic benefits, as it improves insulin sensitivity, preserves gut mucosal barrier and endocrine functions, decreases endotoxaemia and chronic inflammation, and regulates lipid metabolism in liver and adipose tissues. In summary, we identify the IL-22 pathway as a novel target for therapeutic intervention in metabolic diseases. </AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Wang</LastName>
<ForeName>Xiaoting</ForeName>
<Initials>X</Initials>
<AffiliationInfo>
<Affiliation>1] Department of Immunology, Genentech, South San Francisco, California 94080, USA [2].</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Ota</LastName>
<ForeName>Naruhisa</ForeName>
<Initials>N</Initials>
<AffiliationInfo>
<Affiliation>1] Department of Immunology, Genentech, South San Francisco, California 94080, USA [2].</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Manzanillo</LastName>
<ForeName>Paolo</ForeName>
<Initials>P</Initials>
<AffiliationInfo>
<Affiliation>Department of Immunology, Genentech, South San Francisco, California 94080, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Kates</LastName>
<ForeName>Lance</ForeName>
<Initials>L</Initials>
<AffiliationInfo>
<Affiliation>Department of Biomedical Imaging, Genentech, South San Francisco, California 94080, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Zavala-Solorio</LastName>
<ForeName>Jose</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>Department of Biomedical Imaging, Genentech, South San Francisco, California 94080, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Eidenschenk</LastName>
<ForeName>Celine</ForeName>
<Initials>C</Initials>
<AffiliationInfo>
<Affiliation>Department of Immunology, Genentech, South San Francisco, California 94080, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Zhang</LastName>
<ForeName>Juan</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>Department of Immunology, Genentech, South San Francisco, California 94080, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Lesch</LastName>
<ForeName>Justin</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>Department of Immunology, Genentech, South San Francisco, California 94080, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Lee</LastName>
<ForeName>Wyne P</ForeName>
<Initials>WP</Initials>
<AffiliationInfo>
<Affiliation>Department of Immunology, Genentech, South San Francisco, California 94080, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Ross</LastName>
<ForeName>Jed</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>Department of Biomedical Imaging, Genentech, South San Francisco, California 94080, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Diehl</LastName>
<ForeName>Lauri</ForeName>
<Initials>L</Initials>
<AffiliationInfo>
<Affiliation>Department of Pathology, Genentech, South San Francisco, California 94080, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>van Bruggen</LastName>
<ForeName>Nicholas</ForeName>
<Initials>N</Initials>
<AffiliationInfo>
<Affiliation>Department of Biomedical Imaging, Genentech, South San Francisco, California 94080, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Kolumam</LastName>
<ForeName>Ganesh</ForeName>
<Initials>G</Initials>
<AffiliationInfo>
<Affiliation>1] Department of Biomedical Imaging, Genentech, South San Francisco, California 94080, USA [2].</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Ouyang</LastName>
<ForeName>Wenjun</ForeName>
<Initials>W</Initials>
<AffiliationInfo>
<Affiliation>Department of Immunology, Genentech, South San Francisco, California 94080, USA.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>08</Month>
<Day>06</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>England</Country>
<MedlineTA>Nature</MedlineTA>
<NlmUniqueID>0410462</NlmUniqueID>
<ISSNLinking>0028-0836</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D007328">Insulin</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D053759">Interleukin-23</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D007378">Interleukins</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D018123">Receptors, Interleukin</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D054411">Receptors, Leptin</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C415368">interleukin-22</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C415369">interleukin-22 receptor</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D052436">Adipose Tissue, White</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000187">drug effects</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000818">Animals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015496">CD4-Positive T-Lymphocytes</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000276">immunology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000557">secretion</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002908">Chronic Disease</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D044082">Citrobacter rodentium</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000187">drug effects</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000276">immunology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000502">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D003106">Colon</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000187">drug effects</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000276">immunology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000382">microbiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D003920">Diabetes Mellitus</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000276">immunology</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000378">metabolism</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D059305">Diet, High-Fat</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006943">Hyperglycemia</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000178">diet therapy</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000188">drug therapy</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D018928">Immunity, Mucosal</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000187">drug effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007249">Inflammation</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000188">drug therapy</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007328">Insulin</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007333">Insulin Resistance</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D053759">Interleukin-23</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000276">immunology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000494">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007378">Interleukins</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000276">immunology</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000378">metabolism</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000494">pharmacology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000627">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D050356">Lipid Metabolism</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000187">drug effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008099">Liver</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000187">drug effects</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008659">Metabolic Diseases</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000178">diet therapy</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000188">drug therapy</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D051379">Mice</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008810">Mice, Inbred C57BL</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008820">Mice, Obese</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009765">Obesity</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D018123">Receptors, Interleukin</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000172">deficiency</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D054411">Receptors, Leptin</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000172">deficiency</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25105356</PMID>
<DateCreated>
<Year>2014</Year>
<Month>10</Month>
<Day>09</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>10</Month>
<Day>23</Day>
</DateCompleted>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0098-9134</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>40</Volume>
<Issue>9</Issue>
<PubDate>
<Year>2014</Year>
<Month>Sep</Month>
</PubDate>
</JournalIssue>
<Title>Journal of gerontological nursing</Title>
<ISOAbbreviation>J Gerontol Nurs</ISOAbbreviation>
</Journal>
<ArticleTitle>Policy implications of a literature review of bariatric surgery in older adults.</ArticleTitle>
<Pagination>
<MedlinePgn>14-9</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>In the past decade, bariatric surgery has garnered attention as a treatment for obesity in older adults. Its increased popularity is a direct response to growing obesity rates in this segment of the population. Bariatric surgery among older adults has emerged as a contentious issue debated by federal and state governments, health care providers, and patients. It is important for geriatric nurses to comprehend the policy and health implications of bariatric surgery for older adults. The purpose of this paper is to (a) discuss the burden of growing obesity rates on the health of older adults, (b) present the results of a literature review of bariatric surgery outcomes in older adults, and (c) evaluate the policy implications of insurance coverage of bariatric procedures.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Caceres</LastName>
<ForeName>Billy A</ForeName>
<Initials>BA</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016454">Review</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>J Gerontol Nurs</MedlineTA>
<NlmUniqueID>7510258</NlmUniqueID>
<ISSNLinking>0098-9134</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>N</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000368">Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D050110">Bariatric Surgery</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D006291">Health Policy</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006297">Health Services Accessibility</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008484">Medicaid</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006278">Medicare</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009765">Obesity</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000601">surgery</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" Type="Geographic" UI="D014481">United States</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25318167</PMID>
<DateCreated>
<Year>2014</Year>
<Month>10</Month>
<Day>16</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>07</Day>
</DateCompleted>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0031-2991</ISSN>
<JournalIssue CitedMedium="Print">
<Issue>2</Issue>
<PubDate>
<MedlineDate>2014 Apr-Jun</MedlineDate>
</PubDate>
</JournalIssue>
<Title>Patologicheskaia fiziologiia i èksperimental'naia terapiia</Title>
<ISOAbbreviation>Patol Fiziol Eksp Ter</ISOAbbreviation>
</Journal>
<ArticleTitle>[Biological function of trophology and the pathogenesis of metabolic syndrome--syndrome of overeating. Phylogenetically theory of general pathology, role of leptin and adiponectin].</ArticleTitle>
<Pagination>
<MedlinePgn>68-79</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>Metabolic syndrome (overeating) is a phylogenetically-determined succession of symptoms with the same pathogenesis. There is only one etiological factor, namely, increased consumption of physiologically optimal food. Enterocytes and omental fat cells are a phylogenetically early paracrine-regulated cell community that realizes the biological reactions of exo- and endotrophy. Visceral obesity, high levels of unesterified fatty acids (FA), formation of a pool of micellar FA in the blood, integration of these FA into endothelial cell plasma membrane and enlargement of adipocytes are the causes of hydrodynamic pressure elevation. Toll-like receptors recognize the associates between albumin and greater than physiological number of FA as "foreing" and initiate inflammatory response. "Endoplasm stress" develops in lipid-overloaded cells, protein synthesis (folding) in them is impaired and apoptosis-like cell death is activated. Visceral fat is a phylogenetically early depot of FA to fulfill the biological function of homeostasis, trophology, endoecology and adaptation; it is regulated at the level of paracrine communities and is anatomically limited. The subcutaneous fat depot fulfills the phylogenetically late function of locomotion; the depot size is not anatomically limited. Visceral fat cells have no receptors for phylogenetically late insulin (INS); specialized adipocyes bearing INS and GLUT4 receptors are cells that form the subcutaneous depot. These cells are regulated by phylogenetically late humoral factors at the entire body level. Leptin is an initiator of humoral hypothalamic regulation of in vivo number of ontogenetically programmed number of visceral INS-insensitive fat cells. It prevents "endoplasm stress" and apoptosis, being designed to regulate the amount of consumed food. Leptin initiates storage of FA from visceral pool into subcutaneous pool. Adiponectin is a phylogenetically late humoral hypothalamic regulatory factor that controls optimal number of fat cells in vivo. Its biological role consists in regulation of the number (proliferation) of insulin-dependent adipocytes in subcutaneous fatty tissue.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Titov</LastName>
<ForeName>V N</ForeName>
<Initials>VN</Initials>
</Author>
</AuthorList>
<Language>rus</Language>
<PublicationTypeList>
<PublicationType UI="D004740">English Abstract</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016454">Review</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>Russia (Federation)</Country>
<MedlineTA>Patol Fiziol Eksp Ter</MedlineTA>
<NlmUniqueID>0376421</NlmUniqueID>
<ISSNLinking>0031-2991</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D052242">Adiponectin</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D020738">Leptin</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000222">Adaptation, Physiological</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D052242">Adiponectin</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000235">genetics</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000818">Animals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D020738">Leptin</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000235">genetics</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D024821">Metabolic Syndrome X</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000209">etiology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009765">Obesity</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000209">etiology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25318170</PMID>
<DateCreated>
<Year>2014</Year>
<Month>10</Month>
<Day>16</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>07</Day>
</DateCompleted>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0031-2991</ISSN>
<JournalIssue CitedMedium="Print">
<Issue>2</Issue>
<PubDate>
<MedlineDate>2014 Apr-Jun</MedlineDate>
</PubDate>
</JournalIssue>
<Title>Patologicheskaia fiziologiia i èksperimental'naia terapiia</Title>
<ISOAbbreviation>Patol Fiziol Eksp Ter</ISOAbbreviation>
</Journal>
<ArticleTitle>[Infection as a obesity pathogenesis factor].</ArticleTitle>
<Pagination>
<MedlinePgn>94-100</MedlinePgn>
</Pagination>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Schwarz</LastName>
<ForeName>V Ya</ForeName>
<Initials>VY</Initials>
</Author>
</AuthorList>
<Language>rus</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016454">Review</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>Russia (Federation)</Country>
<MedlineTA>Patol Fiziol Eksp Ter</MedlineTA>
<NlmUniqueID>0376421</NlmUniqueID>
<ISSNLinking>0031-2991</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000818">Animals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001424">Bacterial Infections</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000150">complications</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000276">immunology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D007113">Immunity, Innate</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009765">Obesity</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000209">etiology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000276">immunology</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25317593</PMID>
<DateCreated>
<Year>2014</Year>
<Month>10</Month>
<Day>16</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>12</Day>
</DateCompleted>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">1476-4687</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>514</Volume>
<Issue>7522</Issue>
<PubDate>
<Year>2014</Year>
<Month>Oct</Month>
<Day>16</Day>
</PubDate>
</JournalIssue>
<Title>Nature</Title>
<ISOAbbreviation>Nature</ISOAbbreviation>
</Journal>
<ArticleTitle>Q&amp;A: Jules Hoffmann. Fighting fit.</ArticleTitle>
<Pagination>
<MedlinePgn>S5</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1038/514S5a</ELocationID>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Hoffmann</LastName>
<ForeName>Jules</ForeName>
<Initials>J</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Tárnoki</LastName>
<ForeName>Adám</ForeName>
<Initials>A</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Tárnoki</LastName>
<ForeName>Dávid</ForeName>
<Initials>D</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D017203">Interview</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>England</Country>
<MedlineTA>Nature</MedlineTA>
<NlmUniqueID>0410462</NlmUniqueID>
<ISSNLinking>0028-0836</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D004352">Drug Resistance, Microbial</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008611">Mentors</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009369">Neoplasms</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000276">immunology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009613">Nobel Prize</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009765">Obesity</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012108">Research Personnel</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000523">psychology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D013850">Thinking</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D014611">Vaccination</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000639">trends</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25322659</PMID>
<DateCreated>
<Year>2014</Year>
<Month>10</Month>
<Day>17</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>07</Day>
</DateCompleted>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0741-6253</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>31</Volume>
<Issue>5</Issue>
<PubDate>
<Year>2014</Year>
<Month>Oct</Month>
</PubDate>
</JournalIssue>
<Title>Diabetes self-management</Title>
<ISOAbbreviation>Diabetes Self Manag</ISOAbbreviation>
</Journal>
<ArticleTitle>10 keys to long-term weight loss for adults with diabetes.</ArticleTitle>
<Pagination>
<MedlinePgn>64-7</MedlinePgn>
</Pagination>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Hamdy</LastName>
<ForeName>Osama</ForeName>
<Initials>O</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Colberg</LastName>
<ForeName>Sheri</ForeName>
<Initials>S</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Diabetes Self Manag</MedlineTA>
<NlmUniqueID>9883682</NlmUniqueID>
<ISSNLinking>0741-6253</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>K</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000328">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000367">Age Factors</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D003920">Diabetes Mellitus</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000097">blood</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000175">diagnosis</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000453">epidemiology</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000628">therapy</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D064420">Drug-Related Side Effects and Adverse Reactions</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000453">epidemiology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000517">prevention &amp; control</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002149">Energy Intake</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015444">Exercise</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005247">Feeding Behavior</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006126">Group Processes</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008019">Life Style</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009752">Nutritional Status</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009765">Obesity</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000175">diagnosis</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000453">epidemiology</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000628">therapy</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D040242">Risk Reduction Behavior</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012890">Sleep</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D013997">Time Factors</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D016896">Treatment Outcome</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D015431">Weight Loss</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25327033</PMID>
<DateCreated>
<Year>2014</Year>
<Month>10</Month>
<Day>20</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>03</Day>
</DateCompleted>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0004-5772</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>62</Volume>
<Issue>4</Issue>
<PubDate>
<Year>2014</Year>
<Month>Apr</Month>
</PubDate>
</JournalIssue>
<Title>The Journal of the Association of Physicians of India</Title>
<ISOAbbreviation>J Assoc Physicians India</ISOAbbreviation>
</Journal>
<ArticleTitle>Screening among male industrial workers in India shows high prevalence of impaired glucose tolerance, undetected diabetes and cardiovascular risk clustering.</ArticleTitle>
<Pagination>
<MedlinePgn>312-5</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To study the magnitude of undetected diabetes, impaired glucose tolerance (IGT) and clustering of cardiometabolic risk factors among male industrial workers.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">Measurements of 2h post glucose blood glucose (2h PG), blood pressure, body mass index (BMI) and waist circumference (WC) were done in 8741 non-diabetic men of 35-55 years. Presence of family history of diabetes (FH) was noted. Risk associations with diabetes and IGT were studied using multiple logistic regression analysis. Clustering of overweight/obesity, abdominal obesity, hypertension was noted.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">Prevalence of undetected diabetes (14.9%) and IGT (31.4%) were high. FH, age, hypertension and BMI showed strong associations with diabetes and IGT. More than 40% had clustering of risk factors.</AbstractText>
<AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">High prevalence of undetected diabetes, IGT and clustering of cardiometabolic risk factors among young industrial workers mandates that regular screening for metabolic disorders should be undertaken to prevent development of severe morbidity in the productive years of life.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Jagannathan</LastName>
<ForeName>Ram</ForeName>
<Initials>R</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Nanditha</LastName>
<ForeName>Arun</ForeName>
<Initials>A</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Sundaram</LastName>
<ForeName>Selvam</ForeName>
<Initials>S</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Simon</LastName>
<ForeName>Mary</ForeName>
<Initials>M</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Shetty</LastName>
<ForeName>Ananth Samith</ForeName>
<Initials>AS</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Snehalatha</LastName>
<ForeName>Chamukuttan</ForeName>
<Initials>C</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Johnston</LastName>
<ForeName>Desmond G</ForeName>
<Initials>DG</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Ramachandran</LastName>
<ForeName>Ambady</ForeName>
<Initials>A</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>India</Country>
<MedlineTA>J Assoc Physicians India</MedlineTA>
<NlmUniqueID>7505585</NlmUniqueID>
<ISSNLinking>0004-5772</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000328">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002318">Cardiovascular Diseases</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000175">diagnosis</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000453">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D016000">Cluster Analysis</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015331">Cohort Studies</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D003924">Diabetes Mellitus, Type 2</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000175">diagnosis</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000453">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D018149">Glucose Intolerance</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000175">diagnosis</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000453">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" Type="Geographic" UI="D007194">India</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008403">Mass Screening</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008875">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009765">Obesity</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000175">diagnosis</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000453">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015995">Prevalence</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012307">Risk Factors</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25327127</PMID>
<DateCreated>
<Year>2014</Year>
<Month>10</Month>
<Day>20</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>07</Day>
</DateCompleted>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0253-0465</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>107</Volume>
<Issue>9</Issue>
<PubDate>
<Year>2014</Year>
</PubDate>
</JournalIssue>
<Title>Krankenpflege. Soins infirmiers</Title>
<ISOAbbreviation>Krankenpfl Soins Infirm</ISOAbbreviation>
</Journal>
<ArticleTitle>[Sweet confections].</ArticleTitle>
<Pagination>
<MedlinePgn>47</MedlinePgn>
</Pagination>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Taillens</LastName>
<ForeName>Françoise</ForeName>
<Initials>F</Initials>
</Author>
</AuthorList>
<Language>fre</Language>
<PublicationTypeList>
<PublicationType UI="D016421">Editorial</PublicationType>
</PublicationTypeList>
<VernacularTitle>Sucreries.</VernacularTitle>
</Article>
<MedlineJournalInfo>
<Country>Switzerland</Country>
<MedlineTA>Krankenpfl Soins Infirm</MedlineTA>
<NlmUniqueID>8000153</NlmUniqueID>
<ISSNLinking>0253-0465</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D019422">Dietary Sucrose</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>N</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D003924">Diabetes Mellitus, Type 2</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000178">diet therapy</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000451">nursing</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D003927">Diabetic Diet</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000451">nursing</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D019422">Dietary Sucrose</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000008">administration &amp; dosage</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000009">adverse effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009765">Obesity</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000451">nursing</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000517">prevention &amp; control</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012307">Risk Factors</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" Type="Geographic" UI="D013557">Switzerland</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25327134</PMID>
<DateCreated>
<Year>2014</Year>
<Month>10</Month>
<Day>20</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>07</Day>
</DateCompleted>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0253-0465</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>107</Volume>
<Issue>9</Issue>
<PubDate>
<Year>2014</Year>
</PubDate>
</JournalIssue>
<Title>Krankenpflege. Soins infirmiers</Title>
<ISOAbbreviation>Krankenpfl Soins Infirm</ISOAbbreviation>
</Journal>
<ArticleTitle>[Preventing sugar from making life unpleasant].</ArticleTitle>
<Pagination>
<MedlinePgn>71</MedlinePgn>
</Pagination>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Bagnaschi</LastName>
<ForeName>Pia</ForeName>
<Initials>P</Initials>
</Author>
</AuthorList>
<Language>ita</Language>
<PublicationTypeList>
<PublicationType UI="D016421">Editorial</PublicationType>
</PublicationTypeList>
<VernacularTitle>Affinché lo zucchero non renda amara la vita.</VernacularTitle>
</Article>
<MedlineJournalInfo>
<Country>Switzerland</Country>
<MedlineTA>Krankenpfl Soins Infirm</MedlineTA>
<NlmUniqueID>8000153</NlmUniqueID>
<ISSNLinking>0253-0465</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D019422">Dietary Sucrose</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>N</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D019422">Dietary Sucrose</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000008">administration &amp; dosage</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000009">adverse effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009765">Obesity</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000451">nursing</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000517">prevention &amp; control</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011788">Quality of Life</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000523">psychology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012307">Risk Factors</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" Type="Geographic" UI="D013557">Switzerland</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25280035</PMID>
<DateCreated>
<Year>2014</Year>
<Month>10</Month>
<Day>21</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>13</Day>
</DateCompleted>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0394-6320</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>27</Volume>
<Issue>3</Issue>
<PubDate>
<MedlineDate>2014 Jul-Sep</MedlineDate>
</PubDate>
</JournalIssue>
<Title>International journal of immunopathology and pharmacology</Title>
<ISOAbbreviation>Int J Immunopathol Pharmacol</ISOAbbreviation>
</Journal>
<ArticleTitle>Gut hormones and endothelial dysfunction in patients with obesity and diabetes.</ArticleTitle>
<Pagination>
<MedlinePgn>433-6</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>Overweight and obesity are the fifth leading risk for global deaths and its prevalence has doubled since 1980. At least 2.8 million adults, worldwide, die each year as a result of being overweight or obese. The deleterious effects of obesity are tightly related to diabetes, as they are often clinically present in combination to confer increased cardiovascular mortality. Thus, patients with diabetes and obesity are known to develop accelerated atherosclerosis characterized by a dysfunctional endothelium and decreased nitric oxide bioavailability. Recent clinical studies support, indeed, the use of incretin-based antidiabetic therapies for vascular protection. Thus, attention has been focusing on gut hormones and their role, not only in the regulation of appetite but also in vascular health. Intervention directed at modulating these molecules has the potential to decrease mortality of patients with diabetes and obesity. This review will cover part of the ongoing research to understand the role of gut hormones on endothelial function and vascular health. </AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Iantorno</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Critical Care Medicine Department, National Institutes of Health, Bethesda, MD, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Campia</LastName>
<ForeName>U</ForeName>
<Initials>U</Initials>
<AffiliationInfo>
<Affiliation>MedStar Cardiovascular Research Network Washington, DC, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Di Daniele</LastName>
<ForeName>N</ForeName>
<Initials>N</Initials>
<AffiliationInfo>
<Affiliation>Department of Systems Medicine, University of Rome Tor Vergata, Rome, Italy.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Nistico</LastName>
<ForeName>S</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Department of Health Sciences, University of Catanzaro Magna Grecia, Catanzaro, Italy.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Forleo</LastName>
<ForeName>G B</ForeName>
<Initials>GB</Initials>
<AffiliationInfo>
<Affiliation>Department of Systems Medicine, University of Rome Tor Vergata, Rome, Italy.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Cardillo</LastName>
<ForeName>C</ForeName>
<Initials>C</Initials>
<AffiliationInfo>
<Affiliation>Internal Medicine, Catholic University, Rome, Italy.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Tesauro</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Department of Systems Medicine, University of Rome Tor Vergata, Rome, Italy.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016422">Letter</PublicationType>
<PublicationType UI="D016454">Review</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>Italy</Country>
<MedlineTA>Int J Immunopathol Pharmacol</MedlineTA>
<NlmUniqueID>8911335</NlmUniqueID>
<ISSNLinking>0394-6320</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D054439">Ghrelin</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D054795">Incretins</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C505799">obestatin, human</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D003920">Diabetes Mellitus</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000503">physiopathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D004730">Endothelium, Vascular</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000502">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D054439">Ghrelin</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000502">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D054795">Incretins</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000502">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009765">Obesity</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000503">physiopathology</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25341257</PMID>
<DateCreated>
<Year>2014</Year>
<Month>10</Month>
<Day>22</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>17</Day>
</DateCompleted>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0326-4815</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>27</Volume>
<Issue>1</Issue>
<PubDate>
<Year>2014</Year>
</PubDate>
</JournalIssue>
<Title>Acta odontológica latinoamericana : AOL</Title>
<ISOAbbreviation>Acta Odontol Latinoam</ISOAbbreviation>
</Journal>
<ArticleTitle>Assessment of the association between overweight/obesity and traumatic dental injury among Brazilian schoolchildren.</ArticleTitle>
<Pagination>
<MedlinePgn>26-32</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>The aim of this study was to evaluate the association between overweight/obesity and the occurrence of traumatic dental injury among schoolchildren aged 7 to 14 years. A cross-sectional study was carried out involving 590 students at public schools in the city of Campina Grande, Brazil. The classification proposed by O'Brien (1994) was used for the diagnosis of traumatic dental injury. Overweight/obesity was determined based on the body mass index. Clinical examinations were performed by two examiners who had undergone a calibration exercise (Kappa statistics of 0.87 and 0.90 for intra-examiner and inter-examiner, respectively). Data analysis involved the chi-square test and Fisher's exact test with a 5% level of significance. Traumatic dental injury was less prevalent among the schoolchildren with overweight/obesity than those without this condition (8.7% and 13.3%, respectively). When the sample was stratified by gender and age, traumatic dental injury was also more prevalent among schoolchildren without overweight/obesity. When the sample was stratified based on ethnicity, prevalence rates were similar between those with and without overweight/obesity. In the overall sample, no significant association was found between overweight/obesity and traumatic dental injury (p = 0.253). Overweight/obesity among schoolchildren aged 7 to 14 years was not associated with traumatic dental injury in this study. The analysis of physical activity may be important to gain a better understanding of this finding.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Martins</LastName>
<ForeName>Veruska M</ForeName>
<Initials>VM</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Sousa</LastName>
<ForeName>Raulison V</ForeName>
<Initials>RV</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Rocha</LastName>
<ForeName>Eveline S</ForeName>
<Initials>ES</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Leite</LastName>
<ForeName>Rafaella B</ForeName>
<Initials>RB</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Gomes</LastName>
<ForeName>Monalisa C</ForeName>
<Initials>MC</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Granville-Garcia</LastName>
<ForeName>Ana F</ForeName>
<Initials>AF</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>Argentina</Country>
<MedlineTA>Acta Odontol Latinoam</MedlineTA>
<NlmUniqueID>8610218</NlmUniqueID>
<ISSNLinking>0326-4815</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>D</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000293">Adolescent</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000367">Age Factors</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015992">Body Mass Index</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" Type="Geographic" UI="D001938">Brazil</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000453">epidemiology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000208">ethnology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002648">Child</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D003430">Cross-Sectional Studies</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005006">Ethnic Groups</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000706">statistics &amp; numerical data</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009765">Obesity</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000453">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D050177">Overweight</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000453">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015995">Prevalence</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012737">Sex Factors</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D018677">Tooth Injuries</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000453">epidemiology</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25335398</PMID>
<DateCreated>
<Year>2014</Year>
<Month>10</Month>
<Day>22</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>07</Day>
</DateCompleted>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0869-2084</ISSN>
<JournalIssue CitedMedium="Print">
<Issue>6</Issue>
<PubDate>
<Year>2014</Year>
<Month>Jun</Month>
</PubDate>
</JournalIssue>
<Title>Klinicheskaia laboratornaia diagnostika</Title>
<ISOAbbreviation>Klin. Lab. Diagn.</ISOAbbreviation>
</Journal>
<ArticleTitle>[The biological function of trophology, biological reactions of exo- and endotrophy the pathogenesis of metabolic syndrome, leptin and adiponectin: a lecture].</ArticleTitle>
<Pagination>
<MedlinePgn>27-38</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>The metabolic syndrome or overeating syndrome is a phylogenetically conditioned sequence of symptoms with common pathogenesis. The etiological factor of metabolic syndrome is higher consumption of food which is optimal on all other parameters. The enterocytes and adipocytes of omentum constitute in phylogenesis sense a unified cenosis regulated paracrinally and realizing by turns biological reactions of exo- and endotrophy. The visceral adiposity, higher level of unesterified fatty acids, formation of fatty acids pool in the form of micelle in blood, their embedding into endothelium membrane and increase of size of enterocytes are causes of increasing of hydro-dynamic pressure. The associates of albumin with more than physiologically needed amount of fatty acids are accepted by toll-similar receptors as "alien" and reaction of inflammation is initiated. In cells, overloaded with lipids "endoplasmatic stress" is developed, synthesis (folding) of proteins is disordered and their destruction similar to apoptosis is activated In a phylogenesis sense, the visceral fat is fatty acids 'depot to implement biological functions of homeostasis, trophology, endoecology and adaptation and which is regulated at the level of paracrin cenosis an is anatomically limited. The subcutaneous depot is a consequence of implementation of function of locomotion and has no limits in size. The visceral fatty cells have no receptors to philogenically late insulin. The specialized adipocytes with receptors to insulin and glucose transporter type 4 are the cells of subcutaneous depot of fatty acids. They are regulated philogenetically with late humoral mode at the level of organism. The leptin is an initiator of humoral hypothalamic regulation in vivo of size of visceral and insensible to insulin fatty acids qualitatively programmed in ontgogeny. Leptin prevents "endoplasmatic stress" and apoptosis of cells and regulates amount of consumed food Leptin initiates switching storage of fatty acids from visceral pool of fatty acids to subcutaneous pool of adipocytes. Adiponectin represents phylogenetically late humoral initiator of regulation of optimal number of cells from level of hypothalamus in vivo. Adiponectin is biologically assigned to regulate number (proliferation) insulin-depended adipocytes in subcutaneous fatty tissue.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Titov</LastName>
<ForeName>V N</ForeName>
<Initials>VN</Initials>
</Author>
</AuthorList>
<Language>rus</Language>
<PublicationTypeList>
<PublicationType UI="D004740">English Abstract</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D019531">Lectures</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>Russia (Federation)</Country>
<MedlineTA>Klin Lab Diagn</MedlineTA>
<NlmUniqueID>9432021</NlmUniqueID>
<ISSNLinking>0869-2084</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D052242">Adiponectin</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D020738">Leptin</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D052242">Adiponectin</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000818">Animals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006963">Hyperphagia</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000175">diagnosis</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000378">metabolism</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000503">physiopathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D020738">Leptin</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D050356">Lipid Metabolism</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D024821">Metabolic Syndrome X</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000175">diagnosis</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000378">metabolism</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000503">physiopathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009765">Obesity</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000175">diagnosis</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000378">metabolism</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000503">physiopathology</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25338347</PMID>
<DateCreated>
<Year>2014</Year>
<Month>10</Month>
<Day>23</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>04</Day>
</DateCompleted>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">1220-4749</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>52</Volume>
<Issue>2</Issue>
<PubDate>
<MedlineDate>2014 Apr-Jun</MedlineDate>
</PubDate>
</JournalIssue>
<Title>Romanian journal of internal medicine = Revue roumaine de médecine interne</Title>
<ISOAbbreviation>Rom J Intern Med</ISOAbbreviation>
</Journal>
<ArticleTitle>The influence of different fats on postprandial triglyceridemia in normal weight, overweight and obese people.</ArticleTitle>
<Pagination>
<MedlinePgn>102-9</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>This study evaluated the influence of different fats on postprandial triglyceridemia (atherogenic factor). Even if there are some theoretical data about the influence of some fatty acids on triglyceridemia, the evaluation of foods in the same direction is not well established. We selected 36 subjects, apparently healthy, and we observed the influence of butter, sun flower oil, fish oil, olive oil on them. We used as a reference the butter, which is known for rising triglyceridemia. The other oils were used to observe their influence over triglyceridemia.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Mogos</LastName>
<ForeName>T</ForeName>
<Initials>T</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Dondoi</LastName>
<ForeName>Carmen</ForeName>
<Initials>C</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Iacobini</LastName>
<ForeName>Andra</ForeName>
<Initials>A</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>Romania</Country>
<MedlineTA>Rom J Intern Med</MedlineTA>
<NlmUniqueID>9304507</NlmUniqueID>
<ISSNLinking>1220-4749</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D004041">Dietary Fats</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D005395">Fish Oils</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D010938">Plant Oils</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D014280">Triglycerides</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>8001-21-6</RegistryNumber>
<NameOfSubstance UI="C025911">sunflower seed oil</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>8001-25-0</RegistryNumber>
<NameOfSubstance UI="C042763">olive oil</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>8029-34-3</RegistryNumber>
<NameOfSubstance UI="D002079">Butter</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000328">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001835">Body Weight</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002079">Butter</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D004041">Dietary Fats</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000008">administration &amp; dosage</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005395">Fish Oils</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000008">administration &amp; dosage</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009765">Obesity</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000097">blood</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D050177">Overweight</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000097">blood</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D010938">Plant Oils</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000008">administration &amp; dosage</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D019518">Postprandial Period</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D014280">Triglycerides</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000097">blood</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25341327</PMID>
<DateCreated>
<Year>2014</Year>
<Month>10</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>17</Day>
</DateCompleted>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">1320-159X</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>22</Volume>
<Issue>1</Issue>
<PubDate>
<Year>2014</Year>
<Month>Sep</Month>
</PubDate>
</JournalIssue>
<Title>Journal of law and medicine</Title>
<ISOAbbreviation>J Law Med</ISOAbbreviation>
</Journal>
<ArticleTitle>Planning law and public health at an impasse in Australia: the need for targeted law reforms to improve local food environments to reduce overweight and obesity.</ArticleTitle>
<Pagination>
<MedlinePgn>179-87</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>Australia's high rates of overweight and obesity, and the associated increased population risk of non-communicable diseases, pose a challenge to policymakers across sectors beyond the health portfolio. In the last decade, strategies to promote healthy lifestyles and address non-communicable diseases have increasingly interested urban planners in Australia and internationally. However, Australian planning laws continue to operate largely without regard to public health goals, thus limiting the ability of communities to shape healthy built environments. In recent years, local governments have increasingly taken on responsibility for improving public health through community-based initiatives; however, their efforts are hindered by their limited capacity to influence planning priorities under current State-legislated planning schemes. This article considers the emerging body of research exploring the impact of urban planning on health and non-communicable diseases in Australia. It is contended that planning law in Australia is out of step with the evidence of planning's potential impact on health, and reforms are required to ensure consistency with public health priorities.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Mills</LastName>
<ForeName>Caroline</ForeName>
<Initials>C</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>Australia</Country>
<MedlineTA>J Law Med</MedlineTA>
<NlmUniqueID>9431853</NlmUniqueID>
<ISSNLinking>1320-159X</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" Type="Geographic" UI="D001315">Australia</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D057140">Fast Foods</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000009">adverse effects</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000600">supply &amp; distribution</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006291">Health Policy</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009765">Obesity</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000517">prevention &amp; control</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D050177">Overweight</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000517">prevention &amp; control</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011634">Public Health</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012147">Restaurants</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000331">legislation &amp; jurisprudence</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000706">statistics &amp; numerical data</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012939">Social Planning</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25345082</PMID>
<DateCreated>
<Year>2014</Year>
<Month>10</Month>
<Day>27</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>18</Day>
</DateCompleted>
<DateRevised>
<Year>2014</Year>
<Month>11</Month>
<Day>20</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">1565-4753</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>12</Volume>
<Issue>1</Issue>
<PubDate>
<Year>2014</Year>
<Month>Sep</Month>
</PubDate>
</JournalIssue>
<Title>Pediatric endocrinology reviews : PER</Title>
<ISOAbbreviation>Pediatr Endocrinol Rev</ISOAbbreviation>
</Journal>
<ArticleTitle>Globesity: the root causes of the obesity epidemic in the USA and now worldwide.</ArticleTitle>
<Pagination>
<MedlinePgn>17-34</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>The epidemic of obesity is a well-known phenomenon affecting the world population. This pandemic has occurred since the 1980's with increasing frequency, despite multiple attempts and recommendations to mitigate the prevalence of obesity and its co-morbidities. The causes of obesity have been recognized and are largely related to a genetic predisposition and an environmental susceptibility to gain weight due to increased energy intake and reduced energy expenditures. Furthermore, various structural environmental changes that have occurred since the 1980's have created an obesogenic environment with abundance of high-caloric density, low-quality food and under activity. All of this leads to increased body weight gain and a global public health problem--not only a distinct patient's disease that generally fails to respond to diets and/or increased activity. The structural environmental changes resulted from the unintended consequences of laws that created unregulated marketing and advertisements, food subsidies to a "food industrial complex" which manufactures obesogenic foods that foster addiction to its foodstuffs. Additionally, the economic policies implemented over the last 3 to 4 decades have produced a stagnation of income and wages for the preponderance of the population with major wealth disparities between the majority of people versus the top of the socioeconomic group. The current economic realities have resulted in altered family dynamics, eating habits, and food availability compared to previous generations. The root causes of the epidemic of obesity are governmental policies and the food industry which make obesity difficult to escape in the US and now worldwide.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Lifshitz</LastName>
<ForeName>Fima</ForeName>
<Initials>F</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Lifshitz</LastName>
<ForeName>Jere Ziffer</ForeName>
<Initials>JZ</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>Israel</Country>
<MedlineTA>Pediatr Endocrinol Rev</MedlineTA>
<NlmUniqueID>101202124</NlmUniqueID>
<ISSNLinking>1565-4753</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001835">Body Weight</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D004032">Diet</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D014943">Global Health</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D006291">Health Policy</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009765">Obesity</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000453">epidemiology</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000209">etiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D058873">Pandemics</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015995">Prevalence</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012959">Socioeconomic Factors</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" Type="Geographic" UI="D014481">United States</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000453">epidemiology</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25345083</PMID>
<DateCreated>
<Year>2014</Year>
<Month>10</Month>
<Day>27</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>18</Day>
</DateCompleted>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">1565-4753</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>12</Volume>
<Issue>1</Issue>
<PubDate>
<Year>2014</Year>
<Month>Sep</Month>
</PubDate>
</JournalIssue>
<Title>Pediatric endocrinology reviews : PER</Title>
<ISOAbbreviation>Pediatr Endocrinol Rev</ISOAbbreviation>
</Journal>
<ArticleTitle>Body mass index and waist circumference to define thinness, overweight and obesity in Portuguese adolescents: comparison between CDC, IOTF, WHO references.</ArticleTitle>
<Pagination>
<MedlinePgn>35-41</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">This study compared the criteria or classification of Body Mass Index (BMI) by Centers for Disease Control and Prevention (CDC), International Obesity Task Force (IOTF) and World Health Organization (WHO) references and by waist circumference (WC).</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">The sample involved 966 students aged 10 to 16 years. The evaluation of weight status was verified according to CDC, IOTF, WHO criteria and WC curves for Portuguese adolescents.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">For classification of overweight and obesity, the agreement between the criteria of CDC and IOTF was the and WC (K = 0.34). In regard to evaluation of thinness, the agreement between all criteria of BMI was considered moderated to fair (K = 0.33-0.51) and a poor level of agreement between the BMI and WC (K = 0.14-0.16).</AbstractText>
<AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">The highest level of agreement for thinness, overweight and obesity classification in adolescents was obtained with the IOTF and CDC criteria.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Minghelli</LastName>
<ForeName>Beatriz</ForeName>
<Initials>B</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Nunes</LastName>
<ForeName>Carla</ForeName>
<Initials>C</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Oliveira</LastName>
<ForeName>Raul</ForeName>
<Initials>R</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D003160">Comparative Study</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>Israel</Country>
<MedlineTA>Pediatr Endocrinol Rev</MedlineTA>
<NlmUniqueID>101202124</NlmUniqueID>
<ISSNLinking>1565-4753</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000293">Adolescent</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001823">Body Composition</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D015992">Body Mass Index</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001835">Body Weight</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002487">Centers for Disease Control and Prevention (U.S.)</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002648">Child</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009765">Obesity</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000145">classification</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000175">diagnosis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D050177">Overweight</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000145">classification</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000175">diagnosis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" Type="Geographic" UI="D011174">Portugal</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012016">Reference Values</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D013851">Thinness</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000145">classification</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000175">diagnosis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" Type="Geographic" UI="D014481">United States</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D055105">Waist Circumference</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D014944">World Health Organization</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
